{"id": 41891577, "time": "2024-11-12 00:00:18", "headline": "VAALCO Energy Expects Q4 2024 NRI Sales To Be Between 18,600 And 20,800 BOEPD", "summary": "", "symbols": ["EGY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41891577/vaalco-energy-expects-q4-2024-nri-sales-to-be-between-18-600-and-20-800-boepd", "tags": []}
{"id": 41891628, "time": "2024-11-12 00:09:01", "headline": "Ross Gerber, Cathie Wood Or Gary Black? Whose Funds Stack Up Against S&P 500's Gains In 2024?", "summary": "In a year marked by strong market performance, prominent fund managers Gary Black, Ross Gerber, and Cathie Wood are showing mixed results against the benchmark S&amp;P 500&#39;s impressive 25.97% year-to-date return, according to recent market data.", "symbols": ["ARKK", "FFND", "GK", "MSFT", "NVDA", "PP", "RKT", "TSLA"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/news/global/24/11/41891628/ross-gerber-cathie-wood-or-gary-black-whose-funds-stack-up-against-sp-500s-gains-in-2024", "tags": []}
{"id": 41891629, "time": "2024-11-12 00:09:05", "headline": "Bioceres Crop Solutions Q1 Sales $93.300 Miss $109.250M Estimate, Net Loss $5.3M Up From $2.7M YoY", "summary": "", "symbols": ["BIOX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41891629/bioceres-crop-solutions-q1-sales-93-300-miss-109-250m-estimate-net-loss-5-3m-up-from-2-7m-yoy", "tags": []}
{"id": 41891655, "time": "2024-11-12 00:12:58", "headline": "Sohu.com Q3 EPS $(0.39) Down From $(0.30) YoY, Sales $151.99M Up From $145.43M YoY", "summary": "", "symbols": ["SOHU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41891655/sohu-com-q3-eps-0-39-down-from-0-30-yoy-sales-151-99m-up-from-145-43m-yoy", "tags": ["earnings"]}
{"id": 41891663, "time": "2024-11-12 00:16:48", "headline": "Sohu.com Q3 PC Games Total Average MAU Were Of 2.2M (-2% YoY); Mobile Games, Total Average MAU Were 3.2M (+41% YoY)", "summary": "", "symbols": ["SOHU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41891663/sohu-com-q3-pc-games-total-average-mau-were-of-2-2m-2-yoy-mobile-games-total-average-mau-were-3-2m-", "tags": []}
{"id": 41891682, "time": "2024-11-12 00:17:49", "headline": "Dogecoin, Bitcoin Returns Are Dazzling But First Neiro On Ethereum And Popcat Have Run Up 55000% and 20000% So Far In 2024", "summary": "The ongoing cryptocurrency bull run resulted in a dramatic rise in fortunes, with some coins seeing their year-to-date returns go through the roof.\n\n\n\nWhat happened: Meme coins have taken the lead, with Popcat and First Neiro on Ethereum netting eye-popping returns to their holders in 2024.", "symbols": ["BTCUSD", "DOGEUSD", "ETH", "ETHUSD", "SOLUSD", "USDCUSD", "XRPUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41891682/dogecoin-bitcoin-returns-are-dazzling-but-first-neiro-on-ethereum-and-popcat-have-run-up-55000-and-20000-so-far-in-2024", "tags": []}
{"id": 41891698, "time": "2024-11-12 00:19:07", "headline": "Sohu.Com For Q4 Expects Brand Ad Revenues Of $17M-$19M Down 6%-16% YoY, Online Game Revenues $97M-$107M Down 7%-15% YoY; Adjusted Net Loss Of $(26)M-$(36)M", "summary": "", "symbols": ["SOHU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41891698/sohu-com-for-q4-expects-brand-ad-revenues-of-17m-19m-down-6-16-yoy-online-game-revenues-97m-107m-do", "tags": []}
{"id": 41891708, "time": "2024-11-12 00:20:11", "headline": "What In The World Is Going On With Dogecoin?", "summary": "Following Donald Trump&#39;s 2024 presidential win last week, Dogecoin (CRYPTO: DOGE) has surged 159% to 41 cents since election day, spurred by market anticipation of a more ", "symbols": ["DOGEUSD"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/11/41891708/what-in-the-world-is-going-on-with-dogecoin-3", "tags": []}
{"id": 41891722, "time": "2024-11-12 00:21:37", "headline": "Grab Hldgs Q3 2024 GAAP EPS $0.01 Beats $(0.01) Estimate, Sales $716.000M Beat $691.800M Estimate", "summary": "", "symbols": ["GRAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41891722/grab-hldgs-q3-2024-gaap-eps-0-01-beats-0-01-estimate-sales-716-000m-beat-691-800m-estimate", "tags": ["earnings"]}
{"id": 41891729, "time": "2024-11-12 00:25:15", "headline": "Grab Holdings Raises 2024 Guidance: Now Sees Revenue Of $2.76B- $2.78B (Prior $2.70B-$2.75B) Vs. $2.744B Est., And Adj. EBITDA Of $308M- $313M (Prior $250M- $270M)", "summary": "", "symbols": ["GRAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41891729/grab-holdings-raises-2024-guidance-now-sees-revenue-of-2-76b-2-78b-prior-2-70b-2-75b-vs-2-744b-est-", "tags": ["earnings", "guidance"]}
{"id": 41891755, "time": "2024-11-12 00:29:43", "headline": "Grab Holdings Q3 On-Demand GMV Rose 15% YoY (18% On Constant Currency), Driven By A 19% Increase In MTUs And A 22% Rise In Transactions", "summary": "", "symbols": ["GRAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41891755/grab-holdings-q3-on-demand-gmv-rose-15-yoy-18-on-constant-currency-driven-by-a-19-increase-in-mtus-", "tags": []}
{"id": 41891821, "time": "2024-11-12 00:34:40", "headline": "Reported Earlier, Autoliv Raises Q4 Dividend By 3% To $0.70; Extends Buyback Program To End Of 2025, Authorizing Up To 7.5M Shares Or $550M", "summary": "", "symbols": ["ALV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41891821/reported-earlier-autoliv-raises-q4-dividend-by-3-to-0-70-extends-buyback-program-to-end-of-2025-auth", "tags": ["buyback", "dividend"]}
{"id": 41891867, "time": "2024-11-12 00:42:56", "headline": "Reported Earlier, Cardinal Health Accelerates Strategic Growth With $3.9B GI Alliance Acquisition And $1.1B Advanced Diabetes Supply Group Buyout", "summary": "", "symbols": ["APO", "CAH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41891867/reported-earlier-cardinal-health-accelerates-strategic-growth-with-3-9b-gi-alliance-acquisition-and", "tags": ["merger"]}
{"id": 41891904, "time": "2024-11-12 00:49:59", "headline": "Google's Standalone 'Gemini' App For iPhone Spotted With Live Activity \u2014 What It Could Mean For Your AI Experience", "summary": "Google&#39;s Gemini app has been discovered as a standalone offering on the App Store, featuring Gemini Live and being tested in limited regions before a broader rollout.", "symbols": ["GOOG", "GOOGL"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/tech/24/11/41891904/googles-standalone-gemini-app-for-iphone-spotted-with-live-activity-what-it-could-mean-for-your-ai-experience", "tags": ["offering"]}
{"id": 41892111, "time": "2024-11-12 01:12:50", "headline": "Tesla Bull Ross Gerber Hails Bitcoin As The 'True Winner' Of Election As The Apex Crypto Breaks Records", "summary": "Influential investor and CEO of\u00a0Gerber Kawasaki Wealth and Investment Management, Ross Gerber, declared Bitcoin (CRYPTO: BTC) as the true winner of the U.S. elections amid the leading cryptocurrency\u2019s record-shattering rally.", "symbols": ["BTC", "BTCUSD", "ETHUSD", "IBIT"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41892111/tesla-bull-ross-gerber-hails-bitcoin-as-the-true-winner-of-election-as-the-apex-crypto-breaks-records", "tags": ["management"]}
{"id": 41892142, "time": "2024-11-12 01:17:30", "headline": "Reported Earlier, Philip Morris International Affiliate Swedish Match Earns FDA Renewal For Modified Risk Snus Products", "summary": "", "symbols": ["PM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41892142/reported-earlier-philip-morris-international-affiliate-swedish-match-earns-fda-renewal-for-modified", "tags": ["fda"]}
{"id": 41892293, "time": "2024-11-12 01:40:59", "headline": "Jabil And Cyferd Team Up To Launch ID8 Global, The Next Generation Of AI-Driven, Fully Autonomous Supply Chain Solutions", "summary": "", "symbols": ["JBL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41892293/jabil-and-cyferd-team-up-to-launch-id8-global-the-next-generation-of-ai-driven-fully-autonomous-supp", "tags": []}
{"id": 41892306, "time": "2024-11-12 01:45:53", "headline": "Shopify Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts", "summary": " ", "symbols": ["SHOP"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41892306/shopify-gears-up-for-q3-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts", "tags": ["guidance"]}
{"id": 41892403, "time": "2024-11-12 01:50:01", "headline": "Flex LNG Q3 2024 Adj. EPS $0.53 Misses $0.58 Estimate, Sales $90.483M Miss $91.429M Estimate", "summary": "", "symbols": ["FLNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41892403/flex-lng-q3-2024-adj-eps-0-53-misses-0-58-estimate-sales-90-483m-miss-91-429m-estimate", "tags": ["earnings"]}
{"id": 41892405, "time": "2024-11-12 01:51:40", "headline": "Belite Bio Q3 2024 GAAP EPS $(0.28) Beats $(0.29) Estimate, Cash $109M", "summary": "", "symbols": ["BLTE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41892405/belite-bio-q3-2024-gaap-eps-0-28-beats-0-29-estimate-cash-109m", "tags": ["earnings"]}
{"id": 41892426, "time": "2024-11-12 01:55:53", "headline": "Home Depot, Tyson Foods And 3 Stocks To Watch Heading Into Tuesday", "summary": " ", "symbols": ["GRAB", "HD", "JRVR", "OXY", "TSN"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/24/11/41892426/home-depot-tyson-foods-and-3-stocks-to-watch-heading-into-tuesday", "tags": []}
{"id": 41892379, "time": "2024-11-12 01:48:53", "headline": "Tesla Offers A Year Of Supercharging For Free In Europe As It Chases Record Q4 Deliveries To Outpace A Slowdown", "summary": "Tesla is now offering a year of Supercharging for customers in Europe who take delivery of the Model Y SUV before Dec. 31.", "symbols": ["TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/tech/24/11/41892379/tesla-offers-a-year-of-supercharging-for-free-in-europe-as-it-chases-record-q4-deliveries-to-outpace-a-slowdown", "tags": ["offering"]}
{"id": 41892490, "time": "2024-11-12 02:07:52", "headline": "Reported Earlier, LifeWallet Announces $5.9M In Comprehensive Settlements, Beta Tests New Clearinghouse Solution To Tackle Medicare Waste", "summary": "", "symbols": ["LIFW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41892490/reported-earlier-lifewallet-announces-5-9m-in-comprehensive-settlements-beta-tests-new-clearinghouse", "tags": []}
{"id": 41892571, "time": "2024-11-12 02:12:26", "headline": "Daiichi Sankyo And AstraZeneca Submit New BLA For Datopotamab Deruxtecan, Targeting Accelerated Approval For EGFR-Mutated Lung Cancer Treatment", "summary": "", "symbols": ["AZN", "DSNKY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41892571/daiichi-sankyo-and-astrazeneca-submit-new-bla-for-datopotamab-deruxtecan-targeting-accelerated-appro", "tags": []}
{"id": 41892574, "time": "2024-11-12 02:12:39", "headline": "Dow Settles Above 44,000 For The First Time As Tesla Continues To Surge After Trump Win: Investor Sentiment Improves, Fear Index In 'Greed' Zone", "summary": " ", "symbols": ["BAC", "C", "GS", "HD", "JPM", "OXY", "TSLA", "TSN"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/24/11/41892574/dow-settles-above-44000-for-the-first-time-as-tesla-continues-to-surge-after-trump-win-investor-sentiment-improves-fear-index-in-greed-zone", "tags": []}
{"id": 41892690, "time": "2024-11-12 02:22:37", "headline": "Bayer Q3 2024 Adj. EPADS $0.07 Misses $0.17 Estimate, Sales $10.956B Miss $11.533B Estimate", "summary": "", "symbols": ["BAYRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41892690/bayer-q3-2024-adj-epads-0-07-misses-0-17-estimate-sales-10-956b-miss-11-533b-estimate", "tags": []}
{"id": 41892697, "time": "2024-11-12 02:26:07", "headline": "Trump Is The 'Most Pro-Stock Market President,' Says Wharton Professor Jeremy Siegel", "summary": "President-elect Donald Trump\u2018s pro-business policies could potentially drive the stock market to unprecedented levels, according to Jeremy Siegel, a finance professor at the Wharton School of the University of Pennsylvania.", "symbols": ["BTCUSD", "DIA", "JPM", "SPY", "TSLA", "WFC"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/markets/equities/24/11/41892697/trump-is-the-most-pro-stock-market-president-says-wharton-professor-jeremy-siegel", "tags": []}
{"id": 41892698, "time": "2024-11-12 02:26:10", "headline": "AstraZeneca Q3 2024 Adj. EPADS $1.04 Beats $1.03 Estimate, Sales $13.565B Beat $13.088B Estimate", "summary": "", "symbols": ["AZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41892698/astrazeneca-q3-2024-adj-epads-1-04-beats-1-03-estimate-sales-13-565b-beat-13-088b-estimate", "tags": []}
{"id": 41892735, "time": "2024-11-12 02:32:27", "headline": "U.K. Average Earnings Index +Bonus For September 4.3% Vs. 3.9% Est.; 3.9% (Revised) Prior", "summary": "", "symbols": ["EWU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41892735/u-k-average-earnings-index-bonus-for-september-4-3-vs-3-9-est-3-9-revised-prior", "tags": ["earnings"]}
{"id": 41892737, "time": "2024-11-12 02:32:52", "headline": "U.K. Claimant Count Change For October 26.7K Vs. 30.5K Est.; 10.1K (Revised) Prior", "summary": "", "symbols": ["EWU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41892737/u-k-claimant-count-change-for-october-26-7k-vs-30-5k-est-10-1k-revised-prior", "tags": []}
{"id": 41892738, "time": "2024-11-12 02:33:19", "headline": "U.K. Employment Change 3M/3M (MoM) For September 219K Vs. 373K Prior", "summary": "", "symbols": ["EWU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41892738/u-k-employment-change-3m3m-mom-for-september-219k-vs-373k-prior", "tags": []}
{"id": 41892739, "time": "2024-11-12 02:33:42", "headline": "U.K. Unemployment Rate For September 4.3% Vs. 4.1% Est.; 4.0% Prior", "summary": "", "symbols": ["EWU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41892739/u-k-unemployment-rate-for-september-4-3-vs-4-1-est-4-0-prior", "tags": []}
{"id": 41892741, "time": "2024-11-12 02:34:02", "headline": "Germany Consumer Price Index (YoY) For October 2.0% Vs. 2.0% Est.; 1.6% Prior", "summary": "", "symbols": ["EWG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41892741/germany-consumer-price-index-yoy-for-october-2-0-vs-2-0-est-1-6-prior", "tags": []}
{"id": 41892743, "time": "2024-11-12 02:34:20", "headline": "Germany Consumer Price Index (MoM) For October 0.4% Vs. 0.4% Est.; 0.0% Prior", "summary": "", "symbols": ["EWG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41892743/germany-consumer-price-index-mom-for-october-0-4-vs-0-4-est-0-0-prior", "tags": []}
{"id": 41892752, "time": "2024-11-12 02:38:03", "headline": "Michael Saylor's MicroStrategy Shares Hit 24-Year High, Jump Most Since Dot-Com Bubble As Bitcoin Nears $90K Mark For The First Time", "summary": "Shares of Michael Saylor\u2018s MicroStrategy Inc. (NASDAQ:MSTR) rose as much as 25.73% to hit a record closing high at $340 apiece, as compared to a 0.05% decline in the Nasdaq 100 Index Monday. The shares rose by 5.31% to $358.06 per share during the after-hours trade the same day.", "symbols": ["BTCUSD", "COIN", "MARA", "MSTR", "TSLA"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/markets/equities/24/11/41892752/michael-saylors-microstrategy-shares-hit-24-year-high-jumps-most-since-dot-com-bubble-as-bitcoin-nears-90k-mark-for-the-first-time", "tags": []}
{"id": 41893017, "time": "2024-11-12 02:54:40", "headline": "BitFuFu Locks In $100M Loan Facility With Antpool Technologies", "summary": "", "symbols": ["FUFU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41893017/bitfufu-locks-in-100m-loan-facility-with-antpool-technologies", "tags": []}
{"id": 41893027, "time": "2024-11-12 02:58:23", "headline": "Nanobiotix Q3 Update Highlights Strategic Moves: Phase 3 Head And Neck Cancer Trial Transferred To Janssen, Curadigm Platform Expansion; \u20ac53.2M Cash Reserves", "summary": "", "symbols": ["NBTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41893027/nanobiotix-q3-update-highlights-strategic-moves-phase-3-head-and-neck-cancer-trial-transferred-to-ja", "tags": ["fda"]}
{"id": 41893067, "time": "2024-11-12 03:01:59", "headline": "AstraZeneca Raised Its 2024 Guidance: Now Expects Total Revenue And Core EPS To Increase By High Teens Percentage (Previously Anticipated To Rise By Mid-Teens Percentage)", "summary": "", "symbols": ["AZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41893067/astrazeneca-raised-its-2024-guidance-now-expects-total-revenue-and-core-eps-to-increase-by-high-tee", "tags": ["earnings", "guidance"]}
{"id": 41893114, "time": "2024-11-12 03:09:00", "headline": "Bayer Confirms Its 2024 Guidance, Sales Of \u20ac47B-\u20ac49B And Core Earnings Per Share Of \u20ac5.10-\u20ac5.50", "summary": "", "symbols": ["BAYRY", "BAYZF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41893114/bayer-confirms-its-2024-guidance-sales-of-47b-49b-and-core-earnings-per-share-of-5-10-5-50", "tags": ["earnings", "guidance"]}
{"id": 41893264, "time": "2024-11-12 03:17:59", "headline": "Boeing Secures Order From Avia Solutions Group For Up To 80 737 MAX Jets", "summary": "", "symbols": ["BA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41893264/boeing-secures-order-from-avia-solutions-group-for-up-to-80-737-max-jets", "tags": []}
{"id": 41893397, "time": "2024-11-12 03:23:13", "headline": "Trump Reportedly Considers Marco Rubio For Secretary Of State Role Who Shares Similar Stance For China, But Says Stock Market 'Is Not The Economy'", "summary": "Despite their similarities, Rubio and Trump differ in their views on the stock market.", "symbols": [], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/news/global/24/11/41893397/trump-reportedly-considers-marco-rubio-for-secretary-of-state-role-who-shares-similar-stance-for-china-but-says-stock-market-is-not-the-economy", "tags": []}
{"id": 41893409, "time": "2024-11-12 03:26:29", "headline": "UP Fintech Holding Q3 2024 Adj. EPADS $0.12 Misses $0.13 Estimate, Sales $101.054M Beat $98.000M Estimate", "summary": "", "symbols": ["TIGR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41893409/up-fintech-holding-q3-2024-adj-epads-0-12-misses-0-13-estimate-sales-101-054m-beat-98-000m-estimate", "tags": []}
{"id": 41893422, "time": "2024-11-12 03:30:32", "headline": "Logitech's New Smart Office Suite Solves Meeting Room Challenges With Auto Book, Auto Release, And Intuitive Wayfinding Tools", "summary": "", "symbols": ["LOGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41893422/logitechs-new-smart-office-suite-solves-meeting-room-challenges-with-auto-book-auto-release-and-intu", "tags": []}
{"id": 41893442, "time": "2024-11-12 03:32:46", "headline": "Earnings Scheduled For November 12, 2024", "summary": " ", "symbols": ["ABOS", "ABSI", "ACNT", "ACTG", "AE", "AENT", "AGEN", "AHR", "AIOT", "AIRG", "ALC", "ALIT", "ALT", "ALTG", "AMBC", "AMPS", "AMTX", "APEI", "AREB", "ARIS", "ARMN", "ASM", "ATRA", "AUTL", "AVDL", "AXSM", "AZN", "AZTA", "BHIL", "BKV", "BLDE", "BLFS", "BLTE", "BODI", "BRTX", "BTMD", "BTTR", "BW", "BWAY", "BXSL", "BZFD", "CAE", "CAMT", "CART", "CATX", "CAVA", "CBAT", "CBLL", "CCLD", "CGEN", "CHGG", "CHMI", "CLSD", "CNNE", "CRNX", "CRON", "CRVS", "CRWS", "CTS", "CTV", "CVAC", "CWD", "CXAI", "DAC", "DAVA", "DAVE", "DHT", "DHX", "DNA", "DOX", "DRCT", "DSP", "DYAI", "EAF", "EARN", "EGAN", "ELMD", "EPM", "ETON", "EVCM", "EVGO", "EXE", "EYEN", "FA", "FENG", "FGEN", "FIHL", "FLNG", "FNA", "FOUR", "FTCI", "GENI", "GENK", "GMGI", "GOVX", "GRAL", "GRDN", "GROV", "GRPN", "GRVY", "GRWG", "GUTS", "HD", "HNRG", "HNST", "HPP", "HRTX", "HSON", "HTZ", "HUYA", "HYPR", "IAS", "IAUX", "ICMB", "ICUI", "IFS", "IGT", "IHS", "INGM", "INSG", "INTZ", "IRIX", "JHX", "JRSH", "KGEI", "KINS", "KITT", "KODK", "KOPN", "LEGH", "LEGN", "LFT", "LFWD", "LGMK", "LGO", "LGVN", "LIDR", "LNW", "LSTA", "LXRX", "MAPS", "MARA", "MASS", "ME", "MHLD", "MIRM", "MLR", "MNR", "MNTK", "MODG", "MOS", "MPAA", "MRCC", "MVST", "NATL", "NGL", "NMRA", "NOTE", "NPCE", "NRGV", "NRXS", "NSPR", "NTRA", "NVAX", "NVVE", "NWN", "NXE", "NYAX", "NYC", "OABI", "OCX", "ONCY", "ONDS", "ONON", "OPRT", "OPTN", "ORGO", "ORLA", "OUT", "OXY", "PALT", "PANL", "PAY", "PGNY", "PGY", "PHI", "PIII", "PLBY", "PLL", "PLUG", "PLUS", "PRDO", "PRM", "PRSO", "PRTA", "PSQH", "PTVE", "PUBM", "PXLW", "QSI", "QTRX", "RAIL", "RBOT", "RGEN", "RGTI", "RKDA", "RKLB", "RKT", "RLGT", "RMBL", "RMTI", "ROIV", "RPAY", "RUM", "RWAY", "RXT", "SATS", "SCOR", "SDGR", "SDHC", "SDOT", "SDRL", "SE", "SGMO", "SGRY", "SHFS", "SHIM", "SHLS", "SHO", "SHOP", "SIBN", "SID", "SIL", "SILA", "SILV", "SKIN", "SKYH", "SKYX", "SLND", "SLVM", "SMC", "SMWB", "SNCR", "SND", "SNES", "SNT", "SOHO", "SOHU", "SOUN", "SPHR", "SPOT", "SRRK", "SSTI", "STIM", "STNE", "SU", "SURG", "SVCO", "SWKS", "SWTX", "TBN", "TBPH", "TGI", "TH", "THCH", "THS", "TIGR", "TLS", "TME", "TSN", "TSVT", "TTGT", "TWFG", "UAMY", "ULY", "USEG", "VERI", "VOD", "VRME", "VTSI", "VYGR", "WFCF", "WPRT", "WULF", "WVE", "XENE", "XGN", "XTNT", "XXII", "ZI", "ZLAB", "ZVRA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41893442/earnings-scheduled-for-november-12-2024", "tags": ["earnings"]}
{"id": 41893443, "time": "2024-11-12 03:32:53", "headline": "Leidos Partners With University Of Edinburgh To Accelerate AI And Data Science Innovations Across Key Sectors", "summary": "", "symbols": ["LDOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41893443/leidos-partners-with-university-of-edinburgh-to-accelerate-ai-and-data-science-innovations-across-ke", "tags": ["contract"]}
{"id": 41893452, "time": "2024-11-12 03:38:48", "headline": "Zscaler Unveils Industry-First Zero Trust Segmentation, Extending Enhanced Security To Branches, Factories, And Cloud Environments", "summary": "", "symbols": ["ZS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41893452/zscaler-unveils-industry-first-zero-trust-segmentation-extending-enhanced-security-to-branches-facto", "tags": []}
{"id": 41893461, "time": "2024-11-12 03:40:14", "headline": "Dogecoin's Golden Cross Sparks Hype After Meme Coin Doubles Over Last Week: Previous Cycle Saw A 7,000% Rally, Could History Repeat?", "summary": "Dogecoin (CRYPTO: DOGE) has jumped more than 140% in the last seven days as traders spot a technical pattern that previously preceded a massive price surge in the meme cryptocurrency.", "symbols": ["BTCUSD", "DOGEUSD"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41893461/dogecoins-golden-cross-sparks-hype-after-meme-coin-doubles-over-last-week-previous-cycle-saw-a-7000-rally-could-history-repeat", "tags": []}
{"id": 41893527, "time": "2024-11-12 03:43:46", "headline": "Merck To Showcase GARDASIL\u00ae9 Data At IPVC 2024, Emphasizing HPV Vaccination For Adults Up To Age 45", "summary": "", "symbols": ["MRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41893527/merck-to-showcase-gardasil-9-data-at-ipvc-2024-emphasizing-hpv-vaccination-for-adults-up-to-age-45", "tags": []}
{"id": 41893597, "time": "2024-11-12 03:49:49", "headline": "Zuora Expands APAC Operations With New Japan Data Center, Strengthening Customer Experience And Compliance", "summary": "", "symbols": ["ZUO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41893597/zuora-expands-apac-operations-with-new-japan-data-center-strengthening-customer-experience-and-compl", "tags": []}
{"id": 41893598, "time": "2024-11-12 03:50:05", "headline": "Exxon CEO Urges Trump To Reconsider Paris Agreement Exit: 'Stops And Starts Aren't Right For Business'", "summary": "Exxon Mobil CEO Darren Woods has urged President-elect Donald Trump to reconsider withdrawing from the Paris climate agreement.", "symbols": ["XOM"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/markets/equities/24/11/41893598/exxon-ceo-urges-trump-to-reconsider-paris-agreement-exit-stops-and-starts-arent-right-for-business", "tags": ["contract", "management"]}
{"id": 41893620, "time": "2024-11-12 03:52:16", "headline": "Shell Gains Legal Victory As Dutch Court Overturns Milieudefensie Climate Case Ruling, Emphasizing Need For Smart Climate Policies", "summary": "", "symbols": ["SHEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41893620/shell-gains-legal-victory-as-dutch-court-overturns-milieudefensie-climate-case-ruling-emphasizing-ne", "tags": ["legal"]}
{"id": 41893630, "time": "2024-11-12 03:54:42", "headline": "NXP Launches i.MX 94 Processors With Quantum Security And Ethernet TSN For Industrial And Automotive Applications", "summary": "", "symbols": ["NXPI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41893630/nxp-launches-i-mx-94-processors-with-quantum-security-and-ethernet-tsn-for-industrial-and-automotive", "tags": []}
{"id": 41893707, "time": "2024-11-12 04:06:54", "headline": "OpenAI's Sam Altman Thanks Elon Musk For His Early Support Despite An Ongoing Bitter Feud, Shares Advice He'd Give His Younger Self At Stanford", "summary": "OpenAI CEO Sam Altman acknowledged the crucial early financial support from Elon Musk, co-founder of OpenAI, despite their current strained relationship, crediting Musk&#39;s initial investment for helping drive the company&#39;s success.", "symbols": [], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/24/11/41893707/openai-ceo-sam-altman-thanks-elon-musk-for-early-support-in-chatgpts-rise-and-shares-advice-hed-give-his-younger-self-at-stanford", "tags": ["management"]}
{"id": 41893888, "time": "2024-11-12 04:21:31", "headline": "Tesla Rival XPeng's Stock Surges Over 5% After EV Maker Starts Deliveries Of P7+ Sedan In China", "summary": "XPeng has officially begun nationwide deliveries of its XPENG P7+ sedan in China and the company&#39;s NYSE-listed shares are on the rise.", "symbols": ["XPEV"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/tech/24/11/41893888/tesla-rival-xpengs-stock-surges-over-5-after-ev-maker-starts-deliveries-of-p7-sedan-in-china", "tags": []}
{"id": 41893906, "time": "2024-11-12 04:23:30", "headline": "Oppenheimer Reiterates Outperform on Monolithic Power Systems, Maintains $900 Price Target", "summary": "", "symbols": ["MPWR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41893906/oppenheimer-reiterates-outperform-on-monolithic-power-systems-maintains-900-price-target", "tags": ["analyst_other"]}
{"id": 41893958, "time": "2024-11-12 04:32:52", "headline": "Needham Maintains Buy on Autolus Therapeutics, Raises Price Target to $10", "summary": "", "symbols": ["AUTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41893958/needham-maintains-buy-on-autolus-therapeutics-raises-price-target-to-10", "tags": ["analyst_other", "price_target_up"]}
{"id": 41893975, "time": "2024-11-12 04:35:03", "headline": "Needham Reiterates Buy on Monolithic Power Systems, Maintains $950 Price Target", "summary": "", "symbols": ["MPWR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41893975/needham-reiterates-buy-on-monolithic-power-systems-maintains-950-price-target", "tags": ["analyst_other"]}
{"id": 41893982, "time": "2024-11-12 04:37:51", "headline": "AstraZeneca Announces $3.5B Of Capital Investment In The Us Focused On Expanding The Company's Research And Manufacturing Footprint By The End Of 2026", "summary": "", "symbols": ["AZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41893982/astrazeneca-announces-3-5b-of-capital-investment-in-the-us-focused-on-expanding-the-companys-rese", "tags": []}
{"id": 41893999, "time": "2024-11-12 04:39:23", "headline": "Needham Maintains Buy on Monday.Com, Raises Price Target to $350", "summary": "", "symbols": ["MNDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41893999/needham-maintains-buy-on-monday-com-raises-price-target-to-350", "tags": ["analyst_other", "price_target_up"]}
{"id": 41894193, "time": "2024-11-12 04:49:39", "headline": "Needham Maintains Buy on IntL Money Express, Raises Price Target to $25", "summary": "", "symbols": ["IMXI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41894193/needham-maintains-buy-on-intl-money-express-raises-price-target-to-25", "tags": ["analyst_other", "price_target_up"]}
{"id": 41894201, "time": "2024-11-12 04:51:40", "headline": "Dish Network Creditors Reject Bond Exchange Offer, Threatening Merger With DirecTV: Report", "summary": "Dish Network Corp.&#39;s creditors have rejected the company&#39;s bond-exchange offer just ahead of a key deadline, threatening the proposed merger with DirecTV. ", "symbols": [], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/news/24/11/41894201/dish-network-creditors-reject-bond-exchange-offer-threatening-merger-with-directv-report", "tags": ["merger"]}
{"id": 41894211, "time": "2024-11-12 04:52:43", "headline": "Ascendiant Capital Maintains Buy on Myomo, Raises Price Target to $9", "summary": "", "symbols": ["MYO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41894211/ascendiant-capital-maintains-buy-on-myomo-raises-price-target-to-9", "tags": ["analyst_other", "price_target_up"]}
{"id": 41894212, "time": "2024-11-12 04:53:55", "headline": "As Bitcoin Nears $90K, These BTC-Linked Stocks, Including MSTR And Coinbase, Surge In Tuesday Pre-Market", "summary": "Bitcoin\u2018s (CRYPTO: BTC) impressive rally, nearing $90,000, is propelling stocks associated with the cryptocurrency to notable pre-market gains on Tuesday. At the time of writing, Bitcoin was trading at $88,597.72. ", "symbols": ["BTCUSD", "COIN", "MARA", "MSTR", "TSLA"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41894212/as-bitcoin-nears-90k-these-btc-linked-stocks-including-mstr-and-coinbase-surge-in-tuesday-pre-market", "tags": []}
{"id": 41894249, "time": "2024-11-12 05:00:01", "headline": "Stephens & Co. Reiterates Equal-Weight on Chipotle Mexican Grill, Maintains $65 Price Target", "summary": "", "symbols": ["CMG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41894249/stephens-co-reiterates-equal-weight-on-chipotle-mexican-grill-maintains-65-price-target", "tags": ["analyst_other"]}
{"id": 41894308, "time": "2024-11-12 05:05:06", "headline": "Tencent Music Enter Gr Q3 Adj. EPADS $0.16 Misses $0.17 Estimate, Sales $1.00B Beat $980.86M Estimate", "summary": "", "symbols": ["TME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41894308/tencent-music-enter-gr-q3-adj-epads-0-16-misses-0-17-estimate-sales-1-00b-beat-980-86m-estimate", "tags": []}
{"id": 41894309, "time": "2024-11-12 05:06:16", "headline": "HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $10 Price Target", "summary": "", "symbols": ["KPRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41894309/hc-wainwright-co-reiterates-buy-on-kiora-pharmaceuticals-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 41894362, "time": "2024-11-12 05:07:29", "headline": "HUYA Q3 2024 Adj EPS CNY0.34 Misses CNY0.58 Estimate, Sales CNY1.54B Miss CNY1.64B Estimate", "summary": "", "symbols": ["HUYA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41894362/huya-q3-2024-adj-eps-cny0-34-misses-cny0-58-estimate-sales-cny1-54b-miss-cny1-64b-estimate", "tags": ["earnings"]}
{"id": 41894367, "time": "2024-11-12 05:09:36", "headline": "Huya's Average Mobile Monthly Users For The Third Quarter Of 2024 Was 84M, Compared With 86M For The Same Period Of 2023", "summary": "", "symbols": ["HUYA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41894367/huyas-average-mobile-monthly-users-for-the-third-quarter-of-2024-was-84m-compared-with-86m-for-the-", "tags": []}
{"id": 41894390, "time": "2024-11-12 05:10:24", "headline": "On Holding Q3 Adj $0.17 Misses $0.23 Estimate, Sales $734.52M Beat $704.58M Estimate", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41894390/on-holding-q3-adj-0-17-misses-0-23-estimate-sales-734-52m-beat-704-58m-estimate", "tags": []}
{"id": 41894464, "time": "2024-11-12 05:12:11", "headline": "Redburn Atlantic Initiates Coverage On NVIDIA with Buy Rating, Announces Price Target of $178", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41894464/redburn-atlantic-initiates-coverage-on-nvidia-with-buy-rating-announces-price-target-of-178", "tags": ["analyst_init"]}
{"id": 41894473, "time": "2024-11-12 05:12:56", "headline": "Allot Announced That Vodafone UK Has Recently Launched Secure Net Home, Extending Network-native, Next-Generation Threat Protection And Content Control Services To Their Fixed Broadband Customers Using Allot's HomeSecure Solution", "summary": "", "symbols": ["ALLT", "VOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41894473/allot-announced-that-vodafone-uk-has-recently-launched-secure-net-home-extending-network-native-next", "tags": []}
{"id": 41894474, "time": "2024-11-12 05:13:44", "headline": "PLDT Q3 EPS $0.78 Up From $0.77 YoY, Sales $933.46M Down From $934.92M YoY", "summary": "", "symbols": ["PHI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41894474/pldt-q3-eps-0-78-up-from-0-77-yoy-sales-933-46m-down-from-934-92m-yoy", "tags": ["earnings"]}
{"id": 41894506, "time": "2024-11-12 05:16:42", "headline": "SoftBank Group Q1 EPS $(0.40) Up From $(1.22) YoY, Sales $10.92B Down From $11.35B YoY", "summary": "", "symbols": ["SFTBY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41894506/softbank-group-q1-eps-0-40-up-from-1-22-yoy-sales-10-92b-down-from-11-35b-yoy", "tags": ["earnings"]}
{"id": 41894509, "time": "2024-11-12 05:17:17", "headline": "Apple's Next Big Bet? Think Smaller, Says Analyst: 'There Will Never Be Another\u2026 iPhone'", "summary": "Mark Gurman advises investors not to anticipate another transformative product like the iPhone from Apple, but instead to look forward to smaller, profitable initiatives in areas like mixed reality, health products, and the smart home market.", "symbols": ["AAPL"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/tech/24/11/41894509/apples-next-big-bet-think-smaller-says-analyst-there-will-never-be-another-iphone", "tags": []}
{"id": 41894516, "time": "2024-11-12 05:17:42", "headline": "On Holding Raises Outlook: Sees FY24 Net Sales Of CHF2.29B (Prior View: CHF2.26B), Sees Gross Profit Margin Of 60.5% (Prior View: 60.5%)", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41894516/on-holding-raises-outlook-sees-fy24-net-sales-of-chf2-29b-prior-view-chf2-26b-sees-gross-profit-marg", "tags": ["guidance"]}
{"id": 41894569, "time": "2024-11-12 05:18:42", "headline": "CBAK Energy Tech Q3 2024 EPS $0.00 Misses $0.07 Estimate, Sales $44.63M Miss $58.12M Estimate", "summary": "", "symbols": ["CBAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41894569/cbak-energy-tech-q3-2024-eps-0-00-misses-0-07-estimate-sales-44-63m-miss-58-12m-estimate", "tags": ["earnings"]}
{"id": 41894572, "time": "2024-11-12 05:20:18", "headline": "Amdocs Selected By Vivo To Advance Microservices Strategy And Streamline Operations", "summary": "", "symbols": ["DOX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41894572/amdocs-selected-by-vivo-to-advance-microservices-strategy-and-streamline-operations", "tags": []}
{"id": 41894588, "time": "2024-11-12 05:20:53", "headline": "Wolfe Research Downgrades Alnylam Pharmaceuticals to Underperform", "summary": "", "symbols": ["ALNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41894588/wolfe-research-downgrades-alnylam-pharmaceuticals-to-underperform", "tags": ["analyst_down"]}
{"id": 41894614, "time": "2024-11-12 05:27:00", "headline": "Wolfe Research Upgrades argenx to Outperform, Announces $697 Price Target", "summary": "", "symbols": ["ARGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41894614/wolfe-research-upgrades-argenx-to-outperform-announces-697-price-target", "tags": ["analyst_up"]}
{"id": 41894615, "time": "2024-11-12 05:27:30", "headline": "Tesla Q4 Deliveries Expected To Set New Records But Not Enough To Avoid Yearly Sales Decline, Says Researcher", "summary": "Tesla sales in China and worldwide will likely set new records in the last quarter but not enough to avoid a decline in full-year sales, according to researcher Troy Teslike.", "symbols": ["TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/tech/24/11/41894615/tesla-q4-deliveries-expected-to-set-new-records-but-not-enough-to-avoid-yearly-sales-decline-says-researcher", "tags": []}
{"id": 41894658, "time": "2024-11-12 05:32:02", "headline": "Phillip Securities Downgrades Airbnb to Reduce, Announces $120 Price Target", "summary": "", "symbols": ["ABNB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41894658/phillip-securities-downgrades-airbnb-to-reduce-announces-120-price-target", "tags": ["analyst_down"]}
{"id": 41894660, "time": "2024-11-12 05:32:31", "headline": "Reported Earlier, Vodafone Group H1 Total Revenue Increase By 1.6%, As Organic Service Revenue Growth Was Partially Offset By Adverse Foreign Exchange Movements", "summary": "", "symbols": ["VOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41894660/reported-earlier-vodafone-group-h1-total-revenue-increase-by-1-6-as-organic-service-revenue-growth-", "tags": ["earnings"]}
{"id": 41894668, "time": "2024-11-12 05:34:43", "headline": "Reported Earlier, Vodafone Group Reiterates FY25 Guidance For Adjusted  EBITDAaL And Adjusted Free Cash Flow", "summary": "", "symbols": ["VOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41894668/reported-earlier-vodafone-group-reiterates-fy25-guidance-for-adjusted-ebitdaal-and-adjusted-free-cas", "tags": ["analyst_other", "guidance"]}
{"id": 41894694, "time": "2024-11-12 05:37:13", "headline": "Gilead Said Bicstar Study Shows Sustained Efficacy And Safety Of Biktarvy", "summary": "", "symbols": ["GILD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41894694/gilead-said-bicstar-study-shows-sustained-efficacy-and-safety-of-biktarvy", "tags": []}
{"id": 41894695, "time": "2024-11-12 05:37:26", "headline": "Needham Maintains Buy on Sapiens Intl Corp, Lowers Price Target to $35", "summary": "", "symbols": ["SPNS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41894695/needham-maintains-buy-on-sapiens-intl-corp-lowers-price-target-to-35", "tags": ["analyst_other", "price_target_down"]}
{"id": 41894848, "time": "2024-11-12 05:48:18", "headline": "Needham Maintains Buy on Zeta Global Holdings, Raises Price Target to $43", "summary": "", "symbols": ["ZETA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41894848/needham-maintains-buy-on-zeta-global-holdings-raises-price-target-to-43", "tags": ["analyst_other", "price_target_up"]}
{"id": 41894849, "time": "2024-11-12 05:48:24", "headline": "TH International Q3 EPS $(0.04) Up From $(0.09) YoY, Sales $51.28M Down From $59.81M YoY", "summary": "", "symbols": ["THCH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41894849/th-international-q3-eps-0-04-up-from-0-09-yoy-sales-51-28m-down-from-59-81m-yoy", "tags": ["earnings"]}
{"id": 41894961, "time": "2024-11-12 05:55:39", "headline": "Infineon Technologies Q4 Adj $0.54 Beats $0.45 Estimate, Sales $4.31B Miss $4.34B Estimate", "summary": "", "symbols": ["IFNNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41894961/infineon-technologies-q4-adj-0-54-beats-0-45-estimate-sales-4-31b-miss-4-34b-estimate", "tags": []}
{"id": 41895065, "time": "2024-11-12 06:01:32", "headline": "Home Depot Q3 2024 Adj. EPS $3.78 Beats $3.64 Estimate, Sales $40.217B Beat $39.173B Estimate", "summary": "", "symbols": ["HD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895065/home-depot-q3-2024-adj-eps-3-78-beats-3-64-estimate-sales-40-217b-beat-39-173b-estimate", "tags": ["earnings"]}
{"id": 41895077, "time": "2024-11-12 06:01:48", "headline": "Rockwell Medical Q3 2024 Adj EPS $0.09 Beats $0.01 Estimate, Sales $28.32M Beat $26.50M Estimate", "summary": "", "symbols": ["RMTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895077/rockwell-medical-q3-2024-adj-eps-0-09-beats-0-01-estimate-sales-28-32m-beat-26-50m-estimate", "tags": ["earnings"]}
{"id": 41895086, "time": "2024-11-12 06:02:08", "headline": "Triumph Group Q2 2025 Adj EPS $0.20 Beats $0.01 Estimate, Sales $287.50M Beat $283.09M Estimate", "summary": "", "symbols": ["TGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895086/triumph-group-q2-2025-adj-eps-0-20-beats-0-01-estimate-sales-287-50m-beat-283-09m-estimate", "tags": ["earnings"]}
{"id": 41895087, "time": "2024-11-12 06:02:28", "headline": "Home Depot Q3 Comp Sales -1.3%, Comp Sales US -1.2%", "summary": "", "symbols": ["HD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895087/home-depot-q3-comp-sales-1-3-comp-sales-us-1-2", "tags": []}
{"id": 41895101, "time": "2024-11-12 06:03:12", "headline": "Northwest Natural Hldg Q3 2024 GAAP EPS $(0.71) Beats $(0.77) Estimate, Sales $136.934M Beat $132.467M Estimate", "summary": "", "symbols": ["NWN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895101/northwest-natural-hldg-q3-2024-gaap-eps-0-71-beats-0-77-estimate-sales-136-934m-beat-132-467m-estim", "tags": ["earnings"]}
{"id": 41895112, "time": "2024-11-12 06:04:49", "headline": "HC Wainwright & Co. Downgrades Phunware to Neutral, Lowers Price Target to $6", "summary": "", "symbols": ["PHUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895112/hc-wainwright-co-downgrades-phunware-to-neutral-lowers-price-target-to-6", "tags": ["analyst_down", "price_target_down"]}
{"id": 41895118, "time": "2024-11-12 06:05:34", "headline": "Northwest Natural Gas Affirms FY24 Adjusted EPS Guidance Of $2.20-$2.40 Vs $2.31 Est.", "summary": "", "symbols": ["NWN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895118/northwest-natural-gas-affirms-fy24-adjusted-eps-guidance-of-2-20-2-40-vs-2-31-est", "tags": ["earnings", "guidance"]}
{"id": 41895120, "time": "2024-11-12 06:06:27", "headline": "Home Depot Raises FY24 GAAP EPS Guidance from $14.51-$14.81 to $14.81 vs $14.84 Est; Sales from $156.49B-$158.01B to $158.78B vs $157.38B Est", "summary": "", "symbols": ["HD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895120/home-depot-raises-fy24-gaap-eps-guidance-from-14-51-14-81-to-14-81-vs-14-84-est-sales-from-156-49b-1", "tags": ["earnings", "guidance"]}
{"id": 41895171, "time": "2024-11-12 06:07:00", "headline": "22nd Century Group Q3 2024 GAAP EPS $(0.27) Up From $(6.70) YoY, Sales $5.95M Down From $7.87M YoY", "summary": "", "symbols": ["XXII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895171/22nd-century-group-q3-2024-gaap-eps-0-27-up-from-6-70-yoy-sales-5-95m-down-from-7-87m-yoy", "tags": ["earnings"]}
{"id": 41895178, "time": "2024-11-12 06:08:44", "headline": "Pactiv Evergreen Q3 2024 Adj. EPS $0.36, Inline, Sales $1.333B Miss $1.374B Estimate", "summary": "", "symbols": ["PTVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895178/pactiv-evergreen-q3-2024-adj-eps-0-36-inline-sales-1-333b-miss-1-374b-estimate", "tags": ["earnings"]}
{"id": 41895180, "time": "2024-11-12 06:09:01", "headline": "Gravity Reports Q3 Total Revenues Of $97,629 Thousand, 4.4% Increase From Prior Quarter And 27.1% Decrease From Last Year", "summary": "", "symbols": ["GRVY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895180/gravity-reports-q3-total-revenues-of-97-629-thousand-4-4-increase-from-prior-quarter-and-27-1-decre", "tags": []}
{"id": 41895183, "time": "2024-11-12 06:09:13", "headline": "Brenntag Q3 EPS $0.18 Down From $0.26 YoY, Sales $4.47B Up From $4.45B YoY", "summary": "", "symbols": ["BNTGY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895183/brenntag-q3-eps-0-18-down-from-0-26-yoy-sales-4-47b-up-from-4-45b-yoy", "tags": ["earnings"]}
{"id": 41895185, "time": "2024-11-12 06:09:17", "headline": "22nd Century Says Q3 Cigarette Net Revenues, Including Export Volume, Increased To $4.1M Or 18% Compared To $3.5M In The Prior Year Comparable Period", "summary": "", "symbols": ["XXII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895185/22nd-century-says-q3-cigarette-net-revenues-including-export-volume-increased-to-4-1m-or-18-compare", "tags": []}
{"id": 41895197, "time": "2024-11-12 06:10:56", "headline": "HC Wainwright & Co. Maintains Buy on Galiano Gold, Raises Price Target to $4.6", "summary": "", "symbols": ["GAU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895197/hc-wainwright-co-maintains-buy-on-galiano-gold-raises-price-target-to-4-6", "tags": ["analyst_other", "price_target_up"]}
{"id": 41895256, "time": "2024-11-12 06:11:02", "headline": "Why Grab Holdings Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket", "summary": " ", "symbols": ["API", "BAER", "BNOX", "BTCT", "CERO", "DXYZ", "EFSH", "GRAB", "LAZR", "LGMK", "LIFW", "MMV", "MTNB", "NGNE", "OGEN", "SGN", "TAOP", "TSHA", "XBP", "ZETA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41895256/why-grab-holdings-shares-are-trading-higher-by-around-12-here-are-20-stocks-moving-premarket", "tags": ["why_moving"]}
{"id": 41895285, "time": "2024-11-12 06:11:37", "headline": "First Watch Restaurant Reports Launch Of Secondary Offering By Certain Funds Managed By Advent International, L.P. Of 8M Shares Of Common Stock", "summary": "", "symbols": ["FWRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895285/first-watch-restaurant-reports-launch-of-secondary-offering-by-certain-funds-managed-by-advent-inter", "tags": ["offering"]}
{"id": 41895346, "time": "2024-11-12 06:12:18", "headline": "BeiGene Q3 2024 GAAP EPADS $(1.15) Beats $(1.20) Estimate, Sales $1.00B Beat $979.78M Estimate", "summary": "", "symbols": ["BGNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895346/beigene-q3-2024-gaap-epads-1-15-beats-1-20-estimate-sales-1-00b-beat-979-78m-estimate", "tags": []}
{"id": 41895347, "time": "2024-11-12 06:12:31", "headline": "India Consumer Price Index (YoY) For October 6.21% Vs. 5.81% Est.; 5.49% Prior", "summary": "", "symbols": ["INDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41895347/india-consumer-price-index-yoy-for-october-6-21-vs-5-81-est-5-49-prior", "tags": []}
{"id": 41895350, "time": "2024-11-12 06:12:52", "headline": "Eurozone ZEW Economic Sentiment For November 12.5 Vs. 20.5 Est.; 20.1 Prior", "summary": "", "symbols": ["VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41895350/eurozone-zew-economic-sentiment-for-november-12-5-vs-20-5-est-20-1-prior", "tags": []}
{"id": 41895359, "time": "2024-11-12 06:13:04", "headline": "HC Wainwright & Co. Maintains Buy on First Mining Gold, Lowers Price Target to C$0.35", "summary": "", "symbols": ["TSX:FF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895359/hc-wainwright-co-maintains-buy-on-first-mining-gold-lowers-price-target-to-c-0-35", "tags": ["analyst_other", "price_target_down"]}
{"id": 41895360, "time": "2024-11-12 06:13:06", "headline": "Germany ZEW Economic Sentiment For November 7.4 Vs. 13.2 Est.; 13.1 Prior", "summary": "", "symbols": ["EWG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41895360/germany-zew-economic-sentiment-for-november-7-4-vs-13-2-est-13-1-prior", "tags": []}
{"id": 41895361, "time": "2024-11-12 06:13:25", "headline": "Germany ZEW Current Conditions For November -91.4 Vs. -86.0 Est.; -86.9 Prior", "summary": "", "symbols": ["EWG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41895361/germany-zew-current-conditions-for-november-91-4-vs-86-0-est-86-9-prior", "tags": []}
{"id": 41895371, "time": "2024-11-12 06:16:32", "headline": "Triumph Group Continues To Expect FY25 Net Sales Of Approximately $1.2B (Est $1.209B), Raises Adjusted EPS Outlook From $0.52 To Range Of $0.70 - $0.76 (Est $0.41)", "summary": "", "symbols": ["TGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895371/triumph-group-continues-to-expect-fy25-net-sales-of-approximately-1-2b-est-1-209b-raises-adjusted-ep", "tags": ["earnings", "guidance"]}
{"id": 41895565, "time": "2024-11-12 06:19:10", "headline": "Collins Aerospace Receives $19M Contract From The Department Of Defense To Equip Fleet Of New H-47 Chinooks For The UK Royal Air Force", "summary": "", "symbols": ["RTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895565/collins-aerospace-receives-19m-contract-from-the-department-of-defense-to-equip-fleet-of-new-h-47-ch", "tags": ["contract"]}
{"id": 41895567, "time": "2024-11-12 06:19:32", "headline": "HC Wainwright & Co. Reiterates Buy on CG Oncology, Maintains $75 Price Target", "summary": "", "symbols": ["CGON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895567/hc-wainwright-co-reiterates-buy-on-cg-oncology-maintains-75-price-target", "tags": ["analyst_other"]}
{"id": 41895596, "time": "2024-11-12 06:20:59", "headline": "Top 3 Industrials Stocks That Are Ticking Portfolio Bombs", "summary": " ", "symbols": ["AMSC", "GHM", "RDW"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/short-ideas/24/11/41895596/top-3-industrials-stocks-that-are-ticking-portfolio-bombs-2", "tags": []}
{"id": 41895599, "time": "2024-11-12 06:21:15", "headline": "Needham Reiterates Buy on Taysha Gene Therapies, Maintains $6 Price Target", "summary": "", "symbols": ["TSHA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895599/needham-reiterates-buy-on-taysha-gene-therapies-maintains-6-price-target", "tags": ["analyst_other"]}
{"id": 41895601, "time": "2024-11-12 06:21:16", "headline": "Revelation Biosciences Has Completed The GMP Manufacture Of Gemini Drug Product To Support Anticipated Clinical Studies In The U.S. The Company Intends To Utilize The Current Supply Of Gemini For The Upcoming Phase 1B Clinical Trial In Chronic Kidney Disease Patients And Future Phase 2 Studies", "summary": "", "symbols": ["REVB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895601/revelation-biosciences-has-completed-the-gmp-manufacture-of-gemini-drug-product-to-support-anticipat", "tags": ["fda"]}
{"id": 41895626, "time": "2024-11-12 06:22:48", "headline": "HC Wainwright & Co. Maintains Buy on EMX Royalty, Raises Price Target to $7", "summary": "", "symbols": ["EMX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895626/hc-wainwright-co-maintains-buy-on-emx-royalty-raises-price-target-to-7", "tags": ["analyst_other", "price_target_up"]}
{"id": 41895635, "time": "2024-11-12 06:27:01", "headline": "Matrix Service Says Awarded Engineering, Fabrication, And Construction Work For Inner Steel Tank Scope Of Work On Full Containment Storage Tank For Delaware River Partners In Gibbstown, New Jersey", "summary": "", "symbols": ["MTRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895635/matrix-service-says-awarded-engineering-fabrication-and-construction-work-for-inner-steel-tank-scope", "tags": ["contract"]}
{"id": 41895712, "time": "2024-11-12 06:30:50", "headline": "First Advantage Q3 2024 Adj. EPS $0.26 Beats $0.25 Estimate, Sales $199.119M Miss $204.297M Estimate", "summary": "", "symbols": ["FA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895712/first-advantage-q3-2024-adj-eps-0-26-beats-0-25-estimate-sales-199-119m-miss-204-297m-estimate", "tags": ["earnings"]}
{"id": 41895714, "time": "2024-11-12 06:31:01", "headline": "Vertical Aerospace Unveils \"Flightpath 2030\" Strategy; Continues To Explore All Alternative Options Available With Respect To Its Funding Needs", "summary": "", "symbols": ["EVTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895714/vertical-aerospace-unveils-flightpath-2030-strategy-continues-to-explore-all-alternative-options-ava", "tags": []}
{"id": 41895715, "time": "2024-11-12 06:31:16", "headline": "Sotherly Hotels Q3 AFFO $(0.02), Sales $40.70M Miss $42.00M Estimate", "summary": "", "symbols": ["SOHO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895715/sotherly-hotels-q3-affo-0-02-sales-40-70m-miss-42-00m-estimate", "tags": []}
{"id": 41895719, "time": "2024-11-12 06:31:49", "headline": "Sea Q3 2024 GAAP EPS $0.24 Misses $0.25 Estimate, Sales $4.328B Beat $4.076B Estimate", "summary": "", "symbols": ["SE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895719/sea-q3-2024-gaap-eps-0-24-misses-0-25-estimate-sales-4-328b-beat-4-076b-estimate", "tags": ["earnings"]}
{"id": 41895724, "time": "2024-11-12 06:32:21", "headline": "FTC Solar Q3 2024 Adj. EPS $(0.10) Misses $(0.09) Estimate, Sales $10.136M Beat $9.895M Estimate", "summary": "", "symbols": ["FTCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895724/ftc-solar-q3-2024-adj-eps-0-10-misses-0-09-estimate-sales-10-136m-beat-9-895m-estimate", "tags": ["earnings"]}
{"id": 41895725, "time": "2024-11-12 06:32:22", "headline": "SpringWorks Therapeutics Q3 2024 GAAP EPS $(0.72) Beats $(0.75) Estimate, Sales $49.30M Miss $53.17M Estimate", "summary": "", "symbols": ["SWTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895725/springworks-therapeutics-q3-2024-gaap-eps-0-72-beats-0-75-estimate-sales-49-30m-miss-53-17m-estimat", "tags": ["earnings"]}
{"id": 41895726, "time": "2024-11-12 06:32:29", "headline": "Vertical Aerospace Says VX4 Prototype Begins Untethered, Piloted Thrustborne Testing Following Expansion Of Permit To Fly From UK Civil Aviation Authority", "summary": "", "symbols": ["EVTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895726/vertical-aerospace-says-vx4-prototype-begins-untethered-piloted-thrustborne-testing-following-expans", "tags": []}
{"id": 41895727, "time": "2024-11-12 06:32:32", "headline": "Sotherly Hotels Revises 2024 AFFO Guidance From $0.64-$0.69 To $0.65-$0.68", "summary": "", "symbols": ["SOHO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895727/sotherly-hotels-revises-2024-affo-guidance-from-0-64-0-69-to-0-65-0-68", "tags": ["guidance"]}
{"id": 41895739, "time": "2024-11-12 06:32:43", "headline": "HC Wainwright & Co. Reiterates Buy on Mineralys Therapeutics, Maintains $30 Price Target", "summary": "", "symbols": ["MLYS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895739/hc-wainwright-co-reiterates-buy-on-mineralys-therapeutics-maintains-30-price-target", "tags": ["analyst_other"]}
{"id": 41895742, "time": "2024-11-12 06:33:17", "headline": "Rigetti Computing Q3 2024 GAAP EPS $(0.08) Beats $(0.09) Estimate, Sales $2.378M Miss $3.332M Estimate", "summary": "", "symbols": ["RGTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895742/rigetti-computing-q3-2024-gaap-eps-0-08-beats-0-09-estimate-sales-2-378m-miss-3-332m-estimate", "tags": ["earnings"]}
{"id": 41895743, "time": "2024-11-12 06:33:27", "headline": "Camtek Q3 2024 Adj. EPS $0.75 Beats $0.69 Estimate, Sales $112.340M Beat $108.680M Estimate", "summary": "", "symbols": ["CAMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895743/camtek-q3-2024-adj-eps-0-75-beats-0-69-estimate-sales-112-340m-beat-108-680m-estimate", "tags": ["earnings"]}
{"id": 41895745, "time": "2024-11-12 06:33:34", "headline": "SpringWorks Therapeutics' Cash, Cash Equivalents And Marketable Securities As Of September 30, 2024 Of $498M; Expected To Fund The Company Through Profitability, Which Is Anticipated In The First Half Of 2026", "summary": "", "symbols": ["SWTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41895745/springworks-therapeutics-cash-cash-equivalents-and-marketable-securities-as-of-september-30-2024-", "tags": []}
{"id": 41895746, "time": "2024-11-12 06:33:51", "headline": "Trane Technologies, Autodesk Enter Strategic Collaboration Aimed At Optimizing Commercial Building Design For Sustainability", "summary": "", "symbols": ["ADSK", "TT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895746/trane-technologies-autodesk-enter-strategic-collaboration-aimed-at-optimizing-commercial-building-de", "tags": []}
{"id": 41895747, "time": "2024-11-12 06:33:54", "headline": "Clean Energy Technologies Signs MOU With Freyr Technology For AI Computing And Data Center Services In Southeast Asia; Financial Terms Not Disclosed", "summary": "", "symbols": ["CETY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895747/clean-energy-technologies-signs-mou-with-freyr-technology-for-ai-computing-and-data-center-services", "tags": []}
{"id": 41895748, "time": "2024-11-12 06:34:00", "headline": "Zai Lab Q3 2024 GAAP EPS $(0.42) Beats $(0.79) Estimate, Sales $102.265M Beat $102.242M Estimate", "summary": "", "symbols": ["ZLAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895748/zai-lab-q3-2024-gaap-eps-0-42-beats-0-79-estimate-sales-102-265m-beat-102-242m-estimate", "tags": ["earnings"]}
{"id": 41895749, "time": "2024-11-12 06:34:11", "headline": "HC Wainwright & Co. Reiterates Buy on Novavax, Maintains $19 Price Target", "summary": "", "symbols": ["NVAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895749/hc-wainwright-co-reiterates-buy-on-novavax-maintains-19-price-target", "tags": ["analyst_other"]}
{"id": 41895759, "time": "2024-11-12 06:35:09", "headline": "Amazon Set To Introduce New AI Chips In December To Rival Jensen Huang's AI Stalwart: 'We Want To Be Absolutely The Best Place To Run Nvidia'", "summary": "Amazon&#39;s capital spending is expected to reach $75 billion in 2024.", "symbols": ["AMZN", "NVDA"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/tech/24/11/41895759/amazon-set-to-introduce-new-ai-chips-in-december-to-rival-jensen-huangs-ai-stalwart-we-want-to-be-absolutely-the-best-place-to-run-nvidia", "tags": []}
{"id": 41895762, "time": "2024-11-12 06:35:11", "headline": "Nuvalent Q3 2024 GAAP EPS $(1.28) Misses $(0.93) Estimate", "summary": "", "symbols": ["NUVL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895762/nuvalent-q3-2024-gaap-eps-1-28-misses-0-93-estimate", "tags": ["earnings"]}
{"id": 41895766, "time": "2024-11-12 06:35:24", "headline": "Sila Realty Trust Q3 2024 FFO $0.57 Beats $0.52 Estimate, Sales $46.118M Miss $46.380M Estimate", "summary": "", "symbols": ["SILA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895766/sila-realty-trust-q3-2024-ffo-0-57-beats-0-52-estimate-sales-46-118m-miss-46-380m-estimate", "tags": []}
{"id": 41895779, "time": "2024-11-12 06:35:55", "headline": "Nuvalent's Q3 Cash Position Of $1.2B, Including Proceeds From Upsized $575 Million Public Offering, Expected To Extend Operating Runway Into 2028", "summary": "", "symbols": ["NUVL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41895779/nuvalents-q3-cash-position-of-1-2b-including-proceeds-from-upsized-575-million-public-offering-ex", "tags": ["offering"]}
{"id": 41895780, "time": "2024-11-12 06:35:58", "headline": "Ermenegildo Zegna Says Monterubello, Its Controlling Shareholder, Purchased 913,000 Shares and Intends to Acquire Additional 2M Shares In The Coming Weeks", "summary": "", "symbols": ["ZGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895780/ermenegildo-zegna-says-monterubello-its-controlling-shareholder-purchased-913-000-shares-and-intends", "tags": ["merger"]}
{"id": 41895781, "time": "2024-11-12 06:36:09", "headline": "Sea Limited's Shopee On Track To Accomplish 2024 Full Year GMV Growth Guidance Of Mid-20%", "summary": "", "symbols": ["SE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895781/sea-limiteds-shopee-on-track-to-accomplish-2024-full-year-gmv-growth-guidance-of-mid-20", "tags": ["guidance"]}
{"id": 41895790, "time": "2024-11-12 06:36:57", "headline": "First Advantage Affirms FY2024 Adj EPS Guidance from $0.88-0.98 to $0.88-0.98 vs $0.92 Est; Affirms FY2024 Sales Guidance from $750.00M-800.00M to $750.00M-800.00M vs $771.69M Est", "summary": "", "symbols": ["FA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895790/first-advantage-affirms-fy2024-adj-eps-guidance-from-0-88-0-98-to-0-88-0-98-vs-0-92-est-affirms-fy20", "tags": ["earnings", "guidance"]}
{"id": 41895791, "time": "2024-11-12 06:37:01", "headline": "B of A Securities Upgrades iHeartMedia to Neutral, Raises Price Target to $3", "summary": "", "symbols": ["IHRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895791/b-of-a-securities-upgrades-iheartmedia-to-neutral-raises-price-target-to-3", "tags": ["analyst_up", "price_target_up"]}
{"id": 41895800, "time": "2024-11-12 06:37:34", "headline": "HC Wainwright & Co. Reiterates Buy on Unicycive Therapeutics, Maintains $2.5 Price Target", "summary": "", "symbols": ["UNCY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895800/hc-wainwright-co-reiterates-buy-on-unicycive-therapeutics-maintains-2-5-price-target", "tags": ["analyst_other"]}
{"id": 41895801, "time": "2024-11-12 06:37:35", "headline": "FTC Solar Sees Q4 Revenue $10.0M\u2013$14.0M Vs. $9.895M Est.", "summary": "", "symbols": ["FTCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895801/ftc-solar-sees-q4-revenue-10-0m-14-0m-vs-9-895m-est", "tags": ["earnings"]}
{"id": 41895839, "time": "2024-11-12 06:38:16", "headline": "VIAVI Solutions Announced That VIAVI Xgig CXL Exerciser has received CXL 2.0 Gold Suite Certification From The Compute Express Link Consortium", "summary": "", "symbols": ["VIAV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895839/viavi-solutions-announced-that-viavi-xgig-cxl-exerciser-has-received-cxl-2-0-gold-suite-certificatio", "tags": []}
{"id": 41895848, "time": "2024-11-12 06:38:50", "headline": "Crown Crafts Q2 EPS $0.08 Down From $0.18 YoY, Sales $24.46M Up From $24.13M YoY", "summary": "", "symbols": ["CRWS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895848/crown-crafts-q2-eps-0-08-down-from-0-18-yoy-sales-24-46m-up-from-24-13m-yoy", "tags": ["earnings"]}
{"id": 41895850, "time": "2024-11-12 06:39:24", "headline": "Crescent Capital BDC Q3 2024 Adj EPS $0.64 Beats $0.57 Estimate, Sales $51.63M Beat $48.69M Estimate", "summary": "", "symbols": ["CCAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895850/crescent-capital-bdc-q3-2024-adj-eps-0-64-beats-0-57-estimate-sales-51-63m-beat-48-69m-estimate", "tags": ["earnings"]}
{"id": 41895851, "time": "2024-11-12 06:39:25", "headline": "Camtek Expects Q4 Revenue Of $115M Vs $108.7M Est and FY24 Revenue Of $427M Vs $421.3M Est", "summary": "", "symbols": ["CAMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895851/camtek-expects-q4-revenue-of-115m-vs-108-7m-est-and-fy24-revenue-of-427m-vs-421-3m-est", "tags": ["earnings"]}
{"id": 41895852, "time": "2024-11-12 06:39:41", "headline": "HC Wainwright & Co. Reiterates Neutral on RAPT Therapeutics", "summary": "", "symbols": ["RAPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895852/hc-wainwright-co-reiterates-neutral-on-rapt-therapeutics", "tags": ["analyst_other"]}
{"id": 41895853, "time": "2024-11-12 06:39:52", "headline": "Elon Musk Announced Tesla's Berlin Gigafactory 5 Years Ago Today: Here's How EV Giant's Mega Factory Has Evolved", "summary": "EV giant Tesla reminisced CEO Elon Musk announcing its first and sole gigafactory in Europe located near Berlin five years ago in 2019.", "symbols": ["TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/tech/24/11/41895853/elon-musk-announced-teslas-berlin-gigafactory-5-years-ago-today-heres-how-ev-giants-mega-factory-has-evolved", "tags": ["management"]}
{"id": 41895866, "time": "2024-11-12 06:40:27", "headline": "Trinity Capital Lends $40M To Impress, Backing Orthodontic Chain's European Expansion", "summary": "", "symbols": ["TRIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895866/trinity-capital-lends-40m-to-impress-backing-orthodontic-chains-european-expansion", "tags": []}
{"id": 41895937, "time": "2024-11-12 06:41:11", "headline": "Wall Street Futures Show Weakness As Investors Look To Lock In Gains After Strong Post-Election Rally: 'Bull Market Sentiment Remains Intact,' Says Wharton Economist", "summary": "U.S. stocks could open on a negative note on Tuesday after the averages scaled record highs last week. Futures of all three major indices were slightly down on Tuesday, pointing to a cautious sentiment on Wall Street.", "symbols": ["BTC", "BTCUSD", "COIN", "DJT", "HD", "HOOD", "LYV", "MSTR", "OXY", "QQQ", "SPY", "TSLA", "TSN"], "source": "benzinga", "author": "Rounak Jain", "url": "https://www.benzinga.com/news/earnings/24/11/41895937/wall-street-futures-show-weakness-as-investors-look-to-lock-in-gains-after-strong-post-election-rally-bull-market-sentiment-remains-intact-says-wharton-economist", "tags": []}
{"id": 41895974, "time": "2024-11-12 06:41:53", "headline": "GrafTech International Q3 2024 Adj. EPS $(0.13) Misses $(0.09) Estimate, Sales $130.654M Beat $128.635M Estimate", "summary": "", "symbols": ["EAF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41895974/graftech-international-q3-2024-adj-eps-0-13-misses-0-09-estimate-sales-130-654m-beat-128-635m-estim", "tags": ["earnings"]}
{"id": 41895985, "time": "2024-11-12 06:42:47", "headline": "GrafTech Announced That It Has Entered Into A Commitment And Consent Letter With Lenders Holding All Of Its Existing Revolving Commitments To Provide New Debt Financing On Competitive Terms And Extend Maturities Of Its Existing Debt", "summary": "", "symbols": ["EAF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895985/graftech-announced-that-it-has-entered-into-a-commitment-and-consent-letter-with-lenders-holding-all", "tags": []}
{"id": 41896000, "time": "2024-11-12 06:43:00", "headline": "Deutsche Bank Upgrades SentinelOne to Buy, Raises Price Target to $32", "summary": "", "symbols": ["S"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896000/deutsche-bank-upgrades-sentinelone-to-buy-raises-price-target-to-32", "tags": ["analyst_up", "price_target_up"]}
{"id": 41896001, "time": "2024-11-12 06:43:13", "headline": "Intl Game Tech Q3 2024 Adj EPS $(0.02) Misses $0.21 Estimate, Sales $587.00M Miss $591.50M Estimate", "summary": "", "symbols": ["IGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896001/intl-game-tech-q3-2024-adj-eps-0-02-misses-0-21-estimate-sales-587-00m-miss-591-50m-estimate", "tags": ["earnings"]}
{"id": 41896003, "time": "2024-11-12 06:44:22", "headline": "The Wall Street Journal Reported Meta To Offer 'less Personalized' Ads In EU; Option Set To Launch On Instagram And Facebook In Coming Days", "summary": "", "symbols": ["META", "VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896003/the-wall-street-journal-reported-meta-to-offer-less-personalized-ads-in-eu-option-set-to-launch-on-i", "tags": []}
{"id": 41896016, "time": "2024-11-12 06:45:05", "headline": "Havertys CEO Clarence Smith To Step Down, Steven Burdette Named Successor, Effective January 1, 2025", "summary": "", "symbols": ["HVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896016/havertys-ceo-clarence-smith-to-step-down-steven-burdette-named-successor-effective-january-1-2025", "tags": ["management"]}
{"id": 41896017, "time": "2024-11-12 06:45:08", "headline": "Deutsche Bank Downgrades Okta to Hold, Lowers Price Target to $85", "summary": "", "symbols": ["OKTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896017/deutsche-bank-downgrades-okta-to-hold-lowers-price-target-to-85", "tags": ["analyst_down", "price_target_down"]}
{"id": 41896021, "time": "2024-11-12 06:45:16", "headline": "HC Wainwright & Co. Reiterates Neutral on Lyell Immunopharma, Maintains $1 Price Target", "summary": "", "symbols": ["LYEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896021/hc-wainwright-co-reiterates-neutral-on-lyell-immunopharma-maintains-1-price-target", "tags": ["analyst_other"]}
{"id": 41896027, "time": "2024-11-12 06:46:07", "headline": "Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 6% Dividend Yields", "summary": " ", "symbols": ["OHI", "OUT", "RLJ"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-ratings/price-target/24/11/41896027/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-with-over-6-dividend-yields", "tags": ["dividend"]}
{"id": 41896039, "time": "2024-11-12 06:46:44", "headline": "IGT Expects Q4 Revenue For Continuing Operations Of $640M - $690M, Revenue Of $2.50B - $2.55B (Est $2.506B)", "summary": "", "symbols": ["IGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896039/igt-expects-q4-revenue-for-continuing-operations-of-640m-690m-revenue-of-2-50b-2-55b-est-2-506b", "tags": ["earnings"]}
{"id": 41896040, "time": "2024-11-12 06:46:45", "headline": "Target Hospitality Q3 2024 GAAP EPS $0.20 Beats $0.12 Estimate, Sales $95.191M Beat $87.900M Estimate", "summary": "", "symbols": ["TH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896040/target-hospitality-q3-2024-gaap-eps-0-20-beats-0-12-estimate-sales-95-191m-beat-87-900m-estimate", "tags": ["earnings"]}
{"id": 41896044, "time": "2024-11-12 06:47:00", "headline": "HC Wainwright & Co. Maintains Buy on Neurogene, Raises Price Target to $55", "summary": "", "symbols": ["NGNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896044/hc-wainwright-co-maintains-buy-on-neurogene-raises-price-target-to-55", "tags": ["analyst_other", "price_target_up"]}
{"id": 41896050, "time": "2024-11-12 06:47:05", "headline": "GrafTech International Expects FY24 Sales Volume To Improve Low Double-digit Percentage Point YoY, Q4 Sales Volume In Line QoQ, FY25 Sales Volume To Grow In Low Double-digit Percentage Point", "summary": "", "symbols": ["EAF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896050/graftech-international-expects-fy24-sales-volume-to-improve-low-double-digit-percentage-point-yoy-q4", "tags": []}
{"id": 41893976, "time": "2024-11-12 04:35:49", "headline": "AstraZeneca's High-Level Results From KOMET Phase 3 Trial In Adults With Neurofibromatosis Type 1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas Showed That Koselugo (Selumetinib) Met Its Primary Endpoint, Demonstrating A Statistically Significant And Clinically Meaningful Objective Response Rate Versus Placebo", "summary": "", "symbols": ["AZN", "MRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41893976/astrazenecas-high-level-results-from-komet-phase-3-trial-in-adults-with-neurofibromatosis-type-1-", "tags": ["fda"]}
{"id": 41896075, "time": "2024-11-12 06:48:05", "headline": "Target Hospitality Affirms FY2024 Sales Guidance to $375.00M-$385.00M  VS Est. $379M", "summary": "", "symbols": ["TH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896075/target-hospitality-affirms-fy2024-sales-guidance-to-375-00m-385-00m-vs-est-379m", "tags": ["guidance"]}
{"id": 41896076, "time": "2024-11-12 06:48:11", "headline": "Healthcare Realty Trust Names Constance Moore Interim CEO As Todd Meredith Steps Down", "summary": "", "symbols": ["HR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896076/healthcare-realty-trust-names-constance-moore-interim-ceo-as-todd-meredith-steps-down", "tags": ["management"]}
{"id": 41896178, "time": "2024-11-12 06:49:06", "headline": "Keefe, Bruyette & Woods Downgrades Horace Mann Educators to Market Perform, Raises Price Target to $44", "summary": "", "symbols": ["HMN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896178/keefe-bruyette-woods-downgrades-horace-mann-educators-to-market-perform-raises-price-target-to-44", "tags": ["analyst_down", "price_target_up"]}
{"id": 41896196, "time": "2024-11-12 06:50:25", "headline": "Schr\u00f6dinger Announced Research Collaboration And License Agreement With Novartis To Advance Multiple Development Candidates Into Novartis's Portfolio For Further Development, Schr\u00f6dinger To Receive $150M Upfront And Eligible To Receive Up To Approximately $2.3B In Milestone Payments Plus Royalties", "summary": "", "symbols": ["NVS", "SDGR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41896196/schr-dinger-announced-research-collaboration-and-license-agreement-with-novartis-to-advance-multi", "tags": ["contract"]}
{"id": 41896197, "time": "2024-11-12 06:50:35", "headline": "Kolibri Global Reports Strong Initial Production from Alicia Renee Well Pad, Averaging Over 2,800 BOEPD In Tishomingo Field", "summary": "", "symbols": ["KGEI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896197/kolibri-global-reports-strong-initial-production-from-alicia-renee-well-pad-averaging-over-2-800-boe", "tags": []}
{"id": 41896199, "time": "2024-11-12 06:51:04", "headline": "This Airbnb Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday", "summary": " ", "symbols": ["ABNB", "ALNY", "HMN", "MRCY", "OKTA", "PHUN", "UEIC"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-ratings/downgrades/24/11/41896199/this-airbnb-analyst-turns-bearish-here-are-top-5-downgrades-for-tuesday", "tags": ["analyst_down"]}
{"id": 41896201, "time": "2024-11-12 06:51:18", "headline": "HC Wainwright & Co. Reiterates Buy on Innate Pharma, Maintains $11.5 Price Target", "summary": "", "symbols": ["IPHA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896201/hc-wainwright-co-reiterates-buy-on-innate-pharma-maintains-11-5-price-target", "tags": ["analyst_other"]}
{"id": 41896208, "time": "2024-11-12 06:51:35", "headline": "Schrodinger Q3 2024 GAAP EPS $(0.52), Inline, Sales $35.29M Miss $40.57M Estimate", "summary": "", "symbols": ["SDGR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896208/schrodinger-q3-2024-gaap-eps-0-52-inline-sales-35-29m-miss-40-57m-estimate", "tags": ["earnings"]}
{"id": 41896214, "time": "2024-11-12 06:51:57", "headline": "Morgan Stanley Upgrades Intl Flavors & Fragrances to Overweight, Lowers Price Target to $110", "summary": "", "symbols": ["IFF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896214/morgan-stanley-upgrades-intl-flavors-fragrances-to-overweight-lowers-price-target-to-110", "tags": ["analyst_up", "price_target_down"]}
{"id": 41896213, "time": "2024-11-12 06:52:06", "headline": "Economist Peter Schiff Sees 'A Silver Lining' As Gold Plummets, While Investors Rush To Snap Up Bitcoin Gains: 'Typically\u2026Silver Would Be Down Twice As Much'", "summary": "As cryptocurrency prices hover around record levels, investors have been keen on adding them to their portfolios.", "symbols": ["BTC", "BTCUSD", "FBTC", "FGDL", "GBTC", "GLDM", "IAUM", "IBIT", "SIL", "SILJ", "SLV", "XAG", "XAU"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/markets/commodities/24/11/41896213/economist-peter-schiff-sees-a-silver-lining-as-gold-plummets-while-investors-rush-to-snap-up-bitcoin-gains-typicallysilver-would-be-down-twice-as-much", "tags": []}
{"id": 41896233, "time": "2024-11-12 06:52:55", "headline": "Asia And Europe Markets Cool Off, Dollar Strengthens To 4-month High - Global Markets Today While US Slept", "summary": "US markets closed higher on hopeful fiscal policies. Tesla soared, crypto stocks rallied, while traders watch inflation data and Fed rate cuts.", "symbols": ["ADIV", "AGOV", "ASHR", "BBEU", "BOIL", "CQQQ", "DBC", "EEM", "EEMA", "EWU", "EZU", "FLAX", "FXA", "FXB", "FXC", "FXE", "FXI", "GLD", "GSG", "GXC", "IEMG", "IEUR", "IEV", "KDIV", "SPEM", "SPY", "UNG", "USDU", "USO", "UUP", "VGK", "VWO"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/24/11/41896233/asia-and-europe-markes-slip-crude-oil-and-dollar-strengthen-on-trumps-tariffs-global-markets-today-while-us-slept", "tags": []}
{"id": 41896258, "time": "2024-11-12 06:53:18", "headline": "Piedmont Lithium Q3 2024 Adj. EPS $(0.42) Beats $(0.58) Estimate, Sales $27.700M Miss $28.189M Estimate", "summary": "", "symbols": ["PLL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896258/piedmont-lithium-q3-2024-adj-eps-0-42-beats-0-58-estimate-sales-27-700m-miss-28-189m-estimate", "tags": ["earnings"]}
{"id": 41896261, "time": "2024-11-12 06:53:23", "headline": "HC Wainwright & Co. Reiterates Buy on Can Fite Biofarma, Maintains $18 Price Target", "summary": "", "symbols": ["CANF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896261/hc-wainwright-co-reiterates-buy-on-can-fite-biofarma-maintains-18-price-target", "tags": ["analyst_other"]}
{"id": 41896264, "time": "2024-11-12 06:54:25", "headline": "Infineon Technologies Sees Q1 FY 2025 revenue of approximately \u20ac3.2 billion.", "summary": "", "symbols": ["IFNNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896264/infineon-technologies-sees-q1-fy-2025-revenue-of-approximately-3-2-billion", "tags": ["earnings"]}
{"id": 41896269, "time": "2024-11-12 06:55:09", "headline": "Schr\u00f6dinger Expects 2024 Software Revenue Growth Of 8%-13% Versus Prior Guidance Of 6%-13%, With Drug Discovery Revenue Guidance Of $20M-$30M Compared To $30M-$35M Expected Earlier", "summary": "", "symbols": ["SDGR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41896269/schr-dinger-expects-2024-software-revenue-growth-of-8-13-versus-prior-guidance-of-6-13-with-drug-", "tags": ["earnings", "guidance"]}
{"id": 41896273, "time": "2024-11-12 06:55:15", "headline": "Morgan Stanley Upgrades Viking Holdings to Overweight, Raises Price Target to $49", "summary": "", "symbols": ["VIK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896273/morgan-stanley-upgrades-viking-holdings-to-overweight-raises-price-target-to-49", "tags": ["analyst_up", "price_target_up"]}
{"id": 41896181, "time": "2024-11-12 06:49:50", "headline": "Nancy Pelosi's Stock Picks Broadcom And Nvidia Among Key AI Stocks Poised For Chip Boom, Says Analyst", "summary": "Blayne Curtis has assigned Buy ratings to each of these companies.", "symbols": ["AVGO", "GOOG", "GOOGL", "MRVL", "NVDA"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41896181/nancy-pelosis-stock-pick-broadcom-and-nvidia-among-other-key-ai-stock-poised-for-chip-boom-says-analyst", "tags": []}
{"id": 41896278, "time": "2024-11-12 06:57:16", "headline": "Golar LNG Q3 Sales $64.81M Miss $77.62M Estimate", "summary": "", "symbols": ["GLNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896278/golar-lng-q3-sales-64-81m-miss-77-62m-estimate", "tags": []}
{"id": 41896292, "time": "2024-11-12 06:58:13", "headline": "Mizuho Maintains Outperform on NVIDIA, Raises Price Target to $165", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896292/mizuho-maintains-outperform-on-nvidia-raises-price-target-to-165", "tags": ["analyst_other", "price_target_up"]}
{"id": 41896334, "time": "2024-11-12 06:58:42", "headline": "Blackstone Secured Q3 2024 GAAP EPS $0.91 Beats $0.88 Estimate, Sales $343.000M Beat $338.709M Estimate", "summary": "", "symbols": ["BXSL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896334/blackstone-secured-q3-2024-gaap-eps-0-91-beats-0-88-estimate-sales-343-000m-beat-338-709m-estimate", "tags": ["earnings"]}
{"id": 41896340, "time": "2024-11-12 06:59:29", "headline": "Piper Sandler Maintains Underweight on Nevro, Lowers Price Target to $6", "summary": "", "symbols": ["NVRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896340/piper-sandler-maintains-underweight-on-nevro-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 41896500, "time": "2024-11-12 07:00:27", "headline": "Alnylam Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (24 Ratings)", "summary": " ", "symbols": ["ALNY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41896500/alnylam-pharmaceuticals-stock-a-deep-dive-into-analyst-perspectives-24-ratings", "tags": []}
{"id": 41896502, "time": "2024-11-12 07:00:29", "headline": "Treehouse Foods Q3 2024 Adj. EPS $0.74 Misses $0.75 Estimate, Sales $839.100M Miss $881.141M Estimate", "summary": "", "symbols": ["THS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896502/treehouse-foods-q3-2024-adj-eps-0-74-misses-0-75-estimate-sales-839-100m-miss-881-141m-estimate", "tags": ["earnings"]}
{"id": 41896507, "time": "2024-11-12 07:00:34", "headline": "The Analyst Verdict: Lyell Immunopharma In The Eyes Of 4 Experts", "summary": " ", "symbols": ["LYEL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41896507/the-analyst-verdict-lyell-immunopharma-in-the-eyes-of-4-experts", "tags": []}
{"id": 41896508, "time": "2024-11-12 07:00:41", "headline": "Assessing IntL Money Express: Insights From 4 Financial Analysts", "summary": " ", "symbols": ["IMXI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41896508/assessing-intl-money-express-insights-from-4-financial-analysts", "tags": []}
{"id": 41896509, "time": "2024-11-12 07:00:50", "headline": "Scholar Rock Holding Q3 2024 GAAP EPS $(0.66) Misses $(0.58) Estimate", "summary": "", "symbols": ["SRRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896509/scholar-rock-holding-q3-2024-gaap-eps-0-66-misses-0-58-estimate", "tags": ["earnings"]}
{"id": 41896510, "time": "2024-11-12 07:00:51", "headline": "Peeling Back The Layers: Exploring Okta Through Analyst Insights", "summary": " ", "symbols": ["OKTA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41896510/peeling-back-the-layers-exploring-okta-through-analyst-insights", "tags": []}
{"id": 41896511, "time": "2024-11-12 07:00:56", "headline": "Plug Power Q3 2024 GAAP EPS $(0.25) Misses $(0.24) Estimate, Sales $173.730M Miss $210.233M Estimate", "summary": "", "symbols": ["PLUG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896511/plug-power-q3-2024-gaap-eps-0-25-misses-0-24-estimate-sales-173-730m-miss-210-233m-estimate", "tags": ["earnings"]}
{"id": 41896513, "time": "2024-11-12 07:01:00", "headline": "Deep Dive Into SentinelOne Stock: Analyst Perspectives (29 Ratings)", "summary": " ", "symbols": ["S"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41896513/deep-dive-into-sentinelone-stock-analyst-perspectives-29-ratings", "tags": []}
{"id": 41896515, "time": "2024-11-12 07:01:04", "headline": "Vontier's Gilbarco Veeder-Root Wins Second Major Tender With Indian Oil Corporation, Secures $15M Deal For Submersible Turbine Pumps Following September Fuel Dispenser Contract", "summary": "", "symbols": ["VNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896515/vontiers-gilbarco-veeder-root-wins-second-major-tender-with-indian-oil-corporation-secures-15m-deal", "tags": ["contract"]}
{"id": 41896522, "time": "2024-11-12 07:01:09", "headline": "The Latest Analyst Ratings For Chipotle Mexican Grill", "summary": " ", "symbols": ["CMG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41896522/the-latest-analyst-ratings-for-chipotle-mexican-grill", "tags": []}
{"id": 41896525, "time": "2024-11-12 07:01:13", "headline": "Axsome Therapeutics Q3 Sales $104.76M Beat $98.10M Estimate", "summary": "", "symbols": ["AXSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896525/axsome-therapeutics-q3-sales-104-76m-beat-98-10m-estimate", "tags": []}
{"id": 41896538, "time": "2024-11-12 07:01:43", "headline": "OptiNose Q3 2024 GAAP EPS $0.00 Beats $(0.05) Estimate, Sales $20.44M Miss $23.00M Estimate", "summary": "", "symbols": ["OPTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896538/optinose-q3-2024-gaap-eps-0-00-beats-0-05-estimate-sales-20-44m-miss-23-00m-estimate", "tags": ["earnings"]}
{"id": 41896542, "time": "2024-11-12 07:01:52", "headline": "NexGen Reports Best Drill Results Yet, Expands High-Grade Zone At Patterson Corridor East", "summary": "", "symbols": ["NXE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896542/nexgen-reports-best-drill-results-yet-expands-high-grade-zone-at-patterson-corridor-east", "tags": []}
{"id": 41896547, "time": "2024-11-12 07:01:57", "headline": "Altimmune Q3 2024 GAAP EPS $(0.32) Beats $(0.36) Estimate, Sales $5.000K Beat $833.330 Estimate", "summary": "", "symbols": ["ALT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896547/altimmune-q3-2024-gaap-eps-0-32-beats-0-36-estimate-sales-5-000k-beat-833-330-estimate", "tags": ["earnings"]}
{"id": 41896549, "time": "2024-11-12 07:02:00", "headline": "2seventy bio Q3 2024 GAAP EPS $(0.19) Beats $(0.22) Estimate, Sales $13.534M Miss $15.036M Estimate", "summary": "", "symbols": ["TSVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896549/2seventy-bio-q3-2024-gaap-eps-0-19-beats-0-22-estimate-sales-13-534m-miss-15-036m-estimate", "tags": ["earnings"]}
{"id": 41896551, "time": "2024-11-12 07:02:05", "headline": "RumbleON Q3 2024 GAAP EPS $(0.32) Misses $(0.17) Estimate, Sales $295M Miss $301.426M Estimate", "summary": "", "symbols": ["RMBL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896551/rumbleon-q3-2024-gaap-eps-0-32-misses-0-17-estimate-sales-295m-miss-301-426m-estimate", "tags": ["earnings"]}
{"id": 41896557, "time": "2024-11-12 07:02:09", "headline": "Agenus Q3 2024 GAAP EPS $(3.08) Misses $(2.33) Estimate, Sales $25.110M Miss $33.476M Estimate. Cash and Equivalents of $44.8M", "summary": "", "symbols": ["AGEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896557/agenus-q3-2024-gaap-eps-3-08-misses-2-33-estimate-sales-25-110m-miss-33-476m-estimate-cash-and-equi", "tags": ["earnings"]}
{"id": 41896559, "time": "2024-11-12 07:02:11", "headline": "Blade Air Mobility Q3 2024 GAAP EPS $(0.03) Beats $(0.04) Estimate, Sales $74.877M Beat $74.445M Estimate", "summary": "", "symbols": ["BLDE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896559/blade-air-mobility-q3-2024-gaap-eps-0-03-beats-0-04-estimate-sales-74-877m-beat-74-445m-estimate", "tags": ["earnings"]}
{"id": 41896562, "time": "2024-11-12 07:02:18", "headline": "908 Devices Q3 2024 GAAP EPS $(0.84) Misses $(0.28) Estimate, Sales $16.77M Miss $18.33M Estimate", "summary": "", "symbols": ["MASS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896562/908-devices-q3-2024-gaap-eps-0-84-misses-0-28-estimate-sales-16-77m-miss-18-33m-estimate", "tags": ["earnings"]}
{"id": 41896573, "time": "2024-11-12 07:02:51", "headline": "Outfront Media Q3 2024 GAAP EPS $0.19 Beats $0.18 Estimate, Sales $451.900M Miss $456.632M Estimate", "summary": "", "symbols": ["OUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896573/outfront-media-q3-2024-gaap-eps-0-19-beats-0-18-estimate-sales-451-900m-miss-456-632m-estimate", "tags": ["earnings"]}
{"id": 41896574, "time": "2024-11-12 07:02:55", "headline": "Shopify Q3 Sales $2.162B Beat $2.113B Estimate", "summary": "", "symbols": ["SHOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896574/shopify-q3-sales-2-162b-beat-2-113b-estimate", "tags": []}
{"id": 41896579, "time": "2024-11-12 07:03:06", "headline": "Oncolytics Biotech Q3 2024 GAAP EPS C$(0.12) Misses C$(0.10) Estimate", "summary": "", "symbols": ["ONCY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896579/oncolytics-biotech-q3-2024-gaap-eps-c-0-12-misses-c-0-10-estimate", "tags": ["earnings"]}
{"id": 41896592, "time": "2024-11-12 07:03:13", "headline": "Acumen Pharmaceuticals Q3 2024 GAAP EPS $(0.50) Misses $(0.36) Estimate", "summary": "", "symbols": ["ABOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896592/acumen-pharmaceuticals-q3-2024-gaap-eps-0-50-misses-0-36-estimate", "tags": ["earnings"]}
{"id": 41896598, "time": "2024-11-12 07:03:29", "headline": "US Energy Q3 2024 GAAP EPS $(0.08) Misses $(0.04) Estimate, Sales $4.957M Miss $5.816M Estimate", "summary": "", "symbols": ["USEG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896598/us-energy-q3-2024-gaap-eps-0-08-misses-0-04-estimate-sales-4-957m-miss-5-816m-estimate", "tags": ["earnings"]}
{"id": 41896624, "time": "2024-11-12 07:03:41", "headline": "EVgo Q3 2024 GAAP EPS $(0.11) Beats $(0.12) Estimate, Sales $67.535M Beat $65.952M Estimate", "summary": "", "symbols": ["EVGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896624/evgo-q3-2024-gaap-eps-0-11-beats-0-12-estimate-sales-67-535m-beat-65-952m-estimate", "tags": ["earnings"]}
{"id": 41896630, "time": "2024-11-12 07:03:47", "headline": "Avadel Pharmaceuticals Q3 2024 GAAP EPS $(0.03) Beats $(0.06) Estimate, Sales $50.025M Beat $48.607M Estimate", "summary": "", "symbols": ["AVDL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896630/avadel-pharmaceuticals-q3-2024-gaap-eps-0-03-beats-0-06-estimate-sales-50-025m-beat-48-607m-estimat", "tags": ["earnings"]}
{"id": 41896637, "time": "2024-11-12 07:03:56", "headline": "Mosaic Q3 2024 Adj. EPS $0.34 Misses $0.54 Estimate, Sales $2.810B Miss $3.165B Estimate", "summary": "", "symbols": ["MOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896637/mosaic-q3-2024-adj-eps-0-34-misses-0-54-estimate-sales-2-810b-miss-3-165b-estimate", "tags": ["earnings"]}
{"id": 41896640, "time": "2024-11-12 07:04:10", "headline": "Shift4 Payments Q3 2024 Adj. EPS $1.04 Misses $1.07 Estimate, Sales $909.200M Miss $971.345M Estimate", "summary": "", "symbols": ["FOUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896640/shift4-payments-q3-2024-adj-eps-1-04-misses-1-07-estimate-sales-909-200m-miss-971-345m-estimate", "tags": ["earnings"]}
{"id": 41896641, "time": "2024-11-12 07:04:13", "headline": "Oncolytics Biotech Reported Q3 $19.6M In Cash And Cash Equivalents, Projected To Provide Cash Runway Through Key Milestones And Into 2025", "summary": "", "symbols": ["ONCY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41896641/oncolytics-biotech-reported-q3-19-6m-in-cash-and-cash-equivalents-projected-to-provide-cash-runwa", "tags": []}
{"id": 41896647, "time": "2024-11-12 07:04:47", "headline": "Plug Power Sees 2024 Revenue $700M-$800M vs $823.46M Est.", "summary": "", "symbols": ["PLUG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896647/plug-power-sees-2024-revenue-700m-800m-vs-823-46m-est", "tags": ["earnings"]}
{"id": 41896648, "time": "2024-11-12 07:04:50", "headline": "Benchmark Initiates Coverage On VEON with Buy Rating, Announces Price Target of $48", "summary": "", "symbols": ["VEON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896648/benchmark-initiates-coverage-on-veon-with-buy-rating-announces-price-target-of-48", "tags": ["analyst_init"]}
{"id": 41896649, "time": "2024-11-12 07:04:54", "headline": "InspireMD Q3 2024 GAAP EPS $(0.16) Beats $(0.20) Estimate, Sales $1.810M Beat $1.740M Estimate", "summary": "", "symbols": ["NSPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896649/inspiremd-q3-2024-gaap-eps-0-16-beats-0-20-estimate-sales-1-810m-beat-1-740m-estimate", "tags": ["earnings"]}
{"id": 41896650, "time": "2024-11-12 07:04:57", "headline": "Shopify Sees Q4 2024 Revenue Growth Mid-To-High-Twenties Percentage Rate On YoY Basis; Sees Gross Profit Dollars Growth At YoY Similar To Q3 2024", "summary": "", "symbols": ["SHOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896650/shopify-sees-q4-2024-revenue-growth-mid-to-high-twenties-percentage-rate-on-yoy-basis-sees-gross-pro", "tags": ["earnings"]}
{"id": 41896653, "time": "2024-11-12 07:05:02", "headline": "Wabtec Reveals Strategic Investment In Its Transit Business With Acquisitions Of Fanox And Kompozitum In Combined $110M Cash Transaction", "summary": "", "symbols": ["WAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41896653/wabtec-reveals-strategic-investment-in-its-transit-business-with-acquisitions-of-fanox-and-kompozitu", "tags": []}
{"id": 41896666, "time": "2024-11-12 07:05:14", "headline": "OUTFRONT Media Announces Special Dividend Of $0.75/Share", "summary": "", "symbols": ["OUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896666/outfront-media-announces-special-dividend-of-0-75share", "tags": ["dividend"]}
{"id": 41896668, "time": "2024-11-12 07:05:25", "headline": "Shoals Technologies Gr Q3 2024 Adj. EPS $0.08 Misses $0.10 Estimate, Sales $102.165M Beat $98.701M Estimate", "summary": "", "symbols": ["SHLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896668/shoals-technologies-gr-q3-2024-adj-eps-0-08-misses-0-10-estimate-sales-102-165m-beat-98-701m-estima", "tags": ["earnings"]}
{"id": 41896671, "time": "2024-11-12 07:05:51", "headline": "Autolus Therapeutics Q3 2024 GAAP EPS $(0.31) Misses $(0.21) Estimate. Cash And Equivalents $657.1M", "summary": "", "symbols": ["AUTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896671/autolus-therapeutics-q3-2024-gaap-eps-0-31-misses-0-21-estimate-cash-and-equivalents-657-1m", "tags": ["earnings"]}
{"id": 41896675, "time": "2024-11-12 07:06:18", "headline": "Sylvamo Q3 2024 Adj. EPS $2.44 Beats $2.18 Estimate, Sales $965.000M Beat $960.467M Estimate", "summary": "", "symbols": ["SLVM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896675/sylvamo-q3-2024-adj-eps-2-44-beats-2-18-estimate-sales-965-000m-beat-960-467m-estimate", "tags": ["earnings"]}
{"id": 41896677, "time": "2024-11-12 07:06:29", "headline": "Altair Enters Collaboration Agreement With The European Space Agency Through ESA Partnership Initiative For Commercialisation", "summary": "", "symbols": ["ALTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896677/altair-enters-collaboration-agreement-with-the-european-space-agency-through-esa-partnership-initiat", "tags": ["contract"]}
{"id": 41896678, "time": "2024-11-12 07:06:30", "headline": "OptiNose Expects 2024 Xhance Net Revenues Of $75M-$79M Compared To Prior Guidance Of $85M-$90M, With Average Net Revenue Per Prescription To Be Approximately $270, Versus Prior Guidance To Exceed $250", "summary": "", "symbols": ["OPTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41896678/optinose-expects-2024-xhance-net-revenues-of-75m-79m-compared-to-prior-guidance-of-85m-90m-with-a", "tags": ["earnings", "guidance"]}
{"id": 41896682, "time": "2024-11-12 07:07:25", "headline": "BTIG Maintains Buy on Velocity Financial, Raises Price Target to $23", "summary": "", "symbols": ["VEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896682/btig-maintains-buy-on-velocity-financial-raises-price-target-to-23", "tags": ["analyst_other", "price_target_up"]}
{"id": 41896691, "time": "2024-11-12 07:07:36", "headline": "Upstart Intends To Offer $425M Of Convertible Senior Notes Due 2030 In Private Offering", "summary": "", "symbols": ["UPST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896691/upstart-intends-to-offer-425m-of-convertible-senior-notes-due-2030-in-private-offering", "tags": ["offering"]}
{"id": 41896692, "time": "2024-11-12 07:07:48", "headline": "Benson Hill Q3 2024 GAAP EPS $(4.14) Misses $(3.11) Estimate, Sales $34.098M Miss $39.100M Estimate", "summary": "", "symbols": ["BHIL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896692/benson-hill-q3-2024-gaap-eps-4-14-misses-3-11-estimate-sales-34-098m-miss-39-100m-estimate", "tags": ["earnings"]}
{"id": 41896693, "time": "2024-11-12 07:07:58", "headline": "CareCloud Q3 2024 Adj. EPS $0.21 Beats $(0.14) Estimate, Sales $28.546M Beat $28.525M Estimate", "summary": "", "symbols": ["CCLD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896693/carecloud-q3-2024-adj-eps-0-21-beats-0-14-estimate-sales-28-546m-beat-28-525m-estimate", "tags": ["earnings"]}
{"id": 41896695, "time": "2024-11-12 07:08:18", "headline": "Legend Biotech Q3 2024 GAAP EPS $(0.34) Beats $(0.41) Estimate, Sales $160.205M Beat $143.868M Estimate", "summary": "", "symbols": ["LEGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896695/legend-biotech-q3-2024-gaap-eps-0-34-beats-0-41-estimate-sales-160-205m-beat-143-868m-estimate", "tags": ["earnings"]}
{"id": 41896696, "time": "2024-11-12 07:08:25", "headline": "Compugen Q3 2024 GAAP EPS $0.01 Misses $0.06 Estimate, Sales $17.132M Miss $17.862M Estimate", "summary": "", "symbols": ["CGEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896696/compugen-q3-2024-gaap-eps-0-01-misses-0-06-estimate-sales-17-132m-miss-17-862m-estimate", "tags": ["earnings"]}
{"id": 41896697, "time": "2024-11-12 07:08:30", "headline": "Sylvamo Sees Q4 2024 Adj. EBITDA $150M-$165M", "summary": "", "symbols": ["SLYV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896697/sylvamo-sees-q4-2024-adj-ebitda-150m-165m", "tags": []}
{"id": 41896710, "time": "2024-11-12 07:08:37", "headline": "PowerFleet, Inc. Q2 2024 Adj. EPS $0.02 Beats $(0.02) Estimate, Sales $77.018M Beat $74.387M Estimate", "summary": "", "symbols": ["AIOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896710/powerfleet-inc-q2-2024-adj-eps-0-02-beats-0-02-estimate-sales-77-018m-beat-74-387m-estimate", "tags": ["earnings"]}
{"id": 41896775, "time": "2024-11-12 07:08:41", "headline": "TScan Therapeutics Q3 2024 GAAP EPS $(0.25) Beats $(0.29) Estimate, Cash, Cash Equivalents, And Marketable Securities Of $271.1M Expected To Fund Operations Into The Fourth Quarter Of 2026", "summary": "", "symbols": ["TCRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896775/tscan-therapeutics-q3-2024-gaap-eps-0-25-beats-0-29-estimate-cash-cash-equivalents-and-marketable-s", "tags": ["earnings"]}
{"id": 41896823, "time": "2024-11-12 07:08:58", "headline": "Neumora Therapeutics Q3 2024 GAAP EPS $(0.45) Misses $(0.39) Estimate", "summary": "", "symbols": ["NMRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896823/neumora-therapeutics-q3-2024-gaap-eps-0-45-misses-0-39-estimate", "tags": ["earnings"]}
{"id": 41896277, "time": "2024-11-12 06:56:56", "headline": "Bitcoin Nears $90,000\u2014How High Can The Apex Crypto Go?", "summary": "Bitcoin (CRYPTO: BTC) briefly touched $89,864 in early European trading hours, marking a notable surge that saw the cryptocurrency rise 6% in the past 24 hou", "symbols": ["BTCUSD", "ETHUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41896277/bitcoin-nears-90000-how-high-can-the-apex-crypto-go", "tags": []}
{"id": 41896826, "time": "2024-11-12 07:09:29", "headline": "Acacia Research Q3 2024 GAAP EPS $(0.14) Down From $(0.03) YoY, Sales $23.310M Miss $27.250M Estimate", "summary": "", "symbols": ["ACTG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896826/acacia-research-q3-2024-gaap-eps-0-14-down-from-0-03-yoy-sales-23-310m-miss-27-250m-estimate", "tags": ["earnings"]}
{"id": 41896849, "time": "2024-11-12 07:10:17", "headline": "Sylvamo Says Price And Mix Expected To Be Unfavorable $20M-$25M Due To Pulp And Paper Price Decrease In Europe", "summary": "", "symbols": ["SLVM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896849/sylvamo-says-price-and-mix-expected-to-be-unfavorable-20m-25m-due-to-pulp-and-paper-price-decrease-i", "tags": []}
{"id": 41896850, "time": "2024-11-12 07:10:23", "headline": "Zenas BioPharma Completes Targeted Enrollment For Phase 3 INDIGO Trial Of Obexelimab In IgG4-Related Disease; Topline Results Expected By End Of 2025", "summary": "", "symbols": ["ZBIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41896850/zenas-biopharma-completes-targeted-enrollment-for-phase-3-indigo-trial-of-obexelimab-in-igg4-rela", "tags": ["fda"]}
{"id": 41896851, "time": "2024-11-12 07:10:54", "headline": "ITeos Therapeutics Q3 2024 GAAP EPS $(1.05) Beats $(1.17) Estimate, Pro Forma Cash And Investment Balance Of $683.9M As Of September 30, 2024 Expected To Provide Runway Through 2027 Across A Number Of Impactful Portfolio Milestones", "summary": "", "symbols": ["ITOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41896851/iteos-therapeutics-q3-2024-gaap-eps-1-05-beats-1-17-estimate-pro-forma-cash-and-investment-balance-", "tags": ["earnings"]}
{"id": 41896852, "time": "2024-11-12 07:11:04", "headline": "Mosaic Sees FY24 Capital Expenditures $1.1B-$1.2B", "summary": "", "symbols": ["MOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896852/mosaic-sees-fy24-capital-expenditures-1-1b-1-2b", "tags": []}
{"id": 41896956, "time": "2024-11-12 07:11:33", "headline": "Repare Therapeutics Announces Agreement With US National Cancer Institute To Advance The Development Of Camonsertib As An Anticancer Agent In Collaboration With The Cancer Therapy Evaluation Program", "summary": "", "symbols": ["RPTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896956/repare-therapeutics-announces-agreement-with-us-national-cancer-institute-to-advance-the-development", "tags": ["contract"]}
{"id": 41896957, "time": "2024-11-12 07:11:50", "headline": "Mizuho Reiterates Outperform on Red Rock Resorts, Lowers Price Target to $57", "summary": "", "symbols": ["RRR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896957/mizuho-reiterates-outperform-on-red-rock-resorts-lowers-price-target-to-57", "tags": ["analyst_other", "price_target_down"]}
{"id": 41896958, "time": "2024-11-12 07:11:53", "headline": "Shift4 Gross Revenue Less Network Fees Outlook: FY24  $1.35B-$1.36B (Prior $1.35B - $1.38B;) Q4 $400M-$415M", "summary": "", "symbols": ["FOUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896958/shift4-gross-revenue-less-network-fees-outlook-fy24-1-35b-1-36b-prior-1-35b-1-38b-q4-400m-415m", "tags": ["earnings", "guidance"]}
{"id": 41896961, "time": "2024-11-12 07:12:18", "headline": "Repare Therapeutics Enters Agreement With US National Cancer Institute To Advance Development Of Anticancer Agent Camonsertib", "summary": "", "symbols": ["RPTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896961/repare-therapeutics-enters-agreement-with-us-national-cancer-institute-to-advance-development-of-ant", "tags": ["contract"]}
{"id": 41896963, "time": "2024-11-12 07:12:48", "headline": "Blade Air Mobility Sees FY24 Revenue $240M-$250M Vs $247.572M Est.", "summary": "", "symbols": ["BLDE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896963/blade-air-mobility-sees-fy24-revenue-240m-250m-vs-247-572m-est", "tags": ["earnings"]}
{"id": 41896964, "time": "2024-11-12 07:13:00", "headline": "Blade Air Mobility Sees FY25 Passenger Revenue $85M-$95M", "summary": "", "symbols": ["BLDE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896964/blade-air-mobility-sees-fy25-passenger-revenue-85m-95m", "tags": ["earnings"]}
{"id": 41896965, "time": "2024-11-12 07:13:01", "headline": "BioXcel Therapeutics Announced The Achievement Of Clinical And Regulatory Progress For Its Pivotal Phase 3 Trials Of BXCLl501 For The Acute Treatment Of Agitation Associated With Bipolar Disorders Or Schizophrenia (SERENITY At-Home) And Agitation Associated With Alzheimer's Dementia (TRANQUILITY In-Care)", "summary": "", "symbols": ["BTAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41896965/bioxcel-therapeutics-announced-the-achievement-of-clinical-and-regulatory-progress-for-its-pivota", "tags": ["fda"]}
{"id": 41896966, "time": "2024-11-12 07:13:03", "headline": "JMP Securities Maintains Market Outperform on Robinhood Markets, Raises Price Target to $40", "summary": "", "symbols": ["HOOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896966/jmp-securities-maintains-market-outperform-on-robinhood-markets-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 41896968, "time": "2024-11-12 07:13:32", "headline": "Neuronetics Lowers FY2024 Sales Guidance from $78.00M-80.00M to $71.00M-72.00M", "summary": "", "symbols": ["STIM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896968/neuronetics-lowers-fy2024-sales-guidance-from-78-00m-80-00m-to-71-00m-72-00m", "tags": ["guidance"]}
{"id": 41896970, "time": "2024-11-12 07:13:50", "headline": "Neuronetics Sees Q4 Sales $19.000M-$20.000M vs $24.90M Est", "summary": "", "symbols": ["STIM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41896970/neuronetics-sees-q4-sales-19-000m-20-000m-vs-24-90m-est", "tags": []}
{"id": 41897033, "time": "2024-11-12 07:14:17", "headline": "CureVac Q3 Sales EUR493.90M Beat EUR103.76M Estimate; Represents 2,897% Increase From EUR 16.5M Prior Year", "summary": "", "symbols": ["CVAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897033/curevac-q3-sales-eur493-90m-beat-eur103-76m-estimate-represents-2-897-increase-from-eur-16-5m-prior", "tags": []}
{"id": 41897034, "time": "2024-11-12 07:14:33", "headline": "Mizuho Maintains Outperform on Hilton Grand Vacations, Lowers Price Target to $55", "summary": "", "symbols": ["HGV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897034/mizuho-maintains-outperform-on-hilton-grand-vacations-lowers-price-target-to-55", "tags": ["analyst_other", "price_target_down"]}
{"id": 41897035, "time": "2024-11-12 07:14:35", "headline": "Armata Pharmaceuticals Has Achieved Full Enrollment (N=50) Of Its Phase 1b/2a diSArm Study Of Intravenous AP-SA02 For Staphylococcus Aureus Bacteremia, Topline Data Is Expected In The First Quarter Of 2025", "summary": "", "symbols": ["ARMP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41897035/armata-pharmaceuticals-has-achieved-full-enrollment-n-50-of-its-phase-1b2a-disarm-study-of-intrav", "tags": []}
{"id": 41897038, "time": "2024-11-12 07:14:49", "headline": "CareCloud Sees FY24 Revenue $109M-$111M Vs $111.119M Est.", "summary": "", "symbols": ["CCLD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897038/carecloud-sees-fy24-revenue-109m-111m-vs-111-119m-est", "tags": ["earnings"]}
{"id": 41897044, "time": "2024-11-12 07:15:14", "headline": "Keybanc Maintains Overweight on Albemarle, Lowers Price Target to $127", "summary": "", "symbols": ["ALB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897044/keybanc-maintains-overweight-on-albemarle-lowers-price-target-to-127", "tags": ["analyst_other", "price_target_down"]}
{"id": 41897045, "time": "2024-11-12 07:15:36", "headline": "Shoals Technologies Sees FY 2024 Revenue $390M-$400M (Prior $370M-$400M) Vs $383.6M Est., Q4 Revenue Of $97M-$107M Vs $98.7M Est", "summary": "", "symbols": ["SHLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897045/shoals-technologies-sees-fy-2024-revenue-390m-400m-prior-370m-400m-vs-383-6m-est-q4-revenue-of-97m-1", "tags": ["earnings"]}
{"id": 41897048, "time": "2024-11-12 07:16:06", "headline": "Centessa Pharmaceuticals Q3 2024 GAAP EPS $(0.37) Beats $(0.43) Estimate", "summary": "", "symbols": ["CNTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897048/centessa-pharmaceuticals-q3-2024-gaap-eps-0-37-beats-0-43-estimate", "tags": ["earnings"]}
{"id": 41897051, "time": "2024-11-12 07:16:21", "headline": "Mizuho Maintains Outperform on Marriott Vacations, Raises Price Target to $117", "summary": "", "symbols": ["VAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897051/mizuho-maintains-outperform-on-marriott-vacations-raises-price-target-to-117", "tags": ["analyst_other", "price_target_up"]}
{"id": 41897052, "time": "2024-11-12 07:16:24", "headline": "Neuronetics Q3 EPS $(0.44) Misses $(0.23) Estimate, Sales $18.53M Miss $19.13M Estimate", "summary": "", "symbols": ["STIM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897052/neuronetics-q3-eps-0-44-misses-0-23-estimate-sales-18-53m-miss-19-13m-estimate", "tags": ["earnings"]}
{"id": 41897054, "time": "2024-11-12 07:16:47", "headline": "Coda Octopus Secures $576K Order For 15 New Generation F280 GNSS Aided INS, Supporting Foreign Navy Program", "summary": "", "symbols": ["CODA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897054/coda-octopus-secures-576k-order-for-15-new-generation-f280-gnss-aided-ins-supporting-foreign-navy-pr", "tags": []}
{"id": 41897053, "time": "2024-11-12 07:16:28", "headline": "Natera Announced The Completion Of A Study Using Signatera From CALGB (Alliance)/SWOG 80702 Phase 3 Trial, Evaluating The Benefit Of Adding Celecoxib To Folfox In Postoperative Treatment Of Stage III Colorectal Cancer In A Biomarker Unselected Population, Results To Be Presented At ASCO GI In January 2025", "summary": "", "symbols": ["NTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897053/natera-announced-the-completion-of-a-study-using-signatera-from-calgb-alliance-swog-80702-phase-3-tr", "tags": ["fda"]}
{"id": 41897060, "time": "2024-11-12 07:17:10", "headline": "CureVac Reaffirms Its Expected Cash Runway Into 2028", "summary": "", "symbols": ["CVAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897060/curevac-reaffirms-its-expected-cash-runway-into-2028", "tags": []}
{"id": 41897063, "time": "2024-11-12 07:17:14", "headline": "Keybanc Maintains Overweight on Brixmor Property Group, Raises Price Target to $32", "summary": "", "symbols": ["BRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897063/keybanc-maintains-overweight-on-brixmor-property-group-raises-price-target-to-32", "tags": ["analyst_other", "price_target_up"]}
{"id": 41897064, "time": "2024-11-12 07:17:22", "headline": "AstraZeneca Commits $3.5B Investment To Expand R&D And Manufacturing In The U.S., Creating Over 1,000 High-Skilled Jobs; New Facilities Planned Across Multiple States To Support Growth Ambition", "summary": "", "symbols": ["AZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897064/astrazeneca-commits-3-5b-investment-to-expand-r-d-and-manufacturing-in-the-u-s-creating-over-1-000-h", "tags": []}
{"id": 41897065, "time": "2024-11-12 07:17:27", "headline": "Summit Midstream Q3 EPS $(1.90) Down From $(0.27) YoY, Sales $102.42M Down From $121.19M YoY", "summary": "", "symbols": ["SMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897065/summit-midstream-q3-eps-1-90-down-from-0-27-yoy-sales-102-42m-down-from-121-19m-yoy", "tags": ["earnings"]}
{"id": 41897066, "time": "2024-11-12 07:17:37", "headline": "Treehouse Foods Lowers Outlook: Sees FY24 Net Sales Of $3.37B-$3.40B Vs. $3.46B Estimate (Prior View: $3.43B-$3.50B), Sees Adjusted EBITDA Of $335M-$345M (Prior View: $360M-$380M)", "summary": "", "symbols": ["THS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897066/treehouse-foods-lowers-outlook-sees-fy24-net-sales-of-3-37b-3-40b-vs-3-46b-estimate-prior-view-3-43b", "tags": ["guidance"]}
{"id": 41897187, "time": "2024-11-12 07:19:03", "headline": "Smith Douglas Homes Q3 2024 GAAP EPS $0.58 Misses $0.60 Estimate, Sales $277.835M Beat $258.078M Estimate", "summary": "", "symbols": ["SDHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897187/smith-douglas-homes-q3-2024-gaap-eps-0-58-misses-0-60-estimate-sales-277-835m-beat-258-078m-estimat", "tags": ["earnings"]}
{"id": 41897247, "time": "2024-11-12 07:19:35", "headline": "Axsome Says Current Cash Is Sufficient To Fund Anticipated Operations Into Cash Flow Positivity, Based On Current Operating Plan", "summary": "", "symbols": ["AXSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897247/axsome-says-current-cash-is-sufficient-to-fund-anticipated-operations-into-cash-flow-positivity-base", "tags": []}
{"id": 41897248, "time": "2024-11-12 07:19:37", "headline": "Treehouse Foods Sees Q4 Net Sales Of $900M-$930M Vs. $966.72M Estimate, Projects Adjusted EBITDA Of $116M-$126M", "summary": "", "symbols": ["THS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897248/treehouse-foods-sees-q4-net-sales-of-900m-930m-vs-966-72m-estimate-projects-adjusted-ebitda-of-116m", "tags": []}
{"id": 41897249, "time": "2024-11-12 07:19:37", "headline": "IHS Holding Q3 2024 GAAP EPS $(0.61) Misses $0.09 Estimate, Sales $420.282M Beat $410.029M Estimate", "summary": "", "symbols": ["IHS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897249/ihs-holding-q3-2024-gaap-eps-0-61-misses-0-09-estimate-sales-420-282m-beat-410-029m-estimate", "tags": ["earnings"]}
{"id": 41897251, "time": "2024-11-12 07:20:23", "headline": "Agrify Corporation To Acquire Se\u00f1orita Brand Of THC Beverages, Expanding Presence In Hemp-Derived Legal THC Market; Deal Expected To Close By Year-End; Financial Terms Not Disclosed", "summary": "", "symbols": ["AGFY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41897251/agrify-corporation-to-acquire-se-orita-brand-of-thc-beverages-expanding-presence-in-hemp-derived-leg", "tags": ["merger", "contract"]}
{"id": 41897270, "time": "2024-11-12 07:21:12", "headline": "Keybanc Maintains Overweight on Kite Realty Gr Trust, Raises Price Target to $31", "summary": "", "symbols": ["KRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897270/keybanc-maintains-overweight-on-kite-realty-gr-trust-raises-price-target-to-31", "tags": ["analyst_other", "price_target_up"]}
{"id": 41897280, "time": "2024-11-12 07:22:04", "headline": "Apogee Therapeutics Q3 2024 Net Loss Of $(49)M Vs. $(28)M In Q3 2023, $754M Cash, Cash Equivalents And Marketable Securities With Runway Into 2028", "summary": "", "symbols": ["APGE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897280/apogee-therapeutics-q3-2024-net-loss-of-49-m-vs-28-m-in-q3-2023-754m-cash-cash-equivalents-and-mark", "tags": []}
{"id": 41897281, "time": "2024-11-12 07:22:04", "headline": "Pagaya Technologies Q3 2024 Adj EPS $0.44 Beats $(0.19) Estimate, Sales $257.23M Beat $253.21M Estimate", "summary": "", "symbols": ["PGY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897281/pagaya-technologies-q3-2024-adj-eps-0-44-beats-0-19-estimate-sales-257-23m-beat-253-21m-estimate", "tags": ["earnings"]}
{"id": 41897290, "time": "2024-11-12 07:22:40", "headline": "908 Devices Cuts FY24 Reported 2024 Revenue Outlook From $63M - $65M To $56M - $58M, Est $63.673M", "summary": "", "symbols": ["MASS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897290/908-devices-cuts-fy24-reported-2024-revenue-outlook-from-63m-65m-to-56m-58m-est-63-673m", "tags": ["earnings", "guidance"]}
{"id": 41897293, "time": "2024-11-12 07:23:30", "headline": "Pagaya Technologies Sees FY24 Revenue $1.010B-$1.025B Vs $1.013B Est.", "summary": "", "symbols": ["PGY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897293/pagaya-technologies-sees-fy24-revenue-1-010b-1-025b-vs-1-013b-est", "tags": ["earnings"]}
{"id": 41897294, "time": "2024-11-12 07:23:42", "headline": "EVgo Raised The Midpoint Of FY24 Total Revenue Guidance By $2.5M  To $250M-$265M Vs. $257.34M Estimate (Prior View: $240M-$270M)", "summary": "", "symbols": ["EVGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897294/evgo-raised-the-midpoint-of-fy24-total-revenue-guidance-by-2-5m-to-250m-265m-vs-257-34m-estimate-pri", "tags": ["earnings", "guidance"]}
{"id": 41897298, "time": "2024-11-12 07:24:09", "headline": "Keybanc Maintains Overweight on Match Group, Lowers Price Target to $43", "summary": "", "symbols": ["MTCH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897298/keybanc-maintains-overweight-on-match-group-lowers-price-target-to-43", "tags": ["analyst_other", "price_target_down"]}
{"id": 41897340, "time": "2024-11-12 07:24:24", "headline": "DA Davidson Downgrades TriCo to Neutral, Raises Price Target to $53", "summary": "", "symbols": ["TCBK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897340/da-davidson-downgrades-trico-to-neutral-raises-price-target-to-53", "tags": ["analyst_down", "price_target_up"]}
{"id": 41897341, "time": "2024-11-12 07:24:27", "headline": "SU Group Secures Largest Contract In Company History With $4.4M Deal; $3.2M To Be Recognized As Revenue In 2024, Remainder In 2025", "summary": "", "symbols": ["SUGP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897341/su-group-secures-largest-contract-in-company-history-with-4-4m-deal-3-2m-to-be-recognized-as-revenue", "tags": ["earnings", "contract"]}
{"id": 41897343, "time": "2024-11-12 07:24:41", "headline": "CervoMed Q3 2024 GAAP EPS $(0.55) Misses $(0.38) Estimate, CervoMed Had Approximately $46.7M In Cash, Cash Equivalents And Marketable Securities, Expected To Provide Cash Runway Through 2025", "summary": "", "symbols": ["CRVO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897343/cervomed-q3-2024-gaap-eps-0-55-misses-0-38-estimate-cervomed-had-approximately-46-7m-in-cash-cash-e", "tags": ["earnings"]}
{"id": 41897353, "time": "2024-11-12 07:25:45", "headline": "TransCode Therapeutics Urges Shareholders To Approve Potential Reverse Stock Split To Maintain Nasdaq Listing Amidst Capital Raising Needs; Vote Scheduled For November 22", "summary": "", "symbols": ["RNAZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897353/transcode-therapeutics-urges-shareholders-to-approve-potential-reverse-stock-split-to-maintain-nasda", "tags": []}
{"id": 41897363, "time": "2024-11-12 07:26:34", "headline": "Kura Sushi USA Prices Public Offering Of 695,938 Shares At $85 Per Share For Approx. $56.2M In Net Proceeds; Offering Expected To Close On Nov. 13, With Option For Additional 104,390 Shares", "summary": "", "symbols": ["KRUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897363/kura-sushi-usa-prices-public-offering-of-695-938-shares-at-85-per-share-for-approx-56-2m-in-net-proc", "tags": ["offering"]}
{"id": 41897367, "time": "2024-11-12 07:27:09", "headline": "Rockwell Automation Integrates NVIDIA Omniverse Application Programming Interfaces Into Its Emulate3D Digital Twin Software To Enhance Factory Operations", "summary": "", "symbols": ["ROK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897367/rockwell-automation-integrates-nvidia-omniverse-application-programming-interfaces-into-its-emulate3", "tags": []}
{"id": 41897368, "time": "2024-11-12 07:27:26", "headline": "Apple Ordered By EU To End Geo-Blocking On App Store, iTunes And Other Apps", "summary": "These practices involve restricting content based on a user&#39;s geographical location. ", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/news/global/24/11/41897368/apple-ordered-by-eu-to-end-geo-blocking-on-app-store-itunes-and-other-apps", "tags": []}
{"id": 41897377, "time": "2024-11-12 07:27:35", "headline": "IGT Expects Q4 Revenue For Continuing Operations Of $640M - $690M, FY24 Revenue Of $2.50B - $2.55B (Est $2.506B)", "summary": "", "symbols": ["IGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897377/igt-expects-q4-revenue-for-continuing-operations-of-640m-690m-fy24-revenue-of-2-50b-2-55b-est-2-506b", "tags": ["earnings"]}
{"id": 41897393, "time": "2024-11-12 07:28:06", "headline": "Roivant Sciences Reports Q2 EPS Of $(0.31) Compared With $(0.40) YoY;  Company Had Consolidated Cash, Cash Equivalents, Restricted Cash And Marketable Securities Of Approximately $5.4B", "summary": "", "symbols": ["ROIV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897393/roivant-sciences-reports-q2-eps-of-0-31-compared-with-0-40-yoy-company-had-consolidated-cash-cash-eq", "tags": ["earnings"]}
{"id": 41897398, "time": "2024-11-12 07:28:51", "headline": "Perimeter Solutions Q3 2024 GAAP EPS $(0.61) Down From $0.12 YoY, Sales $288.417M Miss $288.530M Estimate", "summary": "", "symbols": ["PRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897398/perimeter-solutions-q3-2024-gaap-eps-0-61-down-from-0-12-yoy-sales-288-417m-miss-288-530m-estimate", "tags": ["earnings"]}
{"id": 41897400, "time": "2024-11-12 07:28:54", "headline": "F5 Reports Early Access Of F5 AI Gateway To Streamline Interactions Between Applications, APIs, And Large Language Models Driving Enterprise AI Adoption", "summary": "", "symbols": ["FFIV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897400/f5-reports-early-access-of-f5-ai-gateway-to-streamline-interactions-between-applications-apis-and-la", "tags": []}
{"id": 41897397, "time": "2024-11-12 07:29:00", "headline": "Bitcoin To Peak Between $100K-150K, Solana To Top $600 This Cycle, Say Hedge Funds, VCs", "summary": "A group of polled venture capital firms and hedge funds expected Bitcoin (CRYPTO: BTC) to peak between $100,000 and $150,000 this bull cycle, down from the astronomical forecasts set by other market researchers.", "symbols": ["BTC", "BTCUSD", "ETHUSD", "SOLUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41897397/bitcoin-to-peak-between-100k-150k-solana-to-top-600-this-cycle-say-hedge-funds-vcs", "tags": []}
{"id": 41897449, "time": "2024-11-12 07:29:45", "headline": "Roivant Sciences Q2 2025 GAAP EPS $(0.31) Misses $(0.26) Estimate", "summary": "", "symbols": ["ROIV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897449/roivant-sciences-q2-2025-gaap-eps-0-31-misses-0-26-estimate", "tags": ["earnings"]}
{"id": 41897450, "time": "2024-11-12 07:29:55", "headline": "IHS Holding Affirms FY2024 Sales Guidance from $1.67B-1.70B to $1.67B-1.70B  VS Est. $1.69B", "summary": "", "symbols": ["IHS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897450/ihs-holding-affirms-fy2024-sales-guidance-from-1-67b-1-70b-to-1-67b-1-70b-vs-est-1-69b", "tags": ["guidance"]}
{"id": 41897510, "time": "2024-11-12 07:30:22", "headline": "Micron Begins Qualification Of The 6550 ION NVMe SSD With Customers", "summary": "", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897510/micron-begins-qualification-of-the-6550-ion-nvme-ssd-with-customers", "tags": []}
{"id": 41897517, "time": "2024-11-12 07:30:37", "headline": "Tyson Foods Q4 2024 Adj. EPS $0.92 Beats $0.69 Estimate, Sales $13.565B Beat $13.392B Estimate", "summary": "", "symbols": ["TSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897517/tyson-foods-q4-2024-adj-eps-0-92-beats-0-69-estimate-sales-13-565b-beat-13-392b-estimate", "tags": ["earnings"]}
{"id": 41897520, "time": "2024-11-12 07:30:48", "headline": "Stephens & Co. Maintains Overweight on Illumina, Raises Price Target to $184", "summary": "", "symbols": ["ILMN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897520/stephens-co-maintains-overweight-on-illumina-raises-price-target-to-184", "tags": ["analyst_other", "price_target_up"]}
{"id": 41897522, "time": "2024-11-12 07:30:59", "headline": "Shimmick Names Ural Yal As New CEO Effective Dec. 2; Succeeds Retiring Steve Richards Following 43-Year Career", "summary": "", "symbols": ["SHIM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897522/shimmick-names-ural-yal-as-new-ceo-effective-dec-2-succeeds-retiring-steve-richards-following-43-yea", "tags": ["management"]}
{"id": 41897528, "time": "2024-11-12 07:31:30", "headline": "Kopin Q3 2024 GAAP EPS $(0.03) Beats $(0.04) Estimate, Sales $13.320M Beat $12.601M Estimate", "summary": "", "symbols": ["KOPN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897528/kopin-q3-2024-gaap-eps-0-03-beats-0-04-estimate-sales-13-320m-beat-12-601m-estimate", "tags": ["earnings"]}
{"id": 41897529, "time": "2024-11-12 07:31:31", "headline": "Cronos Group Q3 2024 Adj. EPS $(0.01), Inline, Sales $34.300M Beat $30.615M Estimate", "summary": "", "symbols": ["CRON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897529/cronos-group-q3-2024-adj-eps-0-01-inline-sales-34-300m-beat-30-615m-estimate", "tags": ["earnings"]}
{"id": 41897530, "time": "2024-11-12 07:31:36", "headline": "Quantum-Si Q3 2024 GAAP EPS $(0.18) Beats $(0.19) Estimate, Sales $787.00K Miss $1.08M Estimate", "summary": "", "symbols": ["QSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897530/quantum-si-q3-2024-gaap-eps-0-18-beats-0-19-estimate-sales-787-00k-miss-1-08m-estimate", "tags": ["earnings"]}
{"id": 41897533, "time": "2024-11-12 07:31:49", "headline": "Repligen Q3 2024 Adj. EPS $0.43 Beats $0.33 Estimate, Sales $154.870M Beat $153.230M Estimate", "summary": "", "symbols": ["RGEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897533/repligen-q3-2024-adj-eps-0-43-beats-0-33-estimate-sales-154-870m-beat-153-230m-estimate", "tags": ["earnings"]}
{"id": 41897534, "time": "2024-11-12 07:31:56", "headline": "WAVE Life Sciences Q3 2024 GAAP EPS $(0.47) Misses $(0.28) Estimate", "summary": "", "symbols": ["WVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897534/wave-life-sciences-q3-2024-gaap-eps-0-47-misses-0-28-estimate", "tags": ["earnings"]}
{"id": 41897535, "time": "2024-11-12 07:31:57", "headline": "Xenia Hotels & Resorts Proposes $365M Senior Notes Offering, Plans Full Redemption Of 2025 Debt", "summary": "", "symbols": ["XHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897535/xenia-hotels-resorts-proposes-365m-senior-notes-offering-plans-full-redemption-of-2025-debt", "tags": ["offering"]}
{"id": 41897554, "time": "2024-11-12 07:32:19", "headline": "DA Davidson Downgrades First Mid Bancshares to Neutral, Raises Price Target to $47", "summary": "", "symbols": ["FMBH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897554/da-davidson-downgrades-first-mid-bancshares-to-neutral-raises-price-target-to-47", "tags": ["analyst_down", "price_target_up"]}
{"id": 41897558, "time": "2024-11-12 07:32:27", "headline": "Nayax Q3 2024 GAAP EPS $0.02 Beats $0.01 Estimate, Sales $83.005M Miss $88.386M Estimate", "summary": "", "symbols": ["NYAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897558/nayax-q3-2024-gaap-eps-0-02-beats-0-01-estimate-sales-83-005m-miss-88-386m-estimate", "tags": ["earnings"]}
{"id": 41897570, "time": "2024-11-12 07:33:02", "headline": "Alight Q3 2024 Adj. EPS $0.09, Inline, Sales $555.000M Beat $539.685M Estimate", "summary": "", "symbols": ["ALIT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897570/alight-q3-2024-adj-eps-0-09-inline-sales-555-000m-beat-539-685m-estimate", "tags": ["earnings"]}
{"id": 41897573, "time": "2024-11-12 07:33:13", "headline": "Surgery Partners Reaffirmed 2024 outlook: revenues over $3.075 billion and Adjusted EBITDA over $508 million.", "summary": "", "symbols": ["SGRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897573/surgery-partners-reaffirmed-2024-outlook-revenues-over-3-075-billion-and-adjusted-ebitda-over-508-mi", "tags": ["guidance"]}
{"id": 41897574, "time": "2024-11-12 07:33:18", "headline": "Danaos Q3 2024 Adj. EPS $6.50 Misses $6.77 Estimate, Sales $256.176M Beat $247.115M Estimate", "summary": "", "symbols": ["DAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897574/danaos-q3-2024-adj-eps-6-50-misses-6-77-estimate-sales-256-176m-beat-247-115m-estimate", "tags": ["earnings"]}
{"id": 41897575, "time": "2024-11-12 07:33:21", "headline": "Suntory Beverage & Food Q3 EPS $0.40 Up From $0.32 YoY, Sales $3.09B Up From $3.08B YoY", "summary": "", "symbols": ["STBFY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897575/suntory-beverage-food-q3-eps-0-40-up-from-0-32-yoy-sales-3-09b-up-from-3-08b-yoy", "tags": ["earnings"]}
{"id": 41897576, "time": "2024-11-12 07:33:21", "headline": "Sphere Entertainment Q1 2025 GAAP EPS $(2.95) Misses $(1.96) Estimate, Sales $227.90M Miss $247.51M Estimate", "summary": "", "symbols": ["SPHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897576/sphere-entertainment-q1-2025-gaap-eps-2-95-misses-1-96-estimate-sales-227-90m-miss-247-51m-estimate", "tags": ["earnings"]}
{"id": 41897577, "time": "2024-11-12 07:33:23", "headline": "Baird Maintains Outperform on Neurogene, Raises Price Target to $72", "summary": "", "symbols": ["NGNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897577/baird-maintains-outperform-on-neurogene-raises-price-target-to-72", "tags": ["analyst_other", "price_target_up"]}
{"id": 41897578, "time": "2024-11-12 07:33:44", "headline": "Sunstone Hotel Invts Q3 Sales $226.392M vs $230.154M Estimate", "summary": "", "symbols": ["SHO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897578/sunstone-hotel-invts-q3-sales-226-392m-vs-230-154m-estimate", "tags": []}
{"id": 41897579, "time": "2024-11-12 07:34:22", "headline": "Quantum-Si Says It Is Likely That It Will Not Achieve Full Year Guided Revenue Range Of $3.7M - $4.2M; Est $3.974M", "summary": "", "symbols": ["QSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897579/quantum-si-says-it-is-likely-that-it-will-not-achieve-full-year-guided-revenue-range-of-3-7m-4-2m-es", "tags": ["earnings"]}
{"id": 41897603, "time": "2024-11-12 07:34:48", "headline": "HC Wainwright & Co. Reiterates Buy on Citius Pharma, Maintains $4 Price Target", "summary": "", "symbols": ["CTXR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897603/hc-wainwright-co-reiterates-buy-on-citius-pharma-maintains-4-price-target", "tags": ["analyst_other"]}
{"id": 41897604, "time": "2024-11-12 07:34:56", "headline": "Innovid Sees Q4 Sales $37.500M-39.500M vs $43.65M Est", "summary": "", "symbols": ["CTV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897604/innovid-sees-q4-sales-37-500m-39-500m-vs-43-65m-est", "tags": []}
{"id": 41897616, "time": "2024-11-12 07:35:10", "headline": "Innovid Lowers FY2024 Sales Guidance from $156.00M-163.00M to $150.50M-$152.50M", "summary": "", "symbols": ["CTV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897616/innovid-lowers-fy2024-sales-guidance-from-156-00m-163-00m-to-150-50m-152-50m", "tags": ["guidance"]}
{"id": 41897617, "time": "2024-11-12 07:35:15", "headline": "Endava Q1 2025 Adj EPS \u00a30.25 Vs. \u00a30.39 YoY, Sales \u00a3195.05M Beat \u00a3194.56M Estimate", "summary": "", "symbols": ["DAVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897617/endava-q1-2025-adj-eps-0-25-vs-0-39-yoy-sales-195-05m-beat-194-56m-estimate", "tags": ["earnings"]}
{"id": 41897618, "time": "2024-11-12 07:35:24", "headline": "Vaxcyte Announces FDA Clearance for VAX-31 Infant Phase 2 Study and Breakthrough Therapy Designation for Adult Phase 3 Study", "summary": "", "symbols": ["PCVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41897618/vaxcyte-announces-fda-clearance-for-vax-31-infant-phase-2-study-and-breakthrough-therapy-designat", "tags": ["fda"]}
{"id": 41897620, "time": "2024-11-12 07:35:44", "headline": "Market-Moving News for November 12th", "summary": "", "symbols": ["CAMT", "SHOP", "TSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41897620/market-moving-news-for-november-12th", "tags": []}
{"id": 41897621, "time": "2024-11-12 07:35:52", "headline": "Baird Maintains Neutral on Nevro, Raises Price Target to $6", "summary": "", "symbols": ["NVRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897621/baird-maintains-neutral-on-nevro-raises-price-target-to-6", "tags": ["analyst_other", "price_target_up"]}
{"id": 41897622, "time": "2024-11-12 07:35:52", "headline": "Garmin Unveils All-new Approach R50 Premium Launch Monitor And Golf Simulator", "summary": "", "symbols": ["GRMN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897622/garmin-unveils-all-new-approach-r50-premium-launch-monitor-and-golf-simulator", "tags": []}
{"id": 41897651, "time": "2024-11-12 07:36:45", "headline": "Alight Expects Q4 Revenue Of $665M-$685M Vs $680.98M Est, Adj EPS Of $0.22-$0.27 Vs $0.22 Est", "summary": "", "symbols": ["ALIT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897651/alight-expects-q4-revenue-of-665m-685m-vs-680-98m-est-adj-eps-of-0-22-0-27-vs-0-22-est", "tags": ["earnings"]}
{"id": 41897624, "time": "2024-11-12 07:36:17", "headline": "Brent Crude Stumbles As Market Sentiments Turn Cautious", "summary": "By RoboForex Analytical Department", "symbols": [], "source": "benzinga", "author": "Dmitriy Gurkovskiy", "url": "https://www.benzinga.com/trading-ideas/24/11/41897624/brent-crude-stumbles-as-market-sentiments-turn-cautious", "tags": []}
{"id": 41897652, "time": "2024-11-12 07:36:57", "headline": "DA Davidson Assumes Monday.Com at Neutral, Maintains Price Target of $300", "summary": "", "symbols": ["MNDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897652/da-davidson-assumes-monday-com-at-neutral-maintains-price-target-of-300", "tags": ["analyst_other"]}
{"id": 41897653, "time": "2024-11-12 07:36:59", "headline": "AAR Inks Multi-Year Deal With Chromalloy To Exclusively Supply CF6-80C2 Engine Parts", "summary": "", "symbols": ["AIR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897653/aar-inks-multi-year-deal-with-chromalloy-to-exclusively-supply-cf6-80c2-engine-parts", "tags": ["contract"]}
{"id": 41897656, "time": "2024-11-12 07:37:13", "headline": "Innovid Q3 2024 GAAP EPS $0.03 Beats $(0.01) Estimate, Sales $38.251M Miss $41.000M Estimate", "summary": "", "symbols": ["CTV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897656/innovid-q3-2024-gaap-eps-0-03-beats-0-01-estimate-sales-38-251m-miss-41-000m-estimate", "tags": ["earnings"]}
{"id": 41897657, "time": "2024-11-12 07:37:19", "headline": "Nayax Lowers FY2024 Sales Guidance from $325.00M-335.00M to $315.00M-$320.00M", "summary": "", "symbols": ["NYAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897657/nayax-lowers-fy2024-sales-guidance-from-325-00m-335-00m-to-315-00m-320-00m", "tags": ["guidance"]}
{"id": 41897658, "time": "2024-11-12 07:37:33", "headline": "Abeona Therapeutics Announces FDA Acceptance Of BLA Resubmission For Pz-cel In Recessive Dystrophic Epidermolysis Bullosa", "summary": "", "symbols": ["ABEO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897658/abeona-therapeutics-announces-fda-acceptance-of-bla-resubmission-for-pz-cel-in-recessive-dystrophic", "tags": ["fda"]}
{"id": 41897674, "time": "2024-11-12 07:38:22", "headline": "Mereo BioPharma Group Q3 2024 GAAP EPS $(0.02) Misses $1.31 Estimate", "summary": "", "symbols": ["MREO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897674/mereo-biopharma-group-q3-2024-gaap-eps-0-02-misses-1-31-estimate", "tags": ["earnings"]}
{"id": 41897679, "time": "2024-11-12 07:38:27", "headline": "Absci Q3 2024 GAAP EPS $(0.24) Misses $(0.20) Estimate, Sales $1.701M Miss $1.753M Estimate", "summary": "", "symbols": ["ABSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897679/absci-q3-2024-gaap-eps-0-24-misses-0-20-estimate-sales-1-701m-miss-1-753m-estimate", "tags": ["earnings"]}
{"id": 41897687, "time": "2024-11-12 07:38:41", "headline": "Alight's Board Initiated Quarterly Dividend Of $0.04/Share", "summary": "", "symbols": ["ALIT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897687/alights-board-initiated-quarterly-dividend-of-0-04share", "tags": ["dividend"]}
{"id": 41897671, "time": "2024-11-12 07:38:06", "headline": "Endava Expects Q2 2025 Revenue Of \u00a3195M-\u00a3197M, Representing A Constant Currency Revenue Increase Of 8.5%-9.5% On A Year Over Year Basis, With Adjusted Diluted EPS Of \u00a30.24-\u00a30.25", "summary": "", "symbols": ["DAVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897671/endava-expects-2024-revenue-of-195m-197m-representing-a-constant-currency-revenue-increase-of-8-5-9", "tags": ["earnings", "offering"]}
{"id": 41897690, "time": "2024-11-12 07:38:53", "headline": "Repligen Raises FY24 GAAP EPS Guidance from $0.17-$0.24 to $0.25-0.32 vs $0.54 Est; Narrows Sales Guidance from $627.00M-$642.00M to $630.00M-639.00M vs $628.98M Est", "summary": "", "symbols": ["RGEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897690/repligen-raises-fy24-gaap-eps-guidance-from-0-17-0-24-to-0-25-0-32-vs-0-54-est-narrows-sales-guidanc", "tags": ["earnings", "guidance"]}
{"id": 41897692, "time": "2024-11-12 07:39:28", "headline": "BrainsWay Raises FY2024 Sales Guidance to $40.00M-$41.00M  VS Est. $39.86M", "summary": "", "symbols": ["BWAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897692/brainsway-raises-fy2024-sales-guidance-to-40-00m-41-00m-vs-est-39-86m", "tags": ["guidance"]}
{"id": 41897765, "time": "2024-11-12 07:39:58", "headline": "BrainsWay Q3 2024 GAAP EPS $0.02 Beats $0.01 Estimate, Sales $10.502M Beat $10.168M Estimate", "summary": "", "symbols": ["BWAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897765/brainsway-q3-2024-gaap-eps-0-02-beats-0-01-estimate-sales-10-502m-beat-10-168m-estimate", "tags": ["earnings"]}
{"id": 41897766, "time": "2024-11-12 07:40:00", "headline": "Pyxis Oncology Q3 2024 GAAP EPS $(0.35) Misses $(0.31) Estimate", "summary": "", "symbols": ["PYXS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897766/pyxis-oncology-q3-2024-gaap-eps-0-35-misses-0-31-estimate", "tags": ["earnings"]}
{"id": 41897767, "time": "2024-11-12 07:40:05", "headline": "Surgery Partners Q3 Adj $0.19 Misses $0.25 Estimate, Sales $770.40M Beat $769.76M Estimate", "summary": "", "symbols": ["SGRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897767/surgery-partners-q3-adj-0-19-misses-0-25-estimate-sales-770-40m-beat-769-76m-estimate", "tags": []}
{"id": 41897769, "time": "2024-11-12 07:40:09", "headline": "Avidity Biosciences Says It Is Opening Up New Therapeutic Field, Precision Cardiology, To Address Root Cause Of Genetic Diseases Of Heart", "summary": "", "symbols": ["RNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897769/avidity-biosciences-says-it-is-opening-up-new-therapeutic-field-precision-cardiology-to-address-root", "tags": []}
{"id": 41897778, "time": "2024-11-12 07:40:40", "headline": "Shimmick Q3 2024 Adj. EPS $0.72 Down From $1.67 YoY, Sales $166.035M Beat $120.050M Estimate", "summary": "", "symbols": ["SHIM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897778/shimmick-q3-2024-adj-eps-0-72-down-from-1-67-yoy-sales-166-035m-beat-120-050m-estimate", "tags": ["earnings"]}
{"id": 41897779, "time": "2024-11-12 07:40:43", "headline": "23andMe Holding Q2 2025 GAAP EPS $(2.32), Sales $44.071M Miss $54.300M Estimate", "summary": "", "symbols": ["ME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897779/23andme-holding-q2-2025-gaap-eps-2-32-sales-44-071m-miss-54-300m-estimate", "tags": ["earnings"]}
{"id": 41897780, "time": "2024-11-12 07:40:52", "headline": "Needham Reiterates Buy on Axsome Therapeutics, Maintains $130 Price Target", "summary": "", "symbols": ["AXSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897780/needham-reiterates-buy-on-axsome-therapeutics-maintains-130-price-target", "tags": ["analyst_other"]}
{"id": 41897783, "time": "2024-11-12 07:41:02", "headline": "Janney Montgomery Scott Upgrades South Atlantic Bancshares to Buy", "summary": "", "symbols": ["SABK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897783/janney-montgomery-scott-upgrades-south-atlantic-bancshares-to-buy", "tags": ["analyst_up"]}
{"id": 41897785, "time": "2024-11-12 07:41:07", "headline": "Repligen Raises FY24 Adj EPS Guidance from $1.42-$1.49 to $1.50-$1.58 vs $1.43 Est", "summary": "", "symbols": ["RGEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897785/repligen-raises-fy24-adj-eps-guidance-from-1-42-1-49-to-1-50-1-58-vs-1-43-est", "tags": ["earnings", "guidance"]}
{"id": 41897786, "time": "2024-11-12 07:41:18", "headline": "Endava Expects 2025 Revenue Of \u00a3800M-\u00a3810M Versus Consensus Of \u00a3802.876M, With Adjusted Diluted EPS Of \u00a31.12-\u00a31.17 Versus Consensus Of \u00a31.133", "summary": "", "symbols": ["DAVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897786/endava-expects-2025-revenue-of-800m-810m-versus-consensus-of-802-876m-with-adjusted-diluted-eps-of-", "tags": ["earnings", "offering"]}
{"id": 41897889, "time": "2024-11-12 07:41:58", "headline": "Dragonfly Energy Signs Memorandum Of Understanding With Bruker To Collaborate And Improve Current And Next-Generation Battery Technology And Battery Materials", "summary": "", "symbols": ["BRKR", "DFLI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897889/dragonfly-energy-signs-memorandum-of-understanding-with-bruker-to-collaborate-and-improve-current-an", "tags": []}
{"id": 41897890, "time": "2024-11-12 07:42:13", "headline": "GeoPark's Confluencia Norte Block Delivers 4,000 BOPD, Confirms High Potential In Vaca Muerta Exploration", "summary": "", "symbols": ["GPRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897890/geoparks-confluencia-norte-block-delivers-4-000-bopd-confirms-high-potential-in-vaca-muerta-explorat", "tags": []}
{"id": 41897894, "time": "2024-11-12 07:42:20", "headline": "ProKidney Q3 2024 GAAP EPS $(0.14) Beats $(0.17) Estimate", "summary": "", "symbols": ["PROK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897894/prokidney-q3-2024-gaap-eps-0-14-beats-0-17-estimate", "tags": ["earnings"]}
{"id": 41897895, "time": "2024-11-12 07:42:23", "headline": "Trump Taps Lee Zeldin To Lead EPA, The Ex-Congressman Who Previously Voted Against Biden's Act Aimed At Combating Climate Change", "summary": "President-elect Donald Trump said on Monday that he will appoint former Congressman Lee Zeldin as the administrator of the Environmental Protection Agency, or EPA.", "symbols": [], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/news/24/11/41897895/trump-taps-lee-zeldin-to-lead-epa-the-ex-congressman-who-previously-voted-against-bidens-act-aimed-at-combating-climate-change", "tags": ["management"]}
{"id": 41897937, "time": "2024-11-12 07:43:03", "headline": "Janney Montgomery Scott Upgrades Avidbank Holdings to Buy, Announces $26 Price Target", "summary": "", "symbols": ["AVBH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897937/janney-montgomery-scott-upgrades-avidbank-holdings-to-buy-announces-26-price-target", "tags": ["analyst_up"]}
{"id": 41897939, "time": "2024-11-12 07:43:27", "headline": "US Stocks May Cool As Trump Win-Fueled Rally Nears Potential Pause Amid Profit-Taking, Says Investment Bank: '...May Limit Further Upside'", "summary": "Citigroup Inc. forecasts a blip in the ongoing stock market rally, which has been unfolding since the U.S. presidential elections. As per the strategists at Citigroup, the rally fueled by Donald Trump&#39;s return to the White House will lose steam as investors start to book profits.", "symbols": ["QQQ", "SPY"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/general/market-summary/24/11/41897939/us-stocks-may-cool-as-trump-win-fueled-rally-nears-potential-pause-amid-profit-taking-says-investment-bank-may-limit-further-upside", "tags": []}
{"id": 41897960, "time": "2024-11-12 07:43:55", "headline": "Viridian Therapeutics Q3 2024 GAAP EPS $(1.15) Misses $(1.06) Estimate, Sales $86.00K Beat $45.77K Estimate", "summary": "", "symbols": ["VRDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897960/viridian-therapeutics-q3-2024-gaap-eps-1-15-misses-1-06-estimate-sales-86-00k-beat-45-77k-estimate", "tags": ["earnings"]}
{"id": 41897964, "time": "2024-11-12 07:44:03", "headline": "Syndax Pharmaceuticals Announced Topline Results From The Relapsed Or Refractory Mutant Npm1 Acute Myeloid Leukemia Cohort In The Phase 2 Portion Of The AUGMENT-101 Trial Of Revumenib", "summary": "", "symbols": ["SNDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41897964/syndax-pharmaceuticals-announced-topline-results-from-the-relapsed-or-refractory-mutant-npm1-acut", "tags": ["fda"]}
{"id": 41897967, "time": "2024-11-12 07:44:28", "headline": "Ondas Holdings Q3 2024 GAAP EPS $(0.15) Misses $(0.12) Estimate, Sales $1.48M Miss $1.85M Estimate", "summary": "", "symbols": ["ONDS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897967/ondas-holdings-q3-2024-gaap-eps-0-15-misses-0-12-estimate-sales-1-48m-miss-1-85m-estimate", "tags": ["earnings"]}
{"id": 41897969, "time": "2024-11-12 07:44:40", "headline": "EchoStar Q3 2024 GAAP EPS $(0.52) Misses $(0.37) Estimate, Total Revenue $3.890B Miss $3.909B Estimate", "summary": "", "symbols": ["SATS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41897969/echostar-q3-2024-gaap-eps-0-52-misses-0-37-estimate-total-revenue-3-890b-miss-3-909b-estimate", "tags": ["earnings"]}
{"id": 41898011, "time": "2024-11-12 07:44:59", "headline": "Viridian Says Current Cash And Equivalents Will Be Sufficient To Fund Its Operations Into H2 Of 2027", "summary": "", "symbols": ["VRDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898011/viridian-says-current-cash-and-equivalents-will-be-sufficient-to-fund-its-operations-into-h2-of-2027", "tags": []}
{"id": 41898040, "time": "2024-11-12 07:46:02", "headline": "ZenaTech Expands Portfolio with Acquisition Of InterlinkONE And Interactive Systems, Integrates With AI Drone For Autonomous Inventory", "summary": "", "symbols": ["ZENA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41898040/zenatech-expands-portfolio-with-acquisition-of-interlinkone-and-interactive-systems-integrates-with", "tags": []}
{"id": 41898052, "time": "2024-11-12 07:46:10", "headline": "Cognyte Authorizes $20M Share Repurchase Program", "summary": "", "symbols": ["CGNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898052/cognyte-authorizes-20m-share-repurchase-program", "tags": ["buyback"]}
{"id": 41898053, "time": "2024-11-12 07:46:18", "headline": "Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $22 Price Target", "summary": "", "symbols": ["AVDL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898053/needham-reiterates-buy-on-avadel-pharmaceuticals-maintains-22-price-target", "tags": ["analyst_other"]}
{"id": 41898054, "time": "2024-11-12 07:46:29", "headline": "Jefferies Downgrades GSK to Hold", "summary": "", "symbols": ["GSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898054/jefferies-downgrades-gsk-to-hold", "tags": ["analyst_down"]}
{"id": 41898058, "time": "2024-11-12 07:47:28", "headline": "ImmunityBio Q3 2024 GAAP EPS $(0.14) Beats $(0.18) Estimate, Sales $6.11M Beat $2.93M Estimate", "summary": "", "symbols": ["IBRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898058/immunitybio-q3-2024-gaap-eps-0-14-beats-0-18-estimate-sales-6-11m-beat-2-93m-estimate", "tags": ["earnings"]}
{"id": 41898059, "time": "2024-11-12 07:47:30", "headline": "Fonar Q1 2025 EPS $0.46 Down From $0.59 YoY, Sales $24.96M Down From $25.84M YoY", "summary": "", "symbols": ["FONR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898059/fonar-q1-2025-eps-0-46-down-from-0-59-yoy-sales-24-96m-down-from-25-84m-yoy", "tags": ["earnings"]}
{"id": 41898060, "time": "2024-11-12 07:47:55", "headline": "Teledyne FLIR Defense Secures $168M IDIQ Contract From U.S. Army For M1135 Stryker Nuclear, Biological, And Chemical Reconnaissance Vehicle Program; $7.5M Initial Delivery Order", "summary": "", "symbols": ["TDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898060/teledyne-flir-defense-secures-168m-idiq-contract-from-u-s-army-for-m1135-stryker-nuclear-biological", "tags": ["contract"]}
{"id": 41898061, "time": "2024-11-12 07:47:56", "headline": "Bicara Therapeutics Q3 2024 GAAP EPS $(1.60) Misses $(0.44) Estimate", "summary": "", "symbols": ["BCAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898061/bicara-therapeutics-q3-2024-gaap-eps-1-60-misses-0-44-estimate", "tags": ["earnings"]}
{"id": 41898062, "time": "2024-11-12 07:48:00", "headline": "Jefferies Downgrades Hudson Pacific Properties to Hold, Lowers Price Target to $5", "summary": "", "symbols": ["HPP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898062/jefferies-downgrades-hudson-pacific-properties-to-hold-lowers-price-target-to-5", "tags": ["analyst_down", "price_target_down"]}
{"id": 41898065, "time": "2024-11-12 07:48:41", "headline": "Needham Reiterates Buy on Genius Sports, Maintains $9 Price Target", "summary": "", "symbols": ["GENI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898065/needham-reiterates-buy-on-genius-sports-maintains-9-price-target", "tags": ["analyst_other"]}
{"id": 41898174, "time": "2024-11-12 07:49:45", "headline": "ReAlpha Tech Corp Q3 EPS $(0.05), Sales $339K", "summary": "", "symbols": ["AIRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898174/realpha-tech-corp-q3-eps-0-05-sales-339k", "tags": ["earnings"]}
{"id": 41898175, "time": "2024-11-12 07:49:45", "headline": "Avalo Therapeutics Has Received $69.4M In Gross Proceeds From The Full Exercise Of The Warrants Issued In March 2024 Private Placement", "summary": "", "symbols": ["AVTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41898175/avalo-therapeutics-has-received-69-4m-in-gross-proceeds-from-the-full-exercise-of-the-warrants-is", "tags": ["offering"]}
{"id": 41898229, "time": "2024-11-12 07:50:56", "headline": "Sypris Solutions Q3 EPS $0.02 Up From $(0.03) YoY, Sales $35.66M Up From $33.58M YoY", "summary": "", "symbols": ["SYPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898229/sypris-solutions-q3-eps-0-02-up-from-0-03-yoy-sales-35-66m-up-from-33-58m-yoy", "tags": ["earnings"]}
{"id": 41898237, "time": "2024-11-12 07:51:35", "headline": "IO Biotech Q3 2024 GAAP EPS $(0.36) Misses $(0.27) Estimate, Ended Third Quarter With Approximately $80M In Cash And Cash Equivalents; The Company Continues To Expect Its Cash Position Will Support Operations Into Q4 Of 2025", "summary": "", "symbols": ["IOBT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898237/io-biotech-q3-2024-gaap-eps-0-36-misses-0-27-estimate-ended-third-quarter-with-approximately-80m-in", "tags": ["earnings"]}
{"id": 41898243, "time": "2024-11-12 07:51:59", "headline": "Jefferies Downgrades AeroVironment to Hold, Maintains Price Target to $240", "summary": "", "symbols": ["AVAV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898243/jefferies-downgrades-aerovironment-to-hold-maintains-price-target-to-240", "tags": ["analyst_down", "analyst_other"]}
{"id": 41898267, "time": "2024-11-12 07:53:44", "headline": "GRAVITY Co Q3 EPS $2.45 Down From $3.09 YoY", "summary": "", "symbols": ["GRVY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898267/gravity-co-q3-eps-2-45-down-from-3-09-yoy", "tags": ["earnings"]}
{"id": 41898269, "time": "2024-11-12 07:54:01", "headline": "BridgeBio Pharma Q3 2024 GAAP EPS $(0.86) Beats $(0.99) Estimate, Sales $2.73M Miss $3.76M Estimate", "summary": "", "symbols": ["BBIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898269/bridgebio-pharma-q3-2024-gaap-eps-0-86-beats-0-99-estimate-sales-2-73m-miss-3-76m-estimate", "tags": ["earnings"]}
{"id": 41898271, "time": "2024-11-12 07:54:27", "headline": "Jacobs Secures Contract For Equalization Basins In L.A.'s Push To Boost Recycled Water Production", "summary": "", "symbols": ["J"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898271/jacobs-secures-contract-for-equalization-basins-in-l-a-s-push-to-boost-recycled-water-production", "tags": ["contract"]}
{"id": 41898322, "time": "2024-11-12 07:56:13", "headline": "Spyre Therapeutics Announced Interim Phase 1 Data From Its First-in-human Trial Of SPY001, An Investigational Novel, Extended Half-life Monoclonal Antibody Targeting \u03b14\u03b27", "summary": "", "symbols": ["SYRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41898322/spyre-therapeutics-announced-interim-phase-1-data-from-its-first-in-human-trial-of-spy001-an-inve", "tags": ["fda"]}
{"id": 41898323, "time": "2024-11-12 07:56:26", "headline": "Benchmark Reiterates Buy on Talos Energy, Maintains $20 Price Target", "summary": "", "symbols": ["TALO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898323/benchmark-reiterates-buy-on-talos-energy-maintains-20-price-target", "tags": ["analyst_other"]}
{"id": 41898332, "time": "2024-11-12 07:57:12", "headline": "Dyne Therapeutics Q3 2024 GAAP EPS $(0.96) Misses $(0.78) Estimate", "summary": "", "symbols": ["DYN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898332/dyne-therapeutics-q3-2024-gaap-eps-0-96-misses-0-78-estimate", "tags": ["earnings"]}
{"id": 41898333, "time": "2024-11-12 07:57:37", "headline": "Magnolia Oil & Gas Intends To Offer $400M Of Senior Unsecured Notes Due 2032", "summary": "", "symbols": ["MGY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898333/magnolia-oil-gas-intends-to-offer-400m-of-senior-unsecured-notes-due-2032", "tags": []}
{"id": 41898344, "time": "2024-11-12 07:57:56", "headline": "Dyne Therapeutics' Cash, Cash Equivalents And Marketable Securities Were $723.7M As Of September 30, 2024, Which Is Anticipated To Fund Operations At Least Into The Second Half Of 2026", "summary": "", "symbols": ["DYN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41898344/dyne-therapeutics-cash-cash-equivalents-and-marketable-securities-were-723-7m-as-of-september-30-", "tags": []}
{"id": 41898355, "time": "2024-11-12 07:58:11", "headline": "Baird Maintains Outperform on Atmus Filtration Techs, Raises Price Target to $48", "summary": "", "symbols": ["ATMU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898355/baird-maintains-outperform-on-atmus-filtration-techs-raises-price-target-to-48", "tags": ["analyst_other", "price_target_up"]}
{"id": 41898356, "time": "2024-11-12 07:58:28", "headline": "Heron Therapeutics Q3 2024 GAAP EPS $(0.03), Inline, Sales $32.80M Miss $36.93M Estimate", "summary": "", "symbols": ["HRTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898356/heron-therapeutics-q3-2024-gaap-eps-0-03-inline-sales-32-80m-miss-36-93m-estimate", "tags": ["earnings"]}
{"id": 41898369, "time": "2024-11-12 07:58:51", "headline": "Benchmark Maintains Buy on PAR Technology, Raises Price Target to $92", "summary": "", "symbols": ["PAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898369/benchmark-maintains-buy-on-par-technology-raises-price-target-to-92", "tags": ["analyst_other", "price_target_up"]}
{"id": 41898372, "time": "2024-11-12 07:59:44", "headline": "Baird Maintains Outperform on Kimco Realty, Raises Price Target to $26", "summary": "", "symbols": ["KIM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898372/baird-maintains-outperform-on-kimco-realty-raises-price-target-to-26", "tags": ["analyst_other", "price_target_up"]}
{"id": 41898373, "time": "2024-11-12 07:59:57", "headline": "EXCLUSIVE: Pineapple Financial Tells Benzinga Co. Expands Network With Additional Of Two Affiliate Brokerages And Reports Record Growth In Agent Network", "summary": "", "symbols": ["PAPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898373/exclusive-pineapple-financial-tells-benzinga-co-expands-network-with-additional-of-two-affiliate-bro", "tags": []}
{"id": 41898699, "time": "2024-11-12 08:00:41", "headline": "Benchmark Reiterates Buy on Grab Holdings, Maintains $6 Price Target", "summary": "", "symbols": ["GRAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898699/benchmark-reiterates-buy-on-grab-holdings-maintains-6-price-target", "tags": ["analyst_other"]}
{"id": 41898727, "time": "2024-11-12 08:00:56", "headline": "Baird Maintains Outperform on Plymouth Industrial REIT, Lowers Price Target to $25", "summary": "", "symbols": ["PLYM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898727/baird-maintains-outperform-on-plymouth-industrial-reit-lowers-price-target-to-25", "tags": ["analyst_other", "price_target_down"]}
{"id": 41898738, "time": "2024-11-12 08:01:20", "headline": "Heron Therapeutics Narrows FY24 Guidance For Product Revenues, Net, Adjusted Operating Expenses, And Adjusted EBITDA", "summary": "", "symbols": ["HRTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898738/heron-therapeutics-narrows-fy24-guidance-for-product-revenues-net-adjusted-operating-expenses-and-ad", "tags": ["guidance"]}
{"id": 41898739, "time": "2024-11-12 08:01:26", "headline": "Hertz Global Holdings Q3 2024 Adj. EPS $(0.68) Misses $(0.50) Estimate, Sales $2.600B Miss $2.696B Estimate", "summary": "", "symbols": ["HTZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898739/hertz-global-holdings-q3-2024-adj-eps-0-68-misses-0-50-estimate-sales-2-600b-miss-2-696b-estimate", "tags": ["earnings"]}
{"id": 41898745, "time": "2024-11-12 08:01:55", "headline": "FreightCar America Q3 2024 Adj. EPS $0.08, Inline, Sales $113.255M Miss $137.826M Estimate", "summary": "", "symbols": ["RAIL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898745/freightcar-america-q3-2024-adj-eps-0-08-inline-sales-113-255m-miss-137-826m-estimate", "tags": ["earnings"]}
{"id": 41898746, "time": "2024-11-12 08:02:00", "headline": "Leerink Partners Upgrades Bristol-Myers Squibb to Outperform, Raises Price Target to $73", "summary": "", "symbols": ["BMY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898746/leerink-partners-upgrades-bristol-myers-squibb-to-outperform-raises-price-target-to-73", "tags": ["analyst_up", "price_target_up"]}
{"id": 41898751, "time": "2024-11-12 08:02:09", "headline": "Baird Maintains Neutral on Aramark, Raises Price Target to $44", "summary": "", "symbols": ["ARMK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898751/baird-maintains-neutral-on-aramark-raises-price-target-to-44", "tags": ["analyst_other", "price_target_up"]}
{"id": 41898753, "time": "2024-11-12 08:02:15", "headline": "Ampco-Pittsburgh Q3 EPS $(0.10) Down From $0.04 YoY, Sales $96.17M Down From $102.22M YoY", "summary": "", "symbols": ["AP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898753/ampco-pittsburgh-q3-eps-0-10-down-from-0-04-yoy-sales-96-17m-down-from-102-22m-yoy", "tags": ["earnings"]}
{"id": 41898757, "time": "2024-11-12 08:02:22", "headline": "Hertz Says Co 'expects to substantially complete the fleet rotation by the end of 2025, at which time it expects that DPU could normalize to under $300.'", "summary": "", "symbols": ["HTZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898757/hertz-says-co-expects-to-substantially-complete-the-fleet-rotation-by-the-end-of-2025-at-which-time", "tags": []}
{"id": 41898758, "time": "2024-11-12 08:02:30", "headline": "Mirum Pharmaceuticals Q3 2024 GAAP EPS $(0.30) Beats $(0.44) Estimate, Sales $90.30M Beat $82.02M Estimate", "summary": "", "symbols": ["MIRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898758/mirum-pharmaceuticals-q3-2024-gaap-eps-0-30-beats-0-44-estimate-sales-90-30m-beat-82-02m-estimate", "tags": ["earnings"]}
{"id": 41898759, "time": "2024-11-12 08:02:35", "headline": "Motorcar Parts of America Q2 Sales $208.19M Beat $204.50M Estimate", "summary": "", "symbols": ["MPAA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898759/motorcar-parts-of-america-q2-sales-208-19m-beat-204-50m-estimate", "tags": []}
{"id": 41898760, "time": "2024-11-12 08:02:40", "headline": "Golden Matrix Group Q3 EPS $(0.03), Same YoY, Sales $40.99M Up From $11.31M YoY", "summary": "", "symbols": ["GMGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898760/golden-matrix-group-q3-eps-0-03-same-yoy-sales-40-99m-up-from-11-31m-yoy", "tags": ["earnings"]}
{"id": 41898762, "time": "2024-11-12 08:02:58", "headline": "Exagen Sees FY2024 Sales $55.000M-56.000M vs $57.22M Est", "summary": "", "symbols": ["XGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898762/exagen-sees-fy2024-sales-55-000m-56-000m-vs-57-22m-est", "tags": []}
{"id": 41898765, "time": "2024-11-12 08:03:03", "headline": "Ginkgo Bioworks Completes Milestone Under Merck Collaboration, Will Receive $9M In Cash", "summary": "", "symbols": ["DNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898765/ginkgo-bioworks-completes-milestone-under-merck-collaboration-will-receive-9m-in-cash", "tags": []}
{"id": 41898768, "time": "2024-11-12 08:03:23", "headline": "EVI Industries Q1 EPS $0.21 Up From $0.09 YoY, Sales $93.62M Up From $88.07M YoY", "summary": "", "symbols": ["EVI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898768/evi-industries-q1-eps-0-21-up-from-0-09-yoy-sales-93-62m-up-from-88-07m-yoy", "tags": ["earnings"]}
{"id": 41898769, "time": "2024-11-12 08:03:36", "headline": "Baird Maintains Neutral on Monday.Com, Raises Price Target to $270", "summary": "", "symbols": ["MNDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898769/baird-maintains-neutral-on-monday-com-raises-price-target-to-270", "tags": ["analyst_other", "price_target_up"]}
{"id": 41898770, "time": "2024-11-12 08:03:49", "headline": "Tokyo Lifestyle Co., Announces Plan Of ADS Ratio Change From 1 ADS Representing 1 Ordinary Share To 1 ADS Representing 10 Ordinary Shares, Effective November 15, 2024", "summary": "", "symbols": ["TKLF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898770/tokyo-lifestyle-co-announces-plan-of-ads-ratio-change-from-1-ads-representing-1-ordinary-share-to-1", "tags": []}
{"id": 41898771, "time": "2024-11-12 08:03:57", "headline": "EXCLUSIVE: Pineapple Adds Luxe Lending And Mortgage Magic, Eyes Strong Revenue Growth", "summary": "Pineapple Financial Inc. (NYSE: PAPL) expands with two new affiliates, strengthening its position as a leader in the Canadian mortgage industry and utilizing AI and data-driven solutions for personalized options.", "symbols": ["PAPL"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/news/24/11/41898771/exclusive-pineapple-adds-luxe-lending-and-mortgage-magic-eyes-strong-revenue-growth", "tags": ["earnings"]}
{"id": 41898772, "time": "2024-11-12 08:03:59", "headline": "Novavax Q3 2024 GAAP EPS $(0.76) Beats $(0.83) Estimate, Sales $84.51M Beat $65.78M Estimate", "summary": "", "symbols": ["NVAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898772/novavax-q3-2024-gaap-eps-0-76-beats-0-83-estimate-sales-84-51m-beat-65-78m-estimate", "tags": ["earnings"]}
{"id": 41898773, "time": "2024-11-12 08:04:02", "headline": "Exagen Q3 EPS $(0.28) Beats $(0.29) Estimate, Sales $12.51M Miss $13.56M Estimate", "summary": "", "symbols": ["XGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898773/exagen-q3-eps-0-28-beats-0-29-estimate-sales-12-51m-miss-13-56m-estimate", "tags": ["earnings"]}
{"id": 41898775, "time": "2024-11-12 08:04:05", "headline": "Actuate Granted FDA Rare Pediatric Disease Designation For Elraglusib In Treatment Of Ewing Sarcoma", "summary": "", "symbols": ["ACTU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898775/actuate-granted-fda-rare-pediatric-disease-designation-for-elraglusib-in-treatment-of-ewing-sarcoma", "tags": ["fda"]}
{"id": 41898787, "time": "2024-11-12 08:04:49", "headline": "ENDRA Life Sciences' TAEUS Technology To Be Showcased At AASLD Liver Meeting 2024; Study Focuses On Noninvasive Liver Fat Assessment In High BMI Patients", "summary": "", "symbols": ["NDRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41898787/endra-life-sciences-taeus-technology-to-be-showcased-at-aasld-liver-meeting-2024-study-focuses-on", "tags": []}
{"id": 41898788, "time": "2024-11-12 08:04:53", "headline": "Aemetis Q3 2024 GAAP EPS $(0.38) Beats $(0.43) Estimate, Sales $81.441M Beat $75.756M Estimate", "summary": "", "symbols": ["AMTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898788/aemetis-q3-2024-gaap-eps-0-38-beats-0-43-estimate-sales-81-441m-beat-75-756m-estimate", "tags": ["earnings"]}
{"id": 41898806, "time": "2024-11-12 08:05:23", "headline": "SmartKem Q3 EPS $(0.86) Up From $(1.78) YoY", "summary": "", "symbols": ["SMTK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898806/smartkem-q3-eps-0-86-up-from-1-78-yoy", "tags": ["earnings"]}
{"id": 41898807, "time": "2024-11-12 08:05:41", "headline": "Lifeward Q3 2024 Adj. EPS $(0.45) Misses $(0.32) Estimate, Sales $6.128M Miss $8.450M Estimate", "summary": "", "symbols": ["LFWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898807/lifeward-q3-2024-adj-eps-0-45-misses-0-32-estimate-sales-6-128m-miss-8-450m-estimate", "tags": ["earnings"]}
{"id": 41898874, "time": "2024-11-12 08:06:01", "headline": "Evaxion Reports Preclinical Results For CMV Vaccine Program EVX-V1; AI-Immunology Platform Identifies CMV Antigens That Trigger Targeted Immune Response, With Proprietary gB Antigen Demonstrating Virus Neutralization", "summary": "", "symbols": ["EVAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41898874/evaxion-reports-preclinical-results-for-cmv-vaccine-program-evx-v1-ai-immunology-platform-identif", "tags": []}
{"id": 41898876, "time": "2024-11-12 08:06:08", "headline": "Novavax Expects 2024 Total Revenues Of $650M-$700M Versus Prior Guidance Of $700M-$800M And Consensus Of $761.458M", "summary": "", "symbols": ["NVAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41898876/novavax-expects-2024-total-revenues-of-650m-700m-versus-prior-guidance-of-700m-800m-and-consensus", "tags": ["guidance"]}
{"id": 41898877, "time": "2024-11-12 08:06:08", "headline": "Barclays Downgrades Atlas Energy Solutions to Equal-Weight, Lowers Price Target to $19", "summary": "", "symbols": ["AESI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898877/barclays-downgrades-atlas-energy-solutions-to-equal-weight-lowers-price-target-to-19", "tags": ["analyst_down", "price_target_down"]}
{"id": 41898879, "time": "2024-11-12 08:06:09", "headline": "BJ's Wholesale Club Names Scott Schmadeke Chief Operations Officer,  Effective Immediately", "summary": "", "symbols": ["BJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898879/bjs-wholesale-club-names-scott-schmadeke-chief-operations-officer-effective-immediately", "tags": []}
{"id": 41898880, "time": "2024-11-12 08:06:41", "headline": "Enlivex Announces Enrollment And Dosing Of First 10 Patients In The Randomized Phase II Stage Of Its Allocetra Trial For Patients With Moderate To Severe Knee Osteoarthritis", "summary": "", "symbols": ["ENLV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41898880/enlivex-announces-enrollment-and-dosing-of-first-10-patients-in-the-randomized-phase-ii-stage-of-", "tags": ["fda"]}
{"id": 41898885, "time": "2024-11-12 08:06:46", "headline": "NV5 Secures $46M In Contracts From Western Utilities For Fire Mitigation And Grid Hardening In Western U.S.; $38M For Undergrounding Power Lines And $8M For Grid Hardening Initiatives", "summary": "", "symbols": ["NVEE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898885/nv5-secures-46m-in-contracts-from-western-utilities-for-fire-mitigation-and-grid-hardening-in-wester", "tags": []}
{"id": 41898889, "time": "2024-11-12 08:07:07", "headline": "Freightcar America Raises FY24 Adjusted EBITDA Outlook To $37M-$39M (Prior View: $35M-$39M), Reiterates FY24 Sales Outlook To $560M-$600M", "summary": "", "symbols": ["RAIL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898889/freightcar-america-raises-fy24-adjusted-ebitda-outlook-to-37m-39m-prior-view-35m-39m-reiterates-fy24", "tags": ["analyst_other", "guidance"]}
{"id": 41898895, "time": "2024-11-12 08:07:21", "headline": "Theriva Biologics Q3 EPS $(6.81) Misses $(6.25) Estimate", "summary": "", "symbols": ["TOVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898895/theriva-biologics-q3-eps-6-81-misses-6-25-estimate", "tags": ["earnings"]}
{"id": 41898900, "time": "2024-11-12 08:07:42", "headline": "Motorcar Parts Of America Says Full-Year Outlook Remains On Track, With Prior Net Sales Outlook At $746M - $766M, Est $766.30M", "summary": "", "symbols": ["MPAA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898900/motorcar-parts-of-america-says-full-year-outlook-remains-on-track-with-prior-net-sales-outlook-at-74", "tags": ["guidance"]}
{"id": 41898901, "time": "2024-11-12 08:07:46", "headline": "Lifeward Lowers FY24 Sales Guidance from $28.00M-$32.00M to $25.00M-$26.00M", "summary": "", "symbols": ["LFWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898901/lifeward-lowers-fy24-sales-guidance-from-28-00m-32-00m-to-25-00m-26-00m", "tags": ["guidance"]}
{"id": 41898902, "time": "2024-11-12 08:07:47", "headline": "Benchmark Maintains Buy on Live Nation Entertainment, Raises Price Target to $144", "summary": "", "symbols": ["LYV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898902/benchmark-maintains-buy-on-live-nation-entertainment-raises-price-target-to-144", "tags": ["analyst_other", "price_target_up"]}
{"id": 41898903, "time": "2024-11-12 08:07:55", "headline": "Tempest Receives FDA Study May Proceed Letter For Its Phase 3 Trial Of Amezalpat Combination Therapy", "summary": "", "symbols": ["TPST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898903/tempest-receives-fda-study-may-proceed-letter-for-its-phase-3-trial-of-amezalpat-combination-therapy", "tags": ["fda"]}
{"id": 41898907, "time": "2024-11-12 08:08:15", "headline": "Simmons First National Corporation Announces Executive Management Updates; CEO Bob Fehlman Set To Retire At The End Of 2024; Executive Chairman George Makris, Jr. Will Assume The Role Of Chairman And CEO; Christopher Van Steenberg Joins Simmons As Chief Operating Officer", "summary": "", "symbols": ["SFNC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898907/simmons-first-national-corporation-announces-executive-management-updates-ceo-bob-fehlman-set-to-ret", "tags": ["management"]}
{"id": 41898911, "time": "2024-11-12 08:09:13", "headline": "Independent Proxy Advisory Firms ISS And Glass Lewis Agree Biglari Capital Has Made Compelling Case For Change At Cracker Barrel; Glass Lewis Recommends That Shareholders Vote FOR 2 Of Biglari Capital's Nominees And ISS Recommends Shareholders Vote For 1 Of Biglari Capital's Nominees", "summary": "", "symbols": ["CBRL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898911/independent-proxy-advisory-firms-iss-and-glass-lewis-agree-biglari-capital-has-made-compelling-case", "tags": []}
{"id": 41898912, "time": "2024-11-12 08:09:38", "headline": "'TSMC board approves US$15 billion for new facility and advanced node capacity' -DigiTimes", "summary": "", "symbols": ["TSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898912/tsmc-board-approves-us-15-billion-for-new-facility-and-advanced-node-capacity-digitimes", "tags": []}
{"id": 41898913, "time": "2024-11-12 08:09:39", "headline": "Benchmark Reiterates Hold on EOG Resources", "summary": "", "symbols": ["EOG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41898913/benchmark-reiterates-hold-on-eog-resources", "tags": ["analyst_other"]}
{"id": 41898915, "time": "2024-11-12 08:09:47", "headline": "Protara Therapeutics Q3 EPS $(0.50) Beats $(0.52) Estimate", "summary": "", "symbols": ["TARA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41898915/protara-therapeutics-q3-eps-0-50-beats-0-52-estimate", "tags": ["earnings"]}
{"id": 41898916, "time": "2024-11-12 08:09:56", "headline": "Genius Group Adopts A Bitcoin Treasury Reserve Strategy, With Bitcoin To Be The Primary Treasury Reserve Asset; Says Will Commit 90% Or More Of Current And Future Reserves To Be Held In Bitcoin", "summary": "", "symbols": ["GNS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41898916/genius-group-adopts-a-bitcoin-treasury-reserve-strategy-with-bitcoin-to-be-the-primary-tre", "tags": []}
{"id": 41898919, "time": "2024-11-12 08:10:06", "headline": "Leading And Lagging Sectors For November 12, 2024", "summary": " ", "symbols": ["XLE", "XLF", "XLI", "XLK", "XLP", "XLU", "XLY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/sector-etfs/24/11/41898919/leading-and-lagging-sectors-for-november-12-2024", "tags": []}
{"id": 41898939, "time": "2024-11-12 08:10:38", "headline": "Trump 'Should Thank' Jerome Powell For Election Win, Says Wharton's Jeremy Siegel: '...His Overly Easy Policy During The Biden Administration Causing All That Inflation'", "summary": "Powell has been a focal point of debate, especially concerning his handling of interest rates.", "symbols": [], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/news/24/11/41898939/trump-should-thank-jerome-powell-for-election-win-says-whartons-jeremy-siegel-his-overly-easy-policy-during-the-biden-administration-causing-all-that-inflation", "tags": []}
{"id": 41898942, "time": "2024-11-12 08:10:39", "headline": "WhiteHawk Energy Calls For Response From Board Of PHX Minerals, Related To Its Proposal To Acquire PHX In A $4.00 Per Share All-Cash Transaction", "summary": "", "symbols": ["PHX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41898942/whitehawk-energy-calls-for-response-from-board-of-phx-minerals-related-to-its-proposal-to-acquire-ph", "tags": ["merger"]}
{"id": 41899137, "time": "2024-11-12 08:11:07", "headline": "Morgan Stanley Maintains Underweight on AMC Networks, Lowers Price Target to $9", "summary": "", "symbols": ["AMCX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899137/morgan-stanley-maintains-underweight-on-amc-networks-lowers-price-target-to-9", "tags": ["analyst_other", "price_target_down"]}
{"id": 41899141, "time": "2024-11-12 08:11:23", "headline": "Nevro Has Received CE Mark Certification In Europe For Its HFX iQ Spinal Cord Stimulation System", "summary": "", "symbols": ["NVRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899141/nevro-has-received-ce-mark-certification-in-europe-for-its-hfx-iq-spinal-cord-stimulation-system", "tags": []}
{"id": 41899142, "time": "2024-11-12 08:11:25", "headline": "Benchmark Reiterates Hold on Intevac", "summary": "", "symbols": ["IVAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899142/benchmark-reiterates-hold-on-intevac", "tags": ["analyst_other"]}
{"id": 41899143, "time": "2024-11-12 08:11:27", "headline": "VerifyMe Q3 2024 GAAP EPS $(0.23) Compared With $(0.09) YoY, Sales $5.435M Beat $5.232M Estimate", "summary": "", "symbols": ["VRME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899143/verifyme-q3-2024-gaap-eps-0-23-compared-with-0-09-yoy-sales-5-435m-beat-5-232m-estimate", "tags": ["earnings"]}
{"id": 41899144, "time": "2024-11-12 08:11:28", "headline": "Tokyo Electron Sees FY2025 GAAP EPS JPY 1,140.67; Sees Sales JPY 2400B.", "summary": "", "symbols": ["TOELY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899144/tokyo-electron-sees-fy2025-gaap-eps-jpy-1-140-67-sees-sales-jpy-2400b", "tags": ["earnings"]}
{"id": 41899166, "time": "2024-11-12 08:11:30", "headline": "CG Oncology Q3 EPS $(0.30) Beats $(0.36) Estimate", "summary": "", "symbols": ["CGON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899166/cg-oncology-q3-eps-0-30-beats-0-36-estimate", "tags": ["earnings"]}
{"id": 41899245, "time": "2024-11-12 08:11:37", "headline": "Zeta Global, Spirit Airlines And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session", "summary": " ", "symbols": ["API", "CIFR", "DXYZ", "OUST", "SAVE", "SCL", "SGMO", "ZETA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41899245/zeta-global-spirit-airlines-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 41899257, "time": "2024-11-12 08:12:11", "headline": "Motorcar Parts of America Q2 2025 Adj EPS $0.31 Beats $0.18 Estimate", "summary": "", "symbols": ["MPAA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899257/motorcar-parts-of-america-q2-2025-adj-eps-0-31-beats-0-18-estimate", "tags": ["earnings"]}
{"id": 41899258, "time": "2024-11-12 08:12:17", "headline": "Jerash Holdings (US) Q2 2025 GAAP EPS $0.05 Misses $0.07 Estimate, Sales $40.240M Beat $37.450M Estimate", "summary": "", "symbols": ["JRSH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899258/jerash-holdings-us-q2-2025-gaap-eps-0-05-misses-0-07-estimate-sales-40-240m-beat-37-450m-estimate", "tags": ["earnings"]}
{"id": 41899259, "time": "2024-11-12 08:12:19", "headline": "Reviva Announces Enrollment Update For Open Label Extension Study Evaluating Brilaroxazine In Schizophrenia; 108 Patients Have Completed 1-Year Of Treatment; Brilaroxazine Is Generally Well Tolerated To Date In Patients With Acute And Stable Schizophrenia", "summary": "", "symbols": ["RVPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41899259/reviva-announces-enrollment-update-for-open-label-extension-study-evaluating-brilaroxazine-in-sch", "tags": []}
{"id": 41899265, "time": "2024-11-12 08:12:36", "headline": "Artelo Biosciences Q3 2024 GAAP EPS $(0.35) Beats $(0.79) Estimate", "summary": "", "symbols": ["ARTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899265/artelo-biosciences-q3-2024-gaap-eps-0-35-beats-0-79-estimate", "tags": ["earnings"]}
{"id": 41899282, "time": "2024-11-12 08:13:00", "headline": "Hour Loop Q3 EPS $0.01, Sales $31.08M Up From $29.15M YoY", "summary": "", "symbols": ["HOUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899282/hour-loop-q3-eps-0-01-sales-31-08m-up-from-29-15m-yoy", "tags": ["earnings"]}
{"id": 41899288, "time": "2024-11-12 08:13:39", "headline": "Moleculin Receives Institutional Review Board Approval For Its MIRACLE Phase 3 Pivotal Trial Of Annamycin In Combination With Cytarabine In R/R Acute Myeloid Leukemia", "summary": "", "symbols": ["MBRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41899288/moleculin-receives-institutional-review-board-approval-for-its-miracle-phase-3-pivotal-trial-of-a", "tags": ["fda"]}
{"id": 41899303, "time": "2024-11-12 08:14:24", "headline": "Top 3 Tech And Telecom Stocks Which Could Rescue Your Portfolio In Q4", "summary": " ", "symbols": ["LILA", "PHI", "TEF"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41899303/top-3-tech-and-telecom-stocks-which-could-rescue-your-portfolio-in-q4", "tags": []}
{"id": 41899308, "time": "2024-11-12 08:14:45", "headline": "RAPT Therapeutics Q3 EPS $(0.47) Beats $(0.54) Estimate", "summary": "", "symbols": ["RAPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899308/rapt-therapeutics-q3-eps-0-47-beats-0-54-estimate", "tags": ["earnings"]}
{"id": 41899334, "time": "2024-11-12 08:15:09", "headline": "Ovid Therapeutics Q3 2024 GAAP EPS $(0.20) Misses $(0.19) Estimate", "summary": "", "symbols": ["OVID"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899334/ovid-therapeutics-q3-2024-gaap-eps-0-20-misses-0-19-estimate", "tags": ["earnings"]}
{"id": 41899337, "time": "2024-11-12 08:15:28", "headline": "Morgan Stanley Reinstates Equal-Weight on Illumina, Announces $156 Price Target", "summary": "", "symbols": ["ILMN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899337/morgan-stanley-reinstates-equal-weight-on-illumina-announces-156-price-target", "tags": []}
{"id": 41899339, "time": "2024-11-12 08:15:39", "headline": "Ovid Therapeutics Q3 EPS $(0.20) Misses $(0.19) Estimate, Sales $173.00K Beat $87.14K Estimate", "summary": "", "symbols": ["OVID"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899339/ovid-therapeutics-q3-eps-0-20-misses-0-19-estimate-sales-173-00k-beat-87-14k-estimate", "tags": ["earnings"]}
{"id": 41899340, "time": "2024-11-12 08:15:47", "headline": "Indaptus Therapeutics Q3 2024 GAAP EPS $(0.32) Beats $(0.48) Estimate", "summary": "", "symbols": ["INDP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899340/indaptus-therapeutics-q3-2024-gaap-eps-0-32-beats-0-48-estimate", "tags": ["earnings"]}
{"id": 41899418, "time": "2024-11-12 08:16:41", "headline": "Neuraxis Q3 Sales $666.63K Up From $477.46K YoY", "summary": "", "symbols": ["NRXS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899418/neuraxis-q3-sales-666-63k-up-from-477-46k-yoy", "tags": []}
{"id": 41899419, "time": "2024-11-12 08:16:52", "headline": "Disc Medicine Q3 EPS $(0.89) Beats $(1.05) Estimate", "summary": "", "symbols": ["IRON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899419/disc-medicine-q3-eps-0-89-beats-1-05-estimate", "tags": ["earnings"]}
{"id": 41899426, "time": "2024-11-12 08:17:36", "headline": "Benchmark Maintains Buy on Nutex Health, Raises Price Target to $60", "summary": "", "symbols": ["NUTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899426/benchmark-maintains-buy-on-nutex-health-raises-price-target-to-60", "tags": ["analyst_other", "price_target_up"]}
{"id": 41899427, "time": "2024-11-12 08:17:42", "headline": "Morgan Stanley Maintains Underweight on Norwegian Cruise Line, Raises Price Target to $26", "summary": "", "symbols": ["NCLH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899427/morgan-stanley-maintains-underweight-on-norwegian-cruise-line-raises-price-target-to-26", "tags": ["analyst_other", "price_target_up"]}
{"id": 41899430, "time": "2024-11-12 08:18:07", "headline": "Compass Therapeutics Q3 2024 GAAP EPS $(0.08) Beats $(0.11) Estimate", "summary": "", "symbols": ["CMPX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899430/compass-therapeutics-q3-2024-gaap-eps-0-08-beats-0-11-estimate", "tags": ["earnings"]}
{"id": 41899449, "time": "2024-11-12 08:18:50", "headline": "Opus Genetics Q3 EPS $(0.29) Down From $0.25 YoY, Sales $3.87M Down From $11.94M YoY", "summary": "", "symbols": ["IRD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899449/opus-genetics-q3-eps-0-29-down-from-0-25-yoy-sales-3-87m-down-from-11-94m-yoy", "tags": ["earnings"]}
{"id": 41899459, "time": "2024-11-12 08:18:54", "headline": "Morgan Stanley Maintains Equal-Weight on Archer-Daniels Midland, Lowers Price Target to $52", "summary": "", "symbols": ["ADM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899459/morgan-stanley-maintains-equal-weight-on-archer-daniels-midland-lowers-price-target-to-52", "tags": ["analyst_other", "price_target_down"]}
{"id": 41899460, "time": "2024-11-12 08:18:57", "headline": "Boeing Lands 737-8 Deal With Avia Solutions: 40 Planes Now, 40 More To Follow", "summary": "Boeing (BA) receives initial order for 40 737-8 aircraft from Avia Solutions Group, with option for 40 more. ", "symbols": ["BA", "GCAD", "MISL"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/contracts/24/11/41899460/boeing-lands-737-8-deal-with-avia-solutions-40-planes-now-40-more-to-follow", "tags": ["contract"]}
{"id": 41899462, "time": "2024-11-12 08:19:06", "headline": "Synchronoss Extends Partnership With Major French Operator For Three Years, Continuing To Provide AI-Enhanced Personal Cloud Solutions To Over 27M Users", "summary": "", "symbols": ["SNCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899462/synchronoss-extends-partnership-with-major-french-operator-for-three-years-continuing-to-provide-ai", "tags": ["contract"]}
{"id": 41899509, "time": "2024-11-12 08:19:16", "headline": "Benchmark Reiterates Buy on Blink Charging, Maintains $5 Price Target", "summary": "", "symbols": ["BLNK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899509/benchmark-reiterates-buy-on-blink-charging-maintains-5-price-target", "tags": ["analyst_other"]}
{"id": 41899584, "time": "2024-11-12 08:20:11", "headline": "Instacart And Coles Supermarkets To Launch Smart Trolleys In Australia; Coles Supermarkets Becomes The First Retailer In The Asia Pacific Region To Deploy Caper Carts, Instacart's AI-Powered Smart Trolleys", "summary": "", "symbols": ["CART"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899584/instacart-and-coles-supermarkets-to-launch-smart-trolleys-in-australia-coles-supermarkets-becomes-th", "tags": []}
{"id": 41899588, "time": "2024-11-12 08:20:28", "headline": "Morgan Stanley Maintains Equal-Weight on OneStream, Raises Price Target to $37", "summary": "", "symbols": ["OS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899588/morgan-stanley-maintains-equal-weight-on-onestream-raises-price-target-to-37", "tags": ["analyst_other", "price_target_up"]}
{"id": 41899593, "time": "2024-11-12 08:21:10", "headline": "Lotus Technology Reports 8,631 Vehicle Deliveries For First Ten Months Of 2024; Europe And China Lead Markets With 35% And 25% Share, Respectively; Begins Open Beta For Urban Navigate On Autopilot And Rolls Out Intelligent Driving Updates", "summary": "", "symbols": ["LOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899593/lotus-technology-reports-8-631-vehicle-deliveries-for-first-ten-months-of-2024-europe-and-china-lead", "tags": []}
{"id": 41899700, "time": "2024-11-12 08:21:27", "headline": "Tokyo Electron Q2 EPS $0.53 Up From $0.27 YoY, Sales $2.87B Down From $2.96B YoY", "summary": "", "symbols": ["TOELY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899700/tokyo-electron-q2-eps-0-53-up-from-0-27-yoy-sales-2-87b-down-from-2-96b-yoy", "tags": ["earnings"]}
{"id": 41899708, "time": "2024-11-12 08:21:31", "headline": "Cellectar Biosciences And SpectronRx Have Signed A Commercial Supply Agreement For The Manufacture Of Cellectar's First-In-Class Cancer Therapy, Iopofosine I 131", "summary": "", "symbols": ["CLRB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41899708/cellectar-biosciences-and-spectronrx-have-signed-a-commercial-supply-agreement-for-the-manufactur", "tags": ["contract"]}
{"id": 41899709, "time": "2024-11-12 08:21:35", "headline": "Citigroup Upgrades Canadian National Railway to Buy, Raises Price Target to $130", "summary": "", "symbols": ["CNI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899709/citigroup-upgrades-canadian-national-railway-to-buy-raises-price-target-to-130", "tags": ["analyst_up", "price_target_up"]}
{"id": 41899710, "time": "2024-11-12 08:21:50", "headline": "Morgan Stanley Maintains Equal-Weight on Match Group, Lowers Price Target to $33", "summary": "", "symbols": ["MTCH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899710/morgan-stanley-maintains-equal-weight-on-match-group-lowers-price-target-to-33", "tags": ["analyst_other", "price_target_down"]}
{"id": 41899711, "time": "2024-11-12 08:22:02", "headline": "Benchmark Maintains Buy on Turning Point Brands, Raises Price Target to $65", "summary": "", "symbols": ["TPB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899711/benchmark-maintains-buy-on-turning-point-brands-raises-price-target-to-65", "tags": ["analyst_other", "price_target_up"]}
{"id": 41899712, "time": "2024-11-12 08:22:05", "headline": "Savara Q3 EPS $(0.11), Inline", "summary": "", "symbols": ["SVRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899712/savara-q3-eps-0-11-inline", "tags": ["earnings"]}
{"id": 41899722, "time": "2024-11-12 08:22:35", "headline": "Tonix Pharmaceuticals Q3 2024 GAAP EPS $(0.23) Beats $(2.93) Estimate, Sales $2.80M Miss $3.08M Estimate", "summary": "", "symbols": ["TNXP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899722/tonix-pharmaceuticals-q3-2024-gaap-eps-0-23-beats-2-93-estimate-sales-2-80m-miss-3-08m-estimate", "tags": ["earnings"]}
{"id": 41899723, "time": "2024-11-12 08:22:53", "headline": "BioLife Solutions Announces Sale Of Its SciSafe Biostorage Subsidiary For $73M In Cash", "summary": "", "symbols": ["BLFS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899723/biolife-solutions-announces-sale-of-its-scisafe-biostorage-subsidiary-for-73m-in-cash", "tags": []}
{"id": 41899725, "time": "2024-11-12 08:23:13", "headline": "Morgan Stanley Maintains Equal-Weight on Aramark, Raises Price Target to $40", "summary": "", "symbols": ["ARMK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899725/morgan-stanley-maintains-equal-weight-on-aramark-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 41899726, "time": "2024-11-12 08:24:23", "headline": "Benchmark Reiterates Buy on CompoSecure, Maintains $17 Price Target", "summary": "", "symbols": ["CMPO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899726/benchmark-reiterates-buy-on-composecure-maintains-17-price-target", "tags": ["analyst_other"]}
{"id": 41899727, "time": "2024-11-12 08:24:32", "headline": "Veritone Q3 Adj $(0.19) Up From $(0.21) YoY, Sales $21.99M Miss $30.54M Estimate", "summary": "", "symbols": ["VERI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899727/veritone-q3-adj-0-19-up-from-0-21-yoy-sales-21-99m-miss-30-54m-estimate", "tags": []}
{"id": 41899734, "time": "2024-11-12 08:25:02", "headline": "Morgan Stanley Maintains Overweight on Walmart, Raises Price Target to $89", "summary": "", "symbols": ["WMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899734/morgan-stanley-maintains-overweight-on-walmart-raises-price-target-to-89", "tags": ["analyst_other", "price_target_up"]}
{"id": 41899753, "time": "2024-11-12 08:25:41", "headline": "Citigroup Downgrades Knight-Swift to Sell, Maintains Price Target to $56", "summary": "", "symbols": ["KNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899753/citigroup-downgrades-knight-swift-to-sell-maintains-price-target-to-56", "tags": ["analyst_down", "analyst_other"]}
{"id": 41899763, "time": "2024-11-12 08:26:01", "headline": "Dime Community Bancshares Prices $125M Offering Of 3,906,250 Shares At $32.00/Share", "summary": "", "symbols": ["DCOM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899763/dime-community-bancshares-prices-125m-offering-of-3-906-250-shares-at-32-00share", "tags": ["offering"]}
{"id": 41899765, "time": "2024-11-12 08:26:17", "headline": "Benchmark Reiterates Buy on IAC, Maintains $110 Price Target", "summary": "", "symbols": ["IAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899765/benchmark-reiterates-buy-on-iac-maintains-110-price-target", "tags": ["analyst_other"]}
{"id": 41899783, "time": "2024-11-12 08:26:52", "headline": "Citigroup Downgrades RXO to Neutral, Maintains Price Target to $33", "summary": "", "symbols": ["RXO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899783/citigroup-downgrades-rxo-to-neutral-maintains-price-target-to-33", "tags": ["analyst_down", "analyst_other"]}
{"id": 41899784, "time": "2024-11-12 08:27:07", "headline": "TWO Announces Appointment Of Travis Swenson As Chief Financial Officer, With An Effective Date Of May 5, 2025", "summary": "", "symbols": ["TWO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899784/two-announces-appointment-of-travis-swenson-as-chief-financial-officer-with-an-effective-date-of-may", "tags": []}
{"id": 41899785, "time": "2024-11-12 08:27:14", "headline": "Morgan Stanley Maintains Underweight on Bristol-Myers Squibb, Raises Price Target to $39", "summary": "", "symbols": ["BMY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899785/morgan-stanley-maintains-underweight-on-bristol-myers-squibb-raises-price-target-to-39", "tags": ["analyst_other", "price_target_up"]}
{"id": 41899787, "time": "2024-11-12 08:27:40", "headline": "Benchmark Reiterates Speculative Buy on Nephros, Maintains $5 Price Target", "summary": "", "symbols": ["NEPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899787/benchmark-reiterates-speculative-buy-on-nephros-maintains-5-price-target", "tags": ["analyst_other"]}
{"id": 41899788, "time": "2024-11-12 08:27:46", "headline": "Mogo's Carta Worldwide Reports 23% Increase In Quarterly Transaction Volume To Record $3B", "summary": "", "symbols": ["MOGO", "TSX:MOGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899788/mogos-carta-worldwide-reports-23-increase-in-quarterly-transaction-volume-to-record-3b", "tags": []}
{"id": 41899791, "time": "2024-11-12 08:29:02", "headline": "Momentus Secures HALO Prototype Order Contract From U.S. Space Development Agency To Support Rapid Satellite Prototyping And Demonstration For Proliferated LEO Constellation; Financial Terms Not Disclosed", "summary": "", "symbols": ["MNTS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899791/momentus-secures-halo-prototype-order-contract-from-u-s-space-development-agency-to-support-rapid-sa", "tags": ["contract"]}
{"id": 41899789, "time": "2024-11-12 08:28:34", "headline": "Foresight Launches 6 Advanced Stereoscopic Sensor Kits To Revolutionize Industrial And Automotive 3D Perception Capabilities, Meeting The Stringent Requirements For Applications In Industrial Automation And Autonomous Mobility", "summary": "", "symbols": ["FRSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899789/foresight-launches-6-advanced-stereoscopic-sensor-kits-to-revolutionize-industrial-and-automotive-3d", "tags": []}
{"id": 41899795, "time": "2024-11-12 08:29:35", "headline": "Morgan Stanley Maintains Overweight on AbbVie, Lowers Price Target to $224", "summary": "", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899795/morgan-stanley-maintains-overweight-on-abbvie-lowers-price-target-to-224", "tags": ["analyst_other", "price_target_down"]}
{"id": 41899877, "time": "2024-11-12 08:30:58", "headline": "Citigroup Downgrades Schneider National to Sell, Lowers Price Target to $30", "summary": "", "symbols": ["SNDR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899877/citigroup-downgrades-schneider-national-to-sell-lowers-price-target-to-30", "tags": ["analyst_down", "price_target_down"]}
{"id": 41899889, "time": "2024-11-12 08:31:21", "headline": "SAIHEAT Reports October 2024 Bitcoin Operations; Earns 3.02 BTC From Self-Mining, Holds 86.66 BTC Across U.S. And Mexico Data Centers", "summary": "", "symbols": ["BTCUSD", "SAIH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41899889/saiheat-reports-october-2024-bitcoin-operations-earns-3-02-btc-from-self-mining-holds-86-6", "tags": []}
{"id": 41899890, "time": "2024-11-12 08:31:27", "headline": "OPEC Cuts 2024 Oil Demand Forecast For Fourth Straight Month Amid China's Economic Slowdown", "summary": "Since July, OPEC has cut its demand growth forecasts by nearly 20%, mirroring a notable decline in crude oil prices.", "symbols": ["USO"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/markets/commodities/24/11/41899890/opec-cuts-2024-oil-demand-forecast-for-fourth-straight-month-amid-chinas-economic-slowdown", "tags": ["guidance"]}
{"id": 41899957, "time": "2024-11-12 08:31:57", "headline": "Mizuho Maintains Outperform on Alibaba Gr Hldgs, Raises Price Target to $113", "summary": "", "symbols": ["BABA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899957/mizuho-maintains-outperform-on-alibaba-gr-hldgs-raises-price-target-to-113", "tags": ["analyst_other", "price_target_up"]}
{"id": 41899960, "time": "2024-11-12 08:32:01", "headline": "ReShape Lifesciences Gains Health Canada Approval For Next-Gen Lap-Band 2.0 FLEX; Enhanced Design With Flex Technology Aims To Improve Patient Experience And Prepares For Canadian Launch", "summary": "", "symbols": ["RSLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41899960/reshape-lifesciences-gains-health-canada-approval-for-next-gen-lap-band-2-0-flex-enhanced-design-wit", "tags": []}
{"id": 41899963, "time": "2024-11-12 08:32:04", "headline": "EVgo Q3 Sales Surge 92% As Charging Revenues And Customer Growth Drive Performance; Stock Jumps", "summary": "EVgo reported 92% year-on-year sales growth to $67.5 million, beating estimates. Network throughput grew 111% and customer accounts reached 1.2 million. Adjusted gross profit and margin improved, while adjusted EBITDA loss and EPS beat estimates. The company revised its FY24 revenue guidance.", "symbols": ["EVGO", "PBW", "SIMS"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/earnings/24/11/41899963/evgo-q3-sales-surge-92-as-charging-revenues-and-customer-growth-drive-performance-stock-jumps", "tags": ["earnings", "guidance"]}
{"id": 41899964, "time": "2024-11-12 08:32:04", "headline": "Femasys Q3 EPS $(0.24) Misses $(0.20) Estimate, Sales $554.91K Miss $652.25K Estimate", "summary": "", "symbols": ["FEMY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899964/femasys-q3-eps-0-24-misses-0-20-estimate-sales-554-91k-miss-652-25k-estimate", "tags": ["earnings"]}
{"id": 41899968, "time": "2024-11-12 08:32:20", "headline": "Bitcoin ETFs Post Record $1.1 Billion Inflow: What Is Going On?", "summary": "Bitcoin (CRYPTO: BTC) spot ETFs recorded a substantial net inflow of $1.114 billion yesterday, marking an all-time high as the cryptocurrency touched near $90,000 levels on Tuesday mo", "symbols": ["BTCUSD", "ETHUSD", "FBTC", "FETH", "IBIT"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41899968/bitcoin-etfs-post-record-1-1-billion-inflow-what-is-going-on", "tags": []}
{"id": 41899982, "time": "2024-11-12 08:32:37", "headline": "Mediobanca Q1 Adj $0.42 Down From $0.45 YoY, Sales $950.29M Up From $940.10M YoY", "summary": "", "symbols": ["MDIBY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899982/mediobanca-q1-adj-0-42-down-from-0-45-yoy-sales-950-29m-up-from-940-10m-yoy", "tags": []}
{"id": 41899984, "time": "2024-11-12 08:32:42", "headline": "Atossa Therapeutics Q3 EPS $(0.06), Inline", "summary": "", "symbols": ["ATOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41899984/atossa-therapeutics-q3-eps-0-06-inline", "tags": ["earnings"]}
{"id": 41900009, "time": "2024-11-12 08:33:47", "headline": "Mizuho Maintains Outperform on Baidu, Lowers Price Target to $115", "summary": "", "symbols": ["BIDU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900009/mizuho-maintains-outperform-on-baidu-lowers-price-target-to-115", "tags": ["analyst_other", "price_target_down"]}
{"id": 41900017, "time": "2024-11-12 08:34:15", "headline": "Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies; DEEp OCEAN Is The First Pivotal Clinical Trial Designed To Study DEEs Broadly", "summary": "", "symbols": ["LBPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41900017/longboard-pharmaceuticals-initiates-phase-3-deep-ocean-study-evaluating-bexicaserin-in-developmen", "tags": ["fda"]}
{"id": 41900019, "time": "2024-11-12 08:34:48", "headline": "Invivyd Publishes CANOPY Phase 3 Trial Data Preprints Showing Long-Term COVID-19 Protection By Pemivibart Against JN.1 Sublineages; Novel Method For Predicting Monoclonal Antibody Activity Against Emerging Variants Detailed In BioRxiv", "summary": "", "symbols": ["IVVD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41900019/invivyd-publishes-canopy-phase-3-trial-data-preprints-showing-long-term-covid-19-protection-by-pe", "tags": ["fda"]}
{"id": 41900026, "time": "2024-11-12 08:35:29", "headline": "Mizuho Maintains Outperform on Dada Nexus, Lowers Price Target to $4", "summary": "", "symbols": ["DADA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900026/mizuho-maintains-outperform-on-dada-nexus-lowers-price-target-to-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 41900027, "time": "2024-11-12 08:35:47", "headline": "Citigroup Downgrades Ross Stores to Neutral, Lowers Price Target to $152", "summary": "", "symbols": ["ROST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900027/citigroup-downgrades-ross-stores-to-neutral-lowers-price-target-to-152", "tags": ["analyst_down", "price_target_down"]}
{"id": 41900028, "time": "2024-11-12 08:36:00", "headline": "ClearSign Technologies  Announces That It Has Received A Purchase Order For A Boiler Burner For Use In An Asphalt Company In California;  Boiler Burner Is Expected To Be Fabricated And Shipped In The Second Quarter Of 2025, No Financial Terms Disclosed", "summary": "", "symbols": ["CLIR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900028/clearsign-technologies-announces-that-it-has-received-a-purchase-order-for-a-boiler-burner-for-use-i", "tags": []}
{"id": 41900033, "time": "2024-11-12 08:36:34", "headline": "Sidus Space Chosen As Exclusive Builder For Lonestar's Lunar Data Storage Spacecraft Fleet; Six LizzieSat Satellites To Deliver Critical Data Storage And Disaster Recovery Solutions", "summary": "", "symbols": ["SIDU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900033/sidus-space-chosen-as-exclusive-builder-for-lonestars-lunar-data-storage-spacecraft-fleet-six-lizzie", "tags": []}
{"id": 41900034, "time": "2024-11-12 08:36:35", "headline": "Mizuho Maintains Outperform on Bilibili, Raises Price Target to $21", "summary": "", "symbols": ["BILI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900034/mizuho-maintains-outperform-on-bilibili-raises-price-target-to-21", "tags": ["analyst_other", "price_target_up"]}
{"id": 41900081, "time": "2024-11-12 08:37:20", "headline": "Tivic Health Validates European Patents In Great Britain, Germany, And France; European Patent EP3615133, Both Titled \"Adaptive Trigger For a Microcurrent Stimulation Device\"; European Patent EP3615134 Entitled \"Sinus Treatment Device With Adaptive Circuit\"", "summary": "", "symbols": ["TIVC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41900081/tivic-health-validates-european-patents-in-great-britain-germany-and-france-european-patent-ep361", "tags": []}
{"id": 41900087, "time": "2024-11-12 08:37:44", "headline": "Mizuho Maintains Outperform on Trip.com Group, Raises Price Target to $78", "summary": "", "symbols": ["TCOM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900087/mizuho-maintains-outperform-on-trip-com-group-raises-price-target-to-78", "tags": ["analyst_other", "price_target_up"]}
{"id": 41900088, "time": "2024-11-12 08:38:05", "headline": "Trio-Tech Intl Q1 EPS $(0.06) Down From $0.05 YoY, Sales $9.80M Down From $9.97M YoY", "summary": "", "symbols": ["TRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41900088/trio-tech-intl-q1-eps-0-06-down-from-0-05-yoy-sales-9-80m-down-from-9-97m-yoy", "tags": ["earnings"]}
{"id": 41900094, "time": "2024-11-12 08:38:21", "headline": "ACNB Corporation Receives All Required Regulatory Approvals To Acquire Traditions Bancorp", "summary": "", "symbols": ["ACNB", "TRBK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/government/24/11/41900094/acnb-corporation-receives-all-required-regulatory-approvals-to-acquire-traditions-bancorp", "tags": ["merger"]}
{"id": 41900096, "time": "2024-11-12 08:38:29", "headline": "Credo and Net One Systems Join Forces To Bring Active Electrical Cables To The Japanese Market", "summary": "", "symbols": ["CRDO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900096/credo-and-net-one-systems-join-forces-to-bring-active-electrical-cables-to-the-japanese-market", "tags": []}
{"id": 41900097, "time": "2024-11-12 08:38:44", "headline": "Hudson Global Q3 2024 Adj EPS $(0.13) Misses $0.18 Estimate, Sales $36.90M Miss $45.38M Estimate", "summary": "", "symbols": ["HSON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41900097/hudson-global-q3-2024-adj-eps-0-13-misses-0-18-estimate-sales-36-90m-miss-45-38m-estimate", "tags": ["earnings"]}
{"id": 41900098, "time": "2024-11-12 08:38:57", "headline": "Principal Financial Group Appoints Deanna Strable As CEO And President", "summary": "", "symbols": ["PFG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900098/principal-financial-group-appoints-deanna-strable-as-ceo-and-president", "tags": ["management"]}
{"id": 41900111, "time": "2024-11-12 08:39:46", "headline": "Cadiz Has Entered Into An Agreement To Purchase 180-Miles Of Steel Pipe From The Terminated Keystone XL Pipeline Project", "summary": "", "symbols": ["CDZI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41900111/cadiz-has-entered-into-an-agreement-to-purchase-180-miles-of-steel-pipe-from-the-terminated-keystone", "tags": ["contract"]}
{"id": 41900120, "time": "2024-11-12 08:40:24", "headline": "Citigroup Upgrades Carter's to Neutral, Maintains Price Target to $50", "summary": "", "symbols": ["CRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900120/citigroup-upgrades-carters-to-neutral-maintains-price-target-to-50", "tags": ["analyst_up", "analyst_other"]}
{"id": 41900128, "time": "2024-11-12 08:40:28", "headline": "Trump Vs. Powell: Dec. 18 Fed Meeting Sets Stage For New Tensions", "summary": "Investors prepare for potential fireworks as Trump vs. Powell sequel may unfold at Fed&#39;s final 2024 meeting. Will Trump&#39;s 2nd term reignite tensions?", "symbols": [], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/federal-reserve/24/11/41900128/trump-vs-powell-dec-18-fed-meeting-sets-stage-for-new-tensions", "tags": []}
{"id": 41900006, "time": "2024-11-12 08:33:11", "headline": "Mustang Bio Granted Extension By Nasdaq Hearings Panel To Meet Listing Criteria; Must Comply With $1.00 Bid Price By Jan 31, 2025, And $2.5M Stockholders' Equity By Feb 18, 2025", "summary": "", "symbols": ["MBIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900006/mustang-bio-granted-extension-by-nasdaq-hearings-panel-to-meet-listing-criteria-must-comply-with-1-0", "tags": []}
{"id": 41900130, "time": "2024-11-12 08:40:57", "headline": "Cenntro Q3 Revenue $16.7M, Up 190% YoY; EPS $(0.29) vs ($0.53) YoY", "summary": "", "symbols": ["CENN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41900130/cenntro-q3-revenue-16-7m-up-190-yoy-eps-0-29-vs-0-53-yoy", "tags": ["earnings"]}
{"id": 41900133, "time": "2024-11-12 08:41:06", "headline": "Cantor Fitzgerald Reiterates Overweight on Taysha Gene Therapies, Maintains $7 Price Target", "summary": "", "symbols": ["TSHA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900133/cantor-fitzgerald-reiterates-overweight-on-taysha-gene-therapies-maintains-7-price-target", "tags": ["analyst_other"]}
{"id": 41900332, "time": "2024-11-12 08:42:18", "headline": "Thumzup Launches Video Feature With Instagram Reels Integration, Allowing Users To Monetize Posts Through Participating Advertisers", "summary": "", "symbols": ["META", "TZUP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900332/thumzup-launches-video-feature-with-instagram-reels-integration-allowing-users-to-monetize-posts-thr", "tags": []}
{"id": 41900340, "time": "2024-11-12 08:42:54", "headline": "Joby Aviation Begins Construction On First Vertiport For Dubai Air Taxi Network", "summary": "", "symbols": ["JOBY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900340/joby-aviation-begins-construction-on-first-vertiport-for-dubai-air-taxi-network", "tags": []}
{"id": 41900351, "time": "2024-11-12 08:43:10", "headline": "Seaport Global Downgrades Asbury Automotive Gr to Neutral", "summary": "", "symbols": ["ABG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900351/seaport-global-downgrades-asbury-automotive-gr-to-neutral", "tags": ["analyst_down"]}
{"id": 41900353, "time": "2024-11-12 08:43:20", "headline": "Cantor Fitzgerald Reiterates Overweight on ALX Oncology Holdings", "summary": "", "symbols": ["ALXO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900353/cantor-fitzgerald-reiterates-overweight-on-alx-oncology-holdings", "tags": ["analyst_other"]}
{"id": 41900383, "time": "2024-11-12 08:45:07", "headline": "Mega Matrix Q3 Sales $10.30M, Up 49.3% QoQ; Quarterly Active Users Reached 3.2M, With An ARPU Of $3 And An ARPPU Of $25.90", "summary": "", "symbols": ["MPU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41900383/mega-matrix-q3-sales-10-30m-up-49-3-qoq-quarterly-active-users-reached-3-2m-with-an-arpu-of-3-and-a", "tags": []}
{"id": 41900389, "time": "2024-11-12 08:45:39", "headline": "Suntory Beverage & Food Sees FY2024 GAAP EPS JPY 279.94\n; Sees Sales JPY 1,687B", "summary": "", "symbols": ["STBFY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900389/suntory-beverage-food-sees-fy2024-gaap-eps-jpy-279-94-sees-sales-jpy-1-687b", "tags": ["earnings"]}
{"id": 41900404, "time": "2024-11-12 08:46:38", "headline": "OneMedNet Announces As Of November 12, 2024, The Company Has Invested In ~ 34 Bitcoin", "summary": "", "symbols": ["ONMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900404/onemednet-announces-as-of-november-12-2024-the-company-has-invested-in-34-bitcoin", "tags": []}
{"id": 41900408, "time": "2024-11-12 08:47:14", "headline": "Elliott Investment Pushes Honeywell To Split Into Two Independent Companies, Citing $5B Stake And Predicting 51-75% Share Price Increase Over Two Years", "summary": "", "symbols": ["HON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900408/elliott-investment-pushes-honeywell-to-split-into-two-independent-companies-citing-5b-stake-and-pred", "tags": []}
{"id": 41900491, "time": "2024-11-12 08:47:32", "headline": "Palisade Bio Q3 EPS $(2.32) Beats $(3.35) Estimate", "summary": "", "symbols": ["PALI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41900491/palisade-bio-q3-eps-2-32-beats-3-35-estimate", "tags": ["earnings"]}
{"id": 41900493, "time": "2024-11-12 08:47:53", "headline": "UBS Initiates Coverage On Altimmune with Buy Rating, Announces Price Target of $26", "summary": "", "symbols": ["ALT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900493/ubs-initiates-coverage-on-altimmune-with-buy-rating-announces-price-target-of-26", "tags": ["analyst_init"]}
{"id": 41900518, "time": "2024-11-12 08:48:48", "headline": "SIMPPLE Announces JV With Evolve Consulting ApS, Yielding Mobilisation Of First A.I.-Driven Facility Management Platform", "summary": "", "symbols": ["SPPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900518/simpple-announces-jv-with-evolve-consulting-aps-yielding-mobilisation-of-first-a-i-driven-facility-m", "tags": []}
{"id": 41900544, "time": "2024-11-12 08:49:19", "headline": "Biodexa Pharmaceuticals Regains Nasdaq Compliance For $1.00 Minimum Bid Price Requirement, Securing Continued Listing", "summary": "", "symbols": ["BDRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900544/biodexa-pharmaceuticals-regains-nasdaq-compliance-for-1-00-minimum-bid-price-requirement-securing-co", "tags": []}
{"id": 41897532, "time": "2024-11-12 07:31:48", "headline": "Tyson Foods Expects FY25 Sales Down 1% To Flat; Says For Fiscal 2025, The USDA Indicates Domestic Protein Production (Beef, Pork, Chicken And Turkey) Should Increase Compared To Fiscal 2024 Levels", "summary": "", "symbols": ["TSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41897532/tyson-foods-expects-fy25-sales-down-1-says-for-fiscal-2025-the-usda-indicates-domestic-protein-produ", "tags": []}
{"id": 41900655, "time": "2024-11-12 08:50:26", "headline": "Lockheed's Global Defense Expansion Drives Gains, While Technicals Hint At Pause", "summary": "Lockheed Martin&#39;s potential defense tech deal with Taiwan aligns with its focus on high-tech solutions, while its charts show a mixed outlook.", "symbols": ["AMZN", "BA", "LMT", "META", "MSFT", "NOC", "RTX"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/11/41900655/lockheed-martin-shares-shine-as-taiwan-eyes-big-defense-buys", "tags": ["guidance", "contract"]}
{"id": 41900664, "time": "2024-11-12 08:50:50", "headline": "Oppenheimer Maintains Outperform on Zeta Global Holdings, Raises Price Target to $42", "summary": "", "symbols": ["ZETA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900664/oppenheimer-maintains-outperform-on-zeta-global-holdings-raises-price-target-to-42", "tags": ["analyst_other", "price_target_up"]}
{"id": 41900697, "time": "2024-11-12 08:51:43", "headline": "UBS Initiates Coverage On Inventiva with Neutral Rating, Announces Price Target of $3", "summary": "", "symbols": ["IVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900697/ubs-initiates-coverage-on-inventiva-with-neutral-rating-announces-price-target-of-3", "tags": ["analyst_init"]}
{"id": 41900750, "time": "2024-11-12 08:52:39", "headline": "MARA Stock Surges 30% On Ohio Power Play Ahead Of Q3 Earnings", "summary": "MARA Holdings Inc (NASDAQ:MARA), a digital asset technology company engaged in mining cryptocurrencies, saw its shares close at $25.01 on Monday. That\u2019s a whopping 29.92% daily gain following news of its Ohio power acquisition.", "symbols": ["BTCUSD", "MARA"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41900750/mara-stock-surges-30-on-ohio-power-play-ahead-of-q3-earnings", "tags": ["earnings"]}
{"id": 41900772, "time": "2024-11-12 08:53:41", "headline": "Oppenheimer Maintains Outperform on Agilysys, Raises Price Target to $135", "summary": "", "symbols": ["AGYS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900772/oppenheimer-maintains-outperform-on-agilysys-raises-price-target-to-135", "tags": ["analyst_other", "price_target_up"]}
{"id": 41900776, "time": "2024-11-12 08:54:16", "headline": "UBS Upgrades Buckle to Neutral, Raises Price Target to $46", "summary": "", "symbols": ["BKE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900776/ubs-upgrades-buckle-to-neutral-raises-price-target-to-46", "tags": ["analyst_up", "price_target_up"]}
{"id": 41900807, "time": "2024-11-12 08:55:08", "headline": "Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["SISI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41900807/trading-halt-halt-status-updated-at-8-55-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 41900808, "time": "2024-11-12 08:55:08", "headline": "Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["JTAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41900808/trading-halt-halt-status-updated-at-8-55-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 41900813, "time": "2024-11-12 08:55:19", "headline": "Tyson Foods Q4 Earnings: Revenue And EPS Beat, Beef Gains Outshine Chicken Dip & More", "summary": "Tyson Foods beats Q4 earnings estimates with strong volumes and operational performance, driving a  premarket surge in its stock.", "symbols": ["TSN"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/news/earnings/24/11/41900813/tyson-foods-q4-earnings-revenue-and-eps-beat-beef-gains-outshine-chicken-dip-more", "tags": ["earnings"]}
{"id": 41900821, "time": "2024-11-12 08:55:55", "headline": "USA Redbook (YoY) 4.8%; 6.0% Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41900821/usa-redbook-yoy-4-8-6-0-prior", "tags": []}
{"id": 41900822, "time": "2024-11-12 08:56:09", "headline": "UBS Initiates Coverage On Sagimet Biosciences with Buy Rating, Announces Price Target of $12", "summary": "", "symbols": ["SGMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900822/ubs-initiates-coverage-on-sagimet-biosciences-with-buy-rating-announces-price-target-of-12", "tags": ["analyst_init"]}
{"id": 41900898, "time": "2024-11-12 08:59:23", "headline": "Wells Fargo Upgrades Twilio to Overweight, Raises Price Target to $120", "summary": "", "symbols": ["TWLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900898/wells-fargo-upgrades-twilio-to-overweight-raises-price-target-to-120", "tags": ["analyst_up", "price_target_up"]}
{"id": 41900900, "time": "2024-11-12 08:59:33", "headline": "RBC Capital Reiterates Outperform on NanoXplore, Maintains C$3.25 Price Target", "summary": "", "symbols": ["TSX:GRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900900/rbc-capital-reiterates-outperform-on-nanoxplore-maintains-c-3-25-price-target", "tags": ["analyst_other"]}
{"id": 41900908, "time": "2024-11-12 08:59:45", "headline": "Cannabis Vape Co. Ispire Grows Abroad As US Sales Decline Slows Q1 Revenue", "summary": "Ispire Technology Inc. (NASDAQ: ISPR), a company with a focus on innovations in vaping technology and precision dosing, reported on Monday first quarter 2025 results for the period ended on Sept. 30, 2024. Revenue totaled $39.3 million, representing a decrease of 8.2% year-over-year to $42.9 million due to lower U.S. product sales (by $8.1 million year-over-year), partially offset by growth in Europe and other regions (notably South Africa).\n\nGross profit increased by 13.2% to $7.7 million from ", "symbols": ["ISPR"], "source": "benzinga", "author": "Jelena Martinovic", "url": "https://www.benzinga.com/news/earnings/24/11/41900908/cannabis-vape-co-ispire-grows-abroad-as-us-sales-decline-slows-q1-revenue", "tags": ["earnings"]}
{"id": 41900994, "time": "2024-11-12 09:00:13", "headline": "B of A Securities Downgrades Sun Communities to Underperform, Lowers Price Target to $114", "summary": "", "symbols": ["SUI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41900994/b-of-a-securities-downgrades-sun-communities-to-underperform-lowers-price-target-to-114", "tags": ["analyst_down", "price_target_down"]}
{"id": 41901024, "time": "2024-11-12 09:00:17", "headline": "Peering Into Entegris's Recent Short Interest", "summary": " ", "symbols": ["ENTG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41901024/peering-into-entegriss-recent-short-interest", "tags": []}
{"id": 41901093, "time": "2024-11-12 09:00:23", "headline": "(EPD) - Analyzing Enterprise Prods Partners's Short Interest", "summary": " ", "symbols": ["EPD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41901093/epd-analyzing-enterprise-prods-partnerss-short-interest", "tags": []}
{"id": 41901097, "time": "2024-11-12 09:00:24", "headline": "The Latest Analyst Ratings For Aramark", "summary": " ", "symbols": ["ARMK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41901097/the-latest-analyst-ratings-for-aramark", "tags": []}
{"id": 41901122, "time": "2024-11-12 09:00:29", "headline": "Looking Into Royal Gold's Recent Short Interest", "summary": " ", "symbols": ["RGLD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41901122/looking-into-royal-golds-recent-short-interest", "tags": []}
{"id": 41901141, "time": "2024-11-12 09:00:32", "headline": "What 27 Analyst Ratings Have To Say About OneStream", "summary": " ", "symbols": ["OS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41901141/what-27-analyst-ratings-have-to-say-about-onestream", "tags": []}
{"id": 41901192, "time": "2024-11-12 09:00:39", "headline": "Peeling Back The Layers: Exploring Hilton Grand Vacations Through Analyst Insights", "summary": " ", "symbols": ["HGV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41901192/peeling-back-the-layers-exploring-hilton-grand-vacations-through-analyst-insights", "tags": []}
{"id": 41901157, "time": "2024-11-12 09:00:43", "headline": "Enveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal", "summary": "Enveric licenses EB-002 to MycoMedica for neuropsychiatric treatment, focusing on EB-003&#39;s development with potential milestones up to $62M.", "symbols": ["ENVB"], "source": "benzinga", "author": "Franca Quarneti", "url": "https://www.benzinga.com/markets/cannabis/24/11/41901157/enveric-biosciences-out-licenses-key-program-to-mycomedica-in-62m-deal", "tags": ["contract"]}
{"id": 41901244, "time": "2024-11-12 09:00:47", "headline": "Navigating 14 Analyst Ratings For AbbVie", "summary": " ", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41901244/navigating-14-analyst-ratings-for-abbvie", "tags": []}
{"id": 41901268, "time": "2024-11-12 09:00:55", "headline": "Expert Outlook: Norwegian Cruise Line Through The Eyes Of 15 Analysts", "summary": " ", "symbols": ["NCLH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41901268/expert-outlook-norwegian-cruise-line-through-the-eyes-of-15-analysts", "tags": ["guidance"]}
{"id": 41901286, "time": "2024-11-12 09:01:02", "headline": "Unveiling 7 Analyst Insights On Albemarle", "summary": " ", "symbols": ["ALB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41901286/unveiling-7-analyst-insights-on-albemarle", "tags": []}
{"id": 41901289, "time": "2024-11-12 09:01:03", "headline": "Earnings Outlook For Cisco Systems", "summary": " ", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41901289/earnings-outlook-for-cisco-systems", "tags": ["earnings", "guidance"]}
{"id": 41901318, "time": "2024-11-12 09:01:12", "headline": "Earnings Outlook For Ecopetrol", "summary": " ", "symbols": ["EC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41901318/earnings-outlook-for-ecopetrol", "tags": ["earnings", "guidance"]}
{"id": 41901319, "time": "2024-11-12 09:01:14", "headline": "Wells Fargo Downgrades Sprinklr to Underweight, Lowers Price Target to $6", "summary": "", "symbols": ["CXM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41901319/wells-fargo-downgrades-sprinklr-to-underweight-lowers-price-target-to-6", "tags": ["analyst_down", "price_target_down"]}
{"id": 41901327, "time": "2024-11-12 09:01:28", "headline": "Exploring Enlight Renewable Energy's Earnings Expectations", "summary": " ", "symbols": ["ENLT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41901327/exploring-enlight-renewable-energys-earnings-expectations", "tags": ["earnings"]}
{"id": 41901330, "time": "2024-11-12 09:01:34", "headline": "AMD Unveils Versal Premium Series Gen 2, Industry's First FPGA With CXL 3.1 And PCIe Gen6, Boosting System Acceleration For Data-Intensive Workloads In Data Centers, Communications, And Defense", "summary": "", "symbols": ["AMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41901330/amd-unveils-versal-premium-series-gen-2-industrys-first-fpga-with-cxl-3-1-and-pcie-gen6-boosting-sys", "tags": []}
{"id": 41901339, "time": "2024-11-12 09:01:54", "headline": "B of A Securities Upgrades Veris Residential to Buy, Raises Price Target to $23", "summary": "", "symbols": ["VRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41901339/b-of-a-securities-upgrades-veris-residential-to-buy-raises-price-target-to-23", "tags": ["analyst_up", "price_target_up"]}
{"id": 41901350, "time": "2024-11-12 09:02:13", "headline": "A Look Ahead: Kulicke & Soffa Indus's Earnings Forecast", "summary": " ", "symbols": ["KLIC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41901350/a-look-ahead-kulicke-soffa-induss-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 41901354, "time": "2024-11-12 09:02:23", "headline": "Mainz Biomed Partners With Thermo Fisher Scientific To Develop Next-Gen Colorectal Cancer Screening Product, Focusing On Early Detection And Advanced Adenoma Identification", "summary": "", "symbols": ["MYNZ", "TMO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41901354/mainz-biomed-partners-with-thermo-fisher-scientific-to-develop-next-gen-colorectal-cancer-screening", "tags": ["contract"]}
{"id": 41901359, "time": "2024-11-12 09:02:31", "headline": "Insights Ahead: Spruce Power Holding's Quarterly Earnings", "summary": " ", "symbols": ["SPRU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41901359/insights-ahead-spruce-power-holdings-quarterly-earnings", "tags": ["earnings"]}
{"id": 41901363, "time": "2024-11-12 09:02:49", "headline": "Earnings Preview For Capricor Therapeutics", "summary": " ", "symbols": ["CAPR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41901363/earnings-preview-for-capricor-therapeutics", "tags": ["earnings"]}
{"id": 41901436, "time": "2024-11-12 09:03:19", "headline": "Shineco Implements 1-for-24 Reverse Stock Split To Regain Nasdaq Compliance; Trading To Begin On Post-Split Basis", "summary": "", "symbols": ["SISI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41901436/shineco-implements-1-for-24-reverse-stock-split-to-regain-nasdaq-compliance-trading-to-begin-on-post", "tags": []}
{"id": 41901437, "time": "2024-11-12 09:03:23", "headline": "Earnings Preview For Mersana Therapeutics", "summary": " ", "symbols": ["MRSN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41901437/earnings-preview-for-mersana-therapeutics", "tags": ["earnings"]}
{"id": 41901440, "time": "2024-11-12 09:03:31", "headline": "Insights Ahead: HIVE Digital Technologies's Quarterly Earnings", "summary": " ", "symbols": ["HIVE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41901440/insights-ahead-hive-digital-technologiess-quarterly-earnings", "tags": ["earnings"]}
{"id": 41901445, "time": "2024-11-12 09:03:51", "headline": "A Look Ahead: Griffon's Earnings Forecast", "summary": " ", "symbols": ["GFF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41901445/a-look-ahead-griffons-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 41901448, "time": "2024-11-12 09:03:53", "headline": "Wells Fargo Downgrades Five9 to Equal-Weight, Lowers Price Target to $40", "summary": "", "symbols": ["FIVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41901448/wells-fargo-downgrades-five9-to-equal-weight-lowers-price-target-to-40", "tags": ["analyst_down", "price_target_down"]}
{"id": 41901449, "time": "2024-11-12 09:03:53", "headline": "Enveric Biosciences Enters $62M Out-Licensing Deal With MycoMedica Life Sciences For EB-002 Neuropsychiatric Drug Development; Agreement Includes Milestone Payments And Tiered Royalties", "summary": "", "symbols": ["ENVB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41901449/enveric-biosciences-enters-62m-out-licensing-deal-with-mycomedica-life-sciences-for-eb-002-neurop", "tags": ["contract"]}
{"id": 41901451, "time": "2024-11-12 09:03:59", "headline": "Earnings Outlook For Tarsus Pharmaceuticals", "summary": " ", "symbols": ["TARS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41901451/earnings-outlook-for-tarsus-pharmaceuticals", "tags": ["earnings", "guidance"]}
{"id": 41901465, "time": "2024-11-12 09:04:41", "headline": "NANO Nuclear Energy Joins U.S. Commerce Department's Civil Nuclear/SMR Working Group To Support Export Of Advanced Nuclear Technologies To Southeast Asia", "summary": "", "symbols": ["NNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41901465/nano-nuclear-energy-joins-u-s-commerce-departments-civil-nuclearsmr-working-group-to-support-export", "tags": []}
{"id": 41901466, "time": "2024-11-12 09:04:43", "headline": "Preview: Safe Bulkers's Earnings", "summary": " ", "symbols": ["SB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41901466/preview-safe-bulkerss-earnings", "tags": ["earnings"]}
{"id": 41901469, "time": "2024-11-12 09:04:58", "headline": "scPharmaceuticals's Earnings Outlook", "summary": " ", "symbols": ["SCPH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41901469/scpharmaceuticalss-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41901494, "time": "2024-11-12 09:05:14", "headline": "Maiden Hldgs Q3 Adj $(0.16) Down From $(0.12) YoY, Sales $13.40M Up From $12.48M YoY", "summary": "", "symbols": ["MHLD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41901494/maiden-hldgs-q3-adj-0-16-down-from-0-12-yoy-sales-13-40m-up-from-12-48m-yoy", "tags": []}
{"id": 41901504, "time": "2024-11-12 09:05:44", "headline": "Honeywell And Curtiss-Wright Launch HCR-25 Cockpit Voice Recorder For Boeing And Airbus To Meet FAA's 25-Hour Recording Mandate", "summary": "", "symbols": ["BA", "CW", "EADSY", "HON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41901504/honeywell-and-curtiss-wright-launch-hcr-25-cockpit-voice-recorder-for-boeing-and-airbus-to-meet-faas", "tags": []}
{"id": 41901537, "time": "2024-11-12 09:06:43", "headline": "Telos Q3 2024 Adj. EPS $(0.10) Beats $(0.14) Estimate, Sales $23.783M Beat $22.986M Estimate", "summary": "", "symbols": ["TLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41901537/telos-q3-2024-adj-eps-0-10-beats-0-14-estimate-sales-23-783m-beat-22-986m-estimate", "tags": ["earnings"]}
{"id": 41901562, "time": "2024-11-12 09:07:04", "headline": "Adams Resources & Energy To Be Acquired By Tres Energy Affiliate In $138.9M All-Cash Deal; Shareholders To Receive $38 Per Share, A 39% Premium", "summary": "", "symbols": ["AE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41901562/adams-resources-energy-to-be-acquired-by-tres-energy-affiliate-in-138-9m-all-cash-deal-shareholders", "tags": ["merger", "contract"]}
{"id": 41901570, "time": "2024-11-12 09:07:13", "headline": "Telos Sees Q4 Revenue $24.5M-$26.5M", "summary": "", "symbols": ["TLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41901570/telos-sees-q4-revenue-24-5m-26-5m", "tags": ["earnings"]}
{"id": 41901727, "time": "2024-11-12 09:08:30", "headline": "Blink Charging Partners With ChargeHub To Enable EV Roaming Across North America, Expanding Access To Blink Chargers For ChargeHub Users And Enhancing Charging Convenience For EV Drivers", "summary": "", "symbols": ["BLNK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41901727/blink-charging-partners-with-chargehub-to-enable-ev-roaming-across-north-america-expanding-access-to", "tags": ["contract"]}
{"id": 41901753, "time": "2024-11-12 09:09:12", "headline": "Siebert Financial Q3 Revenue $22.6M Up From $18.0M YoY", "summary": "", "symbols": ["SIEB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41901753/siebert-financial-q3-revenue-22-6m-up-from-18-0m-yoy", "tags": ["earnings"]}
{"id": 41901756, "time": "2024-11-12 09:09:17", "headline": "Dave Inc. Signs LOI For Strategic Partnership With Leading Sponsor Bank To Enhance ExtraCash Product, Hold Member Deposits, And Expand Banking Services", "summary": "", "symbols": ["DAVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41901756/dave-inc-signs-loi-for-strategic-partnership-with-leading-sponsor-bank-to-enhance-extracash-product", "tags": ["contract"]}
{"id": 41901766, "time": "2024-11-12 09:10:01", "headline": "Taboola Secures Exclusive Three-Year Partnership With The Weather Company To Enhance Audience Engagement And Revenue Across Digital Platforms; The Weather Company To Provide Forecasts For Taboola News Lockscreen", "summary": "", "symbols": ["TBLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41901766/taboola-secures-exclusive-three-year-partnership-with-the-weather-company-to-enhance-audience-engage", "tags": ["earnings", "contract"]}
{"id": 41901783, "time": "2024-11-12 09:10:58", "headline": "RBC Capital Maintains Outperform on Mattr, Raises Price Target to C$20", "summary": "", "symbols": ["TSX:MATR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41901783/rbc-capital-maintains-outperform-on-mattr-raises-price-target-to-c-20", "tags": ["analyst_other", "price_target_up"]}
{"id": 41901786, "time": "2024-11-12 09:11:06", "headline": "Nutanix Extends AI Infrastructure Platform With Nutanix Enterprise AI", "summary": "", "symbols": ["NTNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41901786/nutanix-extends-ai-infrastructure-platform-with-nutanix-enterprise-ai", "tags": []}
{"id": 41901787, "time": "2024-11-12 09:11:13", "headline": "Nxu Files Registration Statement For Merger With Verde Bioresins; Combined Company To Be Renamed Verde Bioresins, Corp. And Trade On Nasdaq As \"VRDE,\" With Merger Expected To Close In Q1 2025", "summary": "", "symbols": ["NXU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41901787/nxu-files-registration-statement-for-merger-with-verde-bioresins-combined-company-to-be-renamed-verd", "tags": ["merger"]}
{"id": 41901789, "time": "2024-11-12 09:11:18", "headline": "Roth CH Acquisition V Announces Merger Candidate New Era Helium Corp.'s LOI To Form A 50/50 Joint Venture With Sharon AI", "summary": "", "symbols": ["ROCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41901789/roth-ch-acquisition-v-announces-merger-candidate-new-era-helium-corp-s-loi-to-form-a-5050-joint-vent", "tags": ["merger"]}
{"id": 41901832, "time": "2024-11-12 09:11:49", "headline": "Evercore ISI Group Maintains Outperform on Walt Disney, Raises Price Target to $128", "summary": "", "symbols": ["DIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41901832/evercore-isi-group-maintains-outperform-on-walt-disney-raises-price-target-to-128", "tags": ["analyst_other", "price_target_up"]}
{"id": 41902012, "time": "2024-11-12 09:13:26", "headline": "Lemonade Will Hold Its In-Person Investor Day On Tuesday, November 19, 2024 To Showcase A Walkthrough Of The Model And Mechanics That Delivered Cashflow Positivity In Q3, And Are Expected To Deliver Adjusted EBITDA Profitability During 2026.", "summary": "", "symbols": ["LMND"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41902012/lemonade-will-hold-its-in-person-investor-day-on-tuesday-november-19-2024-to-showcase-a-walkthrough", "tags": []}
{"id": 41902123, "time": "2024-11-12 09:13:45", "headline": "Scotiabank Upgrades Softchoice to Sector Outperform, Raises Price Target to C$24", "summary": "", "symbols": ["TSX:SFTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41902123/scotiabank-upgrades-softchoice-to-sector-outperform-raises-price-target-to-c-24", "tags": ["analyst_up", "price_target_up"]}
{"id": 41902162, "time": "2024-11-12 09:14:44", "headline": "Vincerx Pharma Q3 EPS $(0.17) Beats $(0.22) Estimate", "summary": "", "symbols": ["VINC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41902162/vincerx-pharma-q3-eps-0-17-beats-0-22-estimate", "tags": ["earnings"]}
{"id": 41902163, "time": "2024-11-12 09:14:48", "headline": "Vincerx Pharma Q3 2024 GAAP EPS $(0.17) Beats $(0.22) Estimate", "summary": "", "symbols": ["VINC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41902163/vincerx-pharma-q3-2024-gaap-eps-0-17-beats-0-22-estimate", "tags": ["earnings"]}
{"id": 41902184, "time": "2024-11-12 09:15:18", "headline": "Evercore ISI Group Maintains Outperform on Grab Holdings, Raises Price Target to $8", "summary": "", "symbols": ["GRAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41902184/evercore-isi-group-maintains-outperform-on-grab-holdings-raises-price-target-to-8", "tags": ["analyst_other", "price_target_up"]}
{"id": 41902185, "time": "2024-11-12 09:15:23", "headline": "How To Earn $500 A Month From Occidental Petroleum Stock Ahead Of Q3 Earnings", "summary": "Occidental Petroleum Corp. will release earnings results for the third quarter, after the closing bell, on Tuesday, Nov. 12.", "symbols": ["OXY"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41902185/how-to-earn-500-a-month-from-occidental-petroleum-stock-ahead-of-q3-earnings", "tags": ["earnings"]}
{"id": 41902196, "time": "2024-11-12 09:15:59", "headline": "Xenetic Biosciences Presents Data Demonstrating DNase I Significantly Improves Efficacy Of Anti-CTLA-4 Immune Checkpoint Blockade In Preclinical Colorectal Carcinoma Models At Society For Immunotherapy Of Cancer 2024", "summary": "", "symbols": ["XBIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41902196/xenetic-biosciences-presents-data-demonstrating-dnase-i-significantly-improves-efficacy-of-anti-c", "tags": []}
{"id": 41902199, "time": "2024-11-12 09:16:25", "headline": "Crexendo Selected By Akabis As Replacement For Microsoft Metaswitch Platform", "summary": "", "symbols": ["CXDO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41902199/crexendo-selected-by-akabis-as-replacement-for-microsoft-metaswitch-platform", "tags": []}
{"id": 41902203, "time": "2024-11-12 09:16:53", "headline": "Scotiabank Maintains Sector Perform on DREAM OFFICE REAL EST INV TR, Raises Price Target to C$21", "summary": "", "symbols": ["TSX:D"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41902203/scotiabank-maintains-sector-perform-on-dream-office-real-est-inv-tr-raises-price-target-to-c-21", "tags": ["analyst_other", "price_target_up"]}
{"id": 41902208, "time": "2024-11-12 09:17:28", "headline": "Toro Q3 Total Vessel EPS $(0.01) Up From $(0.05) YoY; Revenue $5.3M Down From $6.5M YoY", "summary": "", "symbols": ["TORO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41902208/toro-q3-total-vessel-eps-0-01-up-from-0-05-yoy-revenue-5-3m-down-from-6-5m-yoy", "tags": ["earnings"]}
{"id": 41902213, "time": "2024-11-12 09:17:50", "headline": "Verb Tech Q3 EPS $(3.82) Beats $(4.00) Estimate, Sales $128.00K Miss $300.00K Estimate", "summary": "", "symbols": ["VERB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41902213/verb-tech-q3-eps-3-82-beats-4-00-estimate-sales-128-00k-miss-300-00k-estimate", "tags": ["earnings"]}
{"id": 41901788, "time": "2024-11-12 09:11:08", "headline": "Shopify Q3 Earnings: Ninth Consecutive Quarter of Revenue Beats, GMV Up 24%, Positive Outlook And More", "summary": "Shopify (NYSE: SHOP) reported strong Q3 results with 26% revenue growth, beating analyst estimates. EPS was $0.64, beating estimates of $0.27. Q4 outlook is also positive. Stock up 14.7% premarket.", "symbols": ["SHOP"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/news/earnings/24/11/41901788/shopify-q3-earnings-ninth-consecutive-quarter-of-revenue-beat-gmv-up-24-positive-outlook-and-more", "tags": ["earnings", "guidance"]}
{"id": 41902215, "time": "2024-11-12 09:18:25", "headline": "Milestone Pharmaceuticals Q3 2024 GAAP EPS $(0.14) Beats $(0.16) Estimate", "summary": "", "symbols": ["MIST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41902215/milestone-pharmaceuticals-q3-2024-gaap-eps-0-14-beats-0-16-estimate", "tags": ["earnings"]}
{"id": 41902216, "time": "2024-11-12 09:18:38", "headline": "Evercore ISI Group Maintains Outperform on Live Nation Entertainment, Raises Price Target to $150", "summary": "", "symbols": ["LYV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41902216/evercore-isi-group-maintains-outperform-on-live-nation-entertainment-raises-price-target-to-150", "tags": ["analyst_other", "price_target_up"]}
{"id": 41902367, "time": "2024-11-12 09:19:27", "headline": "LogicMark Partners With Black Knight Medical, Enabling LogicMark To Leverage Black Knight Medical's Expertise In Medical Supply Distribution And Government Contracting To Enhance Access To Medical Alert Devices For Veterans Across The U.S", "summary": "", "symbols": ["LGMK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41902367/logicmark-partners-with-black-knight-medical-enabling-logicmark-to-leverage-black-knight-medicals-ex", "tags": ["contract"]}
{"id": 41902481, "time": "2024-11-12 09:19:51", "headline": "Mullen's Class 1 EV Cargo Van Now Available For Rental On Turo, Meeting Rising Demand For Compact, Sustainable Urban Transport", "summary": "", "symbols": ["MULN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41902481/mullens-class-1-ev-cargo-van-now-available-for-rental-on-turo-meeting-rising-demand-for-compact-sust", "tags": []}
{"id": 41902489, "time": "2024-11-12 09:20:11", "headline": "Ireland Gov. Coalition Partner Supports Drug Decriminalization, Excluding Cocaine And Heroin", "summary": " ", "symbols": [], "source": "benzinga", "author": "Nina Zdinjak", "url": "https://www.benzinga.com/markets/cannabis/24/11/41902489/ireland-gov-coalition-partner-supports-drug-decriminalization-excluding-cocaine-and-heroin", "tags": []}
{"id": 41902550, "time": "2024-11-12 09:20:44", "headline": "Scotiabank Maintains Sector Perform on AMERICAN HOTEL INCOME PPTYS REIT LP, Raises Price Target to C$0.8", "summary": "", "symbols": ["TSX:HOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41902550/scotiabank-maintains-sector-perform-on-american-hotel-income-pptys-reit-lp-raises-price-target-to-c", "tags": ["analyst_other", "price_target_up"]}
{"id": 41902653, "time": "2024-11-12 09:21:50", "headline": "Top 10 Trending Stocks On WallStreetBets As Of November 12, 2024 (Via Swaggy Stocks)", "summary": "", "symbols": ["ACHR", "BTCUSD", "COIN", "CORN", "LOT", "MARA", "MSTR", "NVDA", "RKLB", "TSLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41902653/top-10-trending-stocks-on-wallstreetbets-as-of-november-12-2024-via-swaggy-stocks", "tags": []}
{"id": 41902698, "time": "2024-11-12 09:22:45", "headline": "Home Depot Q3 Earnings: Revenue And EPS Beat, Lifts Full-Year Forecast Despite Customer Traffic Dip", "summary": "Home Depot reported strong Q3 earnings, beating estimates and raising full-year outlook. Sales, gross profit, and EPS all increased.", "symbols": ["HD"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/news/earnings/24/11/41902698/home-depot-q3-earnings-revenue-and-eps-beat-lifts-full-year-forecast-despite-customer-traffic-dip", "tags": ["earnings", "guidance"]}
{"id": 41902702, "time": "2024-11-12 09:22:52", "headline": "Reddit Partners With InMarket To Measure The Real-World Impact Of Advertising Campaigns With Lift Conversion Index", "summary": "", "symbols": ["RDDT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41902702/reddit-partners-with-inmarket-to-measure-the-real-world-impact-of-advertising-campaigns-with-lift-co", "tags": ["contract"]}
{"id": 41902735, "time": "2024-11-12 09:23:35", "headline": "Leerink Partners Maintains Outperform on Ardent Health Partners, Raises Price Target to $25", "summary": "", "symbols": ["ARDT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41902735/leerink-partners-maintains-outperform-on-ardent-health-partners-raises-price-target-to-25", "tags": ["analyst_other", "price_target_up"]}
{"id": 41902927, "time": "2024-11-12 09:26:42", "headline": "Peer-Reviewed Journal Discuses Envoy Medical's Fully Implanted Acclaim Cochlear Implant", "summary": "", "symbols": ["COCH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41902927/peer-reviewed-journal-discuses-envoy-medicals-fully-implanted-acclaim-cochlear-implant", "tags": []}
{"id": 41902990, "time": "2024-11-12 09:27:56", "headline": "Installed Building Products Acquires Tatum Insulation III; Terms Not Disclosed", "summary": "", "symbols": ["IBP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41902990/installed-building-products-acquires-tatum-insulation-iii-terms-not-disclosed", "tags": ["merger"]}
{"id": 41903000, "time": "2024-11-12 09:28:09", "headline": "Spirit Aerosystems Says Company, Boeing Entered Into An Advance Payments Agreement; Boeing To Pay Spirit Aerosystems Up To $350M; To Use Advances For Boeing Product Readiness", "summary": "", "symbols": ["BA", "SPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41903000/spirit-aerosystems-says-company-boeing-entered-into-an-advance-payments-agreement-boeing-to-pay-spir", "tags": ["contract"]}
{"id": 41903021, "time": "2024-11-12 09:28:29", "headline": "RBC Capital Maintains Outperform on Ligand Pharmaceuticals, Raises Price Target to $140", "summary": "", "symbols": ["LGND"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41903021/rbc-capital-maintains-outperform-on-ligand-pharmaceuticals-raises-price-target-to-140", "tags": ["analyst_other", "price_target_up"]}
{"id": 41903067, "time": "2024-11-12 09:29:14", "headline": "First Watch Restaurant Group Announces Pricing Of Secondary Offering Of 8M Shares Of Common Stock At A Price Of $19.95 Per Share", "summary": "", "symbols": ["FWRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41903067/first-watch-restaurant-group-announces-pricing-of-secondary-offering-of-8m-shares-of-common-stock-at", "tags": ["offering"]}
{"id": 41903935, "time": "2024-11-12 09:30:42", "headline": "Upstart Stock Is Sliding Tuesday: What's Going On?", "summary": "Upstart Holdings Inc (NASDAQ:UPST) shares are trading lower Tuesday after the company announced a proposed private offering of convertible senior notes.", "symbols": ["UPST"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/offerings/24/11/41903935/upstart-stock-is-sliding-tuesday-whats-going-on", "tags": ["why_moving", "offering"]}
{"id": 41903964, "time": "2024-11-12 09:30:55", "headline": "GoDaddy Returns To Super Bowl Advertising; Back After 8 Years To Showcase GoDaddy Airo, An AI-Powered Experience For Small Businesses", "summary": "", "symbols": ["GDDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41903964/godaddy-returns-to-super-bowl-advertising-back-after-8-years-to-showcase-godaddy-airo-an-ai-powered", "tags": []}
{"id": 41903967, "time": "2024-11-12 09:30:56", "headline": "Leerink Partners Maintains Outperform on Neurogene, Raises Price Target to $72", "summary": "", "symbols": ["NGNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41903967/leerink-partners-maintains-outperform-on-neurogene-raises-price-target-to-72", "tags": ["analyst_other", "price_target_up"]}
{"id": 41903994, "time": "2024-11-12 09:31:15", "headline": "VinFast Auto Files Prospectus Supplement For Potential Sale Of 64.04M Ordinary Shares, Including 3.32M Issuable Upon Warrant Exercise At $11.50 Per Share", "summary": "", "symbols": ["VFS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41903994/vinfast-auto-files-prospectus-supplement-for-potential-sale-of-64-04m-ordinary-shares-including-3-32", "tags": []}
{"id": 41904003, "time": "2024-11-12 09:31:27", "headline": "Santander Chile Appoints Patricia P\u00e9rez As CFO", "summary": "", "symbols": ["BSAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41904003/santander-chile-appoints-patricia-p-rez-as-cfo", "tags": ["management"]}
{"id": 41904005, "time": "2024-11-12 09:31:27", "headline": "Tyson Foods CFO Says Beef And Pork Led To Sales Increase For FY24 Partially Offset By Chicken Segment", "summary": "", "symbols": ["TSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41904005/tyson-foods-cfo-says-beef-and-pork-led-to-sales-increase-for-fy24-partially-offset-by-chicken-segmen", "tags": ["management"]}
{"id": 41904011, "time": "2024-11-12 09:31:32", "headline": "VinFast Announces Reorganization And Recapitalization Plan To Enhance Efficiency And Support Growth; New Vietnam-Based Subsidiary VFDI To Hold International Operations, Vingroup To Provide Up To $1.4B In Loans, Founder To Grant $2.1B, And $3.3B Of Loans To Be Converted Into Preference Shares", "summary": "", "symbols": ["VFS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41904011/vinfast-announces-reorganization-and-recapitalization-plan-to-enhance-efficiency-and-support-growth", "tags": []}
{"id": 41904046, "time": "2024-11-12 09:32:17", "headline": "TCBP Awarded Non-Dilutive Funding Of of $250,000 From The ScaleReady's G-Rex Grant Program", "summary": "", "symbols": ["TCBP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41904046/tcbp-awarded-non-dilutive-funding-of-of-250-000-from-the-scalereadys-g-rex-grant-program", "tags": ["offering", "contract"]}
{"id": 41904070, "time": "2024-11-12 09:32:50", "headline": "What's Going On With Honeywell Stock Tuesday?", "summary": "Honeywell International Inc (NASDAQ:HON) shares are popping in early trading Tuesday after activist investor Elliott Investment Management announced it built a stake in the company and is pushing for changes.", "symbols": ["HON"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41904070/whats-going-on-with-honeywell-stock-tuesday", "tags": ["why_moving"]}
{"id": 41904093, "time": "2024-11-12 09:34:37", "headline": "Cineverse 360 Ad Platform Seeing Strong Revenue Growth Driven By Direct And Programmatic Sales; C360 Now Receives More Than 20B CTV Ad Requests Per Month, With October 2024 Its Most Successful Month To Date, Up 53% YoY", "summary": "", "symbols": ["CNVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41904093/cineverse-360-ad-platform-seeing-strong-revenue-growth-driven-by-direct-and-programmatic-sales-c360", "tags": ["earnings"]}
{"id": 41904096, "time": "2024-11-12 09:34:47", "headline": "Cronos Cannabis Co. Reports 38% YOY Increase In Q3 Revenue, Boosts International Sales", "summary": "Cronos&#39; Q3 net revenue totaled $34.3 million, up by $9.5 million year-over-year. Q3 net income totaled $7.3 million compared to a net loss of $1.6 million in the prior year&#39;s period. The company has set an operating expense savings target of $5 to $10 million for 2024,", "symbols": ["CRON", "TSX:CRON"], "source": "benzinga", "author": "Jelena Martinovic", "url": "https://www.benzinga.com/news/earnings/24/11/41904096/cronos-cannabis-co-reports-38-yoy-increase-in-q3-revenue-boosts-international-sales", "tags": ["earnings"]}
{"id": 41904140, "time": "2024-11-12 09:35:15", "headline": "International Game Technology Misses Q3 Earnings Due To Restructuring Costs, Jackpot Sales Are Down", "summary": "IGT reported a Q3 earnings miss due to restructuring charges and a decline in sales from last year&#39;s elevated U.S. multi-state jackpot activity.\n\n\n\n", "symbols": ["IGT"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/24/11/41904140/international-game-technology-misses-q3-earnings-due-to-restructuring-costs-decline-in-jackpot-driven-sales", "tags": ["earnings"]}
{"id": 41904175, "time": "2024-11-12 09:35:28", "headline": "Wells Fargo Maintains Overweight on BJ's Wholesale Club, Raises Price Target to $100", "summary": "", "symbols": ["BJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41904175/wells-fargo-maintains-overweight-on-bjs-wholesale-club-raises-price-target-to-100", "tags": ["analyst_other", "price_target_up"]}
{"id": 41904190, "time": "2024-11-12 09:35:49", "headline": "Navitas and Richardson Electronics Expand Technology Partnership To EMEA For Next-Gen Silicon Carbide Power Devices", "summary": "", "symbols": ["NVTS", "RELL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41904190/navitas-and-richardson-electronics-expand-technology-partnership-to-emea-for-next-gen-silicon-carbid", "tags": ["contract"]}
{"id": 41904195, "time": "2024-11-12 09:35:56", "headline": "RBC Capital Reiterates Sector Perform on Dream Residential, Maintains C$8 Price Target", "summary": "", "symbols": ["TSX:DRR", "TSX:DRR.U"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41904195/rbc-capital-reiterates-sector-perform-on-dream-residential-maintains-c-8-price-target", "tags": ["analyst_other"]}
{"id": 41904200, "time": "2024-11-12 09:36:22", "headline": "Wells Fargo Maintains Underweight on Excelerate Energy, Raises Price Target to $22", "summary": "", "symbols": ["EE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41904200/wells-fargo-maintains-underweight-on-excelerate-energy-raises-price-target-to-22", "tags": ["analyst_other", "price_target_up"]}
{"id": 41904235, "time": "2024-11-12 09:37:21", "headline": "Wells Fargo Maintains Underweight on SLR Inv, Raises Price Target to $13", "summary": "", "symbols": ["SLRC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41904235/wells-fargo-maintains-underweight-on-slr-inv-raises-price-target-to-13", "tags": ["analyst_other", "price_target_up"]}
{"id": 41904293, "time": "2024-11-12 09:38:31", "headline": "Wells Fargo Maintains Overweight on Tectonic Therapeutic, Raises Price Target to $79", "summary": "", "symbols": ["TECX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41904293/wells-fargo-maintains-overweight-on-tectonic-therapeutic-raises-price-target-to-79", "tags": ["analyst_other", "price_target_up"]}
{"id": 41904358, "time": "2024-11-12 09:39:57", "headline": "Wells Fargo Maintains Overweight on RAPT Therapeutics, Lowers Price Target to $4", "summary": "", "symbols": ["RAPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41904358/wells-fargo-maintains-overweight-on-rapt-therapeutics-lowers-price-target-to-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 41904427, "time": "2024-11-12 09:40:58", "headline": "Wells Fargo Maintains Overweight on Howmet Aerospace, Raises Price Target to $129", "summary": "", "symbols": ["HWM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41904427/wells-fargo-maintains-overweight-on-howmet-aerospace-raises-price-target-to-129", "tags": ["analyst_other", "price_target_up"]}
{"id": 41904627, "time": "2024-11-12 09:42:57", "headline": "RBC Capital Reiterates Sector Perform on Choice Properties, Maintains C$15 Price Target", "summary": "", "symbols": ["TSX:CHP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41904627/rbc-capital-reiterates-sector-perform-on-choice-properties-maintains-c-15-price-target", "tags": ["analyst_other"]}
{"id": 41904643, "time": "2024-11-12 09:43:26", "headline": "Wells Fargo Maintains Overweight on ServiceNow, Raises Price Target to $1150", "summary": "", "symbols": ["NOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41904643/wells-fargo-maintains-overweight-on-servicenow-raises-price-target-to-1150", "tags": ["analyst_other", "price_target_up"]}
{"id": 41904730, "time": "2024-11-12 09:44:57", "headline": "Wells Fargo Maintains Equal-Weight on Salesforce, Raises Price Target to $330", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41904730/wells-fargo-maintains-equal-weight-on-salesforce-raises-price-target-to-330", "tags": ["analyst_other", "price_target_up"]}
{"id": 41904746, "time": "2024-11-12 09:45:11", "headline": "RBC Capital Maintains Outperform on Zeta Global Holdings, Raises Price Target to $43", "summary": "", "symbols": ["ZETA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41904746/rbc-capital-maintains-outperform-on-zeta-global-holdings-raises-price-target-to-43", "tags": ["analyst_other", "price_target_up"]}
{"id": 41904765, "time": "2024-11-12 09:45:32", "headline": "AstraZeneca CEO Says Too Early To Judge Whether Wang Probe Will Have Short Or Long Term Impact On China Outlook", "summary": "", "symbols": ["AZN", "FXI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41904765/astrazeneca-ceo-says-too-early-to-judge-whether-wang-probe-will-have-short-or-long-term-impact-on-ch", "tags": ["guidance", "management"]}
{"id": 41904854, "time": "2024-11-12 09:45:58", "headline": "Pfizer Explores Sale Of Hospital Drugs Unit, Hires Goldman Sachs For Advice", "summary": "", "symbols": ["PFE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41904854/pfizer-explores-sale-of-hospital-drugs-unit-hires-goldman-sachs-for-advice", "tags": []}
{"id": 41904976, "time": "2024-11-12 09:48:10", "headline": "Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls", "summary": "Novavax reports Q3 2024 sales of $84.5 million, beating estimates, with a net loss of $121 million. EPS improves, FDA approves new vaccine, and revenue guidance is lowered.", "symbols": ["NVAX"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/24/11/41904976/novavax-stock-falls-on-lower-2024-revenue-forecast-q3-earnings-beat-consensus-estimates", "tags": ["earnings", "guidance", "fda"]}
{"id": 41905038, "time": "2024-11-12 09:49:49", "headline": "STRATA Skin Sciences Wins Court Order Against LaserOptek, Pinnacle, And Monarch Aesthetic Services, Enjoining False Advertising And Marketing Of Pallas Lasers In The U.S.", "summary": "", "symbols": ["SSKN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41905038/strata-skin-sciences-wins-court-order-against-laseroptek-pinnacle-and-monarch-aesthetic-services-enj", "tags": ["legal"]}
{"id": 41905141, "time": "2024-11-12 09:50:04", "headline": "Canaccord Genuity Maintains Buy on Block, Raises Price Target to $120", "summary": "", "symbols": ["SQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41905141/canaccord-genuity-maintains-buy-on-block-raises-price-target-to-120", "tags": ["analyst_other", "price_target_up"]}
{"id": 41905244, "time": "2024-11-12 09:51:27", "headline": "'Netflix's Ads Tier Now at 70 Million Monthly Users' - The Information", "summary": "", "symbols": ["NFLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41905244/netflixs-ads-tier-now-at-70-million-monthly-users-the-information", "tags": []}
{"id": 41905277, "time": "2024-11-12 09:51:45", "headline": "RBC Capital Maintains Outperform on Voya Financial, Raises Price Target to $95", "summary": "", "symbols": ["VOYA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41905277/rbc-capital-maintains-outperform-on-voya-financial-raises-price-target-to-95", "tags": ["analyst_other", "price_target_up"]}
{"id": 41905346, "time": "2024-11-12 09:53:20", "headline": "EchoStar Q3 Earnings And Sales Falter, But Gains Ground With Sling TV Subscribers", "summary": "EchoStar&#39;s Q3 earnings miss estimates with wider losses and a 5% revenue decline, despite gains in Sling TV subscribers.", "symbols": ["SATS"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/news/earnings/24/11/41905346/echostar-q3-earnings-and-sales-falter-but-gains-ground-with-sling-tv-subscribers", "tags": ["earnings"]}
{"id": 41905354, "time": "2024-11-12 09:53:41", "headline": "Barclays Upgrades First Quantum Minerals to Overweight, Raises Price Target to C$25", "summary": "", "symbols": ["TSX:FM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41905354/barclays-upgrades-first-quantum-minerals-to-overweight-raises-price-target-to-c-25", "tags": ["analyst_up", "price_target_up"]}
{"id": 41893066, "time": "2024-11-12 03:01:31", "headline": "SpaceX CEO Elon Musk Mocks Russia's 'Familiar' Looking Amur Rocket Prototype, Says It Needs To Be Bigger", "summary": "SpaceX CEO Elon Musk on Monday mocked Russia&#39;s new experimental launch vehicle called the Grasshopper, saying it &#34;looks familiar&#34; to the company&#39;s Falcon 9 rocket.", "symbols": [], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/general/space/24/11/41893066/spacex-ceo-elon-musk-mocks-russias-familiar-looking-amur-rocket-prototype-says-it-needs-to-be-bigger", "tags": ["management"]}
{"id": 41905392, "time": "2024-11-12 09:55:06", "headline": "Home Depot Exec On China Tariffs, Whatever Policy Changes Happen Will Have An Industry-Wide Impact", "summary": "", "symbols": ["FXI", "HD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41905392/home-depot-exec-on-china-tariffs-whatever-policy-changes-happen-will-have-an-industry-wide-impact", "tags": []}
{"id": 41905406, "time": "2024-11-12 09:55:31", "headline": "RBC Capital Reiterates Sector Perform on Spruce Biosciences, Maintains $2 Price Target", "summary": "", "symbols": ["SPRB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41905406/rbc-capital-reiterates-sector-perform-on-spruce-biosciences-maintains-2-price-target", "tags": ["analyst_other"]}
{"id": 41905566, "time": "2024-11-12 09:56:32", "headline": "908 Devices Rationalizing Bioprocessing And Life Science Instrumentation Investments By Completing A Reduction In Force In November Of Approximately 11% To Reduce Operating Expenses Across Sales, Marketing And Research And Development", "summary": "", "symbols": ["MASS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41905566/908-devices-rationalizing-bioprocessing-and-life-science-instrumentation-investments-by-completing-a", "tags": []}
{"id": 41905610, "time": "2024-11-12 09:57:32", "headline": "Watching ChromaDex; Traders Circulate Stock Picked By Zacks Under $10 Newsletter", "summary": "", "symbols": ["CDXC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41905610/watching-chromadex-traders-circulate-stock-picked-by-zacks-under-10-newsletter", "tags": []}
{"id": 41905621, "time": "2024-11-12 09:58:18", "headline": "New York State Judge Pauses Proceedings In Trump Hush Money Criminal Case On Prosecutors' Request", "summary": "", "symbols": ["DJT", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41905621/new-york-state-judge-pauses-proceedings-in-trump-hush-money-criminal-case-on-pros", "tags": []}
{"id": 41905636, "time": "2024-11-12 09:58:41", "headline": "BTC Digital Shares Halted On Circuit Breaker To The Upside, Stock Now Up 112.3%", "summary": "", "symbols": ["BTCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41905636/btc-digital-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-112-3", "tags": ["halt"]}
{"id": 41905643, "time": "2024-11-12 09:58:57", "headline": "Trump Closes In On Taylor Swift's X Follower Count With Election Momentum", "summary": "Donald Trump&#39;s follower count on social media platform X is up since Election Day. Here&#39;s a look at how many followers he&#39;s gained and why a social media battle could be ahead.", "symbols": ["DJT"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/social-media/24/11/41905643/trump-closes-in-on-taylor-swifts-x-follower-count-with-election-momentum", "tags": []}
{"id": 41905648, "time": "2024-11-12 09:59:13", "headline": "Barclays Maintains Overweight on Aspen Aerogels, Lowers Price Target to $25", "summary": "", "symbols": ["ASPN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41905648/barclays-maintains-overweight-on-aspen-aerogels-lowers-price-target-to-25", "tags": ["analyst_other", "price_target_down"]}
{"id": 41905729, "time": "2024-11-12 10:00:13", "headline": "Insights Into NVIDIA's Performance Versus Peers In Semiconductors &amp; Semiconductor Equipment Sector", "summary": " ", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41905729/insights-into-nvidias-performance-versus-peers-in-semiconductors-amp-semiconductor-equipment-sector", "tags": []}
{"id": 41905741, "time": "2024-11-12 10:00:17", "headline": "The Analyst Verdict: Kite Realty Gr Trust In The Eyes Of 6 Experts", "summary": " ", "symbols": ["KRG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41905741/the-analyst-verdict-kite-realty-gr-trust-in-the-eyes-of-6-experts", "tags": []}
{"id": 41905759, "time": "2024-11-12 10:00:22", "headline": "Performance Comparison: Microsoft And Competitors In Software Industry", "summary": " ", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41905759/performance-comparison-microsoft-and-competitors-in-software-industry", "tags": []}
{"id": 41905768, "time": "2024-11-12 10:00:24", "headline": "Ardent Health Partners Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)", "summary": " ", "symbols": ["ARDT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41905768/ardent-health-partners-stock-a-deep-dive-into-analyst-perspectives-7-ratings", "tags": []}
{"id": 41905783, "time": "2024-11-12 10:00:31", "headline": "Evaluating Apple Against Peers In Technology Hardware, Storage &amp; Peripherals Industry", "summary": " ", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41905783/evaluating-apple-against-peers-in-technology-hardware-storage-amp-peripherals-industry", "tags": []}
{"id": 41905784, "time": "2024-11-12 10:00:33", "headline": "Analyst Ratings For Kimco Realty", "summary": " ", "symbols": ["KIM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41905784/analyst-ratings-for-kimco-realty", "tags": []}
{"id": 41905791, "time": "2024-11-12 10:00:39", "headline": "Comparative Study: Meta Platforms And Industry Competitors In Interactive Media &amp; Services Industry", "summary": " ", "symbols": ["META"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41905791/comparative-study-meta-platforms-and-industry-competitors-in-interactive-media-amp-services-industr", "tags": []}
{"id": 41905795, "time": "2024-11-12 10:00:45", "headline": "Beyond The Numbers: 21 Analysts Discuss Twilio Stock", "summary": " ", "symbols": ["TWLO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41905795/beyond-the-numbers-21-analysts-discuss-twilio-stock", "tags": []}
{"id": 41905797, "time": "2024-11-12 10:00:48", "headline": "Industry Comparison: Evaluating Amazon.com Against Competitors In Broadline Retail Industry", "summary": " ", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41905797/industry-comparison-evaluating-amazon-com-against-competitors-in-broadline-retail-industry", "tags": []}
{"id": 41905809, "time": "2024-11-12 10:00:53", "headline": "Decoding 12 Analyst Evaluations For Sprinklr", "summary": " ", "symbols": ["CXM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41905809/decoding-12-analyst-evaluations-for-sprinklr", "tags": []}
{"id": 41905815, "time": "2024-11-12 10:01:01", "headline": "Barclays Maintains Overweight on CACI International, Raises Price Target to $625", "summary": "", "symbols": ["CACI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41905815/barclays-maintains-overweight-on-caci-international-raises-price-target-to-625", "tags": ["analyst_other", "price_target_up"]}
{"id": 41905816, "time": "2024-11-12 10:01:01", "headline": "Unveiling 24 Analyst Insights On Zeta Global Holdings", "summary": " ", "symbols": ["ZETA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41905816/unveiling-24-analyst-insights-on-zeta-global-holdings", "tags": []}
{"id": 41905842, "time": "2024-11-12 10:01:18", "headline": "Insights Ahead: Caesarstone's Quarterly Earnings", "summary": " ", "symbols": ["CSTE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41905842/insights-ahead-caesarstones-quarterly-earnings", "tags": ["earnings"]}
{"id": 41905846, "time": "2024-11-12 10:01:27", "headline": "A Look Ahead: BrightView Hldgs's Earnings Forecast", "summary": " ", "symbols": ["BV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41905846/a-look-ahead-brightview-hldgss-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 41905881, "time": "2024-11-12 10:01:49", "headline": "Barclays Maintains Equal-Weight on FIGS, Lowers Price Target to $4", "summary": "", "symbols": ["FIGS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41905881/barclays-maintains-equal-weight-on-figs-lowers-price-target-to-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 41905882, "time": "2024-11-12 10:01:54", "headline": "Earnings Outlook For Harrow", "summary": " ", "symbols": ["HROW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41905882/earnings-outlook-for-harrow", "tags": ["earnings", "guidance"]}
{"id": 41905902, "time": "2024-11-12 10:02:21", "headline": "Dada Nexus Earnings Preview", "summary": " ", "symbols": ["DADA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41905902/dada-nexus-earnings-preview", "tags": ["earnings"]}
{"id": 41905904, "time": "2024-11-12 10:02:22", "headline": "'Disney Explores Wider Field Of Candidates To Succeed Iger; Disney Board Members Are Considering Outsiders Including The CEO Of Videogame Company Electronic Arts' - WSJ", "summary": "", "symbols": ["DIS", "EA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41905904/disney-explores-wider-field-of-candidates-to-succeed-iger-disney-board-members-are-considering-outsi", "tags": ["management"]}
{"id": 41905912, "time": "2024-11-12 10:02:38", "headline": "MicroStrategy's Options: A Look at What the Big Money is Thinking", "summary": " ", "symbols": ["MSTR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41905912/microstrategys-options-a-look-at-what-the-big-money-is-thinking", "tags": []}
{"id": 41905913, "time": "2024-11-12 10:02:39", "headline": "Uncovering Potential: Liquidia's Earnings Preview", "summary": " ", "symbols": ["LQDA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41905913/uncovering-potential-liquidias-earnings-preview", "tags": ["earnings"]}
{"id": 41905918, "time": "2024-11-12 10:02:43", "headline": "Behind the Scenes of Coinbase Glb's Latest Options Trends", "summary": " ", "symbols": ["COIN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41905918/behind-the-scenes-of-coinbase-glbs-latest-options-trends", "tags": []}
{"id": 41905920, "time": "2024-11-12 10:02:44", "headline": "Barclays Maintains Overweight on MercadoLibre, Lowers Price Target to $2200", "summary": "", "symbols": ["MELI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41905920/barclays-maintains-overweight-on-mercadolibre-lowers-price-target-to-2200", "tags": ["analyst_other", "price_target_down"]}
{"id": 41905921, "time": "2024-11-12 10:02:46", "headline": "Earnings Preview: Acelyrin", "summary": " ", "symbols": ["SLRN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41905921/earnings-preview-acelyrin", "tags": ["earnings"]}
{"id": 41905922, "time": "2024-11-12 10:02:48", "headline": "Unpacking the Latest Options Trading Trends in Target", "summary": " ", "symbols": ["TGT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41905922/unpacking-the-latest-options-trading-trends-in-target", "tags": []}
{"id": 41905925, "time": "2024-11-12 10:02:59", "headline": "A Glimpse of Canoo's Earnings Potential", "summary": " ", "symbols": ["GOEV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41905925/a-glimpse-of-canoos-earnings-potential", "tags": ["earnings"]}
{"id": 41905933, "time": "2024-11-12 10:03:05", "headline": "Bridger Aerospace Soars 20% After Q3 Beat: CEO Praises 'Strong Performance' Of Super Scoopers, Air Attack Aircraft", "summary": "Bridger Aerospace Group Holdings shares are trading higher after the company reported third-quarter 2024 results.", "symbols": ["BAER"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/earnings/24/11/41905933/bridger-aerospace-soars-20-after-q3-beat-ceo-praises-strong-performance-of-super-scoopers-air-attack-aircraft", "tags": ["why_moving", "management"]}
{"id": 41905938, "time": "2024-11-12 10:03:10", "headline": "Earnings Preview For 374Water", "summary": " ", "symbols": ["SCWO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41905938/earnings-preview-for-374water", "tags": ["earnings"]}
{"id": 41905942, "time": "2024-11-12 10:03:21", "headline": "Fed's Waller Says Private Sector Best Suited To Innovate On Payment Systems; Fed Ready To Support Private Innovation, Mindful Of Financial Stability; Government Should Have Clear Objective When Providing Financial Services; There Are Times When Government Can Address Market Inefficiencies; Makes No Comment On Economy, Monetary Policy Outlook; Still Doesn't See Case For Fed Digital Dollar", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41905942/feds-waller-says-private-sector-best-suited-to-innovate-on-payment-systems-fed-ready-to-support-priv", "tags": ["guidance"]}
{"id": 41905952, "time": "2024-11-12 10:03:52", "headline": "Insights into Bitfarms's Upcoming Earnings", "summary": " ", "symbols": ["BITF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41905952/insights-into-bitfarmss-upcoming-earnings", "tags": ["earnings"]}
{"id": 41905973, "time": "2024-11-12 10:04:12", "headline": "Barclays Maintains Equal-Weight on Pacira BioSciences, Lowers Price Target to $17", "summary": "", "symbols": ["PCRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41905973/barclays-maintains-equal-weight-on-pacira-biosciences-lowers-price-target-to-17", "tags": ["analyst_other", "price_target_down"]}
{"id": 41905969, "time": "2024-11-12 10:04:16", "headline": "5+ Tips To Create A Successful Cannabis Brand For Global Markets", "summary": "Federico Budasoff and Brenda Hern\u00e1ndez share insights into building authentic, resilient cannabis brands in Latin America.", "symbols": [], "source": "benzinga", "author": "Javier Hasse", "url": "https://www.benzinga.com/markets/cannabis/24/11/41905969/5-tips-to-create-a-successful-cannabis-brand-for-global-markets", "tags": []}
{"id": 41905975, "time": "2024-11-12 10:04:24", "headline": "A Preview Of Star Equity Hldgs's Earnings", "summary": " ", "symbols": ["STRR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41905975/a-preview-of-star-equity-hldgss-earnings", "tags": ["earnings"]}
{"id": 41905985, "time": "2024-11-12 10:04:46", "headline": "Broadwind's Earnings: A Preview", "summary": " ", "symbols": ["BWEN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41905985/broadwinds-earnings-a-preview", "tags": ["earnings"]}
{"id": 41906011, "time": "2024-11-12 10:05:23", "headline": "Exploring Radcom's Earnings Expectations", "summary": " ", "symbols": ["RDCM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41906011/exploring-radcoms-earnings-expectations", "tags": ["earnings"]}
{"id": 41906016, "time": "2024-11-12 10:05:31", "headline": "Barclays Maintains Underweight on Phibro Animal Health, Raises Price Target to $20", "summary": "", "symbols": ["PAHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41906016/barclays-maintains-underweight-on-phibro-animal-health-raises-price-target-to-20", "tags": ["analyst_other", "price_target_up"]}
{"id": 41906036, "time": "2024-11-12 10:06:26", "headline": "Barclays Maintains Overweight on Public Storage, Lowers Price Target to $380", "summary": "", "symbols": ["PSA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41906036/barclays-maintains-overweight-on-public-storage-lowers-price-target-to-380", "tags": ["analyst_other", "price_target_down"]}
{"id": 41905928, "time": "2024-11-12 10:03:00", "headline": "Adams Resources & Energy shares are trading higher after the company announced it will be acquired by Tres Energy Affiliate.", "summary": "", "symbols": ["AE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41905928/adams-resources-energy-shares-are-trading-higher-after-the-company-announced-it-will-be-acquired-by", "tags": ["why_moving", "merger"]}
{"id": 41901459, "time": "2024-11-12 09:04:25", "headline": "Viridian Therapeutics shares are trading higher after the company reported better-than-expected Q3 sales results.", "summary": "", "symbols": ["VRDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41901459/viridian-therapeutics-shares-are-trading-higher-after-the-company-reported-better-than-expected-q3-s", "tags": ["why_moving"]}
{"id": 41900878, "time": "2024-11-12 08:58:16", "headline": "EVgo shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY24 revenue guidance.", "summary": "", "symbols": ["EVGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41900878/evgo-shares-are-trading-higher-after-the-company-reported-better-than-expected-q3-financial-results", "tags": ["earnings", "guidance", "why_moving"]}
{"id": 41900778, "time": "2024-11-12 08:54:28", "headline": "OneMedNet shares are trading higher after the company announced an additional strategic investment in Bitcoin.", "summary": "", "symbols": ["ONMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41900778/onemednet-shares-are-trading-higher-after-the-company-announced-an-additional-strategic-investment-i", "tags": ["why_moving"]}
{"id": 41900073, "time": "2024-11-12 08:37:13", "headline": "Sidus Space shares are trading higher after the company announced it was  selected to design and build the first generation of Data Storage Spacecraft for Lonestar.", "summary": "", "symbols": ["SIDU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41900073/sidus-space-shares-are-trading-higher-after-the-company-announced-it-was-selected-to-design-and-buil", "tags": ["why_moving"]}
{"id": 41906230, "time": "2024-11-12 10:08:15", "headline": "Welcome to the Easy Income Portfolio", "summary": " ", "symbols": ["DMLP", "REM", "SRLN"], "source": "benzinga", "author": "Tim Melvin", "url": "https://www.benzinga.com/24/11/41906230/welcome-to-the-easy-income-portfolio", "tags": []}
{"id": 41906238, "time": "2024-11-12 10:08:33", "headline": "Barclays Maintains Underweight on Sapiens Intl Corp, Lowers Price Target to $30", "summary": "", "symbols": ["SPNS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41906238/barclays-maintains-underweight-on-sapiens-intl-corp-lowers-price-target-to-30", "tags": ["analyst_other", "price_target_down"]}
{"id": 41899988, "time": "2024-11-12 08:32:56", "headline": "ReShape Lifesciences shares are trading higher after the company announced that Health Canada has updated the Medical Device License granting approval for the enhanced Lap-Band 2.0 FLEX and Tubing Kit.", "summary": "", "symbols": ["RSLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41899988/reshape-lifesciences-shares-are-trading-higher-after-the-company-announced-that-health-canada-has-up", "tags": ["why_moving"]}
{"id": 41906245, "time": "2024-11-12 10:08:56", "headline": "Ascend Wellness' 20.1% Wholesale Growth, Wider Net Loss In Q3", "summary": "Ascend Wellness reported Q3 revenue amounted to $141.6 million, up 0.3% year-over-year and 0.1% quarter-over-quarter. Q3 net loss was $28.3 million, compared to a net loss of $11.2 million in the third quarter of 2023 and $21.8 million in the prior period. It also initiated cost-saving measures to reduce expenditures by $30 million in 2025.", "symbols": ["AAWH", "CSE:AAWH"], "source": "benzinga", "author": "Jelena Martinovic", "url": "https://www.benzinga.com/news/earnings/24/11/41906245/ascend-wellness-20-1-wholesale-growth-wider-net-loss-in-q3", "tags": ["earnings"]}
{"id": 41898965, "time": "2024-11-12 08:10:50", "headline": "Genius Group shares are trading higher after the company announced the adoption of a Bitcoin treasury reserve strategy, with Bitcoin as its primary treasury reserve asset.", "summary": "", "symbols": ["GNS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41898965/genius-group-shares-are-trading-higher-after-the-company-announced-the-adoption-of-a-bitcoin-treasur", "tags": ["why_moving"]}
{"id": 41897770, "time": "2024-11-12 07:40:34", "headline": "On Holding shares are trading higher after the company reported better-than-expected Q3 sales results and raised its FY24 net sales guidance.", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41897770/on-holding-shares-are-trading-higher-after-the-company-reported-better-than-expected-q3-sales-result", "tags": ["guidance", "why_moving"]}
{"id": 41895750, "time": "2024-11-12 06:34:39", "headline": "Clean Energy Technologies shares are trading higher after the company signed an MOU with Freyr Technology to provide AI computing and data center services in Southeast Asia.", "summary": "", "symbols": ["CETY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41895750/clean-energy-technologies-shares-are-trading-higher-after-the-company-signed-an-mou-with-freyr-techn", "tags": ["why_moving"]}
{"id": 41895351, "time": "2024-11-12 06:12:52", "headline": "BeiGene shares are trading higher after the company reported better-than-expected Q3 EPADS and sales.", "summary": "", "symbols": ["BGNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41895351/beigene-shares-are-trading-higher-after-the-company-reported-better-than-expected-q3-epads-and-sales", "tags": ["why_moving"]}
{"id": 41906284, "time": "2024-11-12 10:10:05", "headline": "Barclays Maintains Equal-Weight on TIM, Lowers Price Target to $17.5", "summary": "", "symbols": ["TIMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41906284/barclays-maintains-equal-weight-on-tim-lowers-price-target-to-17-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 41906420, "time": "2024-11-12 10:11:24", "headline": "Kazia Therapeutics Says Got Letter From Nasdaq Informing Co Has Regained Compliance With Minimum Bid Price Requirement For Continued Listing", "summary": "", "symbols": ["KZIA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41906420/kazia-therapeutics-says-got-letter-from-nasdaq-informing-co-has-regained-compliance-with-minimum-bid", "tags": []}
{"id": 41906422, "time": "2024-11-12 10:11:27", "headline": "Oppenheimer Maintains Outperform on Wyndham Hotels & Resorts, Raises Price Target to $115", "summary": "", "symbols": ["WH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41906422/oppenheimer-maintains-outperform-on-wyndham-hotels-resorts-raises-price-target-to-115", "tags": ["analyst_other", "price_target_up"]}
{"id": 41906463, "time": "2024-11-12 10:12:02", "headline": "On November 10, Brooge Energy's Board Appointed Ines Bezaznia As CFO And Interim CEO Of Co", "summary": "", "symbols": ["BROG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41906463/on-november-10-brooge-energys-board-appointed-ines-bezaznia-as-cfo-and-interim-ceo-of-co", "tags": ["management"]}
{"id": 41906520, "time": "2024-11-12 10:12:06", "headline": "BTC Digital Shares Halted To The Upside; Stock Now Up 181.35%", "summary": "", "symbols": ["BTCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41906520/btc-digital-shares-halted-to-the-upside-stock-now-up-181-35", "tags": ["halt"]}
{"id": 41906566, "time": "2024-11-12 10:12:19", "headline": "JP Morgan Maintains Overweight on Air Lease, Raises Price Target to $56", "summary": "", "symbols": ["AL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41906566/jp-morgan-maintains-overweight-on-air-lease-raises-price-target-to-56", "tags": ["analyst_other", "price_target_up"]}
{"id": 41906606, "time": "2024-11-12 10:12:57", "headline": "Oppenheimer Maintains Outperform on Live Nation Entertainment, Raises Price Target to $155", "summary": "", "symbols": ["LYV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41906606/oppenheimer-maintains-outperform-on-live-nation-entertainment-raises-price-target-to-155", "tags": ["analyst_other", "price_target_up"]}
{"id": 41906630, "time": "2024-11-12 10:13:26", "headline": "JP Morgan Maintains Overweight on Amicus Therapeutics, Raises Price Target to $17", "summary": "", "symbols": ["FOLD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41906630/jp-morgan-maintains-overweight-on-amicus-therapeutics-raises-price-target-to-17", "tags": ["analyst_other", "price_target_up"]}
{"id": 41906678, "time": "2024-11-12 10:14:45", "headline": "JP Morgan Maintains Overweight on Aramark, Raises Price Target to $45", "summary": "", "symbols": ["ARMK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41906678/jp-morgan-maintains-overweight-on-aramark-raises-price-target-to-45", "tags": ["analyst_other", "price_target_up"]}
{"id": 41906704, "time": "2024-11-12 10:15:15", "headline": "Oppenheimer Maintains Outperform on RLJ Lodging, Raises Price Target to $12", "summary": "", "symbols": ["RLJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41906704/oppenheimer-maintains-outperform-on-rlj-lodging-raises-price-target-to-12", "tags": ["analyst_other", "price_target_up"]}
{"id": 41906735, "time": "2024-11-12 10:15:54", "headline": "Market Whales and Their Recent Bets on Micron Technology Options", "summary": " ", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41906735/market-whales-and-their-recent-bets-on-micron-technology-options", "tags": []}
{"id": 41906739, "time": "2024-11-12 10:15:59", "headline": "Looking At PDD Holdings's Recent Unusual Options Activity", "summary": " ", "symbols": ["PDD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41906739/looking-at-pdd-holdingss-recent-unusual-options-activity", "tags": []}
{"id": 41906766, "time": "2024-11-12 10:16:25", "headline": "Exxon Mobil Agrees To Sale Of Conventional Permian Assets, Expects To Close Deal By Q1 2025; Privately Owned Hilcorp Is Buyer Of Exxon Conventional Assets, Will Pay Around $1B", "summary": "", "symbols": ["XOM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41906766/exxon-mobil-agrees-to-sale-of-conventional-permian-assets-expects-to-close-deal-by-q1-2025-privately", "tags": ["contract"]}
{"id": 41906803, "time": "2024-11-12 10:17:08", "headline": "Fed's Barkin Says Federal Reserve 'In Position To Respond Appropriately' Regardless Of How Economy Evolves; Fed Has Started Process Of Recalibrating Interest Rates To Somewhat Less Restrictive Levels; U.S. Economy Looks Pretty Good, Labor Market Resilient; From Here, Labor Market Might Be Fine Or Might Continue To Weaken; Inflation Might Be Coming Under Control Or Might Risk Getting Stuck Above Fed's 2% Target; Fed's Focus May Turn To Upside Inflation Risks Or To Downside Employment Risks", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41906803/feds-barkin-says-federal-reserve-in-position-to-respond-appropriately-regardless-of-how-economy-evol", "tags": []}
{"id": 41906890, "time": "2024-11-12 10:17:29", "headline": "JP Morgan Maintains Overweight on Credicorp, Raises Price Target to $219", "summary": "", "symbols": ["BAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41906890/jp-morgan-maintains-overweight-on-credicorp-raises-price-target-to-219", "tags": ["analyst_other", "price_target_up"]}
{"id": 41906923, "time": "2024-11-12 10:17:59", "headline": "TreeHouse Foods Stumbles As Sales Dip And Griddle Recall Hits Q3 Earnings; CEO Bets on Future Margins", "summary": "TreeHouse Foods Q3 sales decline 2.8% YoY, adjusted EPS $0.74 vs $0.75 consensus. Q4 net sales expected at $900M-$930M, 2024 sales and EBITDA outlook lowered.", "symbols": ["THS"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/news/earnings/24/11/41906923/treehouse-foods-stumbles-as-sales-dip-and-griddle-recall-hits-q3-earnings-ceo-bets-on-future-margins", "tags": ["earnings", "guidance", "management"]}
{"id": 41907000, "time": "2024-11-12 10:19:08", "headline": "JP Morgan Maintains Neutral on Federal Realty Investment, Raises Price Target to $122", "summary": "", "symbols": ["FRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41907000/jp-morgan-maintains-neutral-on-federal-realty-investment-raises-price-target-to-122", "tags": ["analyst_other", "price_target_up"]}
{"id": 41907002, "time": "2024-11-12 10:19:12", "headline": "BTC Digital Shares Resume Trade; Quickly Halted To The Upside, Now Up 209.52%", "summary": "", "symbols": ["BTCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41907002/btc-digital-shares-resume-trade-quickly-halted-to-the-upside-now-up-209-52", "tags": ["halt"]}
{"id": 41902155, "time": "2024-11-12 09:14:20", "headline": "Bitcoin To 'Augment' Gold As The 'Next Strategic Reserve Asset,' Says Expert", "summary": "Boosted by post-election euphoria, experts muse whether Bitcoin (CRYPTO: BTC) could potentially close the gap to gold as a strategic reserve asset&lt;/", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41902155/bitcoin-to-augment-gold-as-the-next-strategic-reserve-asset-says-expert", "tags": []}
{"id": 41907137, "time": "2024-11-12 10:20:11", "headline": "AstraZeneca Lifts 2024 Forecast On Better Than Expected Q3 Performance, Says It Takes China Investigations 'Very Seriously'", "summary": "AstraZeneca reports $13.57 billion in Q3 sales, up 18% year-over-year. Announces $3.5B U.S. investment to boost R&amp;D and manufacturing with 1,000 new jobs.", "symbols": ["AZN", "DSKNY"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/11/41907137/astrazeneca-lifts-2024-forecast-on-better-than-expected-q3-performance-says-it-takes-china-investigations-very-seriously", "tags": ["guidance"]}
{"id": 41907142, "time": "2024-11-12 10:20:19", "headline": "What's Going On With GameStop Stock?", "summary": "GameStop Corp (NYSE:GME) shares have seen increased attention in recent trading sessions, rallying about 30% over the past two weeks. Here&#39;s a look at what you need to know.", "symbols": ["CHWY", "GME"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41907142/whats-going-on-with-gamestop-stock-5", "tags": ["why_moving"]}
{"id": 41907166, "time": "2024-11-12 10:21:05", "headline": "Salesforce, Lockheed Martin, Interactive Brokers And More On CNBC's 'Final Trades'", "summary": "On CNBC&#39;s &#34;Halftime Report Final Trades,&#34; Rob Sechan of NewEdge Wealth named Salesforce, Inc. as his final trade.", "symbols": ["CRM", "IBKR", "IJR", "LMT"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/11/41907166/salesforce-lockheed-martin-interactive-brokers-cnbc-final-trades", "tags": []}
{"id": 41907219, "time": "2024-11-12 10:21:52", "headline": "RBC Capital Reiterates Outperform on Sixth Street Specialty, Maintains $23 Price Target", "summary": "", "symbols": ["TSLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41907219/rbc-capital-reiterates-outperform-on-sixth-street-specialty-maintains-23-price-target", "tags": ["analyst_other"]}
{"id": 41907249, "time": "2024-11-12 10:22:25", "headline": "JP Morgan Maintains Overweight on Grab Holdings, Raises Price Target to $5.7", "summary": "", "symbols": ["GRAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41907249/jp-morgan-maintains-overweight-on-grab-holdings-raises-price-target-to-5-7", "tags": ["analyst_other", "price_target_up"]}
{"id": 41907335, "time": "2024-11-12 10:24:19", "headline": "BTC Digital Shares Resumed Trade", "summary": "", "symbols": ["BTCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41907335/btc-digital-shares-resumed-trade", "tags": []}
{"id": 41907380, "time": "2024-11-12 10:25:58", "headline": "RBC Capital Reiterates Sector Perform on Nevro, Maintains $7 Price Target", "summary": "", "symbols": ["NVRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41907380/rbc-capital-reiterates-sector-perform-on-nevro-maintains-7-price-target", "tags": ["analyst_other"]}
{"id": 41907381, "time": "2024-11-12 10:25:58", "headline": "JP Morgan Maintains Neutral on Harmony Gold Mining Co, Raises Price Target to $8.4", "summary": "", "symbols": ["HMY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41907381/jp-morgan-maintains-neutral-on-harmony-gold-mining-co-raises-price-target-to-8-4", "tags": ["analyst_other", "price_target_up"]}
{"id": 41907420, "time": "2024-11-12 10:27:20", "headline": "JP Morgan Maintains Neutral on P10, Raises Price Target to $14", "summary": "", "symbols": ["PX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41907420/jp-morgan-maintains-neutral-on-p10-raises-price-target-to-14", "tags": ["analyst_other", "price_target_up"]}
{"id": 41907447, "time": "2024-11-12 10:27:42", "headline": "Susquehanna Maintains Positive on Array Technologies, Lowers Price Target to $9", "summary": "", "symbols": ["ARRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41907447/susquehanna-maintains-positive-on-array-technologies-lowers-price-target-to-9", "tags": ["analyst_other", "price_target_down"]}
{"id": 41895977, "time": "2024-11-12 06:41:58", "headline": "OPEC Lowers 2024 Global Oil-Demand Growth Forecast to 1.82M B/D From 1.93M B/D; Lowers 2024 Global Oil-Demand Growth Forecast to 1.82M B/D From 1.93M B/D", "summary": "", "symbols": ["FXI", "SPY", "USO", "VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41895977/opec-lowers-2024-global-oil-demand-growth-forecast-to-1-82m-bd-from-1-93m-bd-lowers-2024-global-oil", "tags": ["guidance"]}
{"id": 41907482, "time": "2024-11-12 10:27:56", "headline": "Stock Of The Day: Home Depot Flashes Buy Signal As Earnings Beat Expectations", "summary": "Shares of Home Depot (HD) may have just flashed a sell signal. The 5-day moving average has crossed above the 12-day.", "symbols": ["HD"], "source": "benzinga", "author": "Mark Putrino", "url": "https://www.benzinga.com/trading-ideas/technicals/24/11/41907482/stock-of-the-day-home-depot-flashes-buy-signal-as-earnings-beat-expectations", "tags": ["earnings"]}
{"id": 41907505, "time": "2024-11-12 10:28:22", "headline": "Raoul Pal Predicted Bitcoin To Hit $250,000\u2014But He Thinks Ethereum Could Outperform Under Donald Trump's Administration", "summary": "Raoul Pal, CEO of Real Vision, has suggested that Ethereum (CRYPTO: ETH) could benefit more than Bitcoin (CRYPTO: BTC) ", "symbols": ["BTCUSD", "ETH", "ETHUSD", "SOLUSD", "SUIUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41907505/raoul-pal-predicted-bitcoin-to-hit-250000-but-he-thinks-ethereum-could-outperform-under-donald-trumps-administration", "tags": ["management"]}
{"id": 41907519, "time": "2024-11-12 10:28:38", "headline": "Sea Q3 Earnings: E-Commerce Leads Growth, Shopee On Track To Hit GMV Guidance, Stock Soars", "summary": "Sea Limited (SE) reported strong Q3 revenue growth of 30.8%, beating analyst estimates. However, EPS missed consensus. Digital Entertainment revenue declined while E-commerce and Digital Financial Services saw growth. SeaMoney expanded loan book and Garena&#39;s success expected to continue. SE stock surged 153% YTD and is up 6.71% premarket.", "symbols": ["SE"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/24/11/41907519/sea-ltd-q3-earnings-e-commerce-leads-growth-shopee-on-track-to-hit-gmv-guidance", "tags": ["earnings", "guidance"]}
{"id": 41907560, "time": "2024-11-12 10:29:28", "headline": "Occidental Petroleum Set To Release Q3 Earnings: Can It Justify Warren Buffett's Vote Of Confidence?", "summary": "Occidental shares have taken a hit this year, down over 15%, while Warren Buffett&#39;s Berkshire Hathaway upped its stake.", "symbols": ["OXY"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/technicals/24/11/41907560/occidental-q3-earnings-can-warren-buffetts-favorite-oil-play-reverse-its-slide", "tags": ["earnings"]}
{"id": 41907564, "time": "2024-11-12 10:29:34", "headline": "Susquehanna Maintains Positive on Bloom Energy, Raises Price Target to $16", "summary": "", "symbols": ["BE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41907564/susquehanna-maintains-positive-on-bloom-energy-raises-price-target-to-16", "tags": ["analyst_other", "price_target_up"]}
{"id": 41907592, "time": "2024-11-12 10:30:09", "headline": "Alembic Global Upgrades BWX Technologies to Overweight, Announces $148 Price Target", "summary": "", "symbols": ["BWXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41907592/alembic-global-upgrades-bwx-technologies-to-overweight-announces-148-price-target", "tags": ["analyst_up"]}
{"id": 41907678, "time": "2024-11-12 10:31:14", "headline": "Susquehanna Maintains Negative on RXO, Lowers Price Target to $12", "summary": "", "symbols": ["RXO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41907678/susquehanna-maintains-negative-on-rxo-lowers-price-target-to-12", "tags": ["analyst_other", "price_target_down"]}
{"id": 41907679, "time": "2024-11-12 10:31:15", "headline": "JP Morgan Maintains Neutral on Redfin, Raises Price Target to $8", "summary": "", "symbols": ["RDFN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41907679/jp-morgan-maintains-neutral-on-redfin-raises-price-target-to-8", "tags": ["analyst_other", "price_target_up"]}
{"id": 41907751, "time": "2024-11-12 10:33:03", "headline": "Argus Research Downgrades Old Dominion Freight Line to Hold", "summary": "", "symbols": ["ODFL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41907751/argus-research-downgrades-old-dominion-freight-line-to-hold", "tags": ["analyst_down"]}
{"id": 41907860, "time": "2024-11-12 10:35:06", "headline": "Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation", "summary": "", "symbols": ["ACOG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41907860/trading-halt-halt-status-updated-at-10-35-00-am-et-quotation-resumption-ipo-security-released-for-qu", "tags": []}
{"id": 41907903, "time": "2024-11-12 10:35:46", "headline": "JP Morgan Maintains Underweight on Sinclair, Raises Price Target to $16", "summary": "", "symbols": ["SBGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41907903/jp-morgan-maintains-underweight-on-sinclair-raises-price-target-to-16", "tags": ["analyst_other", "price_target_up"]}
{"id": 41907960, "time": "2024-11-12 10:37:27", "headline": "JP Morgan Maintains Neutral on Tegna, Raises Price Target to $19", "summary": "", "symbols": ["TGNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41907960/jp-morgan-maintains-neutral-on-tegna-raises-price-target-to-19", "tags": ["analyst_other", "price_target_up"]}
{"id": 41907962, "time": "2024-11-12 10:37:58", "headline": "Why This Aramark Analyst Is Raising Forecasts After Mixed Q4 Results", "summary": "Aramark announced a &#34;material&#34; share repurchase in fiscal 2025, for the first time in nearly eight years, according to Truist Securities.", "symbols": ["ARMK"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/news/earnings/earnings-beats/24/11/41907962/why-this-aramark-analyst-is-raising-forecasts-after-mixed-q4-results", "tags": ["earnings", "buyback"]}
{"id": 41902202, "time": "2024-11-12 09:16:45", "headline": "Chinese Currency Hits 3-Month Low: Trump's Anti-China Cabinet Appointments Rattle Investors", "summary": "Chinese markets drop as Trump considers China hawks for top roles, sparking fears of tougher stance. Yuan tumbles, stocks in Shanghai and Hong Kong plummet.", "symbols": ["BABA", "BIDU", "NIO", "PDD", "XPEV"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41902202/trumps-china-hawks-rumored-for-top-roles-yuan-hits-3-month-low", "tags": []}
{"id": 41908034, "time": "2024-11-12 10:39:36", "headline": "Ohio Lawmaker Moves To Ban Hemp Products, Citing Youth Safety Concerns", "summary": "Ohio: Senate Bill 326 proposes strict caps on THC content in hemp products, aiming to curb unregulated sales and protect public health.", "symbols": [], "source": "benzinga", "author": "Rolando Garc\u00eda", "url": "https://www.benzinga.com/government/regulations/24/11/41908034/ohio-lawmaker-moves-to-ban-hemp-products-citing-youth-safety-concerns", "tags": []}
{"id": 41908041, "time": "2024-11-12 10:39:44", "headline": "Market Whales and Their Recent Bets on ABNB Options", "summary": " ", "symbols": ["ABNB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41908041/market-whales-and-their-recent-bets-on-abnb-options", "tags": []}
{"id": 41908044, "time": "2024-11-12 10:39:49", "headline": "Check Out What Whales Are Doing With HON", "summary": " ", "symbols": ["HON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41908044/check-out-what-whales-are-doing-with-hon", "tags": []}
{"id": 41908055, "time": "2024-11-12 10:39:54", "headline": "Advanced Micro Devices Unusual Options Activity For November 12", "summary": " ", "symbols": ["AMD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41908055/advanced-micro-devices-unusual-options-activity-for-november-12", "tags": []}
{"id": 41908083, "time": "2024-11-12 10:40:48", "headline": "JP Morgan Maintains Overweight on Controladora Vuela, Raises Price Target to $17", "summary": "", "symbols": ["VLRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41908083/jp-morgan-maintains-overweight-on-controladora-vuela-raises-price-target-to-17", "tags": ["analyst_other", "price_target_up"]}
{"id": 41908084, "time": "2024-11-12 10:40:50", "headline": "RBC Capital Reiterates Outperform on Evolent Health, Maintains $20 Price Target", "summary": "", "symbols": ["EVH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41908084/rbc-capital-reiterates-outperform-on-evolent-health-maintains-20-price-target", "tags": ["analyst_other"]}
{"id": 41908107, "time": "2024-11-12 10:41:58", "headline": "Blade Air Mobility Delivers Q3 Earnings Beat And Strong Margins As Restructuring Takes Flight", "summary": "Blade Air Mobility reported Q3  revenue growth of 4.8%, with EPS beating estimates. They expect double-digit growth in Medical segment revenue for 2025.", "symbols": ["ARKQ", "ARKX", "BLDE"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/earnings/24/11/41908107/blade-air-mobility-delivers-q3-earnings-beat-and-strong-margins-as-restructuring-takes-flight", "tags": ["earnings"]}
{"id": 41908183, "time": "2024-11-12 10:42:14", "headline": "JP Morgan Maintains Overweight on AnaptysBio, Lowers Price Target to $66", "summary": "", "symbols": ["ANAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41908183/jp-morgan-maintains-overweight-on-anaptysbio-lowers-price-target-to-66", "tags": ["analyst_other", "price_target_down"]}
{"id": 41908290, "time": "2024-11-12 10:43:28", "headline": "BTC Digital Shares Halted On Circuit Breaker To The Upside, Stock Now Up 286.1%", "summary": "", "symbols": ["BTCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41908290/btc-digital-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-223", "tags": ["halt"]}
{"id": 41908303, "time": "2024-11-12 10:43:56", "headline": "JP Morgan Maintains Neutral on Bloomin Brands, Lowers Price Target to $14", "summary": "", "symbols": ["BLMN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41908303/jp-morgan-maintains-neutral-on-bloomin-brands-lowers-price-target-to-14", "tags": ["analyst_other", "price_target_down"]}
{"id": 41908324, "time": "2024-11-12 10:45:16", "headline": "JP Morgan Maintains Neutral on Cable One, Lowers Price Target to $470", "summary": "", "symbols": ["CABO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41908324/jp-morgan-maintains-neutral-on-cable-one-lowers-price-target-to-470", "tags": ["analyst_other", "price_target_down"]}
{"id": 41908329, "time": "2024-11-12 10:45:32", "headline": "RBC Capital Maintains Outperform on Albemarle, Raises Price Target to $133", "summary": "", "symbols": ["ALB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41908329/rbc-capital-maintains-outperform-on-albemarle-raises-price-target-to-133", "tags": ["analyst_other", "price_target_up"]}
{"id": 41908332, "time": "2024-11-12 10:45:51", "headline": "Enphase Energy Unusual Options Activity For November 12", "summary": " ", "symbols": ["ENPH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41908332/enphase-energy-unusual-options-activity-for-november-12", "tags": []}
{"id": 41908345, "time": "2024-11-12 10:45:56", "headline": "Netflix's Options Frenzy: What You Need to Know", "summary": " ", "symbols": ["NFLX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41908345/netflixs-options-frenzy-what-you-need-to-know", "tags": []}
{"id": 41908418, "time": "2024-11-12 10:48:18", "headline": "BTC Digital Shares Resume Trade", "summary": "", "symbols": ["BTCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41908418/btc-digital-shares-reume-trade", "tags": []}
{"id": 41908475, "time": "2024-11-12 10:49:58", "headline": "BTC Digital Shares Halted On Circuit Breaker To The Upside, Stock Now Up 380.2%", "summary": "", "symbols": ["BTCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41908475/btc-digital-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-380-2", "tags": ["halt"]}
{"id": 41905885, "time": "2024-11-12 10:01:55", "headline": "What's Going On With Autoliv Stock On Tuesday?", "summary": "Autoliv shares are down in premarket trading despite announcing a dividend increase, extended share repurchase program, and plans to retire treasury shares, amid a recently revised sales growth forecast for 2024.\n\n\n\n", "symbols": ["ALV"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41905885/whats-going-on-with-autoliv-tuesday-auto-safety-stock-lowers-2024-sales-growth-forecast-to-1", "tags": ["guidance", "why_moving", "buyback", "dividend"]}
{"id": 41908713, "time": "2024-11-12 10:52:07", "headline": "JMP Securities Reiterates Market Perform on Nevro", "summary": "", "symbols": ["NVRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41908713/jmp-securities-reiterates-market-perform-on-nevro", "tags": ["analyst_other"]}
{"id": 41908729, "time": "2024-11-12 10:52:53", "headline": "'The CEO Of GE Vernova, The World's Third Largest Wind Turbine Manufacturer By Market Share Outside Of China, Has Said He Will Keep His Search For New Offshore Turbine Orders On Ice As He Waits For Market Conditions To Improve' - Financial Times", "summary": "", "symbols": ["GEV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41908729/the-ceo-of-ge-vernova-the-worlds-third-largest-wind-turbine-manufacturer-by-market-share-outside-of", "tags": ["management"]}
{"id": 41908737, "time": "2024-11-12 10:53:33", "headline": "Bonk's 18% Surge Eclipses Gains Of 'Dogecoin Killer' Shiba Inu: The 'Mother Of All Rallies' Still To Come, Predicts Millionaire Trader", "summary": "Millionaire trader Unipcs, known as &#34;The BONK Guy,&#34; shared a fresh optimistic outlook on Bonk (CRYPTO: BONK), calling it a standout among meme coins du", "symbols": ["BONKUSD", "DOGEUSD", "SHIBUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41908737/bonks-18-surge-eclipses-gains-of-dogecoin-killer-shiba-inu-the-mother-of-all-rallies-still-to-come-predicts-millionaire-trader", "tags": ["guidance"]}
{"id": 41908738, "time": "2024-11-12 10:53:44", "headline": "Benzinga Market Summary: China Stocks Under Pressure On Trump Administration Picks, Bitcoin Hovers Around $86,000, Shopify Surges On Earnings Report", "summary": "", "symbols": ["BTCUSD", "FXI", "SHOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41908738/benzinga-market-summary-china-stocks-under-pressure-on-trump-administration-picks", "tags": ["earnings"]}
{"id": 41908752, "time": "2024-11-12 10:53:57", "headline": "FuelCell Energy Stock Is Falling Today: What's Going On?", "summary": "Shares of FuelCell Energy, Inc. (NASDAQ: FCEL) are trading lower Tuesday, potentially in response to Plug Power&#39;s (NASDAQ: PLUG) disappointing third-quarter financial report. Here&#39;s what you need to know.", "symbols": ["FCEL", "PLUG"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/news/earnings/24/11/41908752/fuelcell-energy-stock-is-falling-today-whats-going-on", "tags": ["why_moving"]}
{"id": 41908753, "time": "2024-11-12 10:53:58", "headline": "JP Morgan Maintains Overweight on Krispy Kreme, Lowers Price Target to $13", "summary": "", "symbols": ["DNUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41908753/jp-morgan-maintains-overweight-on-krispy-kreme-lowers-price-target-to-13", "tags": ["analyst_other", "price_target_down"]}
{"id": 41908770, "time": "2024-11-12 10:54:15", "headline": "JMP Securities Reiterates Market Outperform on Taysha Gene Therapies, Maintains $5 Price Target", "summary": "", "symbols": ["TSHA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41908770/jmp-securities-reiterates-market-outperform-on-taysha-gene-therapies-maintains-5-price-target", "tags": ["analyst_other"]}
{"id": 41908787, "time": "2024-11-12 10:55:14", "headline": "Applovin Stock Up 600% In 2024, Joins Nasdaq-100 Index Monday", "summary": "Nasdaq announced last Friday that Applovin will join the Nasdaq-100 Index next Monday prior to the market open.", "symbols": ["APP", "NDAQ"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41908787/applovin-stock-up-600-in-2024-joins-nasdaq-100-index-monday", "tags": []}
{"id": 41908789, "time": "2024-11-12 10:55:22", "headline": "Market Clubhouse Morning Memo - November 12th, 2024 (Trade Strategy For SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META And TSLA)", "summary": "Good Morning Traders! In today&#39;s Market Clubhouse Morning Memo, we will discuss SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA.", "symbols": ["AAPL", "GOOGL", "META", "MSFT", "NVDA", "QQQ", "SPY", "TSLA"], "source": "benzinga", "author": "RIPS", "url": "https://www.benzinga.com/markets/24/11/41908789/market-clubhouse-morning-memo-november-12th-2024-trade-strategy-for-spy-qqq-aapl-msft-nvda-googl-met", "tags": []}
{"id": 41908820, "time": "2024-11-12 10:56:33", "headline": "BTCS Shares Halted On Circuit Breaker To The Upside, Stock Now Up 96.3%", "summary": "", "symbols": ["BTCS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41908820/btcs-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-96-3", "tags": ["halt"]}
{"id": 41908824, "time": "2024-11-12 10:57:07", "headline": "JP Morgan Maintains Neutral on National Fuel Gas, Lowers Price Target to $64", "summary": "", "symbols": ["NFG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41908824/jp-morgan-maintains-neutral-on-national-fuel-gas-lowers-price-target-to-64", "tags": ["analyst_other", "price_target_down"]}
{"id": 41908833, "time": "2024-11-12 10:57:25", "headline": "BTC Digital Shares Halted On Circuit Breaker To The Upside, Stock Now Up 525%", "summary": "", "symbols": ["BTCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41908833/btc-digital-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-525", "tags": ["halt"]}
{"id": 41908838, "time": "2024-11-12 10:57:49", "headline": "Tencent Music's Q3 Revenue Tops $1 Billion, But Monthly Active Users Fall 3%, Stock Reacts", "summary": "\nTencent Music Entertainment Group&#39;s Q3 revenue grew 6.8% to $1.00 billion but missed analyst estimates. Online music revenue rose, but social entertainment and other services declined. MAUs for online music decreased, while paying users increased. Gross margin and operating profit also increased. CEO emphasized growth strategy and focus on quality.", "symbols": ["TME"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/news/earnings/24/11/41908838/tencent-musics-q3-revenue-tops-1-billion-but-monthly-active-users-fall-3-stock-reacts", "tags": ["earnings", "management"]}
{"id": 41908848, "time": "2024-11-12 10:57:54", "headline": "Needham Reiterates Buy on LivaNova, Maintains $75 Price Target", "summary": "", "symbols": ["LIVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41908848/needham-reiterates-buy-on-livanova-maintains-75-price-target", "tags": ["analyst_other"]}
{"id": 41908951, "time": "2024-11-12 10:59:12", "headline": "JP Morgan Maintains Overweight on Solid Biosciences, Lowers Price Target to $12", "summary": "", "symbols": ["SLDB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41908951/jp-morgan-maintains-overweight-on-solid-biosciences-lowers-price-target-to-12", "tags": ["analyst_other", "price_target_down"]}
{"id": 41908808, "time": "2024-11-12 10:56:14", "headline": "'Trump expected to try to halt TikTok ban, allies say' - Washington Post", "summary": "", "symbols": ["FXI", "GOOG", "GOOGL", "ORCL", "PINS", "SNAP", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41908808/trump-expected-to-try-to-halt-tiktok-ban-allies-say-washington-post", "tags": []}
{"id": 41909185, "time": "2024-11-12 11:00:12", "headline": "HC Wainwright & Co. Reiterates Buy on Armata Pharmaceuticals, Maintains $7 Price Target", "summary": "", "symbols": ["ARMP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41909185/hc-wainwright-co-reiterates-buy-on-armata-pharmaceuticals-maintains-7-price-target", "tags": ["analyst_other"]}
{"id": 41909224, "time": "2024-11-12 11:00:16", "headline": "Bilibili Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)", "summary": " ", "symbols": ["BILI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41909224/bilibili-stock-a-deep-dive-into-analyst-perspectives-6-ratings", "tags": []}
{"id": 41909226, "time": "2024-11-12 11:00:18", "headline": "(CNM) - Analyzing Core & Main's Short Interest", "summary": " ", "symbols": ["CNM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41909226/cnm-analyzing-core-mains-short-interest", "tags": []}
{"id": 41909227, "time": "2024-11-12 11:00:21", "headline": "ValueAct Takes $1B Stake In Meta Platforms", "summary": "", "symbols": ["META"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41909227/valueact-takes-1b-stake-in-meta-platforms", "tags": []}
{"id": 41909229, "time": "2024-11-12 11:00:23", "headline": "How Is The Market Feeling About MicroCloud Hologram?", "summary": " ", "symbols": ["HOLO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41909229/how-is-the-market-feeling-about-microcloud-hologram", "tags": []}
{"id": 41909230, "time": "2024-11-12 11:00:25", "headline": "Peeling Back The Layers: Exploring Nevro Through Analyst Insights", "summary": " ", "symbols": ["NVRO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41909230/peeling-back-the-layers-exploring-nevro-through-analyst-insights", "tags": []}
{"id": 41909231, "time": "2024-11-12 11:00:29", "headline": "(SMCI) - Analyzing Super Micro Computer's Short Interest", "summary": " ", "symbols": ["SMCI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41909231/smci-analyzing-super-micro-computers-short-interest", "tags": []}
{"id": 41909233, "time": "2024-11-12 11:00:35", "headline": "Navigating 7 Analyst Ratings For Red Rock Resorts", "summary": " ", "symbols": ["RRR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41909233/navigating-7-analyst-ratings-for-red-rock-resorts", "tags": []}
{"id": 41909236, "time": "2024-11-12 11:00:47", "headline": "Critical Insights From BJ's Wholesale Club Analyst Ratings: What You Need To Know", "summary": " ", "symbols": ["BJ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41909236/critical-insights-from-bjs-wholesale-club-analyst-ratings-what-you-need-to-know", "tags": []}
{"id": 41909240, "time": "2024-11-12 11:00:54", "headline": "4 Analysts Assess Hudson Pacific Properties: What You Need To Know", "summary": " ", "symbols": ["HPP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41909240/4-analysts-assess-hudson-pacific-properties-what-you-need-to-know", "tags": []}
{"id": 41909243, "time": "2024-11-12 11:00:58", "headline": "Alvotech's Earnings Outlook", "summary": " ", "symbols": ["ALVO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41909243/alvotechs-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41909245, "time": "2024-11-12 11:01:01", "headline": "The Analyst Verdict: Aspen Aerogels In The Eyes Of 6 Experts", "summary": " ", "symbols": ["ASPN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41909245/the-analyst-verdict-aspen-aerogels-in-the-eyes-of-6-experts", "tags": []}
{"id": 41909259, "time": "2024-11-12 11:01:18", "headline": "BIT Mining Shares Halted On Circuit Breaker To The Upside, Stock Now Up 31%", "summary": "", "symbols": ["BTCM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41909259/bit-mining-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-31", "tags": ["halt"]}
{"id": 41909270, "time": "2024-11-12 11:01:42", "headline": "BTC Digital Shares Resume Trading", "summary": "", "symbols": ["BTCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41909270/btc-digital-shares-resume-trading", "tags": []}
{"id": 41909271, "time": "2024-11-12 11:01:42", "headline": "Earnings Outlook For Afya", "summary": " ", "symbols": ["AFYA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41909271/earnings-outlook-for-afya", "tags": ["earnings", "guidance"]}
{"id": 41909272, "time": "2024-11-12 11:01:49", "headline": "Canaccord Genuity Maintains Hold on Enphase Energy, Lowers Price Target to $76", "summary": "", "symbols": ["ENPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41909272/canaccord-genuity-maintains-hold-on-enphase-energy-lowers-price-target-to-76", "tags": ["analyst_other", "price_target_down"]}
{"id": 41909274, "time": "2024-11-12 11:01:50", "headline": "Earnings Outlook For Omeros", "summary": " ", "symbols": ["OMER"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41909274/earnings-outlook-for-omeros", "tags": ["earnings", "guidance"]}
{"id": 41909281, "time": "2024-11-12 11:02:02", "headline": "Earnings Preview For EZCORP", "summary": " ", "symbols": ["EZPW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41909281/earnings-preview-for-ezcorp", "tags": ["earnings"]}
{"id": 41909287, "time": "2024-11-12 11:02:09", "headline": "PolyPid's Earnings: A Preview", "summary": " ", "symbols": ["PYPD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41909287/polypids-earnings-a-preview", "tags": ["earnings"]}
{"id": 41909290, "time": "2024-11-12 11:02:18", "headline": "A Look Ahead: Allurion Technologies's Earnings Forecast", "summary": " ", "symbols": ["ALUR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41909290/a-look-ahead-allurion-technologiess-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 41909292, "time": "2024-11-12 11:02:25", "headline": "A Glimpse of Lucid Diagnostics's Earnings Potential", "summary": " ", "symbols": ["LUCD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41909292/a-glimpse-of-lucid-diagnosticss-earnings-potential", "tags": ["earnings"]}
{"id": 41909295, "time": "2024-11-12 11:02:41", "headline": "Kore Group Holdings's Earnings: A Preview", "summary": " ", "symbols": ["KORE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41909295/kore-group-holdingss-earnings-a-preview", "tags": ["earnings"]}
{"id": 41909309, "time": "2024-11-12 11:03:02", "headline": "PAVmed's Earnings: A Preview", "summary": " ", "symbols": ["PAVM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41909309/pavmeds-earnings-a-preview", "tags": ["earnings"]}
{"id": 41909314, "time": "2024-11-12 11:03:19", "headline": "An Overview of Ontrak's Earnings", "summary": " ", "symbols": ["OTRK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41909314/an-overview-of-ontraks-earnings", "tags": ["earnings"]}
{"id": 41909317, "time": "2024-11-12 11:03:26", "headline": "HC Wainwright & Co. Maintains Neutral on Agenus, Lowers Price Target to $7", "summary": "", "symbols": ["AGEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41909317/hc-wainwright-co-maintains-neutral-on-agenus-lowers-price-target-to-7", "tags": ["analyst_other", "price_target_down"]}
{"id": 41909320, "time": "2024-11-12 11:03:32", "headline": "An Overview of Adaptimmune Therapeutics's Earnings", "summary": " ", "symbols": ["ADAP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41909320/an-overview-of-adaptimmune-therapeuticss-earnings", "tags": ["earnings"]}
{"id": 41909324, "time": "2024-11-12 11:03:41", "headline": "A Preview Of Creative Realities's Earnings", "summary": " ", "symbols": ["CREX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41909324/a-preview-of-creative-realitiess-earnings", "tags": ["earnings"]}
{"id": 41909326, "time": "2024-11-12 11:03:44", "headline": "Canaccord Genuity Maintains Buy on Lantronix, Lowers Price Target to $5", "summary": "", "symbols": ["LTRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41909326/canaccord-genuity-maintains-buy-on-lantronix-lowers-price-target-to-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 41909356, "time": "2024-11-12 11:04:14", "headline": "'Boeing Delivers Fewest Planes In October Since 2020, Warns Factory Restart After Strike Will Take Weeks' - CNBC", "summary": "", "symbols": ["BA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41909356/boeing-delivers-fewest-planes-in-october-since-2020-warns-factory-restart-after-strike-will-take-wee", "tags": []}
{"id": 41909442, "time": "2024-11-12 11:05:59", "headline": "Boeing Reports 335 Net Orders Through October 31, Delivers 305 Airplanes YTD, Including 234 737 MAX Jets; October Deliveries Fall To 14 Commercial Jets, Down From 34 In 2023; Production Restart Expected In Several Weeks", "summary": "", "symbols": ["BA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41909442/boeing-reports-335-net-orders-through-october-31-delivers-305-airplanes-ytd-including-234-737-max-je", "tags": []}
{"id": 41909445, "time": "2024-11-12 11:06:01", "headline": "Canaccord Genuity Maintains Buy on Monday.Com, Raises Price Target to $310", "summary": "", "symbols": ["MNDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41909445/canaccord-genuity-maintains-buy-on-monday-com-raises-price-target-to-310", "tags": ["analyst_other", "price_target_up"]}
{"id": 41909479, "time": "2024-11-12 11:06:51", "headline": "Schr\u00f6dinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details", "summary": "Schr\u00f6dinger shares rise as they announce a research partnership and licensing agreement with Novartis AG. Schr\u00f6dinger will receive $150 million upfront and eligible to receive up to approximately $2.3 billion in milestone payments plus royalties.", "symbols": ["ARKG", "NVS", "SDGR"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/general/health-care/24/11/41909479/schrodinger-scores-big-despite-q3-miss-as-novartis-collaboration-promises-billions-in-milestones-details", "tags": ["contract"]}
{"id": 41909480, "time": "2024-11-12 11:06:51", "headline": "BTCS Shares Resume Trade", "summary": "", "symbols": ["BTCS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41909480/btcs-shares-resume-trade", "tags": []}
{"id": 41909491, "time": "2024-11-12 11:07:03", "headline": "Canaccord Genuity Maintains Hold on Nevro, Lowers Price Target to $7", "summary": "", "symbols": ["NVRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41909491/canaccord-genuity-maintains-hold-on-nevro-lowers-price-target-to-7", "tags": ["analyst_other", "price_target_down"]}
{"id": 41909525, "time": "2024-11-12 11:08:11", "headline": "Canaccord Genuity Maintains Buy on Zeta Global Holdings, Raises Price Target to $42", "summary": "", "symbols": ["ZETA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41909525/canaccord-genuity-maintains-buy-on-zeta-global-holdings-raises-price-target-to-42", "tags": ["analyst_other", "price_target_up"]}
{"id": 41909545, "time": "2024-11-12 11:08:52", "headline": "Piper Sandler Reiterates Neutral on Tempus AI, Raises Price Target to $70", "summary": "", "symbols": ["TEM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41909545/piper-sandler-reiterates-neutral-on-tempus-ai-raises-price-target-to-70", "tags": ["analyst_other", "price_target_up"]}
{"id": 41909589, "time": "2024-11-12 11:09:42", "headline": "Canaccord Genuity Maintains Buy on Ultragenyx Pharmaceutical, Maintains $121 Price Target", "summary": "", "symbols": ["RARE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41909589/canaccord-genuity-maintains-buy-on-ultragenyx-pharmaceutical-maintains-121-price-target", "tags": ["analyst_other"]}
{"id": 41909673, "time": "2024-11-12 11:10:34", "headline": "New York Fed Survey Says U.S. Households In October Saw Inflation Running At 2.9% Over Next Year, Lowest 1-Year Outlook In 4 Years; Consumers' 3-year Inflation View Down To 2.5% In Oct From 2.7%; 5-year View To 2.8% From 2.9%; Consumers In Oct Saw Lower Likelihood Of Missing A Minimum Debt Payment For The First Time In 5 Months", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41909673/new-york-fed-survey-says-u-s-households-in-october-saw-inflation-running-at-2-9-o", "tags": ["guidance"]}
{"id": 41909679, "time": "2024-11-12 11:10:41", "headline": "HC Wainwright & Co. Reiterates Buy on Compass Therapeutics, Maintains $10 Price Target", "summary": "", "symbols": ["CMPX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41909679/hc-wainwright-co-reiterates-buy-on-compass-therapeutics-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 41909681, "time": "2024-11-12 11:10:52", "headline": "NY Fed Says Consumers In Oct Saw Lowest Likelihood Of A Rise In U.s. Unemployment Rate Over Next Year Since February 2022; Consumers In Oct Saw Lower Chance Of Losing Current Job And Improved Prospects For Finding A New Job If Current One Were Lost", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41909681/ny-fed-says-consumers-in-oct-saw-lowest-likelihood-of-a-rise-in-u-s-unemployment-", "tags": []}
{"id": 41909693, "time": "2024-11-12 11:11:34", "headline": "What Is Going On With Taiwan Semiconductor Stock On Tuesday?", "summary": "\nTaiwan Semiconductor&#39;s board approved $15.5B for expansion and plans to sell bonds to finance it, while concerns remain over US export restrictions.", "symbols": ["TSM"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41909693/what-is-going-on-with-taiwan-semiconductor-stock-on-tuesday", "tags": []}
{"id": 41909694, "time": "2024-11-12 11:11:35", "headline": "Barrington Research Maintains Outperform on Proficient Auto Logistics, Lowers Price Target to $15", "summary": "", "symbols": ["PAL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41909694/barrington-research-maintains-outperform-on-proficient-auto-logistics-lowers-price-target-to-15", "tags": ["analyst_other", "price_target_down"]}
{"id": 41909695, "time": "2024-11-12 11:11:37", "headline": "BTCS Shares halted On Circuit Breaker To The Downside, Stock Now Up 61.2%", "summary": "", "symbols": ["BTCS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41909695/btcs-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-61-2", "tags": ["halt"]}
{"id": 41909696, "time": "2024-11-12 11:11:49", "headline": "BIT Mining Shares Resume Trade", "summary": "", "symbols": ["BTCM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41909696/bit-mining-shares-resume-trade", "tags": []}
{"id": 41909832, "time": "2024-11-12 11:12:55", "headline": "Call Of Duty: Black Ops 6's Pacifist Player Reaches Prestige Without Any Kills", "summary": "Call of Duty player Pilgore hits Prestige without a single kill, showing a new way to play one of gaming&#39;s most combat-focused franchises.", "symbols": ["MSFT"], "source": "benzinga", "author": "Franca Quarneti", "url": "https://www.benzinga.com/general/gaming/24/11/41909832/call-of-duty-black-ops-6s-pacifist-player-reaches-prestige-without-any-kills", "tags": []}
{"id": 41909845, "time": "2024-11-12 11:13:39", "headline": "Jefferies Maintains Buy on Danaos, Maintains $105 Price Target", "summary": "", "symbols": ["DAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41909845/jefferies-maintains-buy-on-danaos-maintains-105-price-target", "tags": ["analyst_other"]}
{"id": 41909846, "time": "2024-11-12 11:13:44", "headline": "Trump's Treasury Pick Frontrunner Scott Bessent Could Shift Wall Street, Crypto", "summary": "Prominent macro hedge fund manager Scott Bessent is emerging as the frontrunner for Treasury Secretary in President-elect Donald Trump&#39;s administration.", "symbols": ["BTCUSD", "KBE", "KRE"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/government/regulations/24/11/41909846/trumps-treasury-pick-frontrunner-scott-bessent-could-shift-wall-street-crypto", "tags": []}
{"id": 41909850, "time": "2024-11-12 11:14:06", "headline": "Mosaic Expects Global Potash Shipments To Rise To The Range Of 72M-74M Tonnes In 2025; Says Because Of An Unfavorable Government Subsidy Environment, Indian Phosphate Demand In Going Unmet", "summary": "", "symbols": ["MOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41909850/mosaic-expects-global-potash-shipments-to-rise-to-the-range-of-72m-74m-tonnes-in-2025-says-because-o", "tags": []}
{"id": 41909862, "time": "2024-11-12 11:14:56", "headline": "Barrington Research Maintains Outperform on SuRo Capital, Maintains $6 Price Target", "summary": "", "symbols": ["SSSS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41909862/barrington-research-maintains-outperform-on-suro-capital-maintains-6-price-target", "tags": ["analyst_other"]}
{"id": 41909877, "time": "2024-11-12 11:15:39", "headline": "Unpacking the Latest Options Trading Trends in Hims & Hers Health", "summary": " ", "symbols": ["HIMS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41909877/unpacking-the-latest-options-trading-trends-in-hims-hers-health", "tags": []}
{"id": 41909881, "time": "2024-11-12 11:15:45", "headline": "Decoding Tesla's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["TSLA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41909881/decoding-teslas-options-activity-whats-the-big-picture", "tags": []}
{"id": 41909908, "time": "2024-11-12 11:16:19", "headline": "Piper Sandler Maintains Neutral on American Finl Gr, Raises Price Target to $150", "summary": "", "symbols": ["AFG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41909908/piper-sandler-maintains-neutral-on-american-finl-gr-raises-price-target-to-150", "tags": ["analyst_other", "price_target_up"]}
{"id": 41909939, "time": "2024-11-12 11:17:21", "headline": "Barrington Research Maintains Outperform on Climb Global Solutions, Raises Price Target to $136", "summary": "", "symbols": ["CLMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41909939/barrington-research-maintains-outperform-on-climb-global-solutions-raises-price-target-to-136", "tags": ["analyst_other", "price_target_up"]}
{"id": 41909957, "time": "2024-11-12 11:18:02", "headline": "HC Wainwright & Co. Maintains Buy on SpringWorks Therapeutics, Lowers Price Target to $74", "summary": "", "symbols": ["SWTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41909957/hc-wainwright-co-maintains-buy-on-springworks-therapeutics-lowers-price-target-to-74", "tags": ["analyst_other", "price_target_down"]}
{"id": 41909966, "time": "2024-11-12 11:18:41", "headline": "Shell Wins Appeal Against Landmark Climate Ruling, Dodging Major Emission Cut Mandate", "summary": "Shell&#39;s appeal against a climate ruling in Dutch court was successful, overturning a mandate to cut emissions. ", "symbols": ["EIPX", "NRES", "SHEL"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/11/41909966/shell-wins-appeal-against-landmark-climate-ruling-dodging-major-emission-cut-mandate", "tags": ["legal"]}
{"id": 41910144, "time": "2024-11-12 11:21:45", "headline": "HC Wainwright & Co. Reiterates Buy on IO Biotech, Maintains $12 Price Target", "summary": "", "symbols": ["IOBT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41910144/hc-wainwright-co-reiterates-buy-on-io-biotech-maintains-12-price-target", "tags": ["analyst_other"]}
{"id": 41910210, "time": "2024-11-12 11:23:39", "headline": "HC Wainwright & Co. Reiterates Buy on Replimune Group, Maintains $17 Price Target", "summary": "", "symbols": ["REPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41910210/hc-wainwright-co-reiterates-buy-on-replimune-group-maintains-17-price-target", "tags": ["analyst_other"]}
{"id": 41910241, "time": "2024-11-12 11:25:20", "headline": "Neurogene Stock Tanks After Adverse Event In Early-Stage Rett Syndrome Gene Therapy Trial", "summary": "Neurogene reports interim Phase 1/2 trial results for NGN-401 gene therapy in treating pediatric Rett syndrome, showing improved safety and efficacy.", "symbols": ["NGNE"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/24/11/41910241/neurogenes-stock-collapses-on-adverse-event-in-early-stage-rett-syndrome-gene-therapy-trial", "tags": ["fda"]}
{"id": 41910284, "time": "2024-11-12 11:27:06", "headline": "BMO Capital Maintains Outperform on Arthur J. Gallagher, Raises Price Target to $325", "summary": "", "symbols": ["AJG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41910284/bmo-capital-maintains-outperform-on-arthur-j-gallagher-raises-price-target-to-325", "tags": ["analyst_other", "price_target_up"]}
{"id": 41910311, "time": "2024-11-12 11:28:23", "headline": "BMO Capital Maintains Market Perform on Bristol-Myers Squibb, Raises Price Target to $61", "summary": "", "symbols": ["BMY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41910311/bmo-capital-maintains-market-perform-on-bristol-myers-squibb-raises-price-target-to-61", "tags": ["analyst_other", "price_target_up"]}
{"id": 41910313, "time": "2024-11-12 11:28:30", "headline": "BTIG Maintains Buy on Atlanticus Holdings, Raises Price Target to $54", "summary": "", "symbols": ["ATLC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41910313/btig-maintains-buy-on-atlanticus-holdings-raises-price-target-to-54", "tags": ["analyst_other", "price_target_up"]}
{"id": 41910344, "time": "2024-11-12 11:30:13", "headline": "Price Over Earnings Overview: Walt Disney", "summary": " ", "symbols": ["DIS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41910344/price-over-earnings-overview-walt-disney", "tags": ["earnings"]}
{"id": 41910517, "time": "2024-11-12 11:30:47", "headline": "TD Cowen Maintains Buy on Live Nation Entertainment, Raises Price Target to $145", "summary": "", "symbols": ["LYV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41910517/td-cowen-maintains-buy-on-live-nation-entertainment-raises-price-target-to-145", "tags": ["analyst_other", "price_target_up"]}
{"id": 41910550, "time": "2024-11-12 11:31:33", "headline": "BMO Capital Maintains Market Perform on Louisiana-Pacific, Raises Price Target to $103", "summary": "", "symbols": ["LPX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41910550/bmo-capital-maintains-market-perform-on-louisiana-pacific-raises-price-target-to-103", "tags": ["analyst_other", "price_target_up"]}
{"id": 41910568, "time": "2024-11-12 11:32:08", "headline": "FOXO Technologies Shares Halted On Circuit Breaker To The Downside, Stock Now Up 26.6%", "summary": "", "symbols": ["FOXO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41910568/foxo-technologies-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-26-6", "tags": ["halt"]}
{"id": 41910569, "time": "2024-11-12 11:32:26", "headline": "Shift4 Payments Misses Revenue Estimates In Q3, Lowers Payment Volume Guidance As Stock Drops", "summary": "Shift4 Payments reported third-quarter results, missing analyst estimates with revenue of $909.20M and EPS of $1.04.", "symbols": ["FOUR"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/24/11/41910569/shift4-payments-q3-earnings-revenue-misses-estimates-despite-strong-growth-lowers-payment-volume-guidance-stock-drops", "tags": ["earnings", "guidance"]}
{"id": 41910589, "time": "2024-11-12 11:32:54", "headline": "Senstar Tech Q3 EPS $0.06 Up From $(0.01) YoY, Sales $9.70M Up From $8.97M YoY", "summary": "", "symbols": ["SNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41910589/senstar-tech-q3-eps-0-06-up-from-0-01-yoy-sales-9-70m-up-from-8-97m-yoy", "tags": ["earnings"]}
{"id": 41910593, "time": "2024-11-12 11:33:03", "headline": "BMO Capital Maintains Market Perform on Power Corp of Canada, Raises Price Target to C$49", "summary": "", "symbols": ["TSX:POW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41910593/bmo-capital-maintains-market-perform-on-power-corp-of-canada-raises-price-target-to-c-49", "tags": ["analyst_other", "price_target_up"]}
{"id": 41910598, "time": "2024-11-12 11:33:32", "headline": "What's Going On With Morgan Stanley Stock Today?", "summary": "Morgan Stanley shares are slightly down in today&#39;s trading after a strong rally yesterday. The company disclosed MSCP&#39;s sale of Sila Services to Goldman Sachs.", "symbols": ["IAI", "KBWB", "MS"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41910598/whats-going-on-with-morgan-stanley-stock-today", "tags": ["why_moving"]}
{"id": 41910599, "time": "2024-11-12 11:33:36", "headline": "TD Cowen Maintains Buy on Delta Air Lines, Raises Price Target to $75", "summary": "", "symbols": ["DAL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41910599/td-cowen-maintains-buy-on-delta-air-lines-raises-price-target-to-75", "tags": ["analyst_other", "price_target_up"]}
{"id": 41910602, "time": "2024-11-12 11:33:43", "headline": "Robinhood CEO Vlad Tenev: Operating A Crypto Business Has 'Undeniable' Advantages", "summary": "Robinhood CEO Tenev highlights the cost efficiency and other benefits of operating a cryptocurrency business, anticipating increased adoption globally.", "symbols": ["HOOD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41910602/robinhood-ceo-vlad-tenev-operating-a-crypto-business-has-undeniable-advantages", "tags": ["management"]}
{"id": 41910672, "time": "2024-11-12 11:36:27", "headline": "BMO Capital Reiterates Market Perform on South Bow, Raises Price Target to C$36", "summary": "", "symbols": ["TSX:SOBO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41910672/bmo-capital-reiterates-market-perform-on-south-bow-raises-price-target-to-c-36", "tags": ["analyst_other", "price_target_up"]}
{"id": 41910675, "time": "2024-11-12 11:36:52", "headline": "FOXO Technologies Shares Resume Trade", "summary": "", "symbols": ["FOXO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41910675/foxo-technologies-shares-resume-trade", "tags": []}
{"id": 41910692, "time": "2024-11-12 11:37:13", "headline": "TD Cowen Maintains Buy on DraftKings, Raises Price Target to $55", "summary": "", "symbols": ["DKNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41910692/td-cowen-maintains-buy-on-draftkings-raises-price-target-to-55", "tags": ["analyst_other", "price_target_up"]}
{"id": 41910745, "time": "2024-11-12 11:39:07", "headline": "BMO Capital Maintains Outperform on AbbVie, Lowers Price Target to $208", "summary": "", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41910745/bmo-capital-maintains-outperform-on-abbvie-lowers-price-target-to-208", "tags": ["analyst_other", "price_target_down"]}
{"id": 41910770, "time": "2024-11-12 11:40:39", "headline": "Why Medical Device Firm Nevro Stock Is Trading Higher On Tuesday", "summary": "Nevro stock rises as it gains CE Mark for its HFX iQ SCS system, the first with AI-based personalized pain relief. 2024 revenue outlook raised amid positive earnings.", "symbols": ["NVRO"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/health-care/24/11/41910770/why-medical-device-firm-nevro-stock-is-trading-higher-on-tuesday", "tags": ["earnings", "guidance"]}
{"id": 41910772, "time": "2024-11-12 11:40:43", "headline": "BMO Capital Maintains Outperform on Neurogene, Lowers Price Target to $60", "summary": "", "symbols": ["NGNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41910772/bmo-capital-maintains-outperform-on-neurogene-lowers-price-target-to-60", "tags": ["analyst_other", "price_target_down"]}
{"id": 41910813, "time": "2024-11-12 11:41:25", "headline": "TD Cowen Maintains Hold on Parker Hannifin, Raises Price Target to $575", "summary": "", "symbols": ["PH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41910813/td-cowen-maintains-hold-on-parker-hannifin-raises-price-target-to-575", "tags": ["analyst_other", "price_target_up"]}
{"id": 41910958, "time": "2024-11-12 11:44:33", "headline": "TD Cowen Maintains Hold on Bridge Investment Group, Lowers Price Target to $10", "summary": "", "symbols": ["BRDG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41910958/td-cowen-maintains-hold-on-bridge-investment-group-lowers-price-target-to-10", "tags": ["analyst_other", "price_target_down"]}
{"id": 41911005, "time": "2024-11-12 11:45:42", "headline": "Looking At IonQ's Recent Unusual Options Activity", "summary": " ", "symbols": ["IONQ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41911005/looking-at-ionqs-recent-unusual-options-activity", "tags": []}
{"id": 41911009, "time": "2024-11-12 11:45:48", "headline": "Vistra Options Trading: A Deep Dive into Market Sentiment", "summary": " ", "symbols": ["VST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41911009/vistra-options-trading-a-deep-dive-into-market-sentiment", "tags": []}
{"id": 41911012, "time": "2024-11-12 11:45:53", "headline": "Behind the Scenes of IBM's Latest Options Trends", "summary": " ", "symbols": ["IBM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41911012/behind-the-scenes-of-ibms-latest-options-trends", "tags": []}
{"id": 41911120, "time": "2024-11-12 11:47:31", "headline": "The German Government Sold Its Bitcoin\u2014Here's How Much It Missed Out On", "summary": "The German government may have missed a substantial financial gain, estimated at $1.6 billion, due to the timing of its Bitcoin (CRYPTO: BTC", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41911120/the-german-government-sold-its-bitcoin-heres-how-much-it-missed-out-on", "tags": []}
{"id": 41911201, "time": "2024-11-12 11:49:39", "headline": "Guggenheim Maintains Buy on Gray Television, Lowers Price Target to $8", "summary": "", "symbols": ["GTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911201/guggenheim-maintains-buy-on-gray-television-lowers-price-target-to-8", "tags": ["analyst_other", "price_target_down"]}
{"id": 41911290, "time": "2024-11-12 11:51:33", "headline": "Guggenheim Maintains Buy on Live Nation Entertainment, Raises Price Target to $146", "summary": "", "symbols": ["LYV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911290/guggenheim-maintains-buy-on-live-nation-entertainment-raises-price-target-to-146", "tags": ["analyst_other", "price_target_up"]}
{"id": 41911338, "time": "2024-11-12 11:52:00", "headline": "Goldman Sachs Maintains Neutral on AvePoint, Raises Price Target to $15", "summary": "", "symbols": ["AVPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911338/goldman-sachs-maintains-neutral-on-avepoint-raises-price-target-to-15", "tags": ["analyst_other", "price_target_up"]}
{"id": 41911379, "time": "2024-11-12 11:53:24", "headline": "AdvisorShares Trust AdvisorShares Pure US Cannabis ETF Shares Halted On Circuit Breaker To The Upside, Stock Now Up 13.1%", "summary": "", "symbols": ["MSOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41911379/advisorshares-trust-advisorshares-pure-us-cannabis-etf-shares-halted-on-circuit-breaker-to-the-upsi", "tags": ["halt"]}
{"id": 41911381, "time": "2024-11-12 11:53:48", "headline": "'AWS is negotiating a huge deal to supply IBM with Nvidia GPUs via the cloud' - Insider", "summary": "", "symbols": ["AMZN", "IBM", "NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911381/aws-is-negotiating-a-huge-deal-to-supply-ibm-with-nvidia-gpus-via-the-cloud-insider", "tags": ["contract", "insider"]}
{"id": 41911383, "time": "2024-11-12 11:54:03", "headline": "Guggenheim Maintains Buy on Madison Square Garden, Lowers Price Target to $48", "summary": "", "symbols": ["MSGE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911383/guggenheim-maintains-buy-on-madison-square-garden-lowers-price-target-to-48", "tags": ["analyst_other", "price_target_down"]}
{"id": 41911418, "time": "2024-11-12 11:55:00", "headline": "Airbus Close To Agreement As Early As Today With Spirit Aerosystems On Fresh Funding And Revised Payment Terms", "summary": "", "symbols": ["EADSY", "SPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911418/airbus-close-to-agreement-as-early-as-today-with-spirit-aerosystems-on-fresh-funding-and-revised-pay", "tags": ["contract"]}
{"id": 41911423, "time": "2024-11-12 11:55:04", "headline": "Goldman Sachs Maintains Neutral on BILL Holdings, Raises Price Target to $77", "summary": "", "symbols": ["BILL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911423/goldman-sachs-maintains-neutral-on-bill-holdings-raises-price-target-to-77", "tags": ["analyst_other", "price_target_up"]}
{"id": 41911431, "time": "2024-11-12 11:55:36", "headline": "Guggenheim Maintains Buy on News, Raises Price Target to $40", "summary": "", "symbols": ["NWSA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911431/guggenheim-maintains-buy-on-news-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 41911449, "time": "2024-11-12 11:56:52", "headline": "Goldman Sachs Maintains Buy on Braze, Lowers Price Target to $47", "summary": "", "symbols": ["BRZE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911449/goldman-sachs-maintains-buy-on-braze-lowers-price-target-to-47", "tags": ["analyst_other", "price_target_down"]}
{"id": 41911474, "time": "2024-11-12 11:57:56", "headline": "Russell 2000 Rallies, JPMorgan Analyst Says Small Cap May Outperform Mega-Cap Peers", "summary": "Small-cap stocks have broken through the 2282-2299 resistance zone, making 2432-2486 the next short-term goal.", "symbols": ["IJR", "IWM", "VB"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41911474/russell-2000-rallies-jpmorgan-analyst-says-small-cap-may-outperform-mega-cap-peers", "tags": []}
{"id": 41911482, "time": "2024-11-12 11:58:10", "headline": "AdvisorShares Trust AdvisorShares Pure US Cannabis ETF Shares Resume Trade", "summary": "", "symbols": ["MSOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41911482/advisorshares-trust-advisorshares-pure-us-cannabis-etf-shares-resume-trade", "tags": []}
{"id": 41911493, "time": "2024-11-12 11:58:40", "headline": "Snap Stock Stumbles As Trump Plans To Push Back Against TikTok Ban: What You Need To Know", "summary": "Snap Inc. (NYSE: SNAP) shares are trading lower on Tuesday in response to news surrounding the future of TikTok in the United States. Here&#39;s what you need to know.", "symbols": ["SNAP"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/general/social-media/24/11/41911493/snap-stock-stumbles-as-trump-plans-to-push-back-against-tiktok-ban-what-you-need-to-know", "tags": ["why_moving"]}
{"id": 41911509, "time": "2024-11-12 11:59:17", "headline": "Goldman Sachs Maintains Sell on United Breweries Co, Lowers Price Target to $9.4", "summary": "", "symbols": ["CCU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911509/goldman-sachs-maintains-sell-on-united-breweries-co-lowers-price-target-to-9-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 41911535, "time": "2024-11-12 12:00:12", "headline": "A Closer Look at 10 Analyst Recommendations For Axsome Therapeutics", "summary": " ", "symbols": ["AXSM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41911535/a-closer-look-at-10-analyst-recommendations-for-axsome-therapeutics", "tags": []}
{"id": 41911546, "time": "2024-11-12 12:00:16", "headline": "Peering Into Morgan Stanley's Recent Short Interest", "summary": " ", "symbols": ["MS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41911546/peering-into-morgan-stanleys-recent-short-interest", "tags": []}
{"id": 41911547, "time": "2024-11-12 12:00:20", "headline": "Peeling Back The Layers: Exploring Delta Air Lines Through Analyst Insights", "summary": " ", "symbols": ["DAL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41911547/peeling-back-the-layers-exploring-delta-air-lines-through-analyst-insights", "tags": []}
{"id": 41911548, "time": "2024-11-12 12:00:22", "headline": "How Is The Market Feeling About Intuitive Surgical?", "summary": " ", "symbols": ["ISRG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41911548/how-is-the-market-feeling-about-intuitive-surgical", "tags": []}
{"id": 41911549, "time": "2024-11-12 12:00:27", "headline": "Peering Into Motorola Solns's Recent Short Interest", "summary": " ", "symbols": ["MSI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41911549/peering-into-motorola-solnss-recent-short-interest", "tags": []}
{"id": 41911551, "time": "2024-11-12 12:00:38", "headline": "Cracking The Code: Understanding Analyst Reviews For Bridge Investment Group", "summary": " ", "symbols": ["BRDG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41911551/cracking-the-code-understanding-analyst-reviews-for-bridge-investment-group", "tags": []}
{"id": 41911554, "time": "2024-11-12 12:00:47", "headline": "Assessing Federal Realty Investment: Insights From 11 Financial Analysts", "summary": " ", "symbols": ["FRT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41911554/assessing-federal-realty-investment-insights-from-11-financial-analysts", "tags": []}
{"id": 41911600, "time": "2024-11-12 12:01:02", "headline": "7 Analysts Assess Baidu: What You Need To Know", "summary": " ", "symbols": ["BIDU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41911600/7-analysts-assess-baidu-what-you-need-to-know", "tags": []}
{"id": 41911611, "time": "2024-11-12 12:01:10", "headline": "Talos Energy Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)", "summary": " ", "symbols": ["TALO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41911611/talos-energy-stock-a-deep-dive-into-analyst-perspectives-5-ratings", "tags": []}
{"id": 41911613, "time": "2024-11-12 12:01:24", "headline": "LifeWallet Announces 1-For-25 Reverse Stock Split To Regain Compliance with Nasdaq's Minimum Bid Price Requirement,  Will Begin Trading On A Split-Adjusted Basis When The Nasdaq Opens On November 18, 2024", "summary": "", "symbols": ["LIFW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911613/lifewallet-announces-1-for-25-reverse-stock-split-to-regain-compliance-with-nasdaqs-minimum-bid-pric", "tags": []}
{"id": 41911614, "time": "2024-11-12 12:01:24", "headline": "Goldman Sachs Maintains Neutral on PAR Technology, Raises Price Target to $71", "summary": "", "symbols": ["PAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911614/goldman-sachs-maintains-neutral-on-par-technology-raises-price-target-to-71", "tags": ["analyst_other", "price_target_up"]}
{"id": 41911621, "time": "2024-11-12 12:01:43", "headline": "What's Next: Seres Therapeutics's Earnings Preview", "summary": " ", "symbols": ["MCRB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41911621/whats-next-seres-therapeuticss-earnings-preview", "tags": ["earnings"]}
{"id": 41911628, "time": "2024-11-12 12:01:56", "headline": "Preview: OptimizeRx's Earnings", "summary": " ", "symbols": ["OPRX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41911628/preview-optimizerxs-earnings", "tags": ["earnings"]}
{"id": 41911634, "time": "2024-11-12 12:02:06", "headline": "An Overview of WidePoint's Earnings", "summary": " ", "symbols": ["WYY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41911634/an-overview-of-widepoints-earnings", "tags": ["earnings"]}
{"id": 41911652, "time": "2024-11-12 12:02:19", "headline": "Earnings Preview For Tenon Medical", "summary": " ", "symbols": ["TNON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41911652/earnings-preview-for-tenon-medical", "tags": ["earnings"]}
{"id": 41906253, "time": "2024-11-12 10:08:57", "headline": "Monolithic Power Systems shares are trading higher. Oppenheimer and Needham reiterated Buy ratings on the stock.", "summary": "", "symbols": ["MPWR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41906253/monolithic-power-systems-shares-are-trading-higher-oppenheimer-and-needham-reiterated-buy-ratings-on", "tags": ["why_moving"]}
{"id": 41911725, "time": "2024-11-12 12:02:38", "headline": "A Peek at Bakkt Hldgs's Future Earnings", "summary": " ", "symbols": ["BKKT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41911725/a-peek-at-bakkt-hldgss-future-earnings", "tags": ["earnings"]}
{"id": 41911728, "time": "2024-11-12 12:02:39", "headline": "Barrington Research Maintains Outperform on Nexstar Media Gr, Maintains $200 Price Target", "summary": "", "symbols": ["NXST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911728/barrington-research-maintains-outperform-on-nexstar-media-gr-maintains-200-price-target", "tags": ["analyst_other"]}
{"id": 41900102, "time": "2024-11-12 08:39:13", "headline": "Nevro Corp shares are trading higher after Baird raised its price target on the stock from $5 to $6. Additioanlly, the company announced it received a CE mark certification in Europe for its HFX iQ spinal cord stimulation system.", "summary": "", "symbols": ["NVRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41900102/nevro-corp-shares-are-trading-higher-after-baird-raised-its-price-target-on-the-stock-from-5-to-6-ad", "tags": ["why_moving"]}
{"id": 41911745, "time": "2024-11-12 12:02:53", "headline": "What to Expect from Quantum's Earnings", "summary": " ", "symbols": ["QMCO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41911745/what-to-expect-from-quantums-earnings", "tags": ["earnings"]}
{"id": 41898357, "time": "2024-11-12 07:58:28", "headline": "DoubleDown Interactive shares are trading higher. The company reported Q3 financial results.", "summary": "", "symbols": ["DDI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41898357/doubledown-interactive-shares-are-trading-higher-the-company-reported-q3-financial-results", "tags": ["why_moving"]}
{"id": 41897693, "time": "2024-11-12 07:39:32", "headline": "Kopin shares are trading higher after the company reported better-than-expected Q3 EPS and sales.", "summary": "", "symbols": ["KOPN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41897693/kopin-shares-are-trading-higher-after-the-company-reported-better-than-expected-q3-eps-and-sales", "tags": ["earnings", "why_moving"]}
{"id": 41911767, "time": "2024-11-12 12:03:32", "headline": "Guggenheim Maintains Buy on United Parks & Resorts, Lowers Price Target to $70", "summary": "", "symbols": ["PRKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911767/guggenheim-maintains-buy-on-united-parks-resorts-lowers-price-target-to-70", "tags": ["analyst_other", "price_target_down"]}
{"id": 41911768, "time": "2024-11-12 12:03:34", "headline": "A Look Ahead: Bitcoin Depot's Earnings Forecast", "summary": " ", "symbols": ["BTM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41911768/a-look-ahead-bitcoin-depots-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 41911775, "time": "2024-11-12 12:03:44", "headline": "Earnings Outlook For Biofrontera", "summary": " ", "symbols": ["BFRI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41911775/earnings-outlook-for-biofrontera", "tags": ["earnings", "guidance"]}
{"id": 41895102, "time": "2024-11-12 06:03:29", "headline": "Home Depot shares are trading higher after the company reported better-than-expected Q3 EPS and sales.", "summary": "", "symbols": ["HD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41895102/home-depot-shares-are-trading-higher-after-the-company-reported-better-than-expected-q3-eps-and-sale", "tags": ["earnings", "why_moving"]}
{"id": 41911778, "time": "2024-11-12 12:03:53", "headline": "Earnings Preview For Valhi", "summary": " ", "symbols": ["VHI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41911778/earnings-preview-for-valhi", "tags": ["earnings"]}
{"id": 41908376, "time": "2024-11-12 10:46:57", "headline": "VEON Has Exposure To 5 High Growth Frontier Markets, Says Bullish Analyst", "summary": "Shares of Veon climbed almost 70% year to date. Analyst Matthew Harrigan initiated coverage with a Buy rating and price target of $48.", "symbols": ["VEON"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41908376/veon-has-exposure-to-5-high-growth-frontier-markets-says-bullish-analyst", "tags": []}
{"id": 41911788, "time": "2024-11-12 12:04:07", "headline": "An Overview of Stronghold Digital Mining's Earnings", "summary": " ", "symbols": ["SDIG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41911788/an-overview-of-stronghold-digital-minings-earnings", "tags": ["earnings"]}
{"id": 41911795, "time": "2024-11-12 12:04:26", "headline": "Goldman Sachs Maintains Buy on Petrobras Brasileiro, Raises Price Target to $17", "summary": "", "symbols": ["PBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911795/goldman-sachs-maintains-buy-on-petrobras-brasileiro-raises-price-target-to-17", "tags": ["analyst_other", "price_target_up"]}
{"id": 41911799, "time": "2024-11-12 12:04:31", "headline": "A Peek at The Oncology Institute's Future Earnings", "summary": " ", "symbols": ["TOI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41911799/a-peek-at-the-oncology-institutes-future-earnings", "tags": ["earnings"]}
{"id": 41897897, "time": "2024-11-12 07:42:35", "headline": "SpringWorks Therapeutics shares are trading lower after the company reported worse-than-expected Q3 sales results.", "summary": "", "symbols": ["SWTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41897897/springworks-therapeutics-shares-are-trading-lower-after-the-company-reported-worse-than-expected-q3", "tags": ["why_moving"]}
{"id": 41911814, "time": "2024-11-12 12:04:55", "headline": "An Overview of Complete Solaria's Earnings", "summary": " ", "symbols": ["CSLR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41911814/an-overview-of-complete-solarias-earnings", "tags": ["earnings"]}
{"id": 41911827, "time": "2024-11-12 12:05:27", "headline": "D. Boral Capital Maintains Buy on ImmunityBio, Maintains $30 Price Target", "summary": "", "symbols": ["IBRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911827/d-boral-capital-maintains-buy-on-immunitybio-maintains-30-price-target", "tags": ["analyst_other"]}
{"id": 41911851, "time": "2024-11-12 12:06:03", "headline": "Chipotle's New Boss: Can CEO Scott Boatwright Spice Up CMG?", "summary": "Chipotle names Scott Boatwright permanent CEO to lead expansion and tech innovations. Investors bullish on stock.", "symbols": ["CMG", "SBUX"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/general/restaurants/24/11/41911851/chipotles-new-boss-can-ceo-scott-boatwright-spice-up-cmg", "tags": ["management"]}
{"id": 41911860, "time": "2024-11-12 12:06:17", "headline": "Blink Charging Expands Reach: New ChargeHub Partnership Puts EV Drivers In The Fast Lane", "summary": "Blink Charging entered data-sharing &amp; roaming agreement with ChargeHub. Blink&#39;s public EV chargers can now be activated by the ChargeHub eMSP app, which serves over a million users.", "symbols": ["BLNK", "WBAT"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/contracts/24/11/41911860/blink-charging-expands-reach-new-chargehub-partnership-puts-ev-drivers-in-the-fast-lane", "tags": ["contract"]}
{"id": 41911931, "time": "2024-11-12 12:07:42", "headline": "Goldman Sachs Maintains Neutral on Vacasa, Lowers Price Target to $5", "summary": "", "symbols": ["VCSA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911931/goldman-sachs-maintains-neutral-on-vacasa-lowers-price-target-to-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 41911946, "time": "2024-11-12 12:08:23", "headline": "What's Going On With US-Listed Chinese Stocks Trading Lower On Tuesday?", "summary": "US-listed Chinese stocks see selloff as tensions and concerns over fiscal stimulus and tariffs persist. Alibaba, JD, Baidu, NIO, LI, and XPEV down.", "symbols": ["BABA", "BIDU", "JD", "NIO"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/24/11/41911946/whats-going-on-with-us-listed-chinese-stocks-like-alibaba-jd-nio-on-tuesday", "tags": ["why_moving"]}
{"id": 41911958, "time": "2024-11-12 12:08:50", "headline": "Cosmos Health Sees FY27 Revenue To Increase By 163%, From $59.35M In 2024 To $155.80M In 2027; Gross Profit To Grow By 653%, From $6.25M In 2024 To $47.06M In 2027; Gross Profit Margin To Expand By 1,970 Basis Points, From 10.50% In 2024 To 30.20% In 2027; Net Income To Increase By 402%, Reaching $20.44M In 2027, Compared To A Loss Of $6.76M In 2024; Adjusted EBITDA To Grow To $29.40M In 2027, From A Loss Of $1.21M In 2024.", "summary": "", "symbols": ["COSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911958/cosmos-health-sees-fy27-revenue-to-increase-by-163-from-59-35m-in-2024-to-155-80m-in-2027-gross-prof", "tags": ["earnings"]}
{"id": 41911959, "time": "2024-11-12 12:08:56", "headline": "Telsey Advisory Group Maintains Outperform on Home Depot, Maintains $455 Price Target", "summary": "", "symbols": ["HD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911959/telsey-advisory-group-maintains-outperform-on-home-depot-maintains-455-price-target", "tags": ["analyst_other"]}
{"id": 41911971, "time": "2024-11-12 12:09:39", "headline": "Goldman Sachs Maintains Buy on Victory Capital Holdings, Raises Price Target to $68", "summary": "", "symbols": ["VCTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41911971/goldman-sachs-maintains-buy-on-victory-capital-holdings-raises-price-target-to-68", "tags": ["analyst_other", "price_target_up"]}
{"id": 41912033, "time": "2024-11-12 12:11:27", "headline": "Telsey Advisory Group Maintains Outperform on On Holding, Maintains $53 Price Target", "summary": "", "symbols": ["ONON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912033/telsey-advisory-group-maintains-outperform-on-on-holding-maintains-53-price-target", "tags": ["analyst_other"]}
{"id": 41912039, "time": "2024-11-12 12:11:40", "headline": "Rumble CEO Chris Pavlovski Posts On X \"In the USA, Rumble took a 17.8% share on Election Day according to @StreamsCharts, way ahead of @twitch with 10%.\"", "summary": "", "symbols": ["AMZN", "RUM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912039/rumble-ceo-chris-pavlovski-posts-on-x-in-the-usa-rumble-took-a-17-8-share-on-election-day-according", "tags": ["management"]}
{"id": 41912041, "time": "2024-11-12 12:11:47", "headline": "Capital One Initiates Coverage On FrontView REIT with Overweight Rating, Announces Price Target of $22", "summary": "", "symbols": ["FVR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912041/capital-one-initiates-coverage-on-frontview-reit-with-overweight-rating-announces-price-target-of-22", "tags": ["analyst_init"]}
{"id": 41885423, "time": "2024-11-12 12:12:35", "headline": "NetEase Games Executives Arrested In $139M Bribery, Money Laundering Scandal: Report (UPDATED)", "summary": "NetEase Games employees, including top executives, were arrested for bribery and money laundering in a $139M case involving suppliers.", "symbols": ["NTES"], "source": "benzinga", "author": "Franca Quarneti", "url": "https://www.benzinga.com/general/gaming/24/11/41885423/netease-games-executives-arrested-in-139m-bribery-money-laundering-scandal-report", "tags": []}
{"id": 41912098, "time": "2024-11-12 12:12:41", "headline": "Keefe, Bruyette & Woods Maintains Outperform on American Intl Gr, Lowers Price Target to $87", "summary": "", "symbols": ["AIG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912098/keefe-bruyette-woods-maintains-outperform-on-american-intl-gr-lowers-price-target-to-87", "tags": ["analyst_other", "price_target_down"]}
{"id": 41912099, "time": "2024-11-12 12:12:42", "headline": "Live Nation Entertainment Shares Are On The Rise Today: Here's What's Going On", "summary": "Shares of Live Nation Entertainment Inc. (NYSE: LYV) are trading higher Tuesday after the company posted third-quarter financial results. Multiple analysts also raised price targets following the print. Here&#39;s what you need to know.", "symbols": ["LYV"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/analyst-ratings/price-target/24/11/41912099/live-nation-entertainment-shares-are-on-the-rise-today-heres-whats-going-on", "tags": ["why_moving"]}
{"id": 41912193, "time": "2024-11-12 12:14:15", "headline": "Musk Spends $130M \u2013 Tesla Gains $344B On Trump Election, Stock Market Focusing On Trump Appointments", "summary": "\n\n\n\nTo gain an edge, this is what you need to know today.", "symbols": ["AAPL", "AMZN", "BTCUSD", "GLD", "GOOG", "META", "MSFT", "NVDA", "QQQ", "SLV", "SPY", "TSLA", "USO"], "source": "benzinga", "author": "The Arora Report", "url": "https://www.benzinga.com/general/market-summary/24/11/41912193/musk-spends-130m-tesla-gains-344b-on-trump-election-stock-market-focusing-on-trump-appoint", "tags": []}
{"id": 41912198, "time": "2024-11-12 12:14:27", "headline": "Micron Unveils New 60TB SSD For Data Centers: Details", "summary": "Micron launches world&#39;s fastest 60TB data center SSD with improved energy efficiency. Ideal for AI workloads.", "symbols": ["DARP", "FEPI", "MPWR", "MU"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/large-cap/24/11/41912198/micron-unveils-new-60tb-ssd-for-data-centers-details", "tags": []}
{"id": 41912203, "time": "2024-11-12 12:14:51", "headline": "iHeartMedia Announces Debt Restructuring, Analyst Turns Bullish And Raises Forecast", "summary": "iHeartMedia&#39;s debt restructuring has boosted given the company more runway to improve operations. Analyst upgraded rating to Neutral, raises PT to $3.", "symbols": ["IHRT"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/24/11/41912203/iheartmedia-announces-debt-restructuring-analyst-turns-bullish-and-raises-forecast-3x", "tags": ["analyst_up", "guidance"]}
{"id": 41912206, "time": "2024-11-12 12:14:55", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on Assurant, Raises Price Target to $212", "summary": "", "symbols": ["AIZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912206/keefe-bruyette-woods-maintains-market-perform-on-assurant-raises-price-target-to-212", "tags": ["analyst_other", "price_target_up"]}
{"id": 41912234, "time": "2024-11-12 12:15:48", "headline": "Price Over Earnings Overview: Omega Healthcare Invts", "summary": " ", "symbols": ["OHI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41912234/price-over-earnings-overview-omega-healthcare-invts", "tags": ["earnings"]}
{"id": 41912240, "time": "2024-11-12 12:16:03", "headline": "Wedbush Maintains Outperform on DoubleDown Interactive, Raises Price Target to $21", "summary": "", "symbols": ["DDI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912240/wedbush-maintains-outperform-on-doubledown-interactive-raises-price-target-to-21", "tags": ["analyst_other", "price_target_up"]}
{"id": 41912244, "time": "2024-11-12 12:16:21", "headline": "Jefferies Maintains Hold on Flex LNG, Maintains $24 Price Target", "summary": "", "symbols": ["FLNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912244/jefferies-maintains-hold-on-flex-lng-maintains-24-price-target", "tags": ["analyst_other"]}
{"id": 41912254, "time": "2024-11-12 12:16:55", "headline": "Keefe, Bruyette & Woods Maintains Underperform on Claros Mortgage Trust, Raises Price Target to $7.25", "summary": "", "symbols": ["CMTG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912254/keefe-bruyette-woods-maintains-underperform-on-claros-mortgage-trust-raises-price-target-to-7-25", "tags": ["analyst_other", "price_target_up"]}
{"id": 41912259, "time": "2024-11-12 12:17:31", "headline": "Spanish Competition Authority Sends BBVA Bid For Sabadell To Phase Two Review", "summary": "", "symbols": ["BBVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912259/spanish-competition-authority-sends-bbva-bid-for-sabadell-to-phase-two-review", "tags": []}
{"id": 41912267, "time": "2024-11-12 12:18:10", "headline": "Live On CNBC, Bill Baruch Announces Bought More Microsoft & Amazon.com", "summary": "", "symbols": ["AMZN", "MSFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912267/live-on-cnbc-bill-baruch-announces-bought-more-microsoft-amazon-com", "tags": []}
{"id": 41912274, "time": "2024-11-12 12:18:30", "headline": "Why PDD Holdings Stock Is Falling", "summary": "PDD Holdings&#39; stock fell Tuesday amid fears of escalating U.S.-China tensions. Weak credit data in China further pressured PDD.", "symbols": ["BABA", "PDD"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/11/41912274/why-pdd-holdings-stock-is-falling-2", "tags": []}
{"id": 41912291, "time": "2024-11-12 12:19:03", "headline": "Keefe, Bruyette & Woods Maintains Underperform on Granite Point Mortgage, Raises Price Target to $3", "summary": "", "symbols": ["GPMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912291/keefe-bruyette-woods-maintains-underperform-on-granite-point-mortgage-raises-price-target-to-3", "tags": ["analyst_other", "price_target_up"]}
{"id": 41912292, "time": "2024-11-12 12:19:04", "headline": "HC Wainwright & Co. Maintains Buy on Syndax Pharmaceuticals, Raises Price Target to $49", "summary": "", "symbols": ["SNDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912292/hc-wainwright-co-maintains-buy-on-syndax-pharmaceuticals-raises-price-target-to-49", "tags": ["analyst_other", "price_target_up"]}
{"id": 41912430, "time": "2024-11-12 12:23:17", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on Jones Lang LaSalle, Raises Price Target to $292", "summary": "", "symbols": ["JLL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912430/keefe-bruyette-woods-maintains-market-perform-on-jones-lang-lasalle-raises-price-target-to-292", "tags": ["analyst_other", "price_target_up"]}
{"id": 41912441, "time": "2024-11-12 12:23:27", "headline": "What's Going On With Sidus Space Today? New Partnership With Lonestar Bodes Well For Stock", "summary": "Sidus will oversee the design, payload integration, planning, and on-orbit support for each of the six satellites.", "symbols": ["SIDU"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41912441/whats-going-on-with-sidus-space-today-new-partnership-with-lonestar-bodes-well-for-stock", "tags": ["why_moving", "contract"]}
{"id": 41912506, "time": "2024-11-12 12:25:06", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Onity Group, Raises Price Target to $45", "summary": "", "symbols": ["ONIT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912506/keefe-bruyette-woods-maintains-outperform-on-onity-group-raises-price-target-to-45", "tags": ["analyst_other", "price_target_up"]}
{"id": 41912508, "time": "2024-11-12 12:25:11", "headline": "Southwest Airlines Flight Makes Emergency Landing In San Jose After Engine Trouble, No Injuries Reported", "summary": "", "symbols": ["LUV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912508/southwest-airlines-flight-makes-emergency-landing-in-san-jose-after-engine-trouble-no-injuries-repor", "tags": []}
{"id": 41912509, "time": "2024-11-12 12:25:15", "headline": "Needham Reiterates Buy on Mereo BioPharma Group, Maintains $7 Price Target", "summary": "", "symbols": ["MREO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912509/needham-reiterates-buy-on-mereo-biopharma-group-maintains-7-price-target", "tags": ["analyst_other"]}
{"id": 41912512, "time": "2024-11-12 12:25:30", "headline": "Live On CNBC, Stephanie Link Announces Bought More International Business Machines", "summary": "", "symbols": ["IBM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912512/live-on-cnbc-stephanie-link-announces-bought-more-international-business-machines", "tags": []}
{"id": 41912518, "time": "2024-11-12 12:25:52", "headline": "Hertz Stock Slides After Posting Weak Q3 Earnings: 'Still Work To Be Done ... We Are On The Right Track'", "summary": "Hertz Global Holdings Inc. (NASDAQ: HTZ) shares are trading lower Tuesday after the company reported third-quarter earnings that fell short of analyst expectations. Here&#39;s what you need to know.", "symbols": ["HTZ"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41912518/hertz-stock-slides-after-posting-weak-q3-earnings-still-work-to-be-done-we-are-on-the-right-track", "tags": ["earnings", "why_moving"]}
{"id": 41912526, "time": "2024-11-12 12:26:16", "headline": "DA Davidson Maintains Buy on Interparfums, Maintains $163 Price Target", "summary": "", "symbols": ["IPAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912526/da-davidson-maintains-buy-on-interparfums-maintains-163-price-target", "tags": ["analyst_other"]}
{"id": 41912543, "time": "2024-11-12 12:26:50", "headline": "Keefe, Bruyette & Woods Maintains Outperform on RenaissanceRe Holdings, Lowers Price Target to $310", "summary": "", "symbols": ["RNR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912543/keefe-bruyette-woods-maintains-outperform-on-renaissancere-holdings-lowers-price-target-to-310", "tags": ["analyst_other", "price_target_down"]}
{"id": 41912552, "time": "2024-11-12 12:27:43", "headline": "Socket Mobile Files For Common Stock Offering Of Up To 1.1M Shares", "summary": "", "symbols": ["SCKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912552/socket-mobile-files-for-common-stock-offering-of-up-to-1-1m-shares", "tags": ["offering"]}
{"id": 41912561, "time": "2024-11-12 12:28:25", "headline": "Needham Reiterates Buy on TScan Therapeutics, Maintains $11 Price Target", "summary": "", "symbols": ["TCRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912561/needham-reiterates-buy-on-tscan-therapeutics-maintains-11-price-target", "tags": ["analyst_other"]}
{"id": 41912573, "time": "2024-11-12 12:28:43", "headline": "Home Depot's Earnings Beat Sets Conservative Tone for FY24, J.P. Morgan Predicts Slowing Deterioration Ahead", "summary": "J.P. Morgan analyst with an Overweight rating, notes that Home Depot&#39;s EPS forecast appears to be somewhat conservative.", "symbols": ["HD", "IEDI", "RTH"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/11/41912573/jp-morgan-sees-hope-for-home-depot-as-q3-decline-eases-2025-recovery-in-sight", "tags": ["earnings", "guidance"]}
{"id": 41912580, "time": "2024-11-12 12:28:49", "headline": "Truist Securities Maintains Buy on Aramark, Raises Price Target to $46", "summary": "", "symbols": ["ARMK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912580/truist-securities-maintains-buy-on-aramark-raises-price-target-to-46", "tags": ["analyst_other", "price_target_up"]}
{"id": 41912598, "time": "2024-11-12 12:29:54", "headline": "Barrington Research Maintains Outperform on Koppers Hldgs, Maintains $64 Price Target", "summary": "", "symbols": ["KOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912598/barrington-research-maintains-outperform-on-koppers-hldgs-maintains-64-price-target", "tags": ["analyst_other"]}
{"id": 41912673, "time": "2024-11-12 12:30:18", "headline": "Truist Securities Maintains Buy on Arcellx, Raises Price Target to $136", "summary": "", "symbols": ["ACLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912673/truist-securities-maintains-buy-on-arcellx-raises-price-target-to-136", "tags": ["analyst_other", "price_target_up"]}
{"id": 41912674, "time": "2024-11-12 12:30:30", "headline": "Price Over Earnings Overview: Arbor Realty Trust", "summary": " ", "symbols": ["ABR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41912674/price-over-earnings-overview-arbor-realty-trust", "tags": ["earnings"]}
{"id": 41912686, "time": "2024-11-12 12:30:45", "headline": "HC Wainwright & Co. Maintains Buy on Scholar Rock Holding, Raises Price Target to $40", "summary": "", "symbols": ["SRRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912686/hc-wainwright-co-maintains-buy-on-scholar-rock-holding-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 41912702, "time": "2024-11-12 12:31:42", "headline": "Plug Power Stock Slides On Q3 Earnings: Revenue Miss, EPS Miss, Soft Guidance And More", "summary": "Plug Power reported third-quarter revenue of $173.73 million, missing analyst estimates of $210.23 million. The company reported a quarterly loss of 25 cents per share, missing analyst estimates for a loss of 24 cents per share, according to Benzinga Pro.", "symbols": ["PLUG"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/earnings/24/11/41912702/plug-power-stock-slides-on-q3-earnings-revenue-miss-eps-miss-soft-guidance-and-more", "tags": ["earnings", "guidance"]}
{"id": 41912703, "time": "2024-11-12 12:31:49", "headline": "Truist Securities Maintains Buy on Digital Realty Trust, Raises Price Target to $202", "summary": "", "symbols": ["DLR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912703/truist-securities-maintains-buy-on-digital-realty-trust-raises-price-target-to-202", "tags": ["analyst_other", "price_target_up"]}
{"id": 41912717, "time": "2024-11-12 12:32:38", "headline": "HC Wainwright & Co. Reiterates Buy on Femasys, Maintains $12 Price Target", "summary": "", "symbols": ["FEMY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912717/hc-wainwright-co-reiterates-buy-on-femasys-maintains-12-price-target", "tags": ["analyst_other"]}
{"id": 41912726, "time": "2024-11-12 12:33:08", "headline": "Truist Securities Maintains Hold on EOG Resources, Raises Price Target to $135", "summary": "", "symbols": ["EOG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912726/truist-securities-maintains-hold-on-eog-resources-raises-price-target-to-135", "tags": ["analyst_other", "price_target_up"]}
{"id": 41912758, "time": "2024-11-12 12:34:16", "headline": "Truist Securities Maintains Hold on Equity Lifestyle Props, Raises Price Target to $71", "summary": "", "symbols": ["ELS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912758/truist-securities-maintains-hold-on-equity-lifestyle-props-raises-price-target-to-71", "tags": ["analyst_other", "price_target_up"]}
{"id": 41912766, "time": "2024-11-12 12:35:12", "headline": "10 Information Technology Stocks Whale Activity In Today's Session", "summary": " ", "symbols": ["AAPL", "AVGO", "CSCO", "FSLR", "MSFT", "MSTR", "NVDA", "RIOT", "SMCI", "ZETA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41912766/10-information-technology-stocks-whale-activity-in-todays-session", "tags": []}
{"id": 41912767, "time": "2024-11-12 12:35:18", "headline": "10 Health Care Stocks Whale Activity In Today's Session", "summary": " ", "symbols": ["AMGN", "CI", "DOCS", "HIMS", "IONS", "JANX", "NVO", "PFE", "RGEN", "TGTX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41912767/10-health-care-stocks-whale-activity-in-todays-session", "tags": []}
{"id": 41912769, "time": "2024-11-12 12:35:23", "headline": "10 Industrials Stocks Whale Activity In Today's Session", "summary": " ", "symbols": ["AXON", "CAR", "DE", "GEV", "MTZ", "PH", "RKLB", "UAL", "URI", "ZIM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41912769/10-industrials-stocks-whale-activity-in-todays-session", "tags": []}
{"id": 41912770, "time": "2024-11-12 12:35:24", "headline": "Truist Securities Maintains Hold on HighPeak Energy, Raises Price Target to $14", "summary": "", "symbols": ["HPK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912770/truist-securities-maintains-hold-on-highpeak-energy-raises-price-target-to-14", "tags": ["analyst_other", "price_target_up"]}
{"id": 41912771, "time": "2024-11-12 12:35:28", "headline": "Trump Presidency Magnificent 7 Stock Impact: Benzinga Readers Pick Tech Titan At Most Risk Following 2024 Election", "summary": "The Magnificent 7 stocks saw impressive gains after Donald Trump won the 2016 election. Will the same hold true going forward?", "symbols": ["AAPL", "AMZN", "GOOG", "GOOGL", "META", "MSFT", "NVDA", "TSLA"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/social-media/24/11/41912771/trump-presidency-magnificent-7-stock-impact-benzinga-readers-pick-tech-titan-at-most-risk-following-2024-election", "tags": []}
{"id": 41912782, "time": "2024-11-12 12:36:11", "headline": "D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target", "summary": "", "symbols": ["CTSO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912782/d-boral-capital-maintains-buy-on-cytosorbents-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 41912783, "time": "2024-11-12 12:36:14", "headline": "Truist Securities Maintains Hold on Peakstone Realty Tr, Raises Price Target to $15", "summary": "", "symbols": ["PKST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912783/truist-securities-maintains-hold-on-peakstone-realty-tr-raises-price-target-to-15", "tags": ["analyst_other", "price_target_up"]}
{"id": 41912787, "time": "2024-11-12 12:36:27", "headline": "'Buckle Up' For The Bull Market's 'Most Fun Phase,' Says Industry Expert: Bitcoin, Ethereum, Dogecoin About To Enter The 'Euphoria' Stage", "summary": "Blockworks co-founder Jason Yanowitz sees the cryptocurrency market moving into the most thrilling phase of a four-stage bull market. \n\n\n\nWhat Happened: Yanowitz outlined the typical bull market phases in a thread on X:", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41912787/buckle-up-for-the-bull-markets-most-fun-phase-says-industry-expert-bitcoin-ethereum-dogecoin-about-to-enter-the-euphoria-stage", "tags": []}
{"id": 41912799, "time": "2024-11-12 12:37:21", "headline": "Truist Securities Maintains Hold on ProAssurance, Raises Price Target to $18", "summary": "", "symbols": ["PRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912799/truist-securities-maintains-hold-on-proassurance-raises-price-target-to-18", "tags": ["analyst_other", "price_target_up"]}
{"id": 41912861, "time": "2024-11-12 12:38:25", "headline": "Truist Securities Maintains Buy on Rexford Industrial Realty, Lowers Price Target to $50", "summary": "", "symbols": ["REXR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912861/truist-securities-maintains-buy-on-rexford-industrial-realty-lowers-price-target-to-50", "tags": ["analyst_other", "price_target_down"]}
{"id": 41912881, "time": "2024-11-12 12:39:21", "headline": "What's Going On With NIO Stock Today?", "summary": "NIO stock drops amid broader declines in US-listed Chinese stocks, while the company ramps up production of its Onvo L60 and prepares for new EV models.", "symbols": ["KARS", "NIO", "PGJ"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41912881/whats-going-on-with-nio-stock-today-9", "tags": ["why_moving"]}
{"id": 41912884, "time": "2024-11-12 12:39:39", "headline": "Truist Securities Reiterates Hold on Sunrun, Lowers Price Target to $12", "summary": "", "symbols": ["RUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912884/truist-securities-reiterates-hold-on-sunrun-lowers-price-target-to-12", "tags": ["analyst_other", "price_target_down"]}
{"id": 41912886, "time": "2024-11-12 12:39:40", "headline": "D. Boral Capital Maintains Buy on Quince Therapeutics, Maintains $12 Price Target", "summary": "", "symbols": ["QNCX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912886/d-boral-capital-maintains-buy-on-quince-therapeutics-maintains-12-price-target", "tags": ["analyst_other"]}
{"id": 41912894, "time": "2024-11-12 12:40:06", "headline": "Alcon Q3 Adj EPS $0.81 Beats $0.74 Estimate, Sales $2.43B Miss $2.46B Estimate", "summary": "", "symbols": ["ALC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41912894/alcon-q3-adj-eps-0-81-beats-0-74-estimate-sales-2-43b-miss-2-46b-estimate", "tags": ["earnings"]}
{"id": 41912902, "time": "2024-11-12 12:40:35", "headline": "Ascendiant Capital Maintains Buy on Phunware, Lowers Price Target to $13", "summary": "", "symbols": ["PHUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912902/ascendiant-capital-maintains-buy-on-phunware-lowers-price-target-to-13", "tags": ["analyst_other", "price_target_down"]}
{"id": 41912909, "time": "2024-11-12 12:41:06", "headline": "Truist Securities Reiterates Buy on Zeta Global Holdings, Raises Price Target to $42", "summary": "", "symbols": ["ZETA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912909/truist-securities-reiterates-buy-on-zeta-global-holdings-raises-price-target-to-42", "tags": ["analyst_other", "price_target_up"]}
{"id": 41912915, "time": "2024-11-12 12:41:57", "headline": "Alcon Updates FY24 Core Diluted EPS From $3.00-$3.10 To $3.00-$3.05 Vs $3.06 Est.; Net Sales From $9.9B-$10.1B To $9.8B-$9.9B Vs $9.93B Est.", "summary": "", "symbols": ["ALC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912915/alcon-updates-fy24-core-diluted-eps-from-3-00-3-10-to-3-00-3-05-vs-3-06-est-net-sales-from-9-9b-10-1", "tags": ["earnings", "offering"]}
{"id": 41912963, "time": "2024-11-12 12:42:43", "headline": "Live On CNBC, Stephanie Link Buys More Boeing", "summary": "", "symbols": ["BA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912963/live-on-cnbc-stephanie-link-buys-more-boeing", "tags": []}
{"id": 41912964, "time": "2024-11-12 12:42:57", "headline": "Northland Capital Markets Maintains Outperform on Cambium Networks, Lowers Price Target to $3", "summary": "", "symbols": ["CMBM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912964/northland-capital-markets-maintains-outperform-on-cambium-networks-lowers-price-target-to-3", "tags": ["analyst_other", "price_target_down"]}
{"id": 41912971, "time": "2024-11-12 12:43:21", "headline": "Stocks Fall On Tariffs Fears, Dollar Hits 6-Month Peak, Yen Tumbles: What's Driving Markets Tuesday?", "summary": "Wall Street saw the first surge in risk aversion after Donald Trump&#39;s election victory last week, as concerns grew over potential tariffs and trade policy shifts spurred by the incoming administration&#39;s key appointments.", "symbols": ["BTCUSD", "CAVA", "DIA", "FLUT", "HD", "IWM", "LYV", "NTRA", "OXY", "QQQ", "SHOP", "SPOT", "SPY", "TLT", "TSN", "XLB", "XLF", "XLK", "XLP"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/news/global/24/11/41912971/stocks-fall-on-tariffs-fears-dollar-hits-6-month-peak-yen-tumbles-whats-driving-markets-tuesday", "tags": []}
{"id": 41912993, "time": "2024-11-12 12:44:06", "headline": "Northland Capital Markets Maintains Outperform on Atmus Filtration Techs, Raises Price Target to $50", "summary": "", "symbols": ["ATMU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912993/northland-capital-markets-maintains-outperform-on-atmus-filtration-techs-raises-price-target-to-50", "tags": ["analyst_other", "price_target_up"]}
{"id": 41912994, "time": "2024-11-12 12:44:08", "headline": "On CNBC, Stephanie Link Announces Bought Rockwell Automation", "summary": "", "symbols": ["ROK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41912994/on-cnbc-stephanie-link-announces-bought-rockwell-automation", "tags": []}
{"id": 41913041, "time": "2024-11-12 12:45:18", "headline": "(DOCU) - Analyzing DocuSign's Short Interest", "summary": " ", "symbols": ["DOCU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41913041/docu-analyzing-docusigns-short-interest", "tags": []}
{"id": 41913043, "time": "2024-11-12 12:45:23", "headline": "Peering Into Southwest Airlines's Recent Short Interest", "summary": " ", "symbols": ["LUV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41913043/peering-into-southwest-airliness-recent-short-interest", "tags": []}
{"id": 41913044, "time": "2024-11-12 12:45:28", "headline": "Peering Into Symbotic's Recent Short Interest", "summary": " ", "symbols": ["SYM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41913044/peering-into-symbotics-recent-short-interest", "tags": []}
{"id": 41913052, "time": "2024-11-12 12:45:37", "headline": "Northland Capital Markets Maintains Outperform on DoubleDown Interactive, Raises Price Target to $21", "summary": "", "symbols": ["DDI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913052/northland-capital-markets-maintains-outperform-on-doubledown-interactive-raises-price-target-to-21", "tags": ["analyst_other", "price_target_up"]}
{"id": 41913106, "time": "2024-11-12 12:48:28", "headline": "What's Going On With Nano Nuclear Energy Stock Tuesday?", "summary": "Nano Nuclear Energy Inc (NASDAQ:NNE) shares are trading higher. The company on Tuesday announced that it joined an industry group to support deployment of U.S. small modular reactors (SMRs). ", "symbols": ["NNE"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41913106/whats-going-on-with-nano-nuclear-energy-stock-tuesday", "tags": ["why_moving"]}
{"id": 41913107, "time": "2024-11-12 12:48:39", "headline": "Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock", "summary": "Leerink upgrades Bristol-Myers Squibb with an increased price target and strong sales projections for Cobenfy and milvexian, predicting significant stock outperformance.", "symbols": ["ABBV", "BMY", "LLY"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/11/41913107/bristol-myers-squibbs-14-billion-potential-analyst-upgrades-stock", "tags": ["analyst_up"]}
{"id": 41913128, "time": "2024-11-12 12:49:18", "headline": "'Databricks Considers Raising Cash To Resolve Employee Stock Squeeze' - The Information", "summary": "", "symbols": ["AMZN", "GOOG", "GOOGL", "MSFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913128/databricks-considers-raising-cash-to-resolve-employee-stock-squeeze-the-information", "tags": []}
{"id": 41913155, "time": "2024-11-12 12:50:38", "headline": "Craig-Hallum Maintains Buy on Zeta Global Holdings, Raises Price Target to $45", "summary": "", "symbols": ["ZETA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913155/craig-hallum-maintains-buy-on-zeta-global-holdings-raises-price-target-to-45", "tags": ["analyst_other", "price_target_up"]}
{"id": 41913230, "time": "2024-11-12 12:52:04", "headline": "Craig-Hallum Maintains Hold on Luminar Technologies, Lowers Price Target to $1", "summary": "", "symbols": ["LAZR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913230/craig-hallum-maintains-hold-on-luminar-technologies-lowers-price-target-to-1", "tags": ["analyst_other", "price_target_down"]}
{"id": 41913289, "time": "2024-11-12 12:53:15", "headline": "Craig-Hallum Maintains Buy on QuickLogic, Lowers Price Target to $10", "summary": "", "symbols": ["QUIK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913289/craig-hallum-maintains-buy-on-quicklogic-lowers-price-target-to-10", "tags": ["analyst_other", "price_target_down"]}
{"id": 41913352, "time": "2024-11-12 12:55:06", "headline": "Maxim Group Maintains Buy on Nutex Health, Raises Price Target to $50", "summary": "", "symbols": ["NUTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913352/maxim-group-maintains-buy-on-nutex-health-raises-price-target-to-50", "tags": ["analyst_other", "price_target_up"]}
{"id": 41913410, "time": "2024-11-12 12:56:23", "headline": "Maxim Group Maintains Buy on Moleculin Biotech, Lowers Price Target to $8", "summary": "", "symbols": ["MBRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913410/maxim-group-maintains-buy-on-moleculin-biotech-lowers-price-target-to-8", "tags": ["analyst_other", "price_target_down"]}
{"id": 41913423, "time": "2024-11-12 12:57:32", "headline": "Raymond James Maintains Outperform on American Coastal, Raises Price Target to $16", "summary": "", "symbols": ["ACIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913423/raymond-james-maintains-outperform-on-american-coastal-raises-price-target-to-16", "tags": ["analyst_other", "price_target_up"]}
{"id": 41913438, "time": "2024-11-12 12:58:44", "headline": "Truist Securities Maintains Buy on WAVE Life Sciences, Raises Price Target to $36", "summary": "", "symbols": ["WVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913438/truist-securities-maintains-buy-on-wave-life-sciences-raises-price-target-to-36", "tags": ["analyst_other", "price_target_up"]}
{"id": 41913450, "time": "2024-11-12 12:59:49", "headline": "Stifel Maintains Hold on Agilon Health, Lowers Price Target to $2", "summary": "", "symbols": ["AGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913450/stifel-maintains-hold-on-agilon-health-lowers-price-target-to-2", "tags": ["analyst_other", "price_target_down"]}
{"id": 41913476, "time": "2024-11-12 13:00:17", "headline": "Why Tencent Music Entertainment (TME) Stock Is Down 8%", "summary": "Tencent Music shares fell 8.4% Tuesday afternoon. Concerns over intensifying U.S.-China relations sparked a broader selloff in Chinese equities.", "symbols": ["TME"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/11/41913476/why-tencent-music-entertainment-tme-stock-is-down-8", "tags": []}
{"id": 41913518, "time": "2024-11-12 13:00:46", "headline": "Stifel Maintains Buy on Applied Mat, Lowers Price Target to $250", "summary": "", "symbols": ["AMAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913518/stifel-maintains-buy-on-applied-mat-lowers-price-target-to-250", "tags": ["analyst_other", "price_target_down"]}
{"id": 41913524, "time": "2024-11-12 13:01:07", "headline": "Chevron's Options: A Look at What the Big Money is Thinking", "summary": " ", "symbols": ["CVX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41913524/chevrons-options-a-look-at-what-the-big-money-is-thinking", "tags": []}
{"id": 41913525, "time": "2024-11-12 13:01:08", "headline": "CNBC Halftime Report Final Trades: Salesforce, Microsoft, Target, Invesco S&P 500 Equal Weight ETF", "summary": "", "symbols": ["CRM", "MSFT", "RSP", "TGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913525/cnbc-halftime-report-final-trades-salesforce-microsoft-target-invesco-s-p-500-equal-weight-etf", "tags": []}
{"id": 41913527, "time": "2024-11-12 13:01:12", "headline": "What the Options Market Tells Us About Home Depot", "summary": " ", "symbols": ["HD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41913527/what-the-options-market-tells-us-about-home-depot", "tags": []}
{"id": 41913529, "time": "2024-11-12 13:01:17", "headline": "Exploring Stratasys's Earnings Expectations", "summary": " ", "symbols": ["SSYS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41913529/exploring-stratasyss-earnings-expectations", "tags": ["earnings"]}
{"id": 41913530, "time": "2024-11-12 13:01:17", "headline": "Behind the Scenes of UnitedHealth Group's Latest Options Trends", "summary": " ", "symbols": ["UNH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41913530/behind-the-scenes-of-unitedhealth-groups-latest-options-trends", "tags": []}
{"id": 41913543, "time": "2024-11-12 13:02:10", "headline": "Stifel Maintains Buy on Aramark, Raises Price Target to $45", "summary": "", "symbols": ["ARMK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913543/stifel-maintains-buy-on-aramark-raises-price-target-to-45", "tags": ["analyst_other", "price_target_up"]}
{"id": 41913557, "time": "2024-11-12 13:03:33", "headline": "Amicus Therapeutics Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)", "summary": " ", "symbols": ["FOLD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41913557/amicus-therapeutics-stock-a-deep-dive-into-analyst-perspectives-8-ratings", "tags": []}
{"id": 41913551, "time": "2024-11-12 13:03:51", "headline": "What to Expect from Owlet's Earnings", "summary": " ", "symbols": ["OWLT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41913551/what-to-expect-from-owlets-earnings", "tags": ["earnings"]}
{"id": 41913559, "time": "2024-11-12 13:04:17", "headline": "DA Davidson Maintains Buy on Zeta Global Holdings, Raises Price Target to $42", "summary": "", "symbols": ["ZETA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913559/da-davidson-maintains-buy-on-zeta-global-holdings-raises-price-target-to-42", "tags": ["analyst_other", "price_target_up"]}
{"id": 41913567, "time": "2024-11-12 13:04:39", "headline": "Stifel Maintains Buy on Global Partners, Raises Price Target to $54", "summary": "", "symbols": ["GLP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913567/stifel-maintains-buy-on-global-partners-raises-price-target-to-54", "tags": ["analyst_other", "price_target_up"]}
{"id": 41913609, "time": "2024-11-12 13:04:53", "headline": "Earnings Outlook For Xos", "summary": " ", "symbols": ["XOS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41913609/earnings-outlook-for-xos", "tags": ["earnings", "guidance"]}
{"id": 41913605, "time": "2024-11-12 13:05:29", "headline": "In-Depth Examination Of 14 Analyst Recommendations For EOG Resources", "summary": " ", "symbols": ["EOG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41913605/in-depth-examination-of-14-analyst-recommendations-for-eog-resources", "tags": []}
{"id": 41913638, "time": "2024-11-12 13:05:39", "headline": "Earnings Outlook For icad", "summary": " ", "symbols": ["ICAD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41913638/earnings-outlook-for-icad", "tags": ["earnings", "guidance"]}
{"id": 41913617, "time": "2024-11-12 13:06:16", "headline": "Stifel Maintains Buy on Neurogene, Raises Price Target to $60", "summary": "", "symbols": ["NGNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913617/stifel-maintains-buy-on-neurogene-raises-price-target-to-60", "tags": ["analyst_other", "price_target_up"]}
{"id": 41913678, "time": "2024-11-12 13:06:18", "headline": "\"Justice Department Sues To Block UnitedHealth's $3.3B Bid For Amedisys; Antitrust Enforcers Argue The Healthcare Giant's Latest Deal Would Illegally Harm Competition\" - WSJ", "summary": "", "symbols": ["AMED", "UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913678/justice-department-sues-to-block-unitedhealths-3-3b-bid-for-amedisys-antitrust-enforcers-argue-the-h", "tags": ["contract"]}
{"id": 41913681, "time": "2024-11-12 13:06:19", "headline": "Stifel Maintains Buy on PureCycle Technologies, Raises Price Target to $15", "summary": "", "symbols": ["PCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913681/stifel-maintains-buy-on-purecycle-technologies-raises-price-target-to-15", "tags": ["analyst_other", "price_target_up"]}
{"id": 41913622, "time": "2024-11-12 13:06:20", "headline": "Deep Dive Into Sixth Street Specialty Stock: Analyst Perspectives (5 Ratings)", "summary": " ", "symbols": ["TSLX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41913622/deep-dive-into-sixth-street-specialty-stock-analyst-perspectives-5-ratings", "tags": []}
{"id": 41913696, "time": "2024-11-12 13:07:18", "headline": "Syndax Pharmaceuticals Stock Falls After Data From Mid-Stage Study Of Revumenib In Form Of Blood Cancer", "summary": "Syndax Pharmaceuticals announces positive Phase 2 trial results for revumenib in relapsed/refractory mNPM1 AML, with key milestones expected in 2024 and 2025.", "symbols": ["SNDX"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/11/41913696/syndax-pharmaceuticals-stock-falls-after-data-from-mid-stage-study-of-revumenib-in-form-of-blood-cancer", "tags": ["fda"]}
{"id": 41913701, "time": "2024-11-12 13:07:18", "headline": "BofA Analyst Doubles Down On Veris Residential Growth, Downgrades Sun Communities - Here's Why", "summary": "Analyst revised ratings for residential REITs. Upgraded VRE to Buy, raised price target. Downgraded SUI, citing governance concerns and lowered target.", "symbols": ["SUI", "VRE"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41913701/bofa-analyst-doubles-down-on-veris-residential-growth-downgrades-sun-communities-heres-why", "tags": ["analyst_up", "analyst_down"]}
{"id": 41913705, "time": "2024-11-12 13:07:18", "headline": "What's Next: Kamada's Earnings Preview", "summary": " ", "symbols": ["KMDA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41913705/whats-next-kamadas-earnings-preview", "tags": ["earnings"]}
{"id": 41913679, "time": "2024-11-12 13:07:28", "headline": "The Latest Analyst Ratings For Wyndham Hotels & Resorts", "summary": " ", "symbols": ["WH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41913679/the-latest-analyst-ratings-for-wyndham-hotels-resorts", "tags": []}
{"id": 41913680, "time": "2024-11-12 13:07:29", "headline": "Earnings Preview: Forian", "summary": " ", "symbols": ["FORA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41913680/earnings-preview-forian", "tags": ["earnings"]}
{"id": 41913706, "time": "2024-11-12 13:08:17", "headline": "What 5 Analyst Ratings Have To Say About Marriott Vacations", "summary": " ", "symbols": ["VAC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41913706/what-5-analyst-ratings-have-to-say-about-marriott-vacations", "tags": []}
{"id": 41913713, "time": "2024-11-12 13:08:17", "headline": "Preview: Taysha Gene Therapies's Earnings", "summary": " ", "symbols": ["TSHA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41913713/preview-taysha-gene-therapiess-earnings", "tags": ["earnings"]}
{"id": 41913720, "time": "2024-11-12 13:09:38", "headline": "Beyond The Numbers: 29 Analysts Discuss ServiceNow Stock", "summary": " ", "symbols": ["NOW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41913720/beyond-the-numbers-29-analysts-discuss-servicenow-stock", "tags": []}
{"id": 41913722, "time": "2024-11-12 13:09:52", "headline": "What's Going On With Mullen Automotive Stock Tuesday?", "summary": "Mullen Automotive, Inc. (NASDAQ:MULN) shares are soaring on Tuesday. The stock began moving higher after the company announced its Class 1 EV cargo van, the Mullen ONE, is available for rent on Turo.", "symbols": ["MULN"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41913722/whats-going-on-with-mullen-automotive-stock-tuesday-2", "tags": ["why_moving"]}
{"id": 41913734, "time": "2024-11-12 13:10:34", "headline": "'JetBlue, American Hint At Revived Partnership Despite Court Loss' - Bloomberg News", "summary": "", "symbols": ["AAL", "JBLU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913734/jetblue-american-hint-at-revived-partnership-despite-court-loss-bloomberg-news", "tags": ["contract", "legal"]}
{"id": 41913736, "time": "2024-11-12 13:10:34", "headline": "DA Davidson Maintains Buy on Tecnoglass, Raises Price Target to $90", "summary": "", "symbols": ["TGLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913736/da-davidson-maintains-buy-on-tecnoglass-raises-price-target-to-90", "tags": ["analyst_other", "price_target_up"]}
{"id": 41913737, "time": "2024-11-12 13:11:00", "headline": "Edible Garden AG Earnings Preview", "summary": " ", "symbols": ["EDBL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41913737/edible-garden-ag-earnings-preview", "tags": ["earnings"]}
{"id": 41913774, "time": "2024-11-12 13:11:35", "headline": "Cisco Q1 Earnings Preview: EPS, Revenue Beat Streak In Focus As Analysts See Potential 'Large-Cap Breakout'", "summary": "Analysts see Cisco&#39;s recent rally stretching valuation, but future growth and customer demand could make the stock attractive.", "symbols": ["CSCO"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/trading-ideas/previews/24/11/41913774/cisco-q1-earnings-preview-eps-revenue-beat-streak-in-focus-as-analysts-see-potential-large-cap-breakout", "tags": ["earnings"]}
{"id": 41913769, "time": "2024-11-12 13:11:42", "headline": "The Analyst Verdict: CACI International In The Eyes Of 11 Experts", "summary": " ", "symbols": ["CACI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41913769/the-analyst-verdict-caci-international-in-the-eyes-of-11-experts", "tags": []}
{"id": 41913772, "time": "2024-11-12 13:11:45", "headline": "DA Davidson Maintains Buy on Fluor, Raises Price Target to $65", "summary": "", "symbols": ["FLR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913772/da-davidson-maintains-buy-on-fluor-raises-price-target-to-65", "tags": ["analyst_other", "price_target_up"]}
{"id": 41913791, "time": "2024-11-12 13:12:32", "headline": "Bank Of America CEO Brian Moynihan Expects Trump Administration To Hit The Ground Running In The Second Term; Says Incoming Trump Administration Should Start To Handle Budget Better; Says New Government Will Need To Deal With The Tax Laws; Says New Administration Needs To Get Government Spending And Revenue Rolling", "summary": "", "symbols": ["BAC", "DJT", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913791/bank-of-america-ceo-brian-moynihan-expects-trump-administration-to-hit-the-ground-running-in-the-sec", "tags": ["earnings", "contract", "management"]}
{"id": 41913770, "time": "2024-11-12 13:12:45", "headline": "Fulcrum Therapeutics's Earnings Outlook", "summary": " ", "symbols": ["FULC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41913770/fulcrum-therapeuticss-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41913845, "time": "2024-11-12 13:13:27", "headline": "Preview: DiaMedica Therapeutics's Earnings", "summary": " ", "symbols": ["DMAC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41913845/preview-diamedica-therapeuticss-earnings", "tags": ["earnings"]}
{"id": 41913784, "time": "2024-11-12 13:13:29", "headline": "'Swisscom Offers New Proposals To Win Italy's Approval For Vodafone Deal' - Reuters News", "summary": "", "symbols": ["VOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913784/swisscom-offers-new-proposals-to-win-italys-approval-for-vodafone-deal-reuters-news", "tags": ["contract"]}
{"id": 41913787, "time": "2024-11-12 13:13:34", "headline": "Earnings Outlook For Strata Skin Sciences", "summary": " ", "symbols": ["SSKN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41913787/earnings-outlook-for-strata-skin-sciences", "tags": ["earnings", "guidance"]}
{"id": 41913788, "time": "2024-11-12 13:13:49", "headline": "12 Analysts Assess Alibaba Gr Hldgs: What You Need To Know", "summary": " ", "symbols": ["BABA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41913788/12-analysts-assess-alibaba-gr-hldgs-what-you-need-to-know", "tags": []}
{"id": 41913838, "time": "2024-11-12 13:14:02", "headline": "DA Davidson Maintains Neutral on Hain Celestial Group, Lowers Price Target to $8", "summary": "", "symbols": ["HAIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913838/da-davidson-maintains-neutral-on-hain-celestial-group-lowers-price-target-to-8", "tags": ["analyst_other", "price_target_down"]}
{"id": 41913876, "time": "2024-11-12 13:15:12", "headline": "'Jury Holds CACI Liable For $42M Over Abu Ghraib Torture' - Law360", "summary": "", "symbols": ["CACI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913876/jury-holds-caci-liable-for-42m-over-abu-ghraib-torture-law360", "tags": []}
{"id": 41913882, "time": "2024-11-12 13:15:31", "headline": "Insights into Intellinetics's Upcoming Earnings", "summary": " ", "symbols": ["INLX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41913882/insights-into-intellineticss-upcoming-earnings", "tags": ["earnings"]}
{"id": 41913913, "time": "2024-11-12 13:17:02", "headline": "Oppenheimer Maintains Outperform on Sony Gr, Adjusts Price Target To $25 from  $108 (5-for-1 stock split)", "summary": "", "symbols": ["SONY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913913/oppenheimer-maintains-outperform-on-sony-gr-adjusts-price-target-to-25-from-108-5-for-1-stock-split", "tags": ["analyst_other"]}
{"id": 41913951, "time": "2024-11-12 13:17:02", "headline": "Bank Of America CEO Says Independent Central Bank Is A Good Place To Be; Less Concerned About Inflation In Near Term", "summary": "", "symbols": ["BAC", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913951/bank-of-america-ceo-says-independent-central-bank-is-a-good-place-to-be-less-concerned-about-inflati", "tags": ["management"]}
{"id": 41913960, "time": "2024-11-12 13:17:24", "headline": "Reported Earlier, Mosaic Names Siani Pires Next CFO With Clint Freeland Retiring", "summary": "", "symbols": ["MOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913960/reported-earlier-mosaic-names-siani-pires-next-cfo-with-clint-freeland-retiring", "tags": ["management"]}
{"id": 41913962, "time": "2024-11-12 13:17:29", "headline": "Aytu BioPharma's Earnings: A Preview", "summary": " ", "symbols": ["AYTU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41913962/aytu-biopharmas-earnings-a-preview", "tags": ["earnings"]}
{"id": 41913940, "time": "2024-11-12 13:17:31", "headline": "Earnings Preview: Durect", "summary": " ", "symbols": ["DRRX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41913940/earnings-preview-durect", "tags": ["earnings"]}
{"id": 41913979, "time": "2024-11-12 13:18:07", "headline": "Jefferies Maintains Hold on American Eagle Outfitters, Lowers Price Target to $19", "summary": "", "symbols": ["AEO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41913979/jefferies-maintains-hold-on-american-eagle-outfitters-lowers-price-target-to-19", "tags": ["analyst_other", "price_target_down"]}
{"id": 41913981, "time": "2024-11-12 13:18:11", "headline": "What To Expect From Walmart's Q3 Earnings?", "summary": "BofA analyst expects Walmart to report a Q3 earnings beat, with gross margin expansion and strong holiday sales despite a shortened season.", "symbols": ["WMT"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41913981/what-to-expect-from-walmarts-q3-earnings", "tags": ["earnings"]}
{"id": 41913983, "time": "2024-11-12 13:18:21", "headline": "What to Expect from Worksport's Earnings", "summary": " ", "symbols": ["WKSP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41913983/what-to-expect-from-worksports-earnings", "tags": ["earnings"]}
{"id": 41913997, "time": "2024-11-12 13:19:07", "headline": "Earnings Preview For Vaxart", "summary": " ", "symbols": ["VXRT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41913997/earnings-preview-for-vaxart", "tags": ["earnings"]}
{"id": 41914004, "time": "2024-11-12 13:19:20", "headline": "Repligen Q3 Earnings Beat Expectations, Highlights Improving Market Conditions, Analyst Says Well-Positioned For Long-Term Growth", "summary": "Repligen Q3 earnings beat expectations with $0.43 EPS and $154.87 million in sales. The company raises 2024 EPS guidance and reports strong growth in CDMO and equipment.", "symbols": ["RGEN"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/health-care/24/11/41914004/repligen-q3-earnings-beat-expectations-highlights-improving-market-conditions-analyst-says-well-positioned-for-long-term-growth", "tags": ["earnings", "guidance"]}
{"id": 41914012, "time": "2024-11-12 13:19:45", "headline": "A Look Ahead: Hyzon Motors's Earnings Forecast", "summary": " ", "symbols": ["HYZN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41914012/a-look-ahead-hyzon-motorss-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 41914022, "time": "2024-11-12 13:20:45", "headline": "Examining the Future: Smith Micro Software's Earnings Outlook", "summary": " ", "symbols": ["SMSI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41914022/examining-the-future-smith-micro-softwares-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41914008, "time": "2024-11-12 13:21:05", "headline": "Jefferies Maintains Buy on Victoria's Secret, Raises Price Target to $40", "summary": "", "symbols": ["VSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41914008/jefferies-maintains-buy-on-victorias-secret-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 41914062, "time": "2024-11-12 13:21:10", "headline": "Earnings Preview: M-Tron Industries", "summary": " ", "symbols": ["MPTI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41914062/earnings-preview-m-tron-industries", "tags": ["earnings"]}
{"id": 41914091, "time": "2024-11-12 13:21:17", "headline": "B. Riley Securities Downgrades Arcadium Lithium to Neutral, Raises Price Target to $5.85", "summary": "", "symbols": ["ALTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41914091/b-riley-securities-downgrades-arcadium-lithium-to-neutral-raises-price-target-to-5-85", "tags": ["analyst_down", "price_target_up"]}
{"id": 41914098, "time": "2024-11-12 13:22:17", "headline": "Insights Ahead: LM Funding America's Quarterly Earnings", "summary": " ", "symbols": ["LMFA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41914098/insights-ahead-lm-funding-americas-quarterly-earnings", "tags": ["earnings"]}
{"id": 41914132, "time": "2024-11-12 13:22:39", "headline": "B. Riley Securities Maintains Buy on Lithium Americas, Raises Price Target to $5", "summary": "", "symbols": ["LAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41914132/b-riley-securities-maintains-buy-on-lithium-americas-raises-price-target-to-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 41914169, "time": "2024-11-12 13:22:55", "headline": "A Peek at NexGel's Future Earnings", "summary": " ", "symbols": ["NXGL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41914169/a-peek-at-nexgels-future-earnings", "tags": ["earnings"]}
{"id": 41914200, "time": "2024-11-12 13:23:42", "headline": "Baidu Unveils iRAG And No-Code Tool Miaoda To Drive AI Application Boom; New iRAG Technology Mitigates Hallucinations In Image Generation, Boosting The Applicability Of AI-Generated Images", "summary": "", "symbols": ["BIDU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41914200/baidu-unveils-irag-and-no-code-tool-miaoda-to-drive-ai-application-boom-new-irag-technology-mitigate", "tags": []}
{"id": 41914369, "time": "2024-11-12 13:26:49", "headline": "Spotify Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call", "summary": " ", "symbols": ["SPOT"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-ratings/price-target/24/11/41914369/spotify-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call", "tags": ["earnings"]}
{"id": 41914425, "time": "2024-11-12 13:27:50", "headline": "Loop Capital Maintains Buy on DoorDash, Raises Price Target to $200", "summary": "", "symbols": ["DASH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41914425/loop-capital-maintains-buy-on-doordash-raises-price-target-to-200", "tags": ["analyst_other", "price_target_up"]}
{"id": 41914135, "time": "2024-11-12 13:22:17", "headline": "Valve's Steam Deck OLED Gets Makeover: Here's What You Need To Know", "summary": "Valve&#39;s limited-edition Steam Deck OLED: White Edition drops Nov. 18 with global availability. Get details on this exclusive release.", "symbols": [], "source": "benzinga", "author": "Franca Quarneti", "url": "https://www.benzinga.com/general/gaming/24/11/41914135/valves-steam-deck-oled-gets-makeover-heres-what-you-need-to-know", "tags": []}
{"id": 41914499, "time": "2024-11-12 13:29:24", "headline": "Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs", "summary": "23andMe restructures, cutting 40% of its workforce and ending its therapeutic programs to save $35 million annually while exploring strategic alternatives.", "symbols": ["GSK", "ME"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/health-care/24/11/41914499/struggling-genetic-testing-company-23andme-to-lay-off-40-of-its-workforce-discontinues-all-therapeutic-programs", "tags": []}
{"id": 41914599, "time": "2024-11-12 13:31:08", "headline": "Trump-Led Market Honeymoon Faces Crucial Test With Wednesday's Inflation Data", "summary": "Trump&#39;s re-election has fueled market optimism, but October inflation data could dampen expectations for Fed rate cuts as prices show signs of rise.", "symbols": ["DIA", "QQQ", "SPY"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41914599/trump-led-market-honeymoon-faces-crucial-test-with-wednesdays-inflation-data", "tags": []}
{"id": 41914671, "time": "2024-11-12 13:33:30", "headline": "Citigroup Maintains Buy on Rigel Pharmaceuticals, Raises Price Target to $49", "summary": "", "symbols": ["RIGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41914671/citigroup-maintains-buy-on-rigel-pharmaceuticals-raises-price-target-to-49", "tags": ["analyst_other", "price_target_up"]}
{"id": 41914720, "time": "2024-11-12 13:35:06", "headline": "What's Going On With Boeing Shares Tuesday?", "summary": "Boeing shares are moving lower on Tuesday after the company reported a decline in October deliveries", "symbols": ["BA"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41914720/whats-going-on-with-boeing-shares-tuesday-2", "tags": ["why_moving"]}
{"id": 41914723, "time": "2024-11-12 13:35:11", "headline": "Citigroup Maintains Buy on Amer Sports, Raises Price Target to $24", "summary": "", "symbols": ["AS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41914723/citigroup-maintains-buy-on-amer-sports-raises-price-target-to-24", "tags": ["analyst_other", "price_target_up"]}
{"id": 41914752, "time": "2024-11-12 13:36:11", "headline": "This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday", "summary": " ", "symbols": ["ARGX", "BMY", "IFF", "IHRT", "S"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41914752/this-bristol-myers-squibb-analyst-turns-bullish-here-are-top-5-upgrades-for-tuesday", "tags": ["analyst_up"]}
{"id": 41914753, "time": "2024-11-12 13:36:15", "headline": "Citigroup Maintains Buy on XPO, Raises Price Target to $179", "summary": "", "symbols": ["XPO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41914753/citigroup-maintains-buy-on-xpo-raises-price-target-to-179", "tags": ["analyst_other", "price_target_up"]}
{"id": 41914795, "time": "2024-11-12 13:37:33", "headline": "Citigroup Maintains Buy on United Parcel Service, Lowers Price Target to $158", "summary": "", "symbols": ["UPS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41914795/citigroup-maintains-buy-on-united-parcel-service-lowers-price-target-to-158", "tags": ["analyst_other", "price_target_down"]}
{"id": 41914818, "time": "2024-11-12 13:38:42", "headline": "Citigroup Maintains Neutral on Union Pacific, Raises Price Target to $267", "summary": "", "symbols": ["UNP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41914818/citigroup-maintains-neutral-on-union-pacific-raises-price-target-to-267", "tags": ["analyst_other", "price_target_up"]}
{"id": 41914832, "time": "2024-11-12 13:39:44", "headline": "Crypto Stocks Like MicroStrategy, Coinbase, Marathon Could 'Outperform The Majority Of Crypto Coins,' Says Veteran Trader", "summary": "Pseudonymous trader Cold Blooded Shiller argues for investing in crypto-related stocks over cryptocurrencies, citing their outperformance and easier access for traditional finance investors.", "symbols": ["BTCUSD", "COIN", "HUT", "MARA", "MSTR", "RIOT", "WULF"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41914832/crypto-stocks-like-microstrategy-coinbase-marathon-could-outperform-the-majority-of-crypto-coins-says-veteran-trader", "tags": []}
{"id": 41914844, "time": "2024-11-12 13:40:05", "headline": "Citigroup Maintains Buy on TFI International, Raises Price Target to $170", "summary": "", "symbols": ["TFII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41914844/citigroup-maintains-buy-on-tfi-international-raises-price-target-to-170", "tags": ["analyst_other", "price_target_up"]}
{"id": 41899284, "time": "2024-11-12 08:13:35", "headline": "Hertz Global Holdings shares are trading lower after the company reported worse-than-expected Q3 financial results.", "summary": "", "symbols": ["HTZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41899284/hertz-global-holdings-shares-are-trading-lower-after-the-company-reported-worse-than-expected-q3-fin", "tags": ["why_moving"]}
{"id": 41914875, "time": "2024-11-12 13:43:15", "headline": "Citigroup Maintains Buy on Saia, Raises Price Target to $651", "summary": "", "symbols": ["SAIA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41914875/citigroup-maintains-buy-on-saia-raises-price-target-to-651", "tags": ["analyst_other", "price_target_up"]}
{"id": 41907029, "time": "2024-11-12 10:19:56", "headline": "MSP Recovery shares are trading higher after the company announced new comprehensive settlements totaling more than $5.9 million.", "summary": "", "symbols": ["LIFW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41907029/msp-recovery-shares-are-trading-higher-after-the-company-announced-new-comprehensive-settlements-tot", "tags": ["why_moving"]}
{"id": 41914947, "time": "2024-11-12 13:44:02", "headline": "Trump Nominates Mike Huckabee To Be United States Ambassador To Israel", "summary": "", "symbols": ["EIS", "ISRA", "SPY", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41914947/trump-nominates-mike-huckabee-to-be-united-states-ambassador-to-israel", "tags": []}
{"id": 41914948, "time": "2024-11-12 13:44:08", "headline": "Citigroup Maintains Neutral on Old Dominion Freight Line, Raises Price Target to $241", "summary": "", "symbols": ["ODFL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41914948/citigroup-maintains-neutral-on-old-dominion-freight-line-raises-price-target-to-241", "tags": ["analyst_other", "price_target_up"]}
{"id": 41914949, "time": "2024-11-12 13:44:15", "headline": "This Nvidia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday", "summary": " ", "symbols": ["ALT", "FVR", "NVDA", "SGMT", "VEON"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41914949/this-nvidia-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-tuesday", "tags": ["analyst_init"]}
{"id": 41914956, "time": "2024-11-12 13:44:18", "headline": "Exxon Mobil Sells $1 Billion in Permian Basin Assets to Focus on Shale: Report", "summary": "Exxon Mobil to sell $1 billion Permian Basin assets to focus on shale production, aligning with strategy to invest in high-value assets.", "symbols": ["DRLL", "XLE", "XOM"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/asset-sales/24/11/41914956/exxon-mobil-sells-1-billion-in-permian-basin-assets-to-focus-on-shale-report", "tags": []}
{"id": 41914981, "time": "2024-11-12 13:45:29", "headline": "Bitcoin Miners Hive Digital, Hut 8, Bitfarms To Report Earnings As Future Of Crypto 'Has Never Been Brighter'", "summary": "Bitcoin (CRYPTO: BTC) has soared to all-time highs following Donald Trump&#39;s election win, also lifting Bitcoin mining stocks on a wave of positive sentiment.", "symbols": ["BITF", "BTCUSD", "CAN", "HIVE", "HUT"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/24/11/41914981/bitcoin-miners-hive-digital-hut-8-bitfarms-to-report-earnings-as-future-of-crypto-has-never-been-brighter", "tags": ["earnings"]}
{"id": 41914980, "time": "2024-11-12 13:45:36", "headline": "How Is The Market Feeling About Hamilton Lane?", "summary": " ", "symbols": ["HLNE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41914980/how-is-the-market-feeling-about-hamilton-lane", "tags": []}
{"id": 41914991, "time": "2024-11-12 13:45:45", "headline": "Peering Into Markel Group's Recent Short Interest", "summary": " ", "symbols": ["MKL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41914991/peering-into-markel-groups-recent-short-interest", "tags": []}
{"id": 41914990, "time": "2024-11-12 13:45:53", "headline": "FDA Issues Warning Letter To Owens & Minor Over Serious Quality Control And Compliance Failures In Sterile Medical Device Manufacturing, Requires Corrective Actions Within 15 Days", "summary": "", "symbols": ["OMI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41914990/fda-issues-warning-letter-to-owens-minor-over-serious-quality-control-and-compliance-failures-in-ste", "tags": ["fda"]}
{"id": 41914997, "time": "2024-11-12 13:46:19", "headline": "How Is The Market Feeling About HP?", "summary": " ", "symbols": ["HPQ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41914997/how-is-the-market-feeling-about-hp", "tags": []}
{"id": 41915030, "time": "2024-11-12 13:46:54", "headline": "Citigroup Maintains Buy on Norfolk Southern, Raises Price Target to $316", "summary": "", "symbols": ["NSC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41915030/citigroup-maintains-buy-on-norfolk-southern-raises-price-target-to-316", "tags": ["analyst_other", "price_target_up"]}
{"id": 41915113, "time": "2024-11-12 13:49:55", "headline": "Citigroup Maintains Buy on JB Hunt Transport Servs, Raises Price Target to $227", "summary": "", "symbols": ["JBHT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41915113/citigroup-maintains-buy-on-jb-hunt-transport-servs-raises-price-target-to-227", "tags": ["analyst_other", "price_target_up"]}
{"id": 41915168, "time": "2024-11-12 13:51:17", "headline": "Citigroup Maintains Buy on FedEx, Raises Price Target to $331", "summary": "", "symbols": ["FDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41915168/citigroup-maintains-buy-on-fedex-raises-price-target-to-331", "tags": ["analyst_other", "price_target_up"]}
{"id": 41915191, "time": "2024-11-12 13:52:26", "headline": "Citigroup Maintains Buy on CSX, Raises Price Target to $44", "summary": "", "symbols": ["CSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41915191/citigroup-maintains-buy-on-csx-raises-price-target-to-44", "tags": ["analyst_other", "price_target_up"]}
{"id": 41915173, "time": "2024-11-12 13:52:44", "headline": "AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio", "summary": "AbbVie stock drops after emraclidine fails Phase 2 trials for schizophrenia, raising questions about its neuroscience strategy and boosting competition for Cobenfy.", "symbols": ["ABBV", "BMY", "NBIX"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/11/41915173/abbvies-schizophrenia-failure-disappoints-but-analysts-show-confidence-in-immunology-portfolio", "tags": ["fda"]}
{"id": 41915240, "time": "2024-11-12 13:53:37", "headline": "Citigroup Maintains Buy on Canadian Pacific Kansas, Lowers Price Target to $91", "summary": "", "symbols": ["CP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41915240/citigroup-maintains-buy-on-canadian-pacific-kansas-lowers-price-target-to-91", "tags": ["analyst_other", "price_target_down"]}
{"id": 41915271, "time": "2024-11-12 13:55:22", "headline": "Citigroup Maintains Neutral on ArcBest, Raises Price Target to $127", "summary": "", "symbols": ["ARCB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41915271/citigroup-maintains-neutral-on-arcbest-raises-price-target-to-127", "tags": ["analyst_other", "price_target_up"]}
{"id": 41915281, "time": "2024-11-12 13:56:13", "headline": "Monday.com Analysts Boost Their Forecasts Following Q3 Earnings", "summary": " ", "symbols": ["MNDY"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41915281/monday-com-analysts-boost-their-forecasts-following-q3-earnings", "tags": ["earnings"]}
{"id": 41915292, "time": "2024-11-12 13:56:58", "headline": "Citigroup Maintains Neutral on Bristol-Myers Squibb, Raises Price Target to $60", "summary": "", "symbols": ["BMY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41915292/citigroup-maintains-neutral-on-bristol-myers-squibb-raises-price-target-to-60", "tags": ["analyst_other", "price_target_up"]}
{"id": 41915327, "time": "2024-11-12 13:58:30", "headline": "Citigroup Maintains Buy on AbbVie, Lowers Price Target to $215", "summary": "", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41915327/citigroup-maintains-buy-on-abbvie-lowers-price-target-to-215", "tags": ["analyst_other", "price_target_down"]}
{"id": 41915397, "time": "2024-11-12 14:00:52", "headline": "Netflix Reaches 70 Million Users On Ad-Supported Plan, Boosts Live Sports Ads", "summary": "Netflix&#39;s ad-supported streaming tier now has 70 million monthly active users, reflecting a growing trend for affordable streaming content.", "symbols": ["MSFT", "NFLX", "QQQ", "SPY", "VZ"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/media/24/11/41915397/netflix-reaches-70-million-users-on-ad-supported-plan-boosts-live-sports-ads", "tags": []}
{"id": 41915422, "time": "2024-11-12 14:01:35", "headline": "Insights into Xos's Upcoming Earnings", "summary": " ", "symbols": ["XOS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41915422/insights-into-xoss-upcoming-earnings", "tags": ["earnings"]}
{"id": 41915424, "time": "2024-11-12 14:01:37", "headline": "A Closer Look at 14 Analyst Recommendations For EOG Resources", "summary": " ", "symbols": ["EOG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41915424/a-closer-look-at-14-analyst-recommendations-for-eog-resources", "tags": []}
{"id": 41915425, "time": "2024-11-12 14:01:45", "headline": "A Look Ahead: Wag Group's Earnings Forecast", "summary": " ", "symbols": ["PET"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41915425/a-look-ahead-wag-groups-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 41915429, "time": "2024-11-12 14:02:21", "headline": "Evaluating Marriott Vacations: Insights From 5 Financial Analysts", "summary": " ", "symbols": ["VAC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41915429/evaluating-marriott-vacations-insights-from-5-financial-analysts", "tags": []}
{"id": 41915431, "time": "2024-11-12 14:02:22", "headline": "American Shared Hospital's Earnings Outlook", "summary": " ", "symbols": ["AMS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41915431/american-shared-hospitals-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41915436, "time": "2024-11-12 14:02:29", "headline": "The Latest Analyst Ratings For Sixth Street Specialty", "summary": " ", "symbols": ["TSLX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41915436/the-latest-analyst-ratings-for-sixth-street-specialty", "tags": []}
{"id": 41915438, "time": "2024-11-12 14:02:30", "headline": "Visa Unusual Options Activity For November 12", "summary": " ", "symbols": ["V"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41915438/visa-unusual-options-activity-for-november-12", "tags": []}
{"id": 41915441, "time": "2024-11-12 14:02:39", "headline": "Analyst Scoreboard: 7 Ratings For Wyndham Hotels & Resorts", "summary": " ", "symbols": ["WH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41915441/analyst-scoreboard-7-ratings-for-wyndham-hotels-resorts", "tags": []}
{"id": 41915442, "time": "2024-11-12 14:02:40", "headline": "Occidental Petroleum's Options Frenzy: What You Need to Know", "summary": " ", "symbols": ["OXY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41915442/occidental-petroleums-options-frenzy-what-you-need-to-know", "tags": []}
{"id": 41915448, "time": "2024-11-12 14:02:53", "headline": "Edible Garden AG's Earnings Outlook", "summary": " ", "symbols": ["EDBL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41915448/edible-garden-ags-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41915453, "time": "2024-11-12 14:03:14", "headline": "Earnings Preview: Fulcrum Therapeutics", "summary": " ", "symbols": ["FULC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41915453/earnings-preview-fulcrum-therapeutics", "tags": ["earnings"]}
{"id": 41915457, "time": "2024-11-12 14:03:20", "headline": "Deep Dive Into ServiceNow Stock: Analyst Perspectives (29 Ratings)", "summary": " ", "symbols": ["NOW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41915457/deep-dive-into-servicenow-stock-analyst-perspectives-29-ratings", "tags": []}
{"id": 41915459, "time": "2024-11-12 14:03:24", "headline": "What to Expect from Strata Skin Sciences's Earnings", "summary": " ", "symbols": ["SSKN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41915459/what-to-expect-from-strata-skin-sciencess-earnings", "tags": ["earnings"]}
{"id": 41915469, "time": "2024-11-12 14:03:42", "headline": "An Overview of Aethlon Medical's Earnings", "summary": " ", "symbols": ["AEMD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41915469/an-overview-of-aethlon-medicals-earnings", "tags": ["earnings"]}
{"id": 41915544, "time": "2024-11-12 14:04:59", "headline": "An Overview of Talphera's Earnings", "summary": " ", "symbols": ["TLPH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41915544/an-overview-of-talpheras-earnings", "tags": ["earnings"]}
{"id": 41915547, "time": "2024-11-12 14:05:02", "headline": "Trump's Fossil Fuel Push May Satisfy AI's Soaring Energy Demand \u2014 But What About Nuclear?", "summary": "Trump&#39;s stance on nuclear energy has generally been supportive, positioning it as a key element in his energy policies.", "symbols": ["CE", "NNE", "SMR", "VST"], "source": "benzinga", "author": "Hayden Buckfire", "url": "https://www.benzinga.com/top-stories/24/11/41915547/trumps-fossil-fuel-push-may-satisfy-ais-soaring-energy-demand-but-what-about-nuclear", "tags": []}
{"id": 41915561, "time": "2024-11-12 14:05:30", "headline": "Preview: Intellinetics's Earnings", "summary": " ", "symbols": ["INLX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41915561/preview-intellineticss-earnings", "tags": ["earnings"]}
{"id": 41915564, "time": "2024-11-12 14:05:45", "headline": "An Overview of Durect's Earnings", "summary": " ", "symbols": ["DRRX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41915564/an-overview-of-durects-earnings", "tags": ["earnings"]}
{"id": 41915568, "time": "2024-11-12 14:05:58", "headline": "Expert Ratings For Alibaba Gr Hldgs", "summary": " ", "symbols": ["BABA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41915568/expert-ratings-for-alibaba-gr-hldgs", "tags": []}
{"id": 41915576, "time": "2024-11-12 14:06:13", "headline": "Earnings Outlook For Bionano Genomics", "summary": " ", "symbols": ["BNGO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41915576/earnings-outlook-for-bionano-genomics", "tags": ["earnings", "guidance"]}
{"id": 41915595, "time": "2024-11-12 14:07:12", "headline": "A Look at LM Funding America's Upcoming Earnings Report", "summary": " ", "symbols": ["LMFA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41915595/a-look-at-lm-funding-americas-upcoming-earnings-report", "tags": ["earnings"]}
{"id": 41915633, "time": "2024-11-12 14:08:17", "headline": "Fed's Kashkari Says Looks Like Strong Labor Market, Strong Economy Will Continue; Fed Won't Model Trump Policies' Effect On Economy Until They Become Clear; Tariff Is A One-time Increase In Prices, That's Not Inflationary In Itself; It's Uncertain How Other Countries Would Respond", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41915633/feds-kashkari-says-looks-like-strong-labor-market-strong-economy-will-continue-fed-wont-model-trump", "tags": []}
{"id": 41915791, "time": "2024-11-12 14:12:49", "headline": "NASDAQ 100 Struggles To Close Gap With S&P 500 During Semiconductor Slowdown", "summary": "S&amp;P 500 surges post-election, NASDAQ 100 lags behind. Analyst wonders if this is a shift in market leadership or temporary pause for tech-heavy index.", "symbols": ["IYZ", "QQQ", "QQQM", "SMH", "SOXL", "SOXX", "VGT", "XLK", "XTL"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41915791/nasdaq-100-struggles-to-close-gap-with-sp-500-during-semiconductor-slowdown", "tags": []}
{"id": 41915798, "time": "2024-11-12 14:13:32", "headline": "Fed's Kashkari Says Don't Want To Declare Victory On Inflation, But Good Reason For Confidence; It Make Take A Year Or Two To Get All The Way Down To 2% Inflation Given Dynamics In Housing; It's A Good Labor Market; Robust Labor Market Is 'Encouraging,' Economy Looks In Strong Position; If Inflation Surprises To Upside Before December, That Might Give Us Pause", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41915798/feds-kashkari-says-dont-want-to-declare-victory-on-inflation-but-good-reason-for-confidence-it-make", "tags": []}
{"id": 41915913, "time": "2024-11-12 14:15:37", "headline": "Apple Music Launched A $450 Limited-Edition Coffee Table Book: '100 Best Albums'", "summary": "Apple Music&#39;s $450 &#34;100 Best Albums&#34; book is a limited-edition collector&#39;s item, featuring a foreword by Zane Lowe and shipping Nov. 25.", "symbols": ["AAPL"], "source": "benzinga", "author": "Franca Quarneti", "url": "https://www.benzinga.com/general/entertainment/24/11/41915913/apple-music-launched-a-450-limited-edition-coffee-table-book-100-best-albums", "tags": []}
{"id": 41915952, "time": "2024-11-12 14:16:37", "headline": "Fed's Kashkari In Higher Productivity Envt, Neutral Rate Is Higher, Meaning Fed Has Less Room To Cut; Data Will Determine How Many Rate Cuts Will Be Needed; We Are Above Neutral Now, We All Agree; We Are Modestly Restrictive", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41915952/feds-kashkari-in-higher-productivity-envt-neutral-rate-is-higher-meaning-fed-has-less-room-to-cut-da", "tags": []}
{"id": 41915976, "time": "2024-11-12 14:16:47", "headline": "Lowe's Companies Unusual Options Activity", "summary": " ", "symbols": ["LOW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41915976/lowes-companies-unusual-options-activity", "tags": []}
{"id": 41916142, "time": "2024-11-12 14:21:55", "headline": "Cantor Fitzgerald Maintains Overweight Rating On Amgen With $405 Price Target, Projecting $33.2B Revenue In 2024; Highlights Pipeline Risks And -4% BMD Loss In AMG-133 Phase 1 Trial", "summary": "", "symbols": ["AMGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41916142/cantor-fitzgerald-maintains-overweight-rating-on-amgen-with-405-price-target-projecting-33-2b-revenu", "tags": ["analyst_other", "earnings", "fda"]}
{"id": 41916179, "time": "2024-11-12 14:23:09", "headline": "Fed's Kashkari Says Bar Of Stopping Fed Balance Sheet Runoff 'Quite High'; Fed Has A Ways To Go Before It Stops Shrinking Balance Sheet", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41916179/feds-kashkari-says-bar-of-stopping-fed-balance-sheet-runoff-quite-high-fed-has-a-ways-to-go-before-i", "tags": []}
{"id": 41916359, "time": "2024-11-12 14:26:43", "headline": "Bitcoin Is The 'Decentralized King,' Says Anthony Pompliano, Whose $100,000 Price Prediction Is Close To Coming True", "summary": "Bitcoin (CRYPTO: BTC) advocate and Morgan Creek Digital co-founder, Anthony Pompliano on Tuesday expressed unwavering confidence in Bitcoin\u2019s long-term dominance despite market fluctuations, asserting that the apex crypto is the king of the ", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41916359/bitcoin-is-the-decentralized-king-says-anthony-pompliano-whose-100000-price-prediction-is-close-to-coming-true", "tags": []}
{"id": 41916361, "time": "2024-11-12 14:27:03", "headline": "Tyson Foods Posts Better-Than-Expected Earnings, Joins Shopify, Sea, Buckle And Other Big Stocks Moving Higher On Tuesday", "summary": " ", "symbols": ["ALIT", "ALT", "BKE", "GRAB", "LYV", "NWTN", "PRTH", "RVNC", "SE", "SHOP", "TSHA", "TSN"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41916361/tyson-foods-posts-better-than-expected-earnings-joins-shopify-sea-buckle-and-other-big-stocks-moving-higher-on-tuesday", "tags": ["earnings", "why_moving"]}
{"id": 41916373, "time": "2024-11-12 14:27:27", "headline": "Nvidia To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday", "summary": " ", "symbols": ["AUTL", "HMN", "IFF", "IHRT", "MNDY", "MYO", "NVDA", "PHUN", "S", "SAIA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-ratings/price-target/24/11/41916373/nvidia-to-rally-around-14-here-are-10-top-analyst-forecasts-for-tuesday", "tags": []}
{"id": 41916428, "time": "2024-11-12 14:30:23", "headline": "Super Bowl LIX Betting Odds: Kansas City Chiefs Favorite To Three-Peat, Can Detroit Lions Spoil The Party, Make Team History?", "summary": "The Kansas City Chiefs are a perfect 9-0 and the betting favorites to win Super Bowl LIX. A look at how the rest of the favorites rank and why history could be on the line.", "symbols": ["AMZN", "CMCSA", "DKNG", "FOX", "FOXA", "PARA", "PARAA"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/sports/24/11/41916428/super-bowl-lix-betting-odds-kansas-city-chiefs-favorite-to-three-peat-can-detroit-lions-spoil-the-party-make-team-history", "tags": []}
{"id": 41916450, "time": "2024-11-12 14:30:56", "headline": "Just How Bullish Is The Market On Trump's Election Win? To Find Out, Look To The Past", "summary": "Stock market bullish on Trump&#39;s second term; AAII Sentiment survey to reveal investor confidence. Historical data shows positive reaction to Trump win in 2016 and Joe Biden&#39;s win in 2020.", "symbols": ["QQQ", "SPY"], "source": "benzinga", "author": "Hayden Buckfire", "url": "https://www.benzinga.com/markets/24/11/41916450/just-how-bullish-is-the-market-on-trumps-election-win-to-find-out-look-to-the-past", "tags": []}
{"id": 41916459, "time": "2024-11-12 14:30:57", "headline": "Behind the Scenes of ASML Holding's Latest Options Trends", "summary": " ", "symbols": ["ASML"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41916459/behind-the-scenes-of-asml-holdings-latest-options-trends", "tags": []}
{"id": 41916474, "time": "2024-11-12 14:31:24", "headline": "Dow Dips Over 200 Points; Home Depot Posts Upbeat Earnings", "summary": " ", "symbols": ["AZI", "BTCT", "GNS", "HD", "NGNE", "PGY", "TSHA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41916474/dow-dips-near-200-points-home-depot-posts-upbeat-earnings", "tags": ["earnings"]}
{"id": 41916466, "time": "2024-11-12 14:31:33", "headline": "Twilio's Options: A Look at What the Big Money is Thinking", "summary": " ", "symbols": ["TWLO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41916466/twilios-options-a-look-at-what-the-big-money-is-thinking", "tags": []}
{"id": 41916504, "time": "2024-11-12 14:32:17", "headline": "Patents Reveal New Prodrugs For Psilocin, Promising Reliable Mental Health Treatments", "summary": "Recent patents on novel psychedelic prodrugs show promise in enhancing stability and efficacy, offering new hope for effective mental health treatments.", "symbols": [], "source": "benzinga", "author": "Juan Sp\u00ednelli", "url": "https://www.benzinga.com/general/health-care/24/11/41916504/patents-reveal-new-prodrugs-for-psilocin-promising-reliable-mental-health-treatments", "tags": ["offering"]}
{"id": 41916578, "time": "2024-11-12 14:35:16", "headline": "'Cheesecake Factory's strategic options for its smaller brands' - Axios", "summary": "", "symbols": ["CAKE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41916578/cheesecake-factorys-strategic-options-for-its-smaller-brands-axios", "tags": []}
{"id": 41916866, "time": "2024-11-12 14:47:33", "headline": "Market Whales and Their Recent Bets on MDB Options", "summary": " ", "symbols": ["MDB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41916866/market-whales-and-their-recent-bets-on-mdb-options", "tags": []}
{"id": 41916867, "time": "2024-11-12 14:47:38", "headline": "Check Out What Whales Are Doing With FICO", "summary": " ", "symbols": ["FICO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41916867/check-out-what-whales-are-doing-with-fico", "tags": []}
{"id": 41916922, "time": "2024-11-12 14:50:21", "headline": "'Recent Market Rumor Suggests That Apple Is Looking To Hon Hai (Foxconn) To Manufacture AI Servers' - DigiTimes Alert", "summary": "", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41916922/recent-market-rumor-suggests-that-apple-is-looking-to-hon-hai-foxconn-to-manufacture-ai-servers-digi", "tags": []}
{"id": 41916916, "time": "2024-11-12 14:49:53", "headline": "Reported Earlier: 'White House plan would provide huge boost for nuclear power' -Axios", "summary": "", "symbols": ["CCJ", "LTBR", "NNE", "OKLO", "SMR", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41916916/white-house-plan-would-provide-huge-boost-for-nuclear-power-axios", "tags": []}
{"id": 41917050, "time": "2024-11-12 14:55:28", "headline": "Justice Department Moves To Block UnitedHealth's Amedisys Takeover: What's Going On?", "summary": "UnitedHealth Group Inc (NYSE:UNH) shares are trading lower Tuesday. The U.S. Justice Department is moving to block the company&#39;s multi-billion acquisition of Amedisys Inc (NASDAQ:AMED).", "symbols": ["AMED", "UNH"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/legal/24/11/41917050/justice-department-moves-to-block-unitedhealths-amedisys-takeover-whats-going-on", "tags": ["why_moving", "merger"]}
{"id": 41917072, "time": "2024-11-12 14:55:51", "headline": "Dogecoin Is The 'Best Trump Proxy,' Industry Expert Claims", "summary": "Alex Fazel, Chief Partnership Officer at Swissborg, sees Dogecoin (CRYPTO: DOGE) as the &#34;best Trump proxy&#34;, highlighting its potential to ", "symbols": ["DOGEUSD", "POPCATUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41917072/dogecoin-is-the-best-trump-proxy-industry-expert-claims", "tags": ["contract"]}
{"id": 41917113, "time": "2024-11-12 14:57:38", "headline": "Who Will Succeed Disney CEO Bog Iger?", "summary": "Disney is seeking a successor to CEO Bob Iger, considering external candidates. James Gorman leads board&#39;s efforts to stabilize succession process.", "symbols": ["DIS", "EA", "IVV", "SPY"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/news/management/24/11/41917113/who-will-succeed-disney-ceo-bog-iger", "tags": ["management"]}
{"id": 41917208, "time": "2024-11-12 15:02:02", "headline": "The Analyst Verdict: Amicus Therapeutics In The Eyes Of 8 Experts", "summary": " ", "symbols": ["FOLD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41917208/the-analyst-verdict-amicus-therapeutics-in-the-eyes-of-8-experts", "tags": []}
{"id": 41917209, "time": "2024-11-12 15:02:04", "headline": "Watching Evaxion Biotech; Zacks Small-Cap Research Gives Stock $7.25 Price Valuation", "summary": "", "symbols": ["EVAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41917209/watching-evaxion-biotech-zacks-small-cap-research-gives-stock-7-25-price-valuation", "tags": []}
{"id": 41917246, "time": "2024-11-12 15:04:34", "headline": "Check-Cap Granted US Patent #12138033 For \"SYSTEM AND METHOD FOR POLYP AND COLON CANCEROUS GROWTH DETECTION THROUGH CAPSULE DYNAMICS\". Also 'Uses a Neural Network to Determine a Probability Score'.", "summary": "", "symbols": ["CHEK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41917246/check-cap-granted-us-patent-12138033-for-system-and-method-for-polyp-and-colon-cancerous-growth-d", "tags": []}
{"id": 41917337, "time": "2024-11-12 15:11:37", "headline": "How Is The Market Feeling About WR Berkley?", "summary": " ", "symbols": ["WRB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41917337/how-is-the-market-feeling-about-wr-berkley", "tags": []}
{"id": 41917343, "time": "2024-11-12 15:11:42", "headline": "How Is The Market Feeling About Williams Companies?", "summary": " ", "symbols": ["WMB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41917343/how-is-the-market-feeling-about-williams-companies", "tags": []}
{"id": 41917349, "time": "2024-11-12 15:11:48", "headline": "Looking Into Associated Cap Gr's Recent Short Interest", "summary": " ", "symbols": ["AC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41917349/looking-into-associated-cap-grs-recent-short-interest", "tags": []}
{"id": 41917456, "time": "2024-11-12 15:14:28", "headline": "Nano Labs Shares Halted On Circuit Breaker To The Upside, Stock Now Up 123.7%", "summary": "", "symbols": ["NA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41917456/nano-labs-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-123-7", "tags": ["halt"]}
{"id": 41917464, "time": "2024-11-12 15:17:12", "headline": "An Overview of FlexShopper's Earnings", "summary": " ", "symbols": ["FPAY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41917464/an-overview-of-flexshoppers-earnings", "tags": ["earnings"]}
{"id": 41917477, "time": "2024-11-12 15:18:26", "headline": "Insights into Stryve Foods's Upcoming Earnings", "summary": " ", "symbols": ["SNAX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41917477/insights-into-stryve-foodss-upcoming-earnings", "tags": ["earnings"]}
{"id": 41917520, "time": "2024-11-12 15:19:26", "headline": "Nano Labs Shares Resume Trade Then Again Halt On Circuit Breaker To The Upside, Stock Now Up 146.5%", "summary": "", "symbols": ["NA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41917520/nano-labs-shares-resume-trade-then-again-halt-on-circuit-breaker-to-the-upside-stock-now-up-146-5", "tags": ["halt"]}
{"id": 41917555, "time": "2024-11-12 15:22:18", "headline": "Genius Sports Q3 EPS $0.05 Beats $(0.01) Estimate, Sales $120.20M Beat $118.94M Estimate", "summary": "", "symbols": ["GENI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41917555/genius-sports-q3-eps-0-05-beats-0-01-estimate-sales-120-20m-beat-118-94m-estimate", "tags": ["earnings"]}
{"id": 41917576, "time": "2024-11-12 15:22:35", "headline": "Wells Fargo Stock Is Up 12% This Month: What's Going On?", "summary": "Wells Fargo stock rose 12% following Donald Trump&#39;s election win. Investors anticipate lower corporate taxes and reduced regulatory constraints.", "symbols": ["WFC"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/11/41917576/wells-fargo-stock-is-up-12-this-month-whats-going-on", "tags": ["why_moving"]}
{"id": 41917798, "time": "2024-11-12 15:31:02", "headline": "(SG) - Analyzing Sweetgreen's Short Interest", "summary": " ", "symbols": ["SG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41917798/sg-analyzing-sweetgreens-short-interest", "tags": []}
{"id": 41917806, "time": "2024-11-12 15:31:07", "headline": "How Is The Market Feeling About Norwegian Cruise Line?", "summary": " ", "symbols": ["NCLH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41917806/how-is-the-market-feeling-about-norwegian-cruise-line", "tags": []}
{"id": 41917810, "time": "2024-11-12 15:31:12", "headline": "Looking Into Eastern Bankshares's Recent Short Interest", "summary": " ", "symbols": ["EBC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41917810/looking-into-eastern-banksharess-recent-short-interest", "tags": []}
{"id": 41917812, "time": "2024-11-12 15:31:14", "headline": "A Closer Look at 8 Analyst Recommendations For Amicus Therapeutics", "summary": " ", "symbols": ["FOLD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41917812/a-closer-look-at-8-analyst-recommendations-for-amicus-therapeutics", "tags": []}
{"id": 41917924, "time": "2024-11-12 15:37:05", "headline": "'OpenAI Co-Founder Greg Brockman Returns To Startup After Monthslong Leave' - Bloomberg News", "summary": "", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41917924/openai-co-founder-greg-brockman-returns-to-startup-after-monthslong-leave-bloomberg-news", "tags": []}
{"id": 41917942, "time": "2024-11-12 15:38:30", "headline": "Reborn Coffee Files To Sell Common Stock, Warrants; No Size Disclosed", "summary": "", "symbols": ["REBN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41917942/reborn-coffee-files-to-sell-common-stock-warrants-no-size-disclosed", "tags": []}
{"id": 41917980, "time": "2024-11-12 15:40:14", "headline": "Starbucks App Gets Delivery Boost From DoorDash; Starbucks App Launches Delivery, Powered By DoorDash, Across The U.S. And Canada", "summary": "", "symbols": ["DASH", "SBUX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41917980/starbucks-app-gets-delivery-boost-from-doordash-starbucks-app-launches-delivery-powered-by-doordash", "tags": []}
{"id": 41917986, "time": "2024-11-12 15:41:19", "headline": "UnitedHealth Says 'Will Vigorously Defend Against The DOJ's Overreaching'", "summary": "", "symbols": ["AMED", "SPY", "UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41917986/unitedhealth-says-will-vigorously-defend-against-the-dojs-overreaching", "tags": []}
{"id": 41918005, "time": "2024-11-12 15:43:17", "headline": "Super Bowl LIX Betting Odds: Kansas City Chiefs Favorite To Three-Peat, Can Detroit Lions Spoil The Party?", "summary": "The Kansas City Chiefs are a perfect 9-0 and the betting favorites to win Super Bowl LIX. A look at how the rest of the favorites rank and why history could be on the line.", "symbols": ["AMZN", "CMCSA", "DKNG", "FOX", "FOXA", "PARA", "PARAA"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/sports/24/11/41918005/super-bowl-lix-betting-odds-kansas-city-chiefs-favorite-to-three-peat-can-detroit-lions-spoil-the-party-make-team-history", "tags": []}
{"id": 41918068, "time": "2024-11-12 15:44:21", "headline": "Nano Labs Shares Resume Trade", "summary": "", "symbols": ["NA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41918068/nano-labs-shares-resume-trade", "tags": []}
{"id": 41917731, "time": "2024-11-12 15:29:44", "headline": "Wall Street Veteran Predicts S&P 500 To Hit 10,000 By 2029: 'Roaring 2020s'", "summary": "Veteran analyst Ed Yardeni predicts S&amp;P 500 to hit 10,000 by 2030, driven by Trump&#39;s policies and improved profit margins. 55% chance of &#39;Roaring 2020s&#39; scenario, he says.", "symbols": ["SPY"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41917731/wall-street-veteran-predicts-sp-500-to-hit-10000-by-2029-roaring-2020s", "tags": []}
{"id": 41918103, "time": "2024-11-12 15:47:48", "headline": "Nu Holdings Options Trading: A Deep Dive into Market Sentiment", "summary": " ", "symbols": ["NU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41918103/nu-holdings-options-trading-a-deep-dive-into-market-sentiment", "tags": []}
{"id": 41918108, "time": "2024-11-12 15:47:57", "headline": "This Is What Whales Are Betting On Applied Mat", "summary": " ", "symbols": ["AMAT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41918108/this-is-what-whales-are-betting-on-applied-mat", "tags": []}
{"id": 41918113, "time": "2024-11-12 15:49:03", "headline": "Lam Research Unusual Options Activity For November 12", "summary": " ", "symbols": ["LRCX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41918113/lam-research-unusual-options-activity-for-november-12", "tags": []}
{"id": 41917910, "time": "2024-11-12 15:36:14", "headline": "'Apple's Next Device Is An AI Wall Tablet For Home Control, Siri And Video Calls; Product Will Spotlight The New Siri And Apple Intelligence; Device Will Tap Into Cameras, Doorbells And Run Apple's Apps' - Bloomberg News", "summary": "", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41917910/apple-to-launch-ai-powered-smart-home-device-as-early-as-march", "tags": []}
{"id": 41918490, "time": "2024-11-12 16:00:59", "headline": "comScore Q3 Sales $88.48M Beat $85.92M Estimate", "summary": "", "symbols": ["SCOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41918490/comscore-q3-sales-88-48m-beat-85-92m-estimate", "tags": []}
{"id": 41918559, "time": "2024-11-12 16:01:25", "headline": "Preview: Intellicheck's Earnings", "summary": " ", "symbols": ["IDN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41918559/preview-intellichecks-earnings", "tags": ["earnings"]}
{"id": 41918568, "time": "2024-11-12 16:01:36", "headline": "Trading Halt: Halted at 4:01:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["VRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41918568/trading-halt-halted-at-4-01-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 41918591, "time": "2024-11-12 16:01:59", "headline": "Skyworks Solutions Q4 Adj $1.55 Beats $1.52 Estimate, Sales $1.02B Inline", "summary": "", "symbols": ["SWKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41918591/skyworks-solutions-q4-adj-1-55-beats-1-52-estimate-sales-1-02b-inline", "tags": []}
{"id": 41918618, "time": "2024-11-12 16:02:44", "headline": "Skyworks Solutions Sees Q1 2025 EPS $1.57 At The Midpoint Vs $1.72 Est.; Revenue $1.05B-$1.08B Vs $1.1B Est.", "summary": "", "symbols": ["SWKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41918618/skyworks-solutions-sees-q1-2025-eps-1-57-at-the-midpoint-vs-1-72-est-revenue-1-05b-1-08b-vs-1-1b-est", "tags": ["earnings"]}
{"id": 41918649, "time": "2024-11-12 16:03:12", "headline": "Exploring Jaguar Health's Earnings Expectations", "summary": " ", "symbols": ["JAGX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41918649/exploring-jaguar-healths-earnings-expectations", "tags": ["earnings"]}
{"id": 41918656, "time": "2024-11-12 16:03:19", "headline": "Perdoceo Education Q3 Adj $0.59 Beats $0.53 Estimate, Sales $169.83M Beat $164.63M Estimate", "summary": "", "symbols": ["PRDO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41918656/perdoceo-education-q3-adj-0-59-beats-0-53-estimate-sales-169-83m-beat-164-63m-estimate", "tags": []}
{"id": 41918662, "time": "2024-11-12 16:03:24", "headline": "ProPhase Labs's Earnings: A Preview", "summary": " ", "symbols": ["PRPH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41918662/prophase-labss-earnings-a-preview", "tags": ["earnings"]}
{"id": 41918673, "time": "2024-11-12 16:03:28", "headline": "Jefferies Maintains Buy on Amgen, Maintains $380 Price Target", "summary": "", "symbols": ["AMGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41918673/jefferies-maintains-buy-on-amgen-maintains-380-price-target", "tags": ["analyst_other"]}
{"id": 41918675, "time": "2024-11-12 16:03:29", "headline": "89bio Announces $100M Underwritten Public Offering", "summary": "", "symbols": ["ETNB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41918675/89bio-announces-100m-underwritten-public-offering", "tags": ["offering"]}
{"id": 41918684, "time": "2024-11-12 16:03:35", "headline": "Quanterix Q3 Sales $35.70M Beat $34.17M Estimate", "summary": "", "symbols": ["QTRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41918684/quanterix-q3-sales-35-70m-beat-34-17m-estimate", "tags": []}
{"id": 41918701, "time": "2024-11-12 16:03:43", "headline": "Insights Ahead: ARS Pharmaceuticals's Quarterly Earnings", "summary": " ", "symbols": ["SPRY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41918701/insights-ahead-ars-pharmaceuticalss-quarterly-earnings", "tags": ["earnings"]}
{"id": 41918722, "time": "2024-11-12 16:04:08", "headline": "Progyny Q3 EPS $0.11 Misses $0.13 Estimate, Sales $286.63M Miss $296.88M Estimate", "summary": "", "symbols": ["PGNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41918722/progyny-q3-eps-0-11-misses-0-13-estimate-sales-286-63m-miss-296-88m-estimate", "tags": ["earnings"]}
{"id": 41918736, "time": "2024-11-12 16:04:18", "headline": "Stryve Foods Earnings Preview", "summary": " ", "symbols": ["SNAX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41918736/stryve-foods-earnings-preview", "tags": ["earnings"]}
{"id": 41918738, "time": "2024-11-12 16:04:19", "headline": "FiscalNote Holdings Q3 EPS $(0.11) Misses $(0.10) Estimate, Sales $29.44M Beat $29.00M Estimate", "summary": "", "symbols": ["NOTE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41918738/fiscalnote-holdings-q3-eps-0-11-misses-0-10-estimate-sales-29-44m-beat-29-00m-estimate", "tags": ["earnings"]}
{"id": 41918750, "time": "2024-11-12 16:04:28", "headline": "Amdocs FY Sales $5.005B Beat $5.002B Estimate", "summary": "", "symbols": ["DOX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41918750/amdocs-fy-sales-5-005b-beat-5-002b-estimate", "tags": []}
{"id": 41918768, "time": "2024-11-12 16:04:39", "headline": "Geovax Labs Q3 2024 GAAP EPS $(0.91) Beats $(1.48) Estimate, Sales $2.789M Beat $918.750K Estimate", "summary": "", "symbols": ["GOVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41918768/geovax-labs-q3-2024-gaap-eps-0-91-beats-1-48-estimate-sales-2-789m-beat-918-750k-estimate", "tags": ["earnings"]}
{"id": 41918769, "time": "2024-11-12 16:04:39", "headline": "Voyager Therapeutics Q3 2024 GAAP EPS $(0.16) Beats $(0.46) Estimate, Sales $24.60M Beat $11.89M Estimate", "summary": "", "symbols": ["VYGR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41918769/voyager-therapeutics-q3-2024-gaap-eps-0-16-beats-0-46-estimate-sales-24-60m-beat-11-89m-estimate", "tags": ["earnings"]}
{"id": 41918772, "time": "2024-11-12 16:04:43", "headline": "Earnings Outlook For Snail", "summary": " ", "symbols": ["SNAL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41918772/earnings-outlook-for-snail", "tags": ["earnings", "guidance"]}
{"id": 41918963, "time": "2024-11-12 16:05:38", "headline": "Prothena Corp Q3 2024 GAAP EPS $(1.10) Beats $(1.18) Estimate, Sales $970.00K Miss $1.23M Estimate", "summary": "", "symbols": ["PRTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41918963/prothena-corp-q3-2024-gaap-eps-1-10-beats-1-18-estimate-sales-970-00k-miss-1-23m-estimate", "tags": ["earnings"]}
{"id": 41918964, "time": "2024-11-12 16:05:39", "headline": "Amdocs Q4 2024 Adj. EPS $1.70, Inline, Sales $1.264B Miss $1.266B Estimate", "summary": "", "symbols": ["DOX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41918964/amdocs-q4-2024-adj-eps-1-70-inline-sales-1-264b-miss-1-266b-estimate", "tags": ["earnings"]}
{"id": 41918966, "time": "2024-11-12 16:05:40", "headline": "Clearside Biomedical Q3 EPS $(0.10) Beats $(0.13) Estimate, Sales $1.04M Beat $122.86K Estimate", "summary": "", "symbols": ["CLSD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41918966/clearside-biomedical-q3-eps-0-10-beats-0-13-estimate-sales-1-04m-beat-122-86k-estimate", "tags": ["earnings"]}
{"id": 41918998, "time": "2024-11-12 16:06:04", "headline": "Organogenesis Holdings Announced A $130M Private Placement Offering Of Series A Convertible Stock", "summary": "", "symbols": ["ORGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41918998/organogenesis-holdings-announced-a-130m-private-placement-offering-of-series-a-convertible-stock", "tags": ["offering"]}
{"id": 41919002, "time": "2024-11-12 16:06:13", "headline": "Xenon Pharmaceuticals Q3 2024 GAAP EPS $(0.81), Inline", "summary": "", "symbols": ["XENE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919002/xenon-pharmaceuticals-q3-2024-gaap-eps-0-81-inline", "tags": ["earnings"]}
{"id": 41919006, "time": "2024-11-12 16:06:17", "headline": "Rumble Q3 2024 Adj EPS $(0.15) Misses $(0.12) Estimate, Sales $25.10M Miss $29.25M Estimate", "summary": "", "symbols": ["RUM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919006/rumble-q3-2024-adj-eps-0-15-misses-0-12-estimate-sales-25-10m-miss-29-25m-estimate", "tags": ["earnings"]}
{"id": 41919007, "time": "2024-11-12 16:06:17", "headline": "ePlus Q2 Adj $1.36 Misses $1.39 Estimate, Sales $515.17M Miss $576.50M Estimate", "summary": "", "symbols": ["PLUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919007/eplus-q2-adj-1-36-misses-1-39-estimate-sales-515-17m-miss-576-50m-estimate", "tags": []}
{"id": 41919008, "time": "2024-11-12 16:06:23", "headline": "12 Information Technology Stocks Moving In Tuesday's Pre-Market Session", "summary": " ", "symbols": ["BOXL", "BTCT", "FOXO", "KLTR", "MASS", "NVNI", "PGY", "RGTI", "SGN", "TAOP", "WK", "XTKG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/11/41919008/12-information-technology-stocks-moving-in-tuesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 41919011, "time": "2024-11-12 16:06:30", "headline": "Fed's Kashkari Warns Of December Interest Rate Pause Risk: 'Surprises To The Upside'", "summary": "Kashkari warns Fed may hold off on Dec rate cut if inflation surprises, discusses housing, tariffs &amp; labor market. Fed committed to independence.", "symbols": ["SPY"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/news/econ-s/24/11/41919011/feds-kashkari-warns-of-december-interest-rate-pause-risk-surprises-to-the-upside", "tags": []}
{"id": 41919009, "time": "2024-11-12 16:06:32", "headline": "EverCommerce Q3 2024 GAAP EPS $(0.05) Misses $(0.01) Estimate, Sales $176.300M Beat $174.816M Estimate", "summary": "", "symbols": ["EVCM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919009/evercommerce-q3-2024-gaap-eps-0-05-misses-0-01-estimate-sales-176-300m-beat-174-816m-estimate", "tags": ["earnings"]}
{"id": 41919026, "time": "2024-11-12 16:06:54", "headline": "PLBY Group Q3 2024 GAAP EPS $(0.45), Sales $12.900M", "summary": "", "symbols": ["PLBY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919026/plby-group-q3-2024-gaap-eps-0-45-sales-12-900m", "tags": ["earnings"]}
{"id": 41919024, "time": "2024-11-12 16:07:06", "headline": "ICU Medical Q3 2024 Adj EPS $1.59 Beats $1.25 Estimate, Sales $589.13M Beat $574.70M Estimate", "summary": "", "symbols": ["ICUI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919024/icu-medical-q3-2024-adj-eps-1-59-beats-1-25-estimate-sales-589-13m-beat-574-70m-estimate", "tags": ["earnings"]}
{"id": 41919010, "time": "2024-11-12 16:07:18", "headline": "12 Industrials Stocks Moving In Tuesday's Pre-Market Session", "summary": " ", "symbols": ["AGFY", "ALIT", "AMPX", "BAER", "CETY", "FGL", "HTZ", "NCL", "RAIL", "SOAR", "TGI", "TISI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/11/41919010/12-industrials-stocks-moving-in-tuesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 41919067, "time": "2024-11-12 16:08:05", "headline": "Wu-Tang's Raekwon And Charlamagne Tha God Celebrate Hashstoria Dispensary Opening In Downtown Newark", "summary": "Hashstoria cannabis dispensary is slated to host the official grand opening celebration in downtown Newark, New Jersey.Located at 799-805 Broad Street in the historic Four Corners district, the dispensary is organizing a full-day event on Nov.13. The event will feature appearances by Raekwon the Chef, Charlamagne Tha God, Bakari Sellers and local officials.", "symbols": [], "source": "benzinga", "author": "Jelena Martinovic", "url": "https://www.benzinga.com/markets/cannabis/24/11/41919067/wu-tangs-raekwon-and-charlamagne-tha-god-celebrate-hashstoria-dispensary-opening-in-downtown-newark", "tags": []}
{"id": 41919045, "time": "2024-11-12 16:08:17", "headline": "12 Health Care Stocks Moving In Tuesday's Pre-Market Session", "summary": " ", "symbols": ["CCLD", "CCLDP", "CERO", "HRTX", "LGMK", "NGNE", "NVRO", "QSI", "RMTI", "SNDX", "STIM", "TSHA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/11/41919045/12-health-care-stocks-moving-in-tuesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 41919052, "time": "2024-11-12 16:08:18", "headline": "Lexicon Pharmaceuticals Q3 2024 GAAP EPS $(0.18) Misses $(0.17) Estimate, Sales $1.800M Miss $2.929M Estimate", "summary": "", "symbols": ["LXRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919052/lexicon-pharmaceuticals-q3-2024-gaap-eps-0-18-misses-0-17-estimate-sales-1-800m-miss-2-929m-estimat", "tags": ["earnings"]}
{"id": 41919041, "time": "2024-11-12 16:08:38", "headline": "Light & Wonder Q3 EPS $0.72 Misses $1.09 Estimate, Sales $817.00M Miss $821.21M Estimate", "summary": "", "symbols": ["LNW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919041/light-wonder-q3-eps-0-72-misses-1-09-estimate-sales-817-00m-miss-821-21m-estimate", "tags": ["earnings"]}
{"id": 41919074, "time": "2024-11-12 16:08:47", "headline": "Chegg Q3 2024 Adj. EPS $0.09 Beats $0.08 Estimate, Sales $136.593M Beat $134.118M Estimate", "summary": "", "symbols": ["CHGG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919074/chegg-q3-2024-adj-eps-0-09-beats-0-08-estimate-sales-136-593m-beat-134-118m-estimate", "tags": ["earnings"]}
{"id": 41919084, "time": "2024-11-12 16:09:10", "headline": "Beauty Health Q3 2024 GAAP EPS $(0.15) Misses $(0.10) Estimate, Sales $78.80M Beat $74.07M Estimate", "summary": "", "symbols": ["SKIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919084/beauty-health-q3-2024-gaap-eps-0-15-misses-0-10-estimate-sales-78-80m-beat-74-07m-estimate", "tags": ["earnings"]}
{"id": 41919056, "time": "2024-11-12 16:09:11", "headline": "Similarweb Q3 2024 Adj. EPS $0.05, Inline, Sales $161.264M Beat $62.774M Estimate", "summary": "", "symbols": ["SMWB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919056/similarweb-q3-2024-adj-eps-0-05-inline-sales-161-264m-beat-62-774m-estimate", "tags": ["earnings"]}
{"id": 41919072, "time": "2024-11-12 16:09:36", "headline": "Smart Sand Q3 Sales $63.158M Miss $74.800M Estimate", "summary": "", "symbols": ["SND"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919072/smart-sand-q3-sales-63-158m-miss-74-800m-estimate", "tags": []}
{"id": 41919083, "time": "2024-11-12 16:10:07", "headline": "PSQ Holdings Q3 EPS $(0.41) Misses $(0.40) Estimate, Sales $6.54M Beat $6.52M Estimate", "summary": "", "symbols": ["PSQH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919083/psq-holdings-q3-eps-0-41-misses-0-40-estimate-sales-6-54m-beat-6-52m-estimate", "tags": ["earnings"]}
{"id": 41919135, "time": "2024-11-12 16:10:24", "headline": "SKYX Platforms Q3 Sales $22.20M Miss $23.41M Estimate", "summary": "", "symbols": ["SKYX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919135/skyx-platforms-q3-sales-22-20m-miss-23-41m-estimate", "tags": []}
{"id": 41917832, "time": "2024-11-12 15:31:28", "headline": "Bitcoin Nears $90,000, Dogecoin Soars, Ethereum Steady \u2014 Trader Eyes $100,000 Breakout If Milestone Hits Today", "summary": "Cryptocurrency markets are trading higher, with Bitcoin ETFs recording another strong trading day.", "symbols": ["AIOZUSD", "BONKUSD", "BTCUSD", "DOGEUSD", "ETHUSD", "SHIBUSD", "SOLUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41917832/bitcoin-nears-90000-dogecoin-soars-ethereum-steady-trader-eyes-100000-breakout-if-milestone-hits-today", "tags": []}
{"id": 41919133, "time": "2024-11-12 16:10:44", "headline": "comScore Q3 2024 Adj EPS $(0.16) Beats $(0.34) Estimate", "summary": "", "symbols": ["SCOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919133/comscore-q3-2024-adj-eps-0-16-beats-0-34-estimate", "tags": ["earnings"]}
{"id": 41919114, "time": "2024-11-12 16:10:59", "headline": "Hudson Pacific Properties Q3 2024 FFO $0.11 Misses $0.12 Estimate, Sales $200.40M Miss $214.70M Estimate", "summary": "", "symbols": ["HPP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919114/hudson-pacific-properties-q3-2024-ffo-0-11-misses-0-12-estimate-sales-200-40m-miss-214-70m-estimate", "tags": []}
{"id": 41919100, "time": "2024-11-12 16:11:00", "headline": "Peraso Q3 2024 Adj. EPS $(0.34) Misses $(0.23) Estimate, Sales $3.841M Miss $4.040M Estimate", "summary": "", "symbols": ["PRSO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919100/peraso-q3-2024-adj-eps-0-34-misses-0-23-estimate-sales-3-841m-miss-4-040m-estimate", "tags": ["earnings"]}
{"id": 41919175, "time": "2024-11-12 16:11:03", "headline": "Runway Gwth Fin Q3 EPS $0.41 Misses $0.44 Estimate, Sales $36.65M Miss $38.68M Estimate", "summary": "", "symbols": ["RWAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919175/runway-gwth-fin-q3-eps-0-41-misses-0-44-estimate-sales-36-65m-miss-38-68m-estimate", "tags": ["earnings"]}
{"id": 41919104, "time": "2024-11-12 16:11:09", "headline": "Chegg Sees Q4 Total Net Revenue $141M-$143M vs $161.46M Est., Subscription Services Revenue $126M-$128M, Adj. EBITDA $32M-$34M", "summary": "", "symbols": ["CHGG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919104/chegg-sees-q4-total-net-revenue-141m-143m-vs-161-46m-est-subscription-services-revenue-126m-128m-adj", "tags": ["earnings"]}
{"id": 41919136, "time": "2024-11-12 16:11:58", "headline": "Atara Biotherapeutics Q3 2024 GAAP EPS $(2.93) Misses $(2.50) Estimate, Sales $40.190M Beat $35.168M Estimate", "summary": "", "symbols": ["ATRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919136/atara-biotherapeutics-q3-2024-gaap-eps-2-93-misses-2-50-estimate-sales-40-190m-beat-35-168m-estimat", "tags": ["earnings"]}
{"id": 41919139, "time": "2024-11-12 16:12:03", "headline": "Energous Corporation Granted U.S. Patent #12142939: Integrated wireless-power-transmission platform designed to operate in multiple bands, and multi-band antennas for use therewith", "summary": "", "symbols": ["WATT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919139/energous-corporation-granted-u-s-patent-12142939-integrated-wireless-power-transmission-platform-des", "tags": []}
{"id": 41919236, "time": "2024-11-12 16:12:09", "headline": "BioLife Solns Q3 2024 GAAP EPS $(0.04) Beats $(0.09) Estimate, Sales $30.600M Beat $25.537M Estimate", "summary": "", "symbols": ["BLFS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919236/biolife-solns-q3-2024-gaap-eps-0-04-beats-0-09-estimate-sales-30-600m-beat-25-537m-estimate", "tags": ["earnings"]}
{"id": 41919244, "time": "2024-11-12 16:12:09", "headline": "GRAIL Q3 EPS $(3.94) Up From $(28.71) YoY, Sales $28.65M Up From $20.72M YoY", "summary": "", "symbols": ["GRAL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919244/grail-q3-eps-3-94-up-from-28-71-yoy-sales-28-65m-up-from-20-72m-yoy", "tags": ["earnings"]}
{"id": 41919230, "time": "2024-11-12 16:12:24", "headline": "Sangamo Therapeutics Q3 EPS $0.04 Beats $(0.03) Estimate, Sales $49.41M Beat $17.94M Estimate", "summary": "", "symbols": ["SGMO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919230/sangamo-therapeutics-q3-eps-0-04-beats-0-03-estimate-sales-49-41m-beat-17-94m-estimate", "tags": ["earnings"]}
{"id": 41919231, "time": "2024-11-12 16:12:26", "headline": "Cava Group Q3 2024 GAAP EPS $0.15 Beats $0.11 Estimate, Sales $243.82M Beat $233.59M Estimate", "summary": "", "symbols": ["CAVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919231/cava-group-q3-2024-gaap-eps-0-15-beats-0-11-estimate-sales-243-82m-beat-233-59m-estimate", "tags": ["earnings"]}
{"id": 41919251, "time": "2024-11-12 16:12:31", "headline": "Crinetics Pharmaceuticals Q3 2024 GAAP EPS $(0.96) Misses $(0.92) Estimate", "summary": "", "symbols": ["CRNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919251/crinetics-pharmaceuticals-q3-2024-gaap-eps-0-96-misses-0-92-estimate", "tags": ["earnings"]}
{"id": 41919245, "time": "2024-11-12 16:12:35", "headline": "Energous Corporation Granted U.S. Patent #12142939: Integrated wireless-power-transmission platform designed to operate in multiple bands, and multi-band antennas for use therewith", "summary": "", "symbols": ["WATT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919245/energous-corporation-granted-u-s-patent-12142939-integrated-wireless-power-transmission-platform-des", "tags": []}
{"id": 41919257, "time": "2024-11-12 16:12:53", "headline": "Azenta Q4 2024 Adj EPS $0.18 Beats $0.10 Estimate, Sales $170.00M Beat $169.61M Estimate", "summary": "", "symbols": ["AZTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919257/azenta-q4-2024-adj-eps-0-18-beats-0-10-estimate-sales-170-00m-beat-169-61m-estimate", "tags": ["earnings"]}
{"id": 41919237, "time": "2024-11-12 16:13:10", "headline": "Natera Q3 2024 GAAP EPS $(0.26) Beats $(0.58) Estimate, Sales $439.800M Beat $361.450M Estimate", "summary": "", "symbols": ["NTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919237/natera-q3-2024-gaap-eps-0-26-beats-0-58-estimate-sales-439-800m-beat-361-450m-estimate", "tags": ["earnings"]}
{"id": 41919260, "time": "2024-11-12 16:13:31", "headline": "Paymentus Holdings Q3 2024 Adj. EPS $0.15 Beats $0.09 Estimate, Sales $231.600M Beat $190.629M Estimate", "summary": "", "symbols": ["PAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919260/paymentus-holdings-q3-2024-adj-eps-0-15-beats-0-09-estimate-sales-231-600m-beat-190-629m-estimate", "tags": ["earnings"]}
{"id": 41919248, "time": "2024-11-12 16:13:48", "headline": "Hyperfine Narrows FY2024 Sales Guidance from $13.00M-16.00M to $14.00M-14.50M", "summary": "", "symbols": ["HYPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919248/hyperfine-narrows-fy2024-sales-guidance-from-13-00m-16-00m-to-14-00m-14-50m", "tags": ["guidance"]}
{"id": 41919330, "time": "2024-11-12 16:14:21", "headline": "Silvaco Group Q3 2024 GAAP EPS $(0.23) Misses $(0.14) Estimate, Sales $11.000M Miss $11.004M Estimate", "summary": "", "symbols": ["SVCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919330/silvaco-group-q3-2024-gaap-eps-0-23-misses-0-14-estimate-sales-11-000m-miss-11-004m-estimate", "tags": ["earnings"]}
{"id": 41919357, "time": "2024-11-12 16:14:23", "headline": "SoundThinking Q3 2024 Adj. EPS $(0.11) Misses $(0.07) Estimate, Sales $26.300M Beat $25.984M Estimate", "summary": "", "symbols": ["SSTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919357/soundthinking-q3-2024-adj-eps-0-11-misses-0-07-estimate-sales-26-300m-beat-25-984m-estimate", "tags": ["earnings"]}
{"id": 41919373, "time": "2024-11-12 16:14:34", "headline": "CAVA Group Raises FY24 Net New Restaurant Openings Outlook From 54 - 57 To 56 - 58, Same Restaurant Sales Growth Outlook From 8.5% - 9.5% To 12.0% -13.0%", "summary": "", "symbols": ["CAVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919373/cava-group-raises-fy24-net-new-restaurant-openings-outlook-from-54-57-to-56-58-same-restaurant-sales", "tags": ["guidance"]}
{"id": 41919376, "time": "2024-11-12 16:14:39", "headline": "Perdoceo Education Sees Q4 EPS $0.46-$0.49 Vs $0.46 Est.; FY24 EPS $2.25-$2.28 Vs $2.19 Est.", "summary": "", "symbols": ["PRDO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919376/perdoceo-education-sees-q4-eps-0-46-0-49-vs-0-46-est-fy24-eps-2-25-2-28-vs-2-19-est", "tags": ["earnings"]}
{"id": 41919383, "time": "2024-11-12 16:14:48", "headline": "Azenta Sees FY25 3%-5% Organic Revenue Growth And 300 Basis Points Adjusted EBITDA Margin Expansion For Fiscal 2025, Excluding B Medical Systems", "summary": "", "symbols": ["AZTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919383/azenta-sees-fy25-3-5-organic-revenue-growth-and-300-basis-points-adjusted-ebitda-margin-expansion-fo", "tags": ["earnings"]}
{"id": 41919446, "time": "2024-11-12 16:15:21", "headline": "ZoomInfo Technologies Q3 2024 Adj. EPS $0.28 Beats $0.22 Estimate, Sales $303.600M Beat $299.384M Estimate", "summary": "", "symbols": ["ZI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919446/zoominfo-technologies-q3-2024-adj-eps-0-28-beats-0-22-estimate-sales-303-600m-beat-299-384m-estimat", "tags": ["earnings"]}
{"id": 41919454, "time": "2024-11-12 16:15:26", "headline": "The Beachbody Company, Inc. Class A Common Stock Q3 2024 GAAP EPS $(1.75), Inline, Sales $102.200M Miss $103.586M Estimate", "summary": "", "symbols": ["BODI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919454/the-beachbody-company-inc-class-a-common-stock-q3-2024-gaap-eps-1-75-inline-sales-102-200m-miss-103", "tags": ["earnings"]}
{"id": 41919457, "time": "2024-11-12 16:15:33", "headline": "OmniAb Q3 2024 GAAP EPS $(0.16) Misses $(0.14) Estimate, Sales $4.17M Miss $8.40M Estimate", "summary": "", "symbols": ["OABI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919457/omniab-q3-2024-gaap-eps-0-16-misses-0-14-estimate-sales-4-17m-miss-8-40m-estimate", "tags": ["earnings"]}
{"id": 41919471, "time": "2024-11-12 16:16:05", "headline": "Rackspace Tech Q3 2024 Adj. EPS $(0.04) Beats $(0.07) Estimate, Sales $676.000M Beat $675.140M Estimate", "summary": "", "symbols": ["RXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919471/rackspace-tech-q3-2024-adj-eps-0-04-beats-0-07-estimate-sales-676-000m-beat-675-140m-estimate", "tags": ["earnings"]}
{"id": 41919473, "time": "2024-11-12 16:16:06", "headline": "Rocket Lab USA Q3 2024 GAAP EPS $(0.10) Beats $(0.11) Estimate, Sales $104.81M Beat $102.28M Estimate", "summary": "", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919473/rocket-lab-usa-q3-2024-gaap-eps-0-10-beats-0-11-estimate-sales-104-81m-beat-102-28m-estimate", "tags": ["earnings"]}
{"id": 41919564, "time": "2024-11-12 16:16:34", "headline": "Rocket Companies Q3 2024 GAAP EPS $0.08, Inline, Sales $647.00M Miss $1.28B Estimate", "summary": "", "symbols": ["RKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919564/rocket-companies-q3-2024-gaap-eps-0-08-inline-sales-647-00m-miss-1-28b-estimate", "tags": ["earnings"]}
{"id": 41919575, "time": "2024-11-12 16:16:46", "headline": "Natera Sees FY24 Revenue $1.61B-$1.64B Vs $1.518B Est", "summary": "", "symbols": ["NTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919575/natera-sees-fy24-revenue-1-61b-1-64b-vs-1-518b-est", "tags": ["earnings"]}
{"id": 41919577, "time": "2024-11-12 16:16:50", "headline": "Occidental Petroleum Q3 2024 Adj. EPS $1.00 Beats $0.74 Estimate", "summary": "", "symbols": ["OXY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919577/occidental-petroleum-q3-2024-adj-eps-1-00-beats-0-74-estimate", "tags": ["earnings"]}
{"id": 41919578, "time": "2024-11-12 16:17:02", "headline": "American Healthcares Q3 Sales $523.814M Beat $485.377M Estimate", "summary": "", "symbols": ["AHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919578/american-healthcares-q3-sales-523-814m-beat-485-377m-estimate", "tags": []}
{"id": 41919580, "time": "2024-11-12 16:17:06", "headline": "Eton Pharmaceuticals Q3 2024 GAAP EPS $0.02 Beats $(0.01) Estimate, Sales $10.324M Beat $9.695M Estimate", "summary": "", "symbols": ["ETON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919580/eton-pharmaceuticals-q3-2024-gaap-eps-0-02-beats-0-01-estimate-sales-10-324m-beat-9-695m-estimate", "tags": ["earnings"]}
{"id": 41919602, "time": "2024-11-12 16:17:36", "headline": "Progyny Sees Q4 EPS $0.31-$0.35; Revenue $266.2M-$281.2M Vs $292.68M Est.; FY24 EPS $1.54-$1.57; Revenue $1.135B-$1.150B Vs $1.17B Est.", "summary": "", "symbols": ["PGNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919602/progyny-sees-q4-eps-0-31-0-35-revenue-266-2m-281-2m-vs-292-68m-est-fy24-eps-1-54-1-57-revenue-1-135b", "tags": ["earnings"]}
{"id": 41919623, "time": "2024-11-12 16:17:53", "headline": "Viant Technology Sees Q4 Sales $82.000M-85.000M vs $64.97M Est", "summary": "", "symbols": ["DSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919623/viant-technology-sees-q4-sales-82-000m-85-000m-vs-64-97m-est", "tags": []}
{"id": 41919624, "time": "2024-11-12 16:17:54", "headline": "Natera Sees FY24 SG&A $775M-$825M; R&D $375M-$400M' Net Cash Inflows $50M-$75M.", "summary": "", "symbols": ["NTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919624/natera-sees-fy24-sg-a-775m-825m-r-d-375m-400m-net-cash-inflows-50m-75m", "tags": []}
{"id": 41919628, "time": "2024-11-12 16:18:09", "headline": "Monroe Cap Q3 2024 Adj. EPS $0.31 Beats $0.27 Estimate, Sales $15.695M Beat $15.250M Estimate", "summary": "", "symbols": ["MRCC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919628/monroe-cap-q3-2024-adj-eps-0-31-beats-0-27-estimate-sales-15-695m-beat-15-250m-estimate", "tags": ["earnings"]}
{"id": 41919630, "time": "2024-11-12 16:18:12", "headline": "Rocket Lab USA Inks Multi-launch Agreement With A Confidential Commercial Satellite Constellation Operator For Its New Medium-lift Rocket Neutron", "summary": "", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919630/rocket-lab-usa-inks-multi-launch-agreement-with-a-confidential-commercial-satellite-constellation-op", "tags": ["contract"]}
{"id": 41919632, "time": "2024-11-12 16:18:17", "headline": "Paymentus Sees Q4 Revenue $215M-$220M vs $203.62M Est., Contribution Profit $79M-$81M, Adj. EBITDA $22M-$24M; FY24 Revenue $829M-$834M vs $776.58M Est., Contribution Profit $305M-$307M, Adj. EBITDA $89M-$91M", "summary": "", "symbols": ["PAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919632/paymentus-sees-q4-revenue-215m-220m-vs-203-62m-est-contribution-profit-79m-81m-adj-ebitda-22m-24m-fy", "tags": ["earnings"]}
{"id": 41919620, "time": "2024-11-12 16:18:22", "headline": "Fidelis Insurance Hldgs Q3 2024 GAAP EPS $0.88 Beats $0.73 Estimate, Sales $686.100M Beat $436.036M Estimate", "summary": "", "symbols": ["FIHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919620/fidelis-insurance-hldgs-q3-2024-gaap-eps-0-88-beats-0-73-estimate-sales-686-100m-beat-436-036m-esti", "tags": ["earnings"]}
{"id": 41919646, "time": "2024-11-12 16:18:44", "headline": "CAE Announced Its CEO Marc Parent Will Be Leaving His Role In August Of 2025.", "summary": "", "symbols": ["CAE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919646/cae-announced-its-ceo-marc-parent-will-be-leaving-his-role-in-august-of-2025", "tags": ["management"]}
{"id": 41919648, "time": "2024-11-12 16:18:45", "headline": "Spotify Technology Q3 2024 GAAP EPS $1.46 Misses $1.76 Estimate, Sales $3.99B Miss $4.02B Estimate", "summary": "", "symbols": ["SPOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919648/spotify-technology-q3-2024-gaap-eps-1-46-misses-1-76-estimate-sales-3-99b-miss-4-02b-estimate", "tags": ["earnings"]}
{"id": 41919655, "time": "2024-11-12 16:18:52", "headline": "Zoominfo Sees Q4 2024 Revenue $296M-$299M Vs $296.8M Estimate; Sees FY24 Revenue $1.201B-$1.204B Vs $1.198B Estimate", "summary": "", "symbols": ["ZI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919655/zoominfo-sees-q4-2024-revenue-296m-299m-vs-296-8m-estimate-sees-fy24-revenue-1-201b-1-204b-vs-1-198b", "tags": ["earnings"]}
{"id": 41919671, "time": "2024-11-12 16:18:59", "headline": "PubMatic Q3 2024 Adj. EPS $0.12 Beats $(0.06) Estimate, Sales $71.786M Beat $66.039M Estimate", "summary": "", "symbols": ["PUBM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919671/pubmatic-q3-2024-adj-eps-0-12-beats-0-06-estimate-sales-71-786m-beat-66-039m-estimate", "tags": ["earnings"]}
{"id": 41919711, "time": "2024-11-12 16:19:10", "headline": "Sky Harbour Group Q3 2024 GAAP EPS $(0.74) Misses $(0.05) Estimate, Sales $4.097M Beat $3.950M Estimate", "summary": "", "symbols": ["SKYH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919711/sky-harbour-group-q3-2024-gaap-eps-0-74-misses-0-05-estimate-sales-4-097m-beat-3-950m-estimate", "tags": ["earnings"]}
{"id": 41919713, "time": "2024-11-12 16:19:14", "headline": "ePlus Sees FY25 Net Sales Are Now Expected To Be Similar To Fiscal Year 2024; Adjusted EBITDA Range Is Now Expected To Be $195M-$205M", "summary": "", "symbols": ["PLUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919713/eplus-sees-fy25-net-sales-are-now-expected-to-be-similar-to-fiscal-year-2024-adjusted-ebitda-range-i", "tags": []}
{"id": 41919714, "time": "2024-11-12 16:19:25", "headline": "Xtant Medical Hldgs Q3 2024 GAAP EPS $(0.04) Misses $(0.03) Estimate, Sales $27.937M Miss $29.300M Estimate", "summary": "", "symbols": ["XTNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919714/xtant-medical-hldgs-q3-2024-gaap-eps-0-04-misses-0-03-estimate-sales-27-937m-miss-29-300m-estimate", "tags": ["earnings"]}
{"id": 41919715, "time": "2024-11-12 16:19:28", "headline": "Silvaco Sees FY24 Revenue $60M-$67M Vs $61.508M Est; Q4 Revenue $18.1M-$21.2M.", "summary": "", "symbols": ["SVCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919715/silvaco-sees-fy24-revenue-60m-67m-vs-61-508m-est-q4-revenue-18-1m-21-2m", "tags": ["earnings"]}
{"id": 41919716, "time": "2024-11-12 16:19:31", "headline": "Alliance Entertainment Q1 EPS $0.01 Up From $(0.07) YoY, Sales $228.99M Up From $226.75M YoY", "summary": "", "symbols": ["AENT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919716/alliance-entertainment-q1-eps-0-01-up-from-0-07-yoy-sales-228-99m-up-from-226-75m-yoy", "tags": ["earnings"]}
{"id": 41919717, "time": "2024-11-12 16:19:33", "headline": "Occidental Petroleum Q3 Sales $7.154B Miss $7.232B Estimate", "summary": "", "symbols": ["OXY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919717/occidental-petroleum-q3-sales-7-154b-miss-7-232b-estimate", "tags": []}
{"id": 41919730, "time": "2024-11-12 16:19:56", "headline": "Corvus Pharma Q3 2024 GAAP EPS $(0.60) Misses $(0.11) Estimate", "summary": "", "symbols": ["CRVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919730/corvus-pharma-q3-2024-gaap-eps-0-60-misses-0-11-estimate", "tags": ["earnings"]}
{"id": 41919733, "time": "2024-11-12 16:19:58", "headline": "Paragon 28 Q3 2024 GAAP EPS $(0.15), Inline, Sales $62.30M Beat $60.58M Estimate", "summary": "", "symbols": ["FNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919733/paragon-28-q3-2024-gaap-eps-0-15-inline-sales-62-30m-beat-60-58m-estimate", "tags": ["earnings"]}
{"id": 41919744, "time": "2024-11-12 16:20:06", "headline": "EverCommerce Sees Q4 Revenue $168M-$172M", "summary": "", "symbols": ["EVCM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919744/evercommerce-sees-q4-revenue-168m-172m", "tags": ["earnings"]}
{"id": 41919759, "time": "2024-11-12 16:20:24", "headline": "Silvaco Sees FY24 Gross Bookings $18.5M-$21.5M. Non-GAAP Operating Income $2.6M-$5.6M.", "summary": "", "symbols": ["SVCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919759/silvaco-sees-fy24-gross-bookings-18-5m-21-5m-non-gaap-operating-income-2-6m-5-6m", "tags": []}
{"id": 41919760, "time": "2024-11-12 16:20:27", "headline": "American Public Education Q3 2024 Adj. EPS $0.04 Beats $0.03 Estimate, Sales $153.100M Miss $153.775M Estimate", "summary": "", "symbols": ["APEI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919760/american-public-education-q3-2024-adj-eps-0-04-beats-0-03-estimate-sales-153-100m-miss-153-775m-est", "tags": ["earnings"]}
{"id": 41919761, "time": "2024-11-12 16:20:37", "headline": "DHT Holdings Q3 2024 GAAP EPS $0.22 Beats $0.19 Estimate, Adj Sales $92.64M Miss $94.19M Estimate", "summary": "", "symbols": ["DHT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919761/dht-holdings-q3-2024-gaap-eps-0-22-beats-0-19-estimate-adj-sales-92-64m-miss-94-19m-estimate", "tags": ["earnings"]}
{"id": 41919762, "time": "2024-11-12 16:20:38", "headline": "P3 Health Partners Q3 2024 GAAP EPS $(0.31) Misses $(0.04) Estimate, Sales $362.124M Miss $364.449M Estimate", "summary": "", "symbols": ["PIII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919762/p3-health-partners-q3-2024-gaap-eps-0-31-misses-0-04-estimate-sales-362-124m-miss-364-449m-estimate", "tags": ["earnings"]}
{"id": 41919763, "time": "2024-11-12 16:20:44", "headline": "VirTra Q3 2024 GAAP EPS $0.05 Beats $0.01 Estimate, Sales $7.484M Beat $6.503M Estimate", "summary": "", "symbols": ["VTSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919763/virtra-q3-2024-gaap-eps-0-05-beats-0-01-estimate-sales-7-484m-beat-6-503m-estimate", "tags": ["earnings"]}
{"id": 41919766, "time": "2024-11-12 16:20:52", "headline": "CeriBell Q3 EPS $(1.85) Down From $(1.32) YoY, Sales $17.20M Up From $11.61M YoY", "summary": "", "symbols": ["CBLL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919766/ceribell-q3-eps-1-85-down-from-1-32-yoy-sales-17-20m-up-from-11-61m-yoy", "tags": ["earnings"]}
{"id": 41919769, "time": "2024-11-12 16:20:54", "headline": "Organogenesis Hldgs Raises FY2024 Sales Guidance from $445.00M-470.00M to $445.00M-480.00M", "summary": "", "symbols": ["ORGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919769/organogenesis-hldgs-raises-fy2024-sales-guidance-from-445-00m-470-00m-to-445-00m-480-00m", "tags": ["guidance"]}
{"id": 41919791, "time": "2024-11-12 16:21:16", "headline": "Paragon 28, Sees FY24 Net Revenue $252M-$256M Vs $251.67M Est.", "summary": "", "symbols": ["FNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919791/paragon-28-sees-fy24-net-revenue-252m-256m-vs-251-67m-est", "tags": ["earnings"]}
{"id": 41919916, "time": "2024-11-12 16:21:44", "headline": "American Public Education Sees FY24 Revenue $620M-$625M Vs $622.52M Estimate", "summary": "", "symbols": ["APEI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919916/american-public-education-sees-fy24-revenue-620m-625m-vs-622-52m-estimate", "tags": ["earnings"]}
{"id": 41919948, "time": "2024-11-12 16:21:46", "headline": "Ascent Industries Q3 2024 GAAP EPS $(0.69), Sales $42.901M Miss $56.100M Estimate", "summary": "", "symbols": ["ACNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919948/ascent-industries-q3-2024-gaap-eps-0-69-sales-42-901m-miss-56-100m-estimate", "tags": ["earnings"]}
{"id": 41919949, "time": "2024-11-12 16:21:46", "headline": "Rocket Lab Says Awarded A Federal Defense Contract With Value Up To $8M By US Air Force Research Laboratory", "summary": "", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919949/rocket-lab-says-awarded-a-federal-defense-contract-with-value-up-to-8m-by-us-air-force-research-labo", "tags": ["contract"]}
{"id": 41919982, "time": "2024-11-12 16:21:49", "headline": "Alta Equipment Group Q3 2024 Adj. EPS $(0.72) Misses $(0.24) Estimate, Sales $448.800M Miss $479.875M Estimate", "summary": "", "symbols": ["ALTG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41919982/alta-equipment-group-q3-2024-adj-eps-0-72-misses-0-24-estimate-sales-448-800m-miss-479-875m-estimat", "tags": ["earnings"]}
{"id": 41919799, "time": "2024-11-12 16:22:00", "headline": "Enveric Biosciences Canada Granted U.S. Patent #12138276:  Halogenated psilocybin derivatives and methods of using", "summary": "", "symbols": ["ENVB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41919799/enveric-biosciences-canada-granted-u-s-patent-12138276-halogenated-psilocybin-derivatives-and-method", "tags": []}
{"id": 41920040, "time": "2024-11-12 16:22:28", "headline": "Alta Equipment Sees FY24 Adj. EBITDA $170M-$175M", "summary": "", "symbols": ["ALTG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920040/alta-equipment-sees-fy24-adj-ebitda-170m-175m", "tags": []}
{"id": 41920050, "time": "2024-11-12 16:22:42", "headline": "Theravance Biopharma Q3 2024 Adj. EPS $(0.26) Misses $(0.23) Estimate, Sales $16.900M Beat $15.344M Estimate", "summary": "", "symbols": ["TBPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920050/theravance-biopharma-q3-2024-adj-eps-0-26-misses-0-23-estimate-sales-16-900m-beat-15-344m-estimate", "tags": ["earnings"]}
{"id": 41920059, "time": "2024-11-12 16:22:51", "headline": "Rocket Lab Schedules The Next Electron Launch For Kin\u00e9is, A Global IoT Connectivity Provider", "summary": "", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920059/rocket-lab-schedules-the-next-electron-launch-for-kin-is-a-global-iot-connectivity-provider", "tags": []}
{"id": 41920065, "time": "2024-11-12 16:22:57", "headline": "Similarweb Sees Q4 Revenue $64.7M-$65.7M", "summary": "", "symbols": ["SMWB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920065/similarweb-sees-q4-revenue-64-7m-65-7m", "tags": ["earnings"]}
{"id": 41920067, "time": "2024-11-12 16:22:59", "headline": "ENGlobal Q3 EPS $(0.10) Up From $(0.14) YoY, Sales $5.68M Down From $9.45M YoY", "summary": "", "symbols": ["ENG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920067/englobal-q3-eps-0-10-up-from-0-14-yoy-sales-5-68m-down-from-9-45m-yoy", "tags": ["earnings"]}
{"id": 41920072, "time": "2024-11-12 16:23:02", "headline": "Arcadia Biosciences Q3 2024 GAAP EPS $(1.18) Misses $(0.81) Estimate, Sales $1.537M Beat $1.399M Estimate", "summary": "", "symbols": ["RKDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920072/arcadia-biosciences-q3-2024-gaap-eps-1-18-misses-0-81-estimate-sales-1-537m-beat-1-399m-estimate", "tags": ["earnings"]}
{"id": 41920076, "time": "2024-11-12 16:23:08", "headline": "Similarweb Sees FY24 Revenue $249M-$250M Vs $247.376M Est.", "summary": "", "symbols": ["SMWB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920076/similarweb-sees-fy24-revenue-249m-250m-vs-247-376m-est", "tags": ["earnings"]}
{"id": 41920127, "time": "2024-11-12 16:23:59", "headline": "Topgolf Callaway Brands Q3 2024 Adj. EPS $0.02 May Not Compare To $(0.16) Estimate, Sales $1.013B Beat $983.026M Estimate", "summary": "", "symbols": ["MODG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920127/topgolf-callaway-brands-q3-2024-adj-eps-0-02-may-not-compare-to-0-16-estimate-sales-1-013b-beat-983", "tags": ["earnings"]}
{"id": 41920128, "time": "2024-11-12 16:24:00", "headline": "Theravance Biopharma Sees FY24 R&D Expense $30M-$36M; Share-Based Compensation $18M-$22M; SG&A $45M-$55M.", "summary": "", "symbols": ["TBPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920128/theravance-biopharma-sees-fy24-r-d-expense-30m-36m-share-based-compensation-18m-22m-sg-a-45m-55m", "tags": []}
{"id": 41920129, "time": "2024-11-12 16:24:05", "headline": "LogicMark Q3 2024 GAAP EPS $(0.20) Beats $(0.43) Estimate, Sales $2.705M Beat $2.438M Estimate", "summary": "", "symbols": ["LGMK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920129/logicmark-q3-2024-gaap-eps-0-20-beats-0-43-estimate-sales-2-705m-beat-2-438m-estimate", "tags": ["earnings"]}
{"id": 41920133, "time": "2024-11-12 16:24:14", "headline": "Core Molding Technologies Announces The Planned Transition And Departure Of John Zimmer, CFO, Effective May 31, 2025. Mr. Zimmer's CFO Role Will Transition To Alex J. Panda, Effective June 1, 2025", "summary": "", "symbols": ["CMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920133/core-molding-technologies-announces-the-planned-transition-and-departure-of-john-zimmer-cfo-effectiv", "tags": ["management"]}
{"id": 41920141, "time": "2024-11-12 16:24:32", "headline": "BioLife Solutions Sees FY24 Revenue $98M-$100M Vs $110.575M Est.", "summary": "", "symbols": ["BLFS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920141/biolife-solutions-sees-fy24-revenue-98m-100m-vs-110-575m-est", "tags": ["earnings"]}
{"id": 41920145, "time": "2024-11-12 16:24:36", "headline": "Integral Ad Science Q3 2024 GAAP EPS $0.10 Beats $0.07 Estimate, Sales $133.500M Miss $138.110M Estimate", "summary": "", "symbols": ["IAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920145/integral-ad-science-q3-2024-gaap-eps-0-10-beats-0-07-estimate-sales-133-500m-miss-138-110m-estimate", "tags": ["earnings"]}
{"id": 41920154, "time": "2024-11-12 16:24:47", "headline": "NeuroPace Raises FY2024 Sales Guidance from $76.00M-78.00M to $78.00M-80.00M", "summary": "", "symbols": ["NPCE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920154/neuropace-raises-fy2024-sales-guidance-from-76-00m-78-00m-to-78-00m-80-00m", "tags": ["guidance"]}
{"id": 41920163, "time": "2024-11-12 16:24:57", "headline": "HealthEquity Announces Retirement of CEO Jon Kessler; Scott Cutler Appointed Successor, Effective January 6, 2025", "summary": "", "symbols": ["HQY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920163/healthequity-announces-retirement-of-ceo-jon-kessler-scott-cutler-appointed-successor-effective-janu", "tags": ["management"]}
{"id": 41920165, "time": "2024-11-12 16:24:57", "headline": "TeraWulf Q3 2024 GAAP EPS $(0.06) Misses $(0.03) Estimate, Sales $27.059M Miss $34.276M Estimate", "summary": "", "symbols": ["WULF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920165/terawulf-q3-2024-gaap-eps-0-06-misses-0-03-estimate-sales-27-059m-miss-34-276m-estimate", "tags": ["earnings"]}
{"id": 41920169, "time": "2024-11-12 16:25:00", "headline": "StoneCo Q3 2024 Revenue R$3.36B; EPS R$1.97", "summary": "", "symbols": ["STNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920169/stoneco-q3-2024-revenue-r-3-36b-eps-r-1-97", "tags": ["earnings"]}
{"id": 41920174, "time": "2024-11-12 16:25:04", "headline": "Rocket Lab Sees Q4 Revenue Of $125M - $135M, Adjusted EBITDA Of $(27)M - $(29)M, GAAP Gross Margins Of 26% - 28%.", "summary": "", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920174/rocket-lab-sees-q4-revenue-of-125m-135m-adjusted-ebitda-of-27-m-29-m-gaap-gross-margins-of-26-28", "tags": ["earnings"]}
{"id": 41920204, "time": "2024-11-12 16:25:18", "headline": "Radiant Logistics Q1 2025 Adj. EPS $0.17 Beats $0.14 Estimate, Sales $203.600M Miss $215.020M Estimate", "summary": "", "symbols": ["RLGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920204/radiant-logistics-q1-2025-adj-eps-0-17-beats-0-14-estimate-sales-203-600m-miss-215-020m-estimate", "tags": ["earnings"]}
{"id": 41920226, "time": "2024-11-12 16:25:36", "headline": "Trading Halt: Halted at 4:25:32 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["SYRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41920226/trading-halt-halted-at-4-25-32-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 41920227, "time": "2024-11-12 16:25:37", "headline": "Insteel Industries Declares A Special Cash Dividend Of $1.00 Per Share Of Common Stock Payable On December 13, 2024, To Shareholders Of Record As Of November 29, 2024", "summary": "", "symbols": ["IIIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920227/insteel-industries-declares-a-special-cash-dividend-of-1-00-per-share-of-common-stock-payable-on-dec", "tags": ["dividend"]}
{"id": 41920230, "time": "2024-11-12 16:25:39", "headline": "SoundThinking Sees FY24 Revenue $104.0M-$106.0M Vs $105.279M Est.", "summary": "", "symbols": ["SSTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920230/soundthinking-sees-fy24-revenue-104-0m-106-0m-vs-105-279m-est", "tags": ["earnings"]}
{"id": 41920233, "time": "2024-11-12 16:25:40", "headline": "Intrusion Q3 2024 GAAP EPS $(0.35) Beats $(0.42) Estimate, Sales $1.504M Miss $1.575M Estimate", "summary": "", "symbols": ["INTZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920233/intrusion-q3-2024-gaap-eps-0-35-beats-0-42-estimate-sales-1-504m-miss-1-575m-estimate", "tags": ["earnings"]}
{"id": 41920234, "time": "2024-11-12 16:25:40", "headline": "Synchronoss Technologies Q3 Adj $(0.26) Misses $0.32 Estimate, Sales $42.96M Miss $43.28M Estimate", "summary": "", "symbols": ["SNCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920234/synchronoss-technologies-q3-adj-0-26-misses-0-32-estimate-sales-42-96m-miss-43-28m-estimate", "tags": []}
{"id": 41920276, "time": "2024-11-12 16:26:17", "headline": "Rocket Lab Expects To Close Out The Year Strongly With More Electron Launches Scheduled In November And December, Alongside Continued Progress Across Neutron And Space Systems", "summary": "", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920276/rocket-lab-expects-to-close-out-the-year-strongly-with-more-electron-launches-scheduled-in-november", "tags": []}
{"id": 41920277, "time": "2024-11-12 16:26:17", "headline": "Viant Technology Q3 2024 Adj. EPS $0.15 Beats $0.05 Estimate, Sales $79.922M Beat $64.966M Estimate", "summary": "", "symbols": ["DSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920277/viant-technology-q3-2024-adj-eps-0-15-beats-0-05-estimate-sales-79-922m-beat-64-966m-estimate", "tags": ["earnings"]}
{"id": 41920279, "time": "2024-11-12 16:26:17", "headline": "Topgolf Callaway Sees FY24 Revenue ~$4.2B Vs $4.21B Estimate", "summary": "", "symbols": ["MODG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920279/topgolf-callaway-sees-fy24-revenue-4-2b-vs-4-21b-estimate", "tags": ["earnings"]}
{"id": 41920300, "time": "2024-11-12 16:26:35", "headline": "Marinus Pharma Q3 EPS $(0.42) Misses $(0.41) Estimate, Sales $8.54M Miss $9.42M Estimate", "summary": "", "symbols": ["MRNS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920300/marinus-pharma-q3-eps-0-42-misses-0-41-estimate-sales-8-54m-miss-9-42m-estimate", "tags": ["earnings"]}
{"id": 41920327, "time": "2024-11-12 16:26:54", "headline": "IAS Sees Q4 Total Revenue $148M-$150M, Adj. EBITDA $55M-$57M; FY24 Total Revenue $525M-$527M, Adj. EBITDA $185M-$187M", "summary": "", "symbols": ["IAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920327/ias-sees-q4-total-revenue-148m-150m-adj-ebitda-55m-57m-fy24-total-revenue-525m-527m-adj-ebitda-185m", "tags": ["earnings"]}
{"id": 41920337, "time": "2024-11-12 16:26:59", "headline": "GEN Restaurant Gr Q3 2024 GAAP EPS $0.01 Beats $(0.01) Estimate, Sales $49.100M Miss $49.838M Estimate", "summary": "", "symbols": ["GENK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920337/gen-restaurant-gr-q3-2024-gaap-eps-0-01-beats-0-01-estimate-sales-49-100m-miss-49-838m-estimate", "tags": ["earnings"]}
{"id": 41920350, "time": "2024-11-12 16:27:10", "headline": "Fractyl Health Q3 2024 GAAP EPS $(0.48), Sales $14.000K Down From $36.000K YoY", "summary": "", "symbols": ["GUTS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920350/fractyl-health-q3-2024-gaap-eps-0-48-sales-14-000k-down-from-36-000k-yoy", "tags": ["earnings"]}
{"id": 41920357, "time": "2024-11-12 16:27:20", "headline": "FiscalNote Announces Tim Hwang To Transition To Executive Chairman And Josh Resnik, Current President & COO, To Become Chief Executive Officer Effective January 1, 2025", "summary": "", "symbols": ["NOTE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920357/fiscalnote-announces-tim-hwang-to-transition-to-executive-chairman-and-josh-resnik-current-president", "tags": []}
{"id": 41920360, "time": "2024-11-12 16:27:24", "headline": "Repay Hldgs Q3 2024 GAAP EPS $0.23, Inline, Sales $79.14M Beat $79.11M Estimate", "summary": "", "symbols": ["RPAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920360/repay-hldgs-q3-2024-gaap-eps-0-23-inline-sales-79-14m-beat-79-11m-estimate", "tags": ["earnings"]}
{"id": 41920405, "time": "2024-11-12 16:28:10", "headline": "Prime Medicine Q3 EPS $(0.44) Misses $(0.39) Estimate, Sales $209.00K", "summary": "", "symbols": ["PRME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920405/prime-medicine-q3-eps-0-44-misses-0-39-estimate-sales-209-00k", "tags": ["earnings"]}
{"id": 41920424, "time": "2024-11-12 16:28:27", "headline": "SoundHound AI Q3 2024 GAAP EPS $(0.06) Beats $(0.07) Estimate, Sales $25.100M Beat $23.020M Estimate", "summary": "", "symbols": ["SOUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920424/soundhound-ai-q3-2024-gaap-eps-0-06-beats-0-07-estimate-sales-25-100m-beat-23-020m-estimate", "tags": ["earnings"]}
{"id": 41920427, "time": "2024-11-12 16:28:31", "headline": "Marathon Digital Holdings Q3 2024 Adj EPS $(0.34) Misses $(0.26) Estimate, Sales $131.60M Miss $151.67M Estimate", "summary": "", "symbols": ["MARA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920427/marathon-digital-holdings-q3-2024-adj-eps-0-34-misses-0-26-estimate-sales-131-60m-miss-151-67m-esti", "tags": ["earnings"]}
{"id": 41920429, "time": "2024-11-12 16:28:35", "headline": "Repay Sees FY24 Revenue $314M-$320M Vs $317.39M Est.", "summary": "", "symbols": ["RPAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920429/repay-sees-fy24-revenue-314m-320m-vs-317-39m-est", "tags": ["earnings"]}
{"id": 41920394, "time": "2024-11-12 16:28:00", "headline": "CAE Q2 2025 Adj. EPS C$0.24 Beats C$0.19 Estimate, Sales C$1.137B Beat C$1.090B Estimate", "summary": "", "symbols": ["CAE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920394/cae-q2-2025-adj-eps-0-24-beats-0-19-estimate-sales-1-137b-beat-1-090b-estimate", "tags": ["earnings"]}
{"id": 41920434, "time": "2024-11-12 16:28:43", "headline": "eGain Q1 2025 Adj. EPS $0.04 Beats $0.01 Estimate, Sales $21.799M Beat $21.680M Estimate", "summary": "", "symbols": ["EGAN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920434/egain-q1-2025-adj-eps-0-04-beats-0-01-estimate-sales-21-799m-beat-21-680m-estimate", "tags": ["earnings"]}
{"id": 41920417, "time": "2024-11-12 16:28:53", "headline": "Rackspace Technology Sees Q4 Adj. EPS $(0.03)-$(0.05) Vs $(0.07) Est.; Revenue $668M-$680M Vs $675.140M Est.", "summary": "", "symbols": ["RXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920417/rackspace-technology-sees-q4-adj-eps-0-03-0-05-vs-0-07-est-revenue-668m-680m-vs-675-140m-est", "tags": ["earnings"]}
{"id": 41920439, "time": "2024-11-12 16:28:57", "headline": "Dyadic International Q3 2024 GAAP EPS $(0.01) Beats $(0.07) Estimate, Sales $1.958M Beat $1.100M Estimate", "summary": "", "symbols": ["DYAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920439/dyadic-international-q3-2024-gaap-eps-0-01-beats-0-07-estimate-sales-1-958m-beat-1-100m-estimate", "tags": ["earnings"]}
{"id": 41920455, "time": "2024-11-12 16:29:12", "headline": "Vodafone Italy Extends And Expands Relationship With Amdocs To Modernize And Migrate Its Systems To The Cloud, Improving Operational Efficiency And Empowering New Innovative Services", "summary": "", "symbols": ["DOX", "VOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920455/vodafone-italy-extends-and-expands-relationship-with-amdocs-to-modernize-and-migrate-its-systems-to", "tags": []}
{"id": 41920466, "time": "2024-11-12 16:29:18", "headline": "NCR Atleos Q3 2024 Adj EPS $0.89 Beats $0.79 Estimate, Sales $1.08B Beat $1.06B Estimate", "summary": "", "symbols": ["NATL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920466/ncr-atleos-q3-2024-adj-eps-0-89-beats-0-79-estimate-sales-1-08b-beat-1-06b-estimate", "tags": ["earnings"]}
{"id": 41920482, "time": "2024-11-12 16:29:25", "headline": "Organogenesis Hldgs Q3 2024 Adj. EPS $0.10 Beats $(0.01) Estimate, Sales $115.177M Beat $108.833M Estimate", "summary": "", "symbols": ["ORGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920482/organogenesis-hldgs-q3-2024-adj-eps-0-10-beats-0-01-estimate-sales-115-177m-beat-108-833m-estimate", "tags": ["earnings"]}
{"id": 41920496, "time": "2024-11-12 16:29:43", "headline": "SenesTech Q3 EPS $(2.07) Up From $(55.93) YoY, Sales $482.00K Miss $580.00K Estimate", "summary": "", "symbols": ["SNES"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920496/senestech-q3-eps-2-07-up-from-55-93-yoy-sales-482-00k-miss-580-00k-estimate", "tags": ["earnings"]}
{"id": 41920510, "time": "2024-11-12 16:29:59", "headline": "Comscore Tightens Full-year 2024 Revenue Outlook From $350M - $360M To $351M - $355M (Est $353.07M), And Reaffirms Guidance For Adjusted EBITDA Margin Of At Least 10%", "summary": "", "symbols": ["SCOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920510/comscore-tightens-full-year-2024-revenue-outlook-from-350m-360m-to-351m-355m-est-353-07m-and-reaffir", "tags": ["earnings", "guidance"]}
{"id": 41920544, "time": "2024-11-12 16:30:17", "headline": "Oportun Financial Q3 2024 Adj. EPS $0.02 Misses $0.04 Estimate, Sales $250.000M Beat $249.579M Estimate", "summary": "", "symbols": ["OPRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920544/oportun-financial-q3-2024-adj-eps-0-02-misses-0-04-estimate-sales-250-000m-beat-249-579m-estimate", "tags": ["earnings"]}
{"id": 41920568, "time": "2024-11-12 16:30:29", "headline": "Dawson Geophysical Q3 EPS $(0.18) Up From $(0.20) YoY, Sales $14.42M Down From $22.96M YoY", "summary": "", "symbols": ["DWSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920568/dawson-geophysical-q3-eps-0-18-up-from-0-20-yoy-sales-14-42m-down-from-22-96m-yoy", "tags": ["earnings"]}
{"id": 41920573, "time": "2024-11-12 16:30:33", "headline": "Ambac Financial Group Q3 2024 Adj. EPS $(0.46) Misses $0.08 Estimate, Sales $114.000M Beat $75.880M Estimate", "summary": "", "symbols": ["AMBC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920573/ambac-financial-group-q3-2024-adj-eps-0-46-misses-0-08-estimate-sales-114-000m-beat-75-880m-estimat", "tags": ["earnings"]}
{"id": 41920574, "time": "2024-11-12 16:30:33", "headline": "FibroGen Q3 2024 GAAP EPS $(0.17) Beats $(0.38) Estimate, Sales $46.333M Beat $34.763M Estimate", "summary": "", "symbols": ["FGEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920574/fibrogen-q3-2024-gaap-eps-0-17-beats-0-38-estimate-sales-46-333m-beat-34-763m-estimate", "tags": ["earnings"]}
{"id": 41920576, "time": "2024-11-12 16:30:34", "headline": "Trading Halt: Halt status updated at 4:30:00 PM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["VRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41920576/trading-halt-halt-status-updated-at-4-30-00-pm-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 41920605, "time": "2024-11-12 16:31:00", "headline": "NCR Atleos Sees FY24 Revenue $4.3M-$4.34M Vs $4.305M Est; Adj EPS $3.12-$3.20 Vs $3.09 Est.", "summary": "", "symbols": ["NATL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920605/ncr-atleos-sees-fy24-revenue-4-3m-4-34m-vs-4-305m-est-adj-eps-3-12-3-20-vs-3-09-est", "tags": ["earnings"]}
{"id": 41920634, "time": "2024-11-12 16:31:08", "headline": "NeuroPace Q3 2024 GAAP EPS $(0.19) Beats $(0.29) Estimate, Sales $21.060M Beat $19.079M Estimate", "summary": "", "symbols": ["NPCE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920634/neuropace-q3-2024-gaap-eps-0-19-beats-0-29-estimate-sales-21-060m-beat-19-079m-estimate", "tags": ["earnings"]}
{"id": 41920639, "time": "2024-11-12 16:31:14", "headline": "FiscalNote Holdings Sees Q4 Sales $29.000M vs $30.59M Est", "summary": "", "symbols": ["NOTE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920639/fiscalnote-holdings-sees-q4-sales-29-000m-vs-30-59m-est", "tags": []}
{"id": 41920640, "time": "2024-11-12 16:31:15", "headline": "FibroGen Reiterates Full Year Net Product Revenue Guidance Of $135M-$150M", "summary": "", "symbols": ["FGEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920640/fibrogen-reiterates-full-year-net-product-revenue-guidance-of-135m-150m", "tags": ["analyst_other", "earnings", "guidance"]}
{"id": 41920643, "time": "2024-11-12 16:31:17", "headline": "PubMatic Sees Q4 Revenue $86M-$90M", "summary": "", "symbols": ["PUBM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920643/pubmatic-sees-q4-revenue-86m-90m", "tags": ["earnings"]}
{"id": 41920647, "time": "2024-11-12 16:31:19", "headline": "V2X  Announces Proposed Secondary Offering Of 2.5M Shares Of Common Stock  By A Certain Selling Stockholder", "summary": "", "symbols": ["VVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920647/v2x-announces-proposed-secondary-offering-of-2-5m-shares-of-common-stock-by-a-certain-selling-stockh", "tags": ["offering"]}
{"id": 41920660, "time": "2024-11-12 16:31:29", "headline": "PubMatic Sees FY24 Revenue $292M-$296M Vs $289.952M Est.", "summary": "", "symbols": ["PUBM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920660/pubmatic-sees-fy24-revenue-292m-296m-vs-289-952m-est", "tags": ["earnings"]}
{"id": 41920676, "time": "2024-11-12 16:31:43", "headline": "Campbell Soup Enters Agreement To Sell Noosa Yoghurt Business To Lakeview Farms; Terms Not Disclosed", "summary": "", "symbols": ["CPB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920676/campbell-soup-enters-agreement-to-sell-noosa-yoghurt-business-to-lakeview-farms-terms-not-disclosed", "tags": ["contract"]}
{"id": 41920683, "time": "2024-11-12 16:31:48", "headline": "Better Choice Co Q3 EPS $0.73 Up From $(2.30) YoY, Sales $11.37M Down From $13.12M YoY", "summary": "", "symbols": ["BTTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920683/better-choice-co-q3-eps-0-73-up-from-2-30-yoy-sales-11-37m-down-from-13-12m-yoy", "tags": ["earnings"]}
{"id": 41920689, "time": "2024-11-12 16:32:31", "headline": "Urgently Q3 2024 GAAP EPS $(0.79) Misses $(0.68) Estimate, Sales $36.246M Miss $36.400M Estimate", "summary": "", "symbols": ["ULY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920689/urgently-q3-2024-gaap-eps-0-79-misses-0-68-estimate-sales-36-246m-miss-36-400m-estimate", "tags": ["earnings"]}
{"id": 41920691, "time": "2024-11-12 16:32:31", "headline": "FiscalNote Holdings Lowers FY2024 Sales Guidance from $121.00M to $120.00M", "summary": "", "symbols": ["NOTE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920691/fiscalnote-holdings-lowers-fy2024-sales-guidance-from-121-00m-to-120-00m", "tags": ["guidance"]}
{"id": 41920725, "time": "2024-11-12 16:32:31", "headline": "Altus Power Q3 EPS $0.11 Beats $0.03 Estimate, Sales $58.68M Beat $57.98M Estimate", "summary": "", "symbols": ["AMPS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920725/altus-power-q3-eps-0-11-beats-0-03-estimate-sales-58-68m-beat-57-98m-estimate", "tags": ["earnings"]}
{"id": 41920742, "time": "2024-11-12 16:32:31", "headline": "Montauk Renewables Q3 2024 GAAP EPS $0.12 Beats $0.09 Estimate, Sales $65.917M Beat $61.083M Estimate", "summary": "", "symbols": ["MNTK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920742/montauk-renewables-q3-2024-gaap-eps-0-12-beats-0-09-estimate-sales-65-917m-beat-61-083m-estimate", "tags": ["earnings"]}
{"id": 41920748, "time": "2024-11-12 16:32:31", "headline": "CORRECTION: Organogenesis Hldgs Raises FY2024 Sales Guidance From $445.00M-$470.00M to $455.00M-$480.00M", "summary": "", "symbols": ["ORGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920748/correction-organogenesis-hldgs-raises-fy2024-sales-guidance-from-445-00m-470-00m-to-455-00m-480-00m", "tags": ["guidance"]}
{"id": 41920749, "time": "2024-11-12 16:32:40", "headline": "EU Will Supply Ukraine With Medical Marijuana But Industry Slow To Launch, Says Official", "summary": " ", "symbols": [], "source": "benzinga", "author": "Nina Zdinjak", "url": "https://www.benzinga.com/markets/cannabis/24/11/41920749/eu-will-supply-ukraine-with-medical-marijuana-but-industry-slow-to-launch-says-official", "tags": []}
{"id": 41920779, "time": "2024-11-12 16:33:45", "headline": "Altus Power Reaffirms Its Previously Stated Revenue Guidance Range Of $196M-201M  Vs $198.27M Est. And $111M-115M Of Adjusted EBITDA", "summary": "", "symbols": ["AMPS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920779/altus-power-reaffirms-its-previously-stated-revenue-guidance-range-of-196m-201m-vs-198-27m-est-and-1", "tags": ["earnings", "guidance"]}
{"id": 41920781, "time": "2024-11-12 16:33:45", "headline": "Kodak Q3 2024 Revenue $261M Vs $269M YoY; EPS $0.15", "summary": "", "symbols": ["KODK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920781/kodak-q3-2024-revenue-261m-vs-269m-yoy-eps-0-15", "tags": ["earnings"]}
{"id": 41920770, "time": "2024-11-12 16:34:16", "headline": "Pixelworks Q3 2024 Adj. EPS $(0.12) Beats $(0.13) Estimate, Sales $9.527M Beat $9.500M Estimate", "summary": "", "symbols": ["PXLW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920770/pixelworks-q3-2024-adj-eps-0-12-beats-0-13-estimate-sales-9-527m-beat-9-500m-estimate", "tags": ["earnings"]}
{"id": 41920791, "time": "2024-11-12 16:34:36", "headline": "Bitcoin Is Now Larger Than Walmart, Netflix, Coca-Cola, Pepsi And McDonald's Combined", "summary": "Leading cryptocurrency Bitcoin (CRYPTO: BTC) is smashing through new all-time highs following the 2024 presidential election and is now valued significantly higher than many publicly traded ", "symbols": ["BTCUSD", "KO", "MCD", "META", "NFLX", "PEP", "WMT"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/education/24/11/41920791/bitcoin-is-now-larger-than-walmart-netflix-coca-cola-pepsi-and-mcdonalds-combined", "tags": []}
{"id": 41920784, "time": "2024-11-12 16:34:45", "headline": "Ryonier Advanced Material Raises \u20ac67M In Green Capital To Invest In Biomaterials Strategy", "summary": "", "symbols": ["RYAM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920784/ryonier-advanced-material-raises-67m-in-green-capital-to-invest-in-biomaterials-strategy", "tags": []}
{"id": 41920789, "time": "2024-11-12 16:34:45", "headline": "Longeveron Q3 2024 GAAP EPS $(0.34) Beats $(0.44) Estimate, Sales $773.000K Beat $397.000K Estimate", "summary": "", "symbols": ["LGVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920789/longeveron-q3-2024-gaap-eps-0-34-beats-0-44-estimate-sales-773-000k-beat-397-000k-estimate", "tags": ["earnings"]}
{"id": 41920790, "time": "2024-11-12 16:34:56", "headline": "Montauk Renewables Sees FY24 RNG Revenue $175M-$185M; Renewable Electricity Revenue $17M-$18M.", "summary": "", "symbols": ["MNTK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920790/montauk-renewables-sees-fy24-rng-revenue-175m-185m-renewable-electricity-revenue-17m-18m", "tags": ["earnings"]}
{"id": 41920782, "time": "2024-11-12 16:35:16", "headline": "Maplebear Q3 2024 GAAP EPS $0.42 Beats $0.22 Estimate, Sales $852.00M Beat $844.08M Estimate", "summary": "", "symbols": ["CART"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920782/maplebear-q3-2024-gaap-eps-0-42-beats-0-22-estimate-sales-852-00m-beat-844-08m-estimate", "tags": ["earnings"]}
{"id": 41920788, "time": "2024-11-12 16:35:47", "headline": "Rivian And Volkswagen Group Launch Joint Venture With Total Deal Size Of Up To $5.8B", "summary": "", "symbols": ["RIVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920788/rivian-and-volkswagen-group-launch-joint-venture-with-total-deal-size-of-up-to-5-8b", "tags": ["contract"]}
{"id": 41920803, "time": "2024-11-12 16:35:48", "headline": "Direct Digital Holdings Q3 EPS $(0.71) Misses $0.13 Estimate, Sales $9.07M Miss $59.70M Estimate", "summary": "", "symbols": ["DRCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920803/direct-digital-holdings-q3-eps-0-71-misses-0-13-estimate-sales-9-07m-miss-59-70m-estimate", "tags": ["earnings"]}
{"id": 41920804, "time": "2024-11-12 16:35:52", "headline": "Maplebear Sees Q4 2024 GTV $8.5B-$8.65B; Sees Adj. EBITDA $230M-$240M", "summary": "", "symbols": ["CART"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920804/maplebear-sees-q4-2024-gtv-8-5b-8-65b-sees-adj-ebitda-230m-240m", "tags": []}
{"id": 41920802, "time": "2024-11-12 16:35:54", "headline": "ICU Medical Updates FY24 Adj EPS Outlook From $4.95 - $5.35 To $5.40 -$5.70, Est $5.22", "summary": "", "symbols": ["ICUI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920802/icu-medical-updates-fy24-adj-eps-outlook-from-4-95-5-35-to-5-40-5-70-est-5-22", "tags": ["earnings", "guidance"]}
{"id": 41920806, "time": "2024-11-12 16:36:00", "headline": "SHF Hldgs Q3 EPS $0.01 Up From $(0.02) YoY, Sales $3.48M Down From $4.33M YoY", "summary": "", "symbols": ["SHFS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920806/shf-hldgs-q3-eps-0-01-up-from-0-02-yoy-sales-3-48m-down-from-4-33m-yoy", "tags": ["earnings"]}
{"id": 41920799, "time": "2024-11-12 16:36:34", "headline": "Biote Q3 EPS $0.33 Beats $0.09 Estimate, Sales $51.38M Inline", "summary": "", "symbols": ["BTMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920799/biote-q3-eps-0-33-beats-0-09-estimate-sales-51-38m-inline", "tags": ["earnings"]}
{"id": 41920809, "time": "2024-11-12 16:36:50", "headline": "Babcock & Wilcox Q3 Adj $(0.16) Up From $(0.18) YoY, Sales $209.90M Miss $229.72M Estimate", "summary": "", "symbols": ["BW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920809/babcock-wilcox-q3-adj-0-16-up-from-0-18-yoy-sales-209-90m-miss-229-72m-estimate", "tags": []}
{"id": 41920812, "time": "2024-11-12 16:37:01", "headline": "Hyperfine Q3 2024 GAAP EPS $(0.14), Inline, Sales $3.643M Beat $3.297M Estimate", "summary": "", "symbols": ["HYPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920812/hyperfine-q3-2024-gaap-eps-0-14-inline-sales-3-643m-beat-3-297m-estimate", "tags": ["earnings"]}
{"id": 41920820, "time": "2024-11-12 16:37:05", "headline": "Grove Collaborative Hldgs Lowers FY2024 Sales Guidance from $205.00M-$215.00M to $200.00M-$205.00M", "summary": "", "symbols": ["GROV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920820/grove-collaborative-hldgs-lowers-fy2024-sales-guidance-from-205-00m-215-00m-to-200-00m-205-00m", "tags": ["guidance"]}
{"id": 41920822, "time": "2024-11-12 16:37:08", "headline": "SI-BONE Q3 2024 GAAP EPS $(0.16) Beats $(0.24) Estimate, Sales $40.340M Miss $40.498M Estimate", "summary": "", "symbols": ["SIBN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920822/si-bone-q3-2024-gaap-eps-0-16-beats-0-24-estimate-sales-40-340m-miss-40-498m-estimate", "tags": ["earnings"]}
{"id": 41920868, "time": "2024-11-12 16:37:20", "headline": "Ensysce Biosciences Q3 2024 GAAP EPS $0.07 Beats $(0.29) Estimate, Sales $3.40M Beat $250.00K Estimate", "summary": "", "symbols": ["ENSC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920868/ensysce-biosciences-q3-2024-gaap-eps-0-07-beats-0-29-estimate-sales-3-40m-beat-250-00k-estimate", "tags": ["earnings"]}
{"id": 41920863, "time": "2024-11-12 16:38:02", "headline": "OmniAb Sees FY24 Cash Balance $50M-$60M", "summary": "", "symbols": ["OABI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920863/omniab-sees-fy24-cash-balance-50m-60m", "tags": []}
{"id": 41920960, "time": "2024-11-12 16:38:11", "headline": "SI-Bone Sees FY24 Worldwide Revenue $165M-$166M Vs Prior $165M-$167M; Expects To Be Adj. EBITDA Positive In Q4", "summary": "", "symbols": ["SIBN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920960/si-bone-sees-fy24-worldwide-revenue-165m-166m-vs-prior-165m-167m-expects-to-be-adj-ebitda-positive-i", "tags": ["earnings"]}
{"id": 41920956, "time": "2024-11-12 16:38:15", "headline": "Quanterix Reaffirms  2024 Revenue Guidance Range Of $134M - $138M, Est $136.23M", "summary": "", "symbols": ["QTRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920956/quanterix-reaffirms-2024-revenue-guidance-range-of-134m-138m-est-136-23m", "tags": ["earnings", "guidance"]}
{"id": 41920964, "time": "2024-11-12 16:38:31", "headline": "Hudson Pacific Sees Q4 2024 FFO $0.09-$0.13 Vs $0.12 Estimate", "summary": "", "symbols": ["HPP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920964/hudson-pacific-sees-q4-2024-ffo-0-09-0-13-vs-0-12-estimate", "tags": []}
{"id": 41920837, "time": "2024-11-12 16:38:38", "headline": "CXApp Q3 2024 Adj. EPS $(0.29) Misses $(0.24) Estimate, Sales $1.897M Beat $1.800M Estimate", "summary": "", "symbols": ["CXAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920837/cxapp-q3-2024-adj-eps-0-29-misses-0-24-estimate-sales-1-897m-beat-1-800m-estimate", "tags": ["earnings"]}
{"id": 41920955, "time": "2024-11-12 16:38:39", "headline": "Spotify Stock Climbs Despite Q3 EPS, Revenue Misses", "summary": "Spotify reported its third-quarter results after Tuesday&#39;s closing bell. Here&#39;s a look at the key figures from the quarter.", "symbols": ["SPOT"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/general/entertainment/24/11/41920955/spotify-stock-climbs-despite-q3-eps-revenue-misses", "tags": ["earnings"]}
{"id": 41920930, "time": "2024-11-12 16:38:48", "headline": "Rocket Pharmaceuticals To Present Updated Data From The Phase 1 Clinical Trial Of RP-A501 For Danon Disease At The American Heart Association's 2024 Late-Breaking Science Sessions", "summary": "", "symbols": ["RCKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41920930/rocket-pharmaceuticals-to-present-updated-data-from-the-phase-1-clinical-trial-of-rp-a501-for-dan", "tags": ["fda"]}
{"id": 41920974, "time": "2024-11-12 16:38:57", "headline": "Zevra Therapeutics Q3 2024 GAAP EPS $(0.69) Misses $(0.42) Estimate, Sales $3.695M Miss $4.869M Estimate", "summary": "", "symbols": ["ZVRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920974/zevra-therapeutics-q3-2024-gaap-eps-0-69-misses-0-42-estimate-sales-3-695m-miss-4-869m-estimate", "tags": ["earnings"]}
{"id": 41920965, "time": "2024-11-12 16:39:36", "headline": "Fate Therapeutics Q3 EPS $(0.40) Beats $(0.42) Estimate, Sales $3.07M Beat $1.32M Estimate", "summary": "", "symbols": ["FATE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920965/fate-therapeutics-q3-eps-0-40-beats-0-42-estimate-sales-3-07m-beat-1-32m-estimate", "tags": ["earnings"]}
{"id": 41920966, "time": "2024-11-12 16:39:48", "headline": "Spotify 3Q Total Premium Subscribers 252M", "summary": "", "symbols": ["SPOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920966/spotify-3q-total-premium-subscribers-252m", "tags": []}
{"id": 41920979, "time": "2024-11-12 16:39:59", "headline": "American Healthcares Q3 Sales $523.81M Beat $485.38M Estimate", "summary": "", "symbols": ["AHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41920979/american-healthcares-q3-sales-523-81m-beat-485-38m-estimate", "tags": []}
{"id": 41920987, "time": "2024-11-12 16:40:03", "headline": "Crinetics Expects That Its Cash & Equivalents To Be Sufficient To Fund Its Current Operating Plan Into 2029", "summary": "", "symbols": ["CRNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41920987/crinetics-expects-that-its-cash-equivalents-to-be-sufficient-to-fund-its-current-operating-plan-into", "tags": []}
{"id": 41921027, "time": "2024-11-12 16:40:22", "headline": "Mach Natural Resources Q3 Sales $256.000M Miss $264.818M Estimate", "summary": "", "symbols": ["MNR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921027/mach-natural-resources-q3-sales-256-000m-miss-264-818m-estimate", "tags": []}
{"id": 41921030, "time": "2024-11-12 16:40:22", "headline": "DHI Group Q3 2024 Adj. EPS $0.05 Beats $0.03 Estimate, Sales $35.283M Beat $35.270M Estimate", "summary": "", "symbols": ["DHX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921030/dhi-group-q3-2024-adj-eps-0-05-beats-0-03-estimate-sales-35-283m-beat-35-270m-estimate", "tags": ["earnings"]}
{"id": 41921041, "time": "2024-11-12 16:40:35", "headline": "Kezar Life Sciences Q3 EPS $(2.78) Beats $(3.10) Estimate", "summary": "", "symbols": ["KZR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921041/kezar-life-sciences-q3-eps-2-78-beats-3-10-estimate", "tags": ["earnings"]}
{"id": 41921046, "time": "2024-11-12 16:40:49", "headline": "Legacy Housing Q3 2024 GAAP EPS $0.65 Beats $0.57 Estimate, Sales $44.300M Miss $48.023M Estimate", "summary": "", "symbols": ["LEGH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921046/legacy-housing-q3-2024-gaap-eps-0-65-beats-0-57-estimate-sales-44-300m-miss-48-023m-estimate", "tags": ["earnings"]}
{"id": 41921048, "time": "2024-11-12 16:40:52", "headline": "Hallador Energy Q3 2024 GAAP EPS $0.04 Beats $(0.10) Estimate, Sales $105.044M Miss $117.100M Estimate", "summary": "", "symbols": ["HNRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921048/hallador-energy-q3-2024-gaap-eps-0-04-beats-0-10-estimate-sales-105-044m-miss-117-100m-estimate", "tags": ["earnings"]}
{"id": 41921044, "time": "2024-11-12 16:40:54", "headline": "American Healthcare REIT Sees FY24 NFFO $1.40-$1.43", "summary": "", "symbols": ["AHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921044/american-healthcare-reit-sees-fy24-nffo-1-40-1-43", "tags": []}
{"id": 41921060, "time": "2024-11-12 16:41:11", "headline": "Airgain Sees Q4 Adj EPS $0.02 vs $0.02 Est; Sees Sales $16.200M-$18.200M vs $17.20M Est", "summary": "", "symbols": ["AIRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921060/airgain-sees-q4-adj-eps-0-02-vs-0-02-est-sees-sales-16-200m-18-200m-vs-17-20m-est", "tags": ["earnings"]}
{"id": 41921072, "time": "2024-11-12 16:41:21", "headline": "Prothena Continues To Expect 2024 Net Cash Used In Operating And Investing Actives To Be $148M - $160M And Expects To End Year With $468M (Midpoint) In Cash, Cash Equivalents And Restricted Cash", "summary": "", "symbols": ["PRTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921072/prothena-continues-to-expect-2024-net-cash-used-in-operating-and-investing-actives-to-be-148m-160m-a", "tags": []}
{"id": 41921081, "time": "2024-11-12 16:41:32", "headline": "Olema Pharmaceuticals Q3 EPS $(0.60) Misses $(0.57) Estimate", "summary": "", "symbols": ["OLMA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921081/olema-pharmaceuticals-q3-eps-0-60-misses-0-57-estimate", "tags": ["earnings"]}
{"id": 41921094, "time": "2024-11-12 16:42:01", "headline": "Southland Holdings Q3 2024 Adj EPS $(1.14) May Not Compare To $(0.09) Estimate, Sales $173.30M May Not Compare To $303.92M Estimate", "summary": "", "symbols": ["SLND"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921094/southland-holdings-q3-2024-adj-eps-1-14-may-not-compare-to-0-09-estimate-sales-173-30m-may-not-comp", "tags": ["earnings"]}
{"id": 41921112, "time": "2024-11-12 16:42:20", "headline": "Evolution Petroleum Q1 2025 Adj. EPS $0.02 Misses $0.04 Estimate, Sales $21.896M Miss $22.038M Estimate", "summary": "", "symbols": ["EPM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921112/evolution-petroleum-q1-2025-adj-eps-0-02-misses-0-04-estimate-sales-21-896m-miss-22-038m-estimate", "tags": ["earnings"]}
{"id": 41921119, "time": "2024-11-12 16:42:26", "headline": "Eledon Pharma Q3 EPS $(0.32) Misses $(0.30) Estimate", "summary": "", "symbols": ["ELDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921119/eledon-pharma-q3-eps-0-32-misses-0-30-estimate", "tags": ["earnings"]}
{"id": 41921127, "time": "2024-11-12 16:42:38", "headline": "Under the Radar - Karat Packaging $KRT", "summary": " ", "symbols": [], "source": "benzinga", "author": "Tim Melvin", "url": "https://www.benzinga.com/24/11/41921127/under-the-radar-karat-packaging-krt", "tags": []}
{"id": 41921175, "time": "2024-11-12 16:42:57", "headline": "Energy Vault Holdings Q3 2024 GAAP EPS $(0.18) Misses $(0.15) Estimate, Sales $1.199M Miss $13.402M Estimate", "summary": "", "symbols": ["NRGV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921175/energy-vault-holdings-q3-2024-gaap-eps-0-18-misses-0-15-estimate-sales-1-199m-miss-13-402m-estimate", "tags": ["earnings"]}
{"id": 41921177, "time": "2024-11-12 16:43:00", "headline": "WM Tech Q3 2024 GAAP EPS $0.03 Misses $0.04 Estimate, Sales $46.552M Beat $44.450M Estimate", "summary": "", "symbols": ["MAPS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921177/wm-tech-q3-2024-gaap-eps-0-03-misses-0-04-estimate-sales-46-552m-beat-44-450m-estimate", "tags": ["earnings"]}
{"id": 41921233, "time": "2024-11-12 16:43:30", "headline": "Erasca Q3 EPS $(0.11) Beats $(0.18) Estimate", "summary": "", "symbols": ["ERAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921233/erasca-q3-eps-0-11-beats-0-18-estimate", "tags": ["earnings"]}
{"id": 41921242, "time": "2024-11-12 16:43:39", "headline": "Nuvve Holding Q3 EPS $(2.47) Up From $(108.00) YoY, Sales $1.92M Down From $2.71M YoY", "summary": "", "symbols": ["NVVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921242/nuvve-holding-q3-eps-2-47-up-from-108-00-yoy-sales-1-92m-down-from-2-71m-yoy", "tags": ["earnings"]}
{"id": 41921352, "time": "2024-11-12 16:43:51", "headline": "Grid Dynamics Holdings Announced The Launch Of A Proposed Underwritten Public Offering Of 5,000,000 Shares Of Its Common Stock; Price Not Disclosed", "summary": "", "symbols": ["GDYN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921352/grid-dynamics-holdings-announced-the-launch-of-a-proposed-underwritten-public-offering-of-5-000-000", "tags": ["offering"]}
{"id": 41921267, "time": "2024-11-12 16:43:52", "headline": "New Jersey Makes History, Offers Medical Marijuana As Employee Benefit", "summary": "New Jersey sets a precedent by adding medical cannabis to government health plans, offering employee benefits for the first time in the U.S.", "symbols": [], "source": "benzinga", "author": "Rolando Garc\u00eda", "url": "https://www.benzinga.com/24/11/41921267/new-jersey-is-making-history-by-offering-medical-cannabis-as-employee-benefit", "tags": ["offering"]}
{"id": 41921361, "time": "2024-11-12 16:44:00", "headline": "NGL Energy Partners Q2 Sales $1.35B Miss $1.56B Estimate", "summary": "", "symbols": ["NGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921361/ngl-energy-partners-q2-sales-1-35b-miss-1-56b-estimate", "tags": []}
{"id": 41921376, "time": "2024-11-12 16:44:03", "headline": "GrowGeneration Affirms FY2024 Sales Guidance from $190.00M-195.00M to $190.00M-$195.00M", "summary": "", "symbols": ["GRWG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921376/growgeneration-affirms-fy2024-sales-guidance-from-190-00m-195-00m-to-190-00m-195-00m", "tags": ["guidance"]}
{"id": 41921406, "time": "2024-11-12 16:44:30", "headline": "WM Tech Sees Q4 Sales $46.000M vs $44.45M Est", "summary": "", "symbols": ["MAPS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921406/wm-tech-sees-q4-sales-46-000m-vs-44-45m-est", "tags": []}
{"id": 41921410, "time": "2024-11-12 16:44:33", "headline": "Journey Medical Q3 EPS $(0.12) Beats $(0.15) Estimate, Sales $14.63M Beat $14.39M Estimate", "summary": "", "symbols": ["DERM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921410/journey-medical-q3-eps-0-12-beats-0-15-estimate-sales-14-63m-beat-14-39m-estimate", "tags": ["earnings"]}
{"id": 41921419, "time": "2024-11-12 16:44:47", "headline": "Astrotech Q4 EPS $(2.01) Down From $(1.41) YoY, Sales $34.00K", "summary": "", "symbols": ["ASTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921419/astrotech-q4-eps-2-01-down-from-1-41-yoy-sales-34-00k", "tags": ["earnings"]}
{"id": 41921427, "time": "2024-11-12 16:44:58", "headline": "BeautyHealth Cuts FY24 Net Sales Outlook From $325M \u2013 $345M To $322M \u2013 $332M, Est $331.57M", "summary": "", "symbols": ["SKIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921427/beautyhealth-cuts-fy24-net-sales-outlook-from-325m-345m-to-322m-332m-est-331-57m", "tags": ["guidance"]}
{"id": 41921451, "time": "2024-11-12 16:45:18", "headline": "Lyra Therapeutics Q3 2024 GAAP EPS $(0.18) Beats $(0.23) Estimate, Sales $195.000K Miss $320.000K Estimate", "summary": "", "symbols": ["LYRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921451/lyra-therapeutics-q3-2024-gaap-eps-0-18-beats-0-23-estimate-sales-195-000k-miss-320-000k-estimate", "tags": ["earnings"]}
{"id": 41921460, "time": "2024-11-12 16:45:27", "headline": "GrowGeneration Q3 2024 GAAP EPS $(0.19) Misses $(0.11) Estimate, Sales $50.006M Beat $47.559M Estimate", "summary": "", "symbols": ["GRWG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921460/growgeneration-q3-2024-gaap-eps-0-19-misses-0-11-estimate-sales-50-006m-beat-47-559m-estimate", "tags": ["earnings"]}
{"id": 41921476, "time": "2024-11-12 16:45:43", "headline": "Sadot Group Q3 2024 GAAP EPS $0.23 Beats $0.20 Estimate, Sales $201.700M Beat $169.503M Estimate", "summary": "", "symbols": ["SDOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921476/sadot-group-q3-2024-gaap-eps-0-23-beats-0-20-estimate-sales-201-700m-beat-169-503m-estimate", "tags": ["earnings"]}
{"id": 41921523, "time": "2024-11-12 16:46:32", "headline": "Viant Technology Announces Acquisition Of IRIS.TV; No Financial Terms Disclosed", "summary": "", "symbols": ["DSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41921523/viant-technology-announces-acquisition-of-iris-tv-no-financial-terms-disclosed", "tags": []}
{"id": 41921541, "time": "2024-11-12 16:46:45", "headline": "Suncor Raises Divided From $0.54 To $0.57/Share", "summary": "", "symbols": ["SU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921541/suncor-raises-divided-from-0-54-to-0-57share", "tags": []}
{"id": 41921548, "time": "2024-11-12 16:46:52", "headline": "Synchronoss Technologies Raises FY2024 Sales Guidance from $170.00M-175.00M to $172.00M-$175.00M", "summary": "", "symbols": ["SNCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921548/synchronoss-technologies-raises-fy2024-sales-guidance-from-170-00m-175-00m-to-172-00m-175-00m", "tags": ["guidance"]}
{"id": 41921556, "time": "2024-11-12 16:46:59", "headline": "Cannae Holdings Q3 2024 GAAP EPS $(0.22), Inline, Sales $113.900M Beat $105.667M Estimate", "summary": "", "symbols": ["CNNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921556/cannae-holdings-q3-2024-gaap-eps-0-22-inline-sales-113-900m-beat-105-667m-estimate", "tags": ["earnings"]}
{"id": 41921564, "time": "2024-11-12 16:47:10", "headline": "Cava Group Stock Rallies On Better-Than-Expected Q3 Results: Details", "summary": "CAVA Group reported its third-quarter results after Tuesday&#39;s closing bell. Here&#39;s a look at the details from the report.", "symbols": ["CAVA"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/general/restaurants/24/11/41921564/cava-group-stock-rallies-on-better-than-expected-q3-results-details", "tags": ["earnings"]}
{"id": 41921585, "time": "2024-11-12 16:47:37", "headline": "AVITA Medical Announces Exclusive Distribution Agreement With Revolution Surgical Pty Ltd To Expand To Australia And New Zealand", "summary": "", "symbols": ["RCEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41921585/avita-medical-announces-exclusive-distribution-agreement-with-revolution-surgical-pty-ltd-to-expa", "tags": ["contract"]}
{"id": 41921600, "time": "2024-11-12 16:47:58", "headline": "QIAGEN Collaborates With McGill University On Microbiome Research; Terms Not Disclosed", "summary": "", "symbols": ["QGEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921600/qiagen-collaborates-with-mcgill-university-on-microbiome-research-terms-not-disclosed", "tags": []}
{"id": 41921622, "time": "2024-11-12 16:49:02", "headline": "SoundHound Sees FY24 Revenue $82M-$85M Vs $82.567M Est; Sees FY25 Revenue $155M-$175M.", "summary": "", "symbols": ["SOUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921622/soundhound-sees-fy24-revenue-82m-85m-vs-82-567m-est-sees-fy25-revenue-155m-175m", "tags": ["earnings"]}
{"id": 41921659, "time": "2024-11-12 16:49:07", "headline": "Biote Lowers FY2024 Sales Guidance from $200.00M-204.00M to $197.00M-$201.00M", "summary": "", "symbols": ["BTMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921659/biote-lowers-fy2024-sales-guidance-from-200-00m-204-00m-to-197-00m-201-00m", "tags": ["guidance"]}
{"id": 41921656, "time": "2024-11-12 16:49:09", "headline": "Eaton Selected By The U.S. Air Force Research Laboratory For A $3.5M Contract To Design Innovative Aerial Refueling System", "summary": "", "symbols": ["ETN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921656/eaton-selected-by-the-u-s-air-force-research-laboratory-for-a-3-5m-contract-to-design-innovative-aer", "tags": ["contract"]}
{"id": 41921608, "time": "2024-11-12 16:49:16", "headline": "DHT Holdings Says 64% Of Available VLCC Spot Days Have Been Booked At Average Rate Of $41,000 Per Day On Discharge-to-discharge Basis Thus Far in Q4", "summary": "", "symbols": ["DHT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921608/dht-holdings-says-64-of-available-vlcc-spot-days-have-been-booked-at-average-rate-of-41-000-per-day", "tags": []}
{"id": 41921704, "time": "2024-11-12 16:49:47", "headline": "Peraso Sees Q4 Sales $3.600M-$4.000M vs $4.74M Est", "summary": "", "symbols": ["PRSO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921704/peraso-sees-q4-sales-3-600m-4-000m-vs-4-74m-est", "tags": []}
{"id": 41921660, "time": "2024-11-12 16:49:58", "headline": "Syros Announces Its SELECT-MDS-1 Phase 3 Trial Of Tamibarotene Did Not Meet Its Primary Endpoint; Company to Discontinue Study, Review Full Data Set, and Evaluate Next Steps", "summary": "", "symbols": ["SYRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41921660/syros-announces-its-select-mds-1-phase-3-trial-of-tamibarotene-did-not-meet-its-primary-endpoint-", "tags": ["fda"]}
{"id": 41921710, "time": "2024-11-12 16:50:03", "headline": "Energous Q3 2024 GAAP EPS $(0.50) Beats $(0.74) Estimate, Sales $230.000K Miss $300.000K Estimate", "summary": "", "symbols": ["WATT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921710/energous-q3-2024-gaap-eps-0-50-beats-0-74-estimate-sales-230-000k-miss-300-000k-estimate", "tags": ["earnings"]}
{"id": 41921705, "time": "2024-11-12 16:50:16", "headline": "Mobile Infrastructure Q3 EPS $(0.06) Up From $(1.77) YoY, Sales $9.76M Up From $8.06M YoY", "summary": "", "symbols": ["BEEP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921705/mobile-infrastructure-q3-eps-0-06-up-from-1-77-yoy-sales-9-76m-up-from-8-06m-yoy", "tags": ["earnings"]}
{"id": 41921707, "time": "2024-11-12 16:50:18", "headline": "Interparfums Sees FY24 Net Sales ~$1.45B Vs $1.453B Estimate; Sees FY24 EPS ~$5.15 Vs $5.15 Estimate", "summary": "", "symbols": ["IPAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921707/interparfums-sees-fy24-net-sales-1-45b-vs-1-453b-estimate-sees-fy24-eps-5-15-vs-5-15-estimate", "tags": ["earnings"]}
{"id": 41921701, "time": "2024-11-12 16:50:19", "headline": "Surgepays Q3 2024 GAAP EPS $(0.73) Misses $(0.27) Estimate, Sales $4.770M Miss $8.642M Estimate", "summary": "", "symbols": ["SURG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921701/surgepays-q3-2024-gaap-eps-0-73-misses-0-27-estimate-sales-4-770m-miss-8-642m-estimate", "tags": ["earnings"]}
{"id": 41921717, "time": "2024-11-12 16:50:22", "headline": "Bitcoin Surpasses Silver's Market Cap In Just 15 Years\u2014Here's How Long It Took Other Giants To Reach This Milestone", "summary": "Bitcoin (CRYPTO: BTC) has reached a new milestone, surpassing the market cap of silver and becoming the world&#39;s eighth-largest asset by valuation.", "symbols": ["AMZN", "APPL", "BTCUSD", "GOOGL", "MSFT", "NVDA"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41921717/bitcoin-surpasses-silvers-market-cap-in-just-15-years-heres-how-long-it-took-other-giants-to-reach-this-milestone", "tags": []}
{"id": 41921699, "time": "2024-11-12 16:50:42", "headline": "Battalion Oil Q3 2024 Revenue $45.3M Vs $54.1M YoY", "summary": "", "symbols": ["BATL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921699/battalion-oil-q3-2024-revenue-45-3m-vs-54-1m-yoy", "tags": ["earnings"]}
{"id": 41921728, "time": "2024-11-12 16:50:42", "headline": "DallasNews Q3 EPS $(0.73) Down From $(0.26) YoY, Sales $31.14M Down From $34.50M YoY", "summary": "", "symbols": ["DALN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921728/dallasnews-q3-eps-0-73-down-from-0-26-yoy-sales-31-14m-down-from-34-50m-yoy", "tags": ["earnings"]}
{"id": 41921715, "time": "2024-11-12 16:50:48", "headline": "Mannatech Q3 EPS $(0.17) Down From $0.01 YoY, Sales $31.7M Down From $32.6M YoY", "summary": "", "symbols": ["MTEX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921715/mannatech-q3-eps-0-17-down-from-0-01-yoy-sales-31-7m-down-from-32-6m-yoy", "tags": ["earnings"]}
{"id": 41921746, "time": "2024-11-12 16:51:12", "headline": "Artiva Biotherapeutics Q3 EPS $(0.92) Misses $(0.91) Estimate", "summary": "", "symbols": ["ARTV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921746/artiva-biotherapeutics-q3-eps-0-92-misses-0-91-estimate", "tags": ["earnings"]}
{"id": 41921741, "time": "2024-11-12 16:51:33", "headline": "Interparfums Sees FY25 Net Sales ~$1.51B Vs $1.527B Estimate; Sees FY25 EPS ~$5.35 Vs $5.69 Estimate", "summary": "", "symbols": ["IPAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921741/interparfums-sees-fy25-net-sales-1-51b-vs-1-527b-estimate-sees-fy25-eps-5-35-vs-5-69-estimate", "tags": ["earnings"]}
{"id": 41921750, "time": "2024-11-12 16:51:43", "headline": "The Beachbody Company Sees Q4 Revenue $77M-$87M; Net Loss $(21M)-$(17M); Adjusted EBITDA $2M-$6M.", "summary": "", "symbols": ["BODI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921750/the-beachbody-company-sees-q4-revenue-77m-87m-net-loss-21m-17m-adjusted-ebitda-2m-6m", "tags": ["earnings"]}
{"id": 41921753, "time": "2024-11-12 16:51:47", "headline": "Cyclacel Pharmaceuticals Q3 2024 GAAP EPS $(0.18) Beats $(0.56) Estimate, Sales $10.000K Beat $5.000K Estimate", "summary": "", "symbols": ["CYCC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921753/cyclacel-pharmaceuticals-q3-2024-gaap-eps-0-18-beats-0-56-estimate-sales-10-000k-beat-5-000k-estima", "tags": ["earnings"]}
{"id": 41921806, "time": "2024-11-12 16:51:55", "headline": "Kentucky American Water Receives Approval For New Rates From Kentucky Public Service Commission Which Supports $330M In System Investments", "summary": "", "symbols": ["AWK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921806/kentucky-american-water-receives-approval-for-new-rates-from-kentucky-public-service-commission-whic", "tags": []}
{"id": 41921866, "time": "2024-11-12 16:52:05", "headline": "OncoCyte Q3 2024 Adj. EPS $(0.41) Beats $(0.44) Estimate, Sales $115.000K Miss $200.000K Estimate", "summary": "", "symbols": ["OCX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921866/oncocyte-q3-2024-adj-eps-0-41-beats-0-44-estimate-sales-115-000k-miss-200-000k-estimate", "tags": ["earnings"]}
{"id": 41921872, "time": "2024-11-12 16:52:13", "headline": "iBio Q1 EPS $(0.46) Beats $(0.48) Estimate", "summary": "", "symbols": ["IBIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921872/ibio-q1-eps-0-46-beats-0-48-estimate", "tags": ["earnings"]}
{"id": 41921876, "time": "2024-11-12 16:52:17", "headline": "Iridex Q3 EPS $(0.12) Misses $(0.09) Estimate, Sales $11.58M Miss $12.50M Estimate", "summary": "", "symbols": ["IRIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921876/iridex-q3-eps-0-12-misses-0-09-estimate-sales-11-58m-miss-12-50m-estimate", "tags": ["earnings"]}
{"id": 41921880, "time": "2024-11-12 16:52:22", "headline": "Honest Co Q3 Sales $99.237M Beat $92.684M Estimate", "summary": "", "symbols": ["HNST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921880/honest-co-q3-sales-99-237m-beat-92-684m-estimate", "tags": []}
{"id": 41921884, "time": "2024-11-12 16:52:29", "headline": "Dave Raises FY2024 Sales Guidance from $310.00M-$325.00M to $340.00M-$343.00M", "summary": "", "symbols": ["DAVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921884/dave-raises-fy2024-sales-guidance-from-310-00m-325-00m-to-340-00m-343-00m", "tags": ["guidance"]}
{"id": 41921887, "time": "2024-11-12 16:52:34", "headline": "eGain Sees Q2 Sales $22.200M-22.600M vs $22.80M Est", "summary": "", "symbols": ["EGAN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921887/egain-sees-q2-sales-22-200m-22-600m-vs-22-80m-est", "tags": []}
{"id": 41921867, "time": "2024-11-12 16:52:38", "headline": "Group 1 Automotive Board Increases Common Share Repurchase Authorization By $333M To $500M", "summary": "", "symbols": ["GPI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921867/group-1-automotive-board-increases-common-share-repurchase-authorization-by-333m-to-500m", "tags": ["buyback"]}
{"id": 41921899, "time": "2024-11-12 16:52:51", "headline": "eGain Affirms FY2025 Adj EPS Guidance from $0.17-0.20 to $0.17-0.20 vs $0.19 Est; Affirms FY2025 Sales Guidance from $92.00M-93.00M to $92.00M-93.00M vs $92.28M Est", "summary": "", "symbols": ["EGAN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921899/egain-affirms-fy2025-adj-eps-guidance-from-0-17-0-20-to-0-17-0-20-vs-0-19-est-affirms-fy2025-sales-g", "tags": ["earnings", "guidance"]}
{"id": 41921917, "time": "2024-11-12 16:53:09", "headline": "Korro Bio Q3 EPS $(2.26) Beats $(2.61) Estimate", "summary": "", "symbols": ["KRRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921917/korro-bio-q3-eps-2-26-beats-2-61-estimate", "tags": ["earnings"]}
{"id": 41921939, "time": "2024-11-12 16:53:23", "headline": "ICF International To Help Improve Grid Reliability For Department Of Energy Infrastructure Upgrades; Terms Not Disclosed", "summary": "", "symbols": ["ICFI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41921939/icf-international-to-help-improve-grid-reliability-for-department-of-energy-infrastructure-upgrades", "tags": ["analyst_up"]}
{"id": 41921991, "time": "2024-11-12 16:54:11", "headline": "Viking Therapeutics To Present Data From Phase 2b VOYAGE Study Of VK2809 In Patients With Biopsy-Confirmed NASH/MASH At 75th Liver Meeting 2024", "summary": "", "symbols": ["VKTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41921991/viking-therapeutics-to-present-data-from-phase-2b-voyage-study-of-vk2809-in-patients-with-biopsy-", "tags": []}
{"id": 41921993, "time": "2024-11-12 16:54:12", "headline": "AEye Q3 Adj $(0.70) Beats $(0.89) Estimate, Sales $104.00K Beat $100.00K Estimate", "summary": "", "symbols": ["LIDR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921993/aeye-q3-adj-0-70-beats-0-89-estimate-sales-104-00k-beat-100-00k-estimate", "tags": []}
{"id": 41921996, "time": "2024-11-12 16:54:15", "headline": "Eyenovia Q3 2024 GAAP EPS $(0.11) Beats $(0.13) Estimate, Sales $1.625K Miss $162.667K Estimate", "summary": "", "symbols": ["EYEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41921996/eyenovia-q3-2024-gaap-eps-0-11-beats-0-13-estimate-sales-1-625k-miss-162-667k-estimate", "tags": ["earnings"]}
{"id": 41922033, "time": "2024-11-12 16:54:47", "headline": "Perspective Therapeutics Q3 2024 GAAP EPS $(0.21), Inline, Sales $369.000K Beat $172.125K Estimate", "summary": "", "symbols": ["CATX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922033/perspective-therapeutics-q3-2024-gaap-eps-0-21-inline-sales-369-000k-beat-172-125k-estimate", "tags": ["earnings"]}
{"id": 41922036, "time": "2024-11-12 16:54:50", "headline": "Singular Genomics Sys Q3 EPS $(6.72) Beats $(7.86) Estimate, Sales $406.00K Miss $825.00K Estimate", "summary": "", "symbols": ["OMIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922036/singular-genomics-sys-q3-eps-6-72-beats-7-86-estimate-sales-406-00k-miss-825-00k-estimate", "tags": ["earnings"]}
{"id": 41922023, "time": "2024-11-12 16:55:00", "headline": "Groupon Q3 2024 GAAP EPS $0.33, Sales $114.500M Miss $117.886M Estimate", "summary": "", "symbols": ["GRPN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922023/groupon-q3-2024-gaap-eps-0-33-sales-114-500m-miss-117-886m-estimate", "tags": ["earnings"]}
{"id": 41922047, "time": "2024-11-12 16:55:05", "headline": "Xtant Medical Hldgs Affirms FY2024 Sales Guidance from $116.00M-120.00M to $116.00M-$120.00M", "summary": "", "symbols": ["XTNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41922047/xtant-medical-hldgs-affirms-fy2024-sales-guidance-from-116-00m-120-00m-to-116-00m-120-00m", "tags": ["guidance"]}
{"id": 41922048, "time": "2024-11-12 16:55:05", "headline": "Trading Halt: Halt status updated at 4:55:00 PM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["SYRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41922048/trading-halt-halt-status-updated-at-4-55-00-pm-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 41922070, "time": "2024-11-12 16:55:20", "headline": "Rocket Lab Q3 Earnings: Revenue Beat, EPS Beat, Continued 'Strong' Demand Growth, Multi-Launch Agreement, Air Force Award And More", "summary": "Rocket Lab reported third-quarter revenue of $104.81 million, beating the\u00a0consensus estimate\u00a0of $102.28 million.", "symbols": ["RKLB"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/general/space/24/11/41922070/rocket-lab-q3-earnings-revenue-beat-eps-beat-continued-strong-demand-growth-multi-launch-agreement-air-force-award-and-more", "tags": ["earnings", "contract"]}
{"id": 41922072, "time": "2024-11-12 16:55:21", "headline": "Ormat Technologies Announces Major EPC Contract With Contact Energy For 101MW Valued At ~$200M", "summary": "", "symbols": ["ORA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41922072/ormat-technologies-announces-major-epc-contract-with-contact-energy-for-101mw-valued-at-200m", "tags": ["contract"]}
{"id": 41922124, "time": "2024-11-12 16:56:23", "headline": "Paltalk Q3 EPS $(0.16) Misses $(0.11) Estimate, Sales $2.12M Miss $2.25M Estimate", "summary": "", "symbols": ["PALT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922124/paltalk-q3-eps-0-16-misses-0-11-estimate-sales-2-12m-miss-2-25m-estimate", "tags": ["earnings"]}
{"id": 41922128, "time": "2024-11-12 16:56:28", "headline": "Life360 Q3 EPS $0.09, Up From $(0.10) Prior Year; Revenue $92.9M, Up From $78.6M Last Year", "summary": "", "symbols": ["LIF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922128/life360-q3-eps-0-09-up-from-0-10-prior-year-revenue-92-9m-up-from-78-6m-last-year", "tags": ["earnings"]}
{"id": 41922133, "time": "2024-11-12 16:56:36", "headline": "Miller Industries Q3 2024 GAAP EPS $1.33, Inline, Sales $314.271M Beat $297.650M Estimate", "summary": "", "symbols": ["MLR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922133/miller-industries-q3-2024-gaap-eps-1-33-inline-sales-314-271m-beat-297-650m-estimate", "tags": ["earnings"]}
{"id": 41922143, "time": "2024-11-12 16:56:50", "headline": "Inseego Sees Q4 Sales $43.000M-47.000M vs $56.82M Est", "summary": "", "symbols": ["INSG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41922143/inseego-sees-q4-sales-43-000m-47-000m-vs-56-82m-est", "tags": []}
{"id": 41922155, "time": "2024-11-12 16:57:03", "headline": "Biohaven Q3 2024 Cash, Cash Equivalents As Of Oct. 2 ~$642M", "summary": "", "symbols": ["BHVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922155/biohaven-q3-2024-cash-cash-equivalents-as-of-oct-2-642m", "tags": []}
{"id": 41922179, "time": "2024-11-12 16:57:40", "headline": "Yatra Online Q2 Adj $(0.01) Beats $(0.02) Estimate, Sales $28.20M Beat $11.92M Estimate", "summary": "", "symbols": ["YTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922179/yatra-online-q2-adj-0-01-beats-0-02-estimate-sales-28-20m-beat-11-92m-estimate", "tags": []}
{"id": 41922206, "time": "2024-11-12 16:57:56", "headline": "Mach Natural Resources Q3 2024 GAAP EPS $0.70 Misses $0.81 Estimate, Sales $256.000M Miss $264.818M Estimate", "summary": "", "symbols": ["MNR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922206/mach-natural-resources-q3-2024-gaap-eps-0-70-misses-0-81-estimate-sales-256-000m-miss-264-818m-esti", "tags": ["earnings"]}
{"id": 41922220, "time": "2024-11-12 16:58:11", "headline": "Cherry Hill Mortgage Q3 2024 Adj. EPS $0.08 Misses $0.15 Estimate, Sales $109.000K", "summary": "", "symbols": ["CHMI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922220/cherry-hill-mortgage-q3-2024-adj-eps-0-08-misses-0-15-estimate-sales-109-000k", "tags": ["earnings"]}
{"id": 41922250, "time": "2024-11-12 16:58:44", "headline": "Checkpoint Therapeutics Q3 2024 GAAP EPS $(0.23) Misses $(0.16) Estimate", "summary": "", "symbols": ["CKPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922250/checkpoint-therapeutics-q3-2024-gaap-eps-0-23-misses-0-16-estimate", "tags": ["earnings"]}
{"id": 41922265, "time": "2024-11-12 16:58:50", "headline": "Life360 Says It Remains On Track To Reach Target Of Sustained Positive EBITDA In 2025; Revises 2024 Consolidated Revenue Outlook From $370M - $378M To $368M - $374M", "summary": "", "symbols": ["LIF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41922265/life360-says-it-remains-on-track-to-reach-target-of-sustained-positive-ebitda-in-2025-revises-2024-c", "tags": ["earnings", "guidance"]}
{"id": 41922296, "time": "2024-11-12 16:58:59", "headline": "ICU Medical And Otsuka Pharmaceutical Factory A Subsidiary Of Otsuka Holdings Co. Announce Creation Of A Joint Venture To Bolster IV Solutions Manufacturing And Innovation In North America", "summary": "", "symbols": ["ICUI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41922296/icu-medical-and-otsuka-pharmaceutical-factory-a-subsidiary-of-otsuka-holdings-co-announce-creatio", "tags": []}
{"id": 41922316, "time": "2024-11-12 16:59:14", "headline": "Flutter Entertainment Q3 2024 $3.248M Vs $2.558M YoY; Adj. EPS $0.43 Vs $(0.10) YoY", "summary": "", "symbols": ["FLUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41922316/flutter-entertainment-q3-2024-3-248m-vs-2-558m-yoy-adj-eps-0-43-vs-0-10-yoy", "tags": ["earnings"]}
{"id": 41922350, "time": "2024-11-12 16:59:52", "headline": "Electromed Q1 EPS $0.16 Beats $0.03 Estimate, Sales $14.67M Beat $13.50M Estimate", "summary": "", "symbols": ["ELMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922350/electromed-q1-eps-0-16-beats-0-03-estimate-sales-14-67m-beat-13-50m-estimate", "tags": ["earnings"]}
{"id": 41922391, "time": "2024-11-12 17:00:10", "headline": "Shopify Filed For Mixed Shelf; Size Not Disclosed", "summary": "", "symbols": ["SHOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41922391/shopify-filed-for-mixed-shelf-size-not-disclosed", "tags": []}
{"id": 41922499, "time": "2024-11-12 17:00:55", "headline": "OneStream Reports Commencement Of Proposed Public Offering Of 15M Shares Of Class A Common Stock; 9M Shares Offered By Selling Stockholders And 5.99M Shares By Company As Part Of Synthetic Secondary Transaction", "summary": "", "symbols": ["OS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41922499/onestream-reports-commencement-of-proposed-public-offering-of-15m-shares-of-class-a-common-stock-9m", "tags": ["offering"]}
{"id": 41922502, "time": "2024-11-12 17:00:55", "headline": "BuzzFeed Q3 EPS $0.05 Up From $(0.33) YoY, Sales $64.32M Up From $59.98M YoY", "summary": "", "symbols": ["BZFD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922502/buzzfeed-q3-eps-0-05-up-from-0-33-yoy-sales-64-32m-up-from-59-98m-yoy", "tags": ["earnings"]}
{"id": 41922506, "time": "2024-11-12 17:00:58", "headline": "'US Scrutinizes Russia Accounts UBS Took Over From Credit Suisse, Sources Say' - Reuters", "summary": "", "symbols": ["UBS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41922506/us-scrutinizes-russia-accounts-ubs-took-over-from-credit-suisse-sources-say-reuters", "tags": []}
{"id": 41922513, "time": "2024-11-12 17:01:04", "headline": "Biohaven Q3 Adj $(1.74) Misses $(1.72) Estimate", "summary": "", "symbols": ["BHVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922513/biohaven-q3-adj-1-74-misses-1-72-estimate", "tags": []}
{"id": 41922556, "time": "2024-11-12 17:01:20", "headline": "SoundHound AI Q3 Earnings: Revenue Beat, EPS Beat, 'Largest Quarter' On Record, 'Incredible' Market Enthusiasm For Conversational AI", "summary": "SoundHound reported third-quarter revenue of $25.1 million, beating the\u00a0consensus estimate\u00a0of $23.02 million.", "symbols": ["SOUN"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/earnings/24/11/41922556/soundhound-ai-q3-earnings-revenue-beat-eps-beat-largest-quarter-on-record-incredible-market-enthusiasm-for-conversational-ai", "tags": ["earnings"]}
{"id": 41922557, "time": "2024-11-12 17:01:21", "headline": "Orchestra BioMed Hldgs Q3 2024 GAAP EPS $(0.41) Beats $(0.43) Estimate, Sales $987.00K Beat $711.50K Estimate", "summary": "", "symbols": ["OBIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922557/orchestra-biomed-hldgs-q3-2024-gaap-eps-0-41-beats-0-43-estimate-sales-987-00k-beat-711-50k-estimat", "tags": ["earnings"]}
{"id": 41922579, "time": "2024-11-12 17:01:42", "headline": "Vicarious Surgical Q3 Adj $(2.87) Misses $(2.55) Estimate", "summary": "", "symbols": ["RBOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922579/vicarious-surgical-q3-adj-2-87-misses-2-55-estimate", "tags": []}
{"id": 41922597, "time": "2024-11-12 17:02:00", "headline": "Seadrill Q3 Sales $354.00M Beat $326.03M Estimate", "summary": "", "symbols": ["SDRL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922597/seadrill-q3-sales-354-00m-beat-326-03m-estimate", "tags": []}
{"id": 41922604, "time": "2024-11-12 17:02:05", "headline": "DHI Group Expect revenue for the Q4 to be down 7% to 8% year over year.", "summary": "", "symbols": ["DHX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41922604/dhi-group-expect-revenue-for-the-q4-to-be-down-7-to-8-year-over-year", "tags": ["earnings"]}
{"id": 41922611, "time": "2024-11-12 17:02:14", "headline": "MEI Pharma Q1 EPS $(1.20) Down From $8.46 YoY", "summary": "", "symbols": ["MEIP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922611/mei-pharma-q1-eps-1-20-down-from-8-46-yoy", "tags": ["earnings"]}
{"id": 41922620, "time": "2024-11-12 17:02:28", "headline": "Microvast Holdings Q3 2024 Adj. EPS $0.05 Beats $(0.07) Estimate, Sales $101.400M Beat $99.697M Estimate", "summary": "", "symbols": ["MVST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922620/microvast-holdings-q3-2024-adj-eps-0-05-beats-0-07-estimate-sales-101-400m-beat-99-697m-estimate", "tags": ["earnings"]}
{"id": 41922634, "time": "2024-11-12 17:02:44", "headline": "Seadrill Sees FY24 Adj. EBITDA $375M-$395M", "summary": "", "symbols": ["SDRL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41922634/seadrill-sees-fy24-adj-ebitda-375m-395m", "tags": []}
{"id": 41922664, "time": "2024-11-12 17:02:52", "headline": "Friedman Industries Q2 EPS $(0.10) Down From $0.48 YoY, Sales $106.80M Down From $130.75M YoY", "summary": "", "symbols": ["FRD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922664/friedman-industries-q2-eps-0-10-down-from-0-48-yoy-sales-106-80m-down-from-130-75m-yoy", "tags": ["earnings"]}
{"id": 41922679, "time": "2024-11-12 17:03:11", "headline": "Turnstone Biologics Q3 EPS $(0.74) Beats $(0.86) Estimate", "summary": "", "symbols": ["TSBX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922679/turnstone-biologics-q3-eps-0-74-beats-0-86-estimate", "tags": ["earnings"]}
{"id": 41922632, "time": "2024-11-12 17:03:13", "headline": "SilverCrest Metals Q3 2024 GAAP EPS $0.06 Misses $0.12 Estimate, Sales $80.400M Up From $63.800M YoY", "summary": "", "symbols": ["SILV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922632/silvercrest-metals-q3-2024-gaap-eps-0-06-misses-0-12-estimate-sales-80-400m-up-from-63-800m-yoy", "tags": ["earnings"]}
{"id": 41922682, "time": "2024-11-12 17:03:13", "headline": "Microvast Holdings Sees Q4 Revenue $90M-$95M", "summary": "", "symbols": ["MVST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41922682/microvast-holdings-sees-q4-revenue-90m-95m", "tags": ["earnings"]}
{"id": 41922702, "time": "2024-11-12 17:03:36", "headline": "Lisata Therapeutics Q3 EPS $(0.59) Beats $(0.75) Estimate", "summary": "", "symbols": ["LSTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922702/lisata-therapeutics-q3-eps-0-59-beats-0-75-estimate", "tags": ["earnings"]}
{"id": 41922712, "time": "2024-11-12 17:03:48", "headline": "Prestige Wealth Announced It Has Entered Into A Definitive Acquisition Agreement To Purchase Tokyo Bay Management for $1.5M", "summary": "", "symbols": ["PWM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41922712/prestige-wealth-announced-it-has-entered-into-a-definitive-acquisition-agreement-to-purchase-tokyo-b", "tags": ["contract"]}
{"id": 41922742, "time": "2024-11-12 17:04:15", "headline": "Ginkgo Bioworks Holdings Q3 EPS $(1.08) Beats $(2.71) Estimate, Sales $89.05M Beat $45.00M Estimate", "summary": "", "symbols": ["DNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922742/ginkgo-bioworks-holdings-q3-eps-1-08-beats-2-71-estimate-sales-89-05m-beat-45-00m-estimate", "tags": ["earnings"]}
{"id": 41922766, "time": "2024-11-12 17:04:36", "headline": "Oportun Financial Sees Q4 Sales $246.000M-$250.000M vs $251.08M Est", "summary": "", "symbols": ["OPRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41922766/oportun-financial-sees-q4-sales-246-000m-250-000m-vs-251-08m-est", "tags": []}
{"id": 41922768, "time": "2024-11-12 17:04:38", "headline": "Vroom Q3 2024 Total Net Loss Per Share Attributable To Common Stockholders, Basic And Diluted $(21.99) Vs $(47.38) YoY", "summary": "", "symbols": ["VRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922768/vroom-q3-2024-total-net-loss-per-share-attributable-to-common-stockholders-basic-and-diluted-21-99-", "tags": ["offering"]}
{"id": 41922792, "time": "2024-11-12 17:04:55", "headline": "Oportun Financial Narrows FY2024 Sales Guidance from $995.00M-$1.01B to $997.00M-$1.00B", "summary": "", "symbols": ["OPRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41922792/oportun-financial-narrows-fy2024-sales-guidance-from-995-00m-1-01b-to-997-00m-1-00b", "tags": ["guidance"]}
{"id": 41922814, "time": "2024-11-12 17:05:13", "headline": "Lument Finance Trust Q3 2024 Adj. EPS $0.10 Beats $0.08 Estimate, Sales $9.484M Down From $9.544M YoY", "summary": "", "symbols": ["LFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922814/lument-finance-trust-q3-2024-adj-eps-0-10-beats-0-08-estimate-sales-9-484m-down-from-9-544m-yoy", "tags": ["earnings"]}
{"id": 41922821, "time": "2024-11-12 17:05:22", "headline": "Ginkgo Bioworks Raises FY24 Revenue From $170M-$190M To $215M-$235M Vs $185.52M Est.", "summary": "", "symbols": ["DNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41922821/ginkgo-bioworks-raises-fy24-revenue-from-170m-190m-to-215m-235m-vs-185-52m-est", "tags": ["earnings"]}
{"id": 41922836, "time": "2024-11-12 17:05:28", "headline": "IN8bio Q3 EPS $(0.15) Beats $(0.16) Estimate", "summary": "", "symbols": ["INAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922836/in8bio-q3-eps-0-15-beats-0-16-estimate", "tags": ["earnings"]}
{"id": 41922840, "time": "2024-11-12 17:05:31", "headline": "Royalty Management Holding Regains Nasdaq Compliance", "summary": "", "symbols": ["RMCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41922840/royalty-management-holding-regains-nasdaq-compliance", "tags": []}
{"id": 41922919, "time": "2024-11-12 17:06:43", "headline": "Groupon Enters Agreements For $197M Financing Transactions", "summary": "", "symbols": ["GRPN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41922919/groupon-enters-agreements-for-197m-financing-transactions", "tags": []}
{"id": 41922939, "time": "2024-11-12 17:07:01", "headline": "CORRECTION: Spotify Technology Q3 EPS $1.59 Misses $1.84 Estimate, Sales $4.38B Beat $4.31B Estimate", "summary": "", "symbols": ["SPOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922939/correction-spotify-technology-q3-eps-1-59-misses-1-84-estimate-sales-4-38b-beat-4-31b-estimate", "tags": ["earnings"]}
{"id": 41922999, "time": "2024-11-12 17:07:45", "headline": "Pangaea Logistics Solns Q3 2024 Adj. EPS $0.24 Misses $0.27 Estimate, Sales $153.115M Beat $141.334M Estimate", "summary": "", "symbols": ["PANL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41922999/pangaea-logistics-solns-q3-2024-adj-eps-0-24-misses-0-27-estimate-sales-153-115m-beat-141-334m-esti", "tags": ["earnings"]}
{"id": 41923074, "time": "2024-11-12 17:08:45", "headline": "Direct Digital Holdings Sees FY2025 Sales $90.000M-110.000M vs $204.14M Est", "summary": "", "symbols": ["DRCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41923074/direct-digital-holdings-sees-fy2025-sales-90-000m-110-000m-vs-204-14m-est", "tags": []}
{"id": 41923102, "time": "2024-11-12 17:09:03", "headline": "Ingram Micro Holding Q3 Adj $0.72 Up From $0.67 YoY, Sales $11.76B Down From $11.93B YoY", "summary": "", "symbols": ["INGM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923102/ingram-micro-holding-q3-adj-0-72-up-from-0-67-yoy-sales-11-76b-down-from-11-93b-yoy", "tags": []}
{"id": 41923118, "time": "2024-11-12 17:09:21", "headline": "Westport Fuel Systems Q3 2024 GAAP EPS $(0.22) Beats $(0.37) Estimate, Sales $66.251M Miss $66.447M Estimate", "summary": "", "symbols": ["WPRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923118/westport-fuel-systems-q3-2024-gaap-eps-0-22-beats-0-37-estimate-sales-66-251m-miss-66-447m-estimate", "tags": ["earnings"]}
{"id": 41923184, "time": "2024-11-12 17:09:37", "headline": "Air T Q2 Revenue $81.2M", "summary": "", "symbols": ["AIRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923184/air-t-q2-revenue-81-2m", "tags": ["earnings"]}
{"id": 41923240, "time": "2024-11-12 17:10:48", "headline": "Suncor Energy Q3 2024 Adj EPS C$1.48 Beats C$1.09 Estimate", "summary": "", "symbols": ["SU", "TSX:SU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923240/suncor-energy-q3-2024-adj-eps-c-1-48-beats-c-1-09-estimate", "tags": ["earnings"]}
{"id": 41923258, "time": "2024-11-12 17:11:06", "headline": "Direct Digital Holdings expect FY2024 Sales $60.00M-$70.00M", "summary": "", "symbols": ["DRCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41923258/direct-digital-holdings-expect-fy2024-sales-60-00m-70-00m", "tags": []}
{"id": 41923261, "time": "2024-11-12 17:11:19", "headline": "TechTarget Q3 Adj $0.42 Beats $0.37 Estimate, Sales $58.47M Beat $58.14M Estimate", "summary": "", "symbols": ["TTGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923261/techtarget-q3-adj-0-42-beats-0-37-estimate-sales-58-47m-beat-58-14m-estimate", "tags": []}
{"id": 41923273, "time": "2024-11-12 17:11:29", "headline": "MARA Holdings Q3 Earnings: Revenue Miss; EPS Miss; 2,070 Bitcoin Mined; Energized Hash Rate Up 9%; Exahash Target 'Firmly In Sight'", "summary": "Bitcoin (CRYPTO: BTC) miner MARA Holdings Inc (NASDAQ:MARA) reported financial results for the third quarter after the close on Tuesday.", "symbols": ["BTCUSD", "MARA"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/earnings/24/11/41923273/mara-holdings-q3-earnings-revenue-miss-eps-miss-2070-bitcoin-mined-energized-hash-rate-up-9-exahash-target-firmly-in-sight", "tags": ["earnings"]}
{"id": 41923285, "time": "2024-11-12 17:12:00", "headline": "Vroom To Restructure $290M Of Unsecured Convertible Notes Into Equity", "summary": "", "symbols": ["VRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41923285/vroom-to-restructure-290m-of-unsecured-convertible-notes-into-equity", "tags": []}
{"id": 41923291, "time": "2024-11-12 17:12:16", "headline": "Synlogic Q3 EPS $(0.01) Up From $(2.57) YoY; Revenue $0 Down From $393K YoY;", "summary": "", "symbols": ["SYBX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41923291/synlogic-q3-eps-0-01-up-from-2-57-yoy-revenue-0-down-from-393k-yoy", "tags": ["earnings"]}
{"id": 41923296, "time": "2024-11-12 17:12:32", "headline": "Alto Neuroscience Q3 2024 GAAP EPS $(0.62) Beats $(0.65) Estimate", "summary": "", "symbols": ["ANRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923296/alto-neuroscience-q3-2024-gaap-eps-0-62-beats-0-65-estimate", "tags": ["earnings"]}
{"id": 41923298, "time": "2024-11-12 17:12:53", "headline": "IonQ Strengthens Technical Moat With Its Latest Series Of Issued Patents", "summary": "", "symbols": ["IONQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41923298/ionq-strengthens-technical-moat-with-its-latest-series-of-issued-patents", "tags": []}
{"id": 41923328, "time": "2024-11-12 17:13:32", "headline": "Airgain Q3 Sales $16.10M Beat $16.00M Estimate", "summary": "", "symbols": ["AIRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923328/airgain-q3-sales-16-10m-beat-16-00m-estimate", "tags": []}
{"id": 41923467, "time": "2024-11-12 17:14:23", "headline": "Kentucky First Federal Q1 EPS $0.00", "summary": "", "symbols": ["KFFB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923467/kentucky-first-federal-q1-eps-0-00", "tags": ["earnings"]}
{"id": 41923480, "time": "2024-11-12 17:14:40", "headline": "vTv Therapeutics Q3 EPS $(0.88) Up From $(3.19) YoY", "summary": "", "symbols": ["VTVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923480/vtv-therapeutics-q3-eps-0-88-up-from-3-19-yoy", "tags": ["earnings"]}
{"id": 41923529, "time": "2024-11-12 17:15:07", "headline": "Climb Bio Q3 EPS $(0.13) Up From $(0.15) YoY", "summary": "", "symbols": ["CLYM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923529/climb-bio-q3-eps-0-13-up-from-0-15-yoy", "tags": ["earnings"]}
{"id": 41923531, "time": "2024-11-12 17:15:09", "headline": "XBP Europe Holdings Q3 EPS From Cont Ops $(0.04) Up From $(0.05) YoY, Sales $35.33M Down From $37.43M YoY", "summary": "", "symbols": ["XBP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923531/xbp-europe-holdings-q3-eps-from-cont-ops-0-04-up-from-0-05-yoy-sales-35-33m-down-from-37-43m-yoy", "tags": ["earnings"]}
{"id": 41923538, "time": "2024-11-12 17:15:35", "headline": "Tempest Therapeutics Q3 EPS $(0.41) Misses $(0.35) Estimate", "summary": "", "symbols": ["TPST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923538/tempest-therapeutics-q3-eps-0-41-misses-0-35-estimate", "tags": ["earnings"]}
{"id": 41923559, "time": "2024-11-12 17:16:42", "headline": "HF Foods Group Q3 EPS $(0.07) Down From $0.03 YoY, Sales $298.39M Beat $290.07M Estimate", "summary": "", "symbols": ["HFFG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923559/hf-foods-group-q3-eps-0-07-down-from-0-03-yoy-sales-298-39m-beat-290-07m-estimate", "tags": ["earnings"]}
{"id": 41923572, "time": "2024-11-12 17:17:08", "headline": "Largo Q3 EPS $(0.16) Up From $(0.19) YoY; Q3 Sales $29.9M Down From $43.9M YoY", "summary": "", "symbols": ["LGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923572/largo-q3-eps-0-16-up-from-0-19-yoy-q3-sales-29-9m-down-from-43-9m-yoy", "tags": ["earnings"]}
{"id": 41923576, "time": "2024-11-12 17:17:17", "headline": "FibroBiologics, Inc. Reports Net Loss $8.1M For Nine Months Ended Sept. 30", "summary": "", "symbols": ["FBLG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923576/fibrobiologics-inc-reports-net-loss-8-1m-for-nine-months-ended-sept-30", "tags": []}
{"id": 41923592, "time": "2024-11-12 17:17:55", "headline": "CaliberCos Q3 EPS $0.01 Beats $(0.13) Estimate, Sales $11.30M Beat $6.19M Estimate", "summary": "", "symbols": ["CWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923592/calibercos-q3-eps-0-01-beats-0-13-estimate-sales-11-30m-beat-6-19m-estimate", "tags": ["earnings"]}
{"id": 41923595, "time": "2024-11-12 17:18:03", "headline": "CXApp Inc. Announces Availability Of AI-Driven Employee Experience Solutions On AWS Marketplace", "summary": "", "symbols": ["CXAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41923595/cxapp-inc-announces-availability-of-ai-driven-employee-experience-solutions-on-aws-marketplace", "tags": []}
{"id": 41923602, "time": "2024-11-12 17:18:36", "headline": "TSS, Inc. Announces Uplisting To The Nasdaq Capital Market, Effective With The Open Of Business On November 14, 2024", "summary": "", "symbols": ["TSSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41923602/tss-inc-announces-uplisting-to-the-nasdaq-capital-market-effective-with-the-open-of-business-on-nove", "tags": []}
{"id": 41923649, "time": "2024-11-12 17:19:42", "headline": "Gladstone Capital Announces $0.40 Supplemental Cash Distribution", "summary": "", "symbols": ["GLAD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41923649/gladstone-capital-announces-0-40-supplemental-cash-distribution", "tags": []}
{"id": 41923677, "time": "2024-11-12 17:20:10", "headline": "Willamette Valley Vineyards Diluted $(0.17) Inline YoY; Revenue $9.370M Up From $9.348M YoY", "summary": "", "symbols": ["WVVI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923677/willamette-valley-vineyards-diluted-0-17-inline-yoy-revenue-9-370m-up-from-9-348m-yoy", "tags": ["earnings", "offering"]}
{"id": 41923683, "time": "2024-11-12 17:20:13", "headline": "i-80 Gold Q3 Sales $11.51M Down From $13.21M YoY", "summary": "", "symbols": ["IAUX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923683/i-80-gold-q3-sales-11-51m-down-from-13-21m-yoy", "tags": []}
{"id": 41923694, "time": "2024-11-12 17:20:25", "headline": "Avino Silver & Gold Mines Q3 2024 Adj. EPS $0.04 Beats $0.03 Estimate, Sales $14.616M Miss $15.883M Estimate", "summary": "", "symbols": ["ASM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923694/avino-silver-gold-mines-q3-2024-adj-eps-0-04-beats-0-03-estimate-sales-14-616m-miss-15-883m-estimat", "tags": ["earnings"]}
{"id": 41923699, "time": "2024-11-12 17:20:28", "headline": "Matterport Q3 2024 Adj. EPS $(0.01), Inline, Sales $43.800M Miss $43.900M Estimate", "summary": "", "symbols": ["MTTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923699/matterport-q3-2024-adj-eps-0-01-inline-sales-43-800m-miss-43-900m-estimate", "tags": ["earnings"]}
{"id": 41923720, "time": "2024-11-12 17:21:09", "headline": "Quince Therapeutics Presents Data From Prior Phase 3 ATTeST Clinical Trial At 2024 International Congress For Ataxia Research", "summary": "", "symbols": ["QNCX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41923720/quince-therapeutics-presents-data-from-prior-phase-3-attest-clinical-trial-at-2024-international-", "tags": ["fda"]}
{"id": 41923723, "time": "2024-11-12 17:21:18", "headline": "byNordic Acquisition Extends Deadline To Complete Business Combination From Nov. 12 To Dec. 12", "summary": "", "symbols": ["BYNO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41923723/bynordic-acquisition-extends-deadline-to-complete-business-combination-from-nov-12-to-dec-12", "tags": []}
{"id": 41923861, "time": "2024-11-12 17:22:27", "headline": "Tandy Leather Factory Q3 EPS $(0.02) Down From $0.08 YoY, Sales $17.4M Down From $17.5M YoY", "summary": "", "symbols": ["TLF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923861/tandy-leather-factory-q3-eps-0-02-down-from-0-08-yoy-sales-17-4m-down-from-17-5m-yoy", "tags": ["earnings"]}
{"id": 41923863, "time": "2024-11-12 17:22:49", "headline": "Aura Biosciences Q3 EPS $(0.42) Beats $(0.45) Estimate", "summary": "", "symbols": ["AURA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923863/aura-biosciences-q3-eps-0-42-beats-0-45-estimate", "tags": ["earnings"]}
{"id": 41923867, "time": "2024-11-12 17:22:56", "headline": "Spotify Stock Climbs Despite Q3 EPS Miss, Revenue Beat (CORRECTED)", "summary": "Spotify reported its third-quarter results after Tuesday&#39;s closing bell. Here&#39;s a look at the key figures from the quarter.", "symbols": ["SPOT"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/general/entertainment/24/11/41923867/spotify-stock-climbs-despite-q3-eps-revenue-misses", "tags": ["earnings"]}
{"id": 41923878, "time": "2024-11-12 17:23:13", "headline": "Seritage Growth Props Q3 EPS $(0.41) Down From $(0.04) YoY, Sales $3.25M Down From $5.05M YoY", "summary": "", "symbols": ["SRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923878/seritage-growth-props-q3-eps-0-41-down-from-0-04-yoy-sales-3-25m-down-from-5-05m-yoy", "tags": ["earnings"]}
{"id": 41923882, "time": "2024-11-12 17:23:22", "headline": "Anitra Q3 2024 GAAP EPS $(0.17) Beats $(0.41) Estimate", "summary": "", "symbols": ["AZTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923882/anitra-q3-2024-gaap-eps-0-17-beats-0-41-estimate", "tags": ["earnings"]}
{"id": 41923884, "time": "2024-11-12 17:23:28", "headline": "Dave Q3 2024 Adj. EPS $1.51 Beats $(0.11) Estimate, Sales $73.200M Miss $80.700M Estimate", "summary": "", "symbols": ["DAVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923884/dave-q3-2024-adj-eps-1-51-beats-0-11-estimate-sales-73-200m-miss-80-700m-estimate", "tags": ["earnings"]}
{"id": 41923902, "time": "2024-11-12 17:23:58", "headline": "Azitra Q3 Revenue $0 Down From $310.70K YoY", "summary": "", "symbols": ["AZTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923902/azitra-q3-revenue-0-down-from-310-70k-yoy", "tags": ["earnings"]}
{"id": 41923928, "time": "2024-11-12 17:24:32", "headline": "Grove Collaborative Hldgs Q3 2024 GAAP EPS $(0.04) Beats $(0.13) Estimate, Sales $48.280M Miss $50.850M Estimate", "summary": "", "symbols": ["GROV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923928/grove-collaborative-hldgs-q3-2024-gaap-eps-0-04-beats-0-13-estimate-sales-48-280m-miss-50-850m-esti", "tags": ["earnings"]}
{"id": 41923930, "time": "2024-11-12 17:24:35", "headline": "ORIC Pharmaceuticals Q3 EPS $(0.49) Misses $(0.47) Estimate", "summary": "", "symbols": ["ORIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923930/oric-pharmaceuticals-q3-eps-0-49-misses-0-47-estimate", "tags": ["earnings"]}
{"id": 41923948, "time": "2024-11-12 17:25:25", "headline": "DEA Faces Lawsuit Alleging Bias In Marijuana Rescheduling Process", "summary": "Researcher David Heldreth sues DEA over alleged legal violations in marijuana rescheduling, citing bias and exclusion of small businesses and Native American tribes.", "symbols": [], "source": "benzinga", "author": "Juan Sp\u00ednelli", "url": "https://www.benzinga.com/news/legal/24/11/41923948/dea-faces-lawsuit-alleging-bias-in-marijuana-rescheduling-process", "tags": ["legal"]}
{"id": 41923976, "time": "2024-11-12 17:25:49", "headline": "TherapeuticsMD Q3 EPS $(0.05) Up From $(0.13) YoY, Sales $547.00K Up From $(53.00K) YoY", "summary": "", "symbols": ["TXMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41923976/therapeuticsmd-q3-eps-0-05-up-from-0-13-yoy-sales-547-00k-up-from-53-00k-yoy", "tags": ["earnings"]}
{"id": 41924002, "time": "2024-11-12 17:26:23", "headline": "Psychemedics Q3 EPS $(0.09) Up From $(0.36) YoY, Sales $5.20M Down From $5.70M YoY", "summary": "", "symbols": ["PMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41924002/psychemedics-q3-eps-0-09-up-from-0-36-yoy-sales-5-20m-down-from-5-70m-yoy", "tags": ["earnings"]}
{"id": 41924009, "time": "2024-11-12 17:26:48", "headline": "Serina Therapeutics Q3 EPS $0.13 Down From $0.23 YoY, Sales $14K Down From $29K YoY", "summary": "", "symbols": ["SER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41924009/serina-therapeutics-q3-eps-0-13-down-from-0-23-yoy-sales-14k-down-from-29k-yoy", "tags": ["earnings"]}
{"id": 41924022, "time": "2024-11-12 17:27:38", "headline": "BioRestorative Therapies Q3 EPS $(0.13) Beats $(0.43) Estimate, Sales $233.60K Miss $350.00K Estimate", "summary": "", "symbols": ["BRTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41924022/biorestorative-therapies-q3-eps-0-13-beats-0-43-estimate-sales-233-60k-miss-350-00k-estimate", "tags": ["earnings"]}
{"id": 41924050, "time": "2024-11-12 17:28:50", "headline": "Cargo Therapeutics Q3 EPS $(0.88) Beats $(1.15) Estimate", "summary": "", "symbols": ["CRGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41924050/cargo-therapeutics-q3-eps-0-88-beats-1-15-estimate", "tags": ["earnings"]}
{"id": 41924061, "time": "2024-11-12 17:29:39", "headline": "SunLink Health Systems Q1 EPS $(0.06), Same YoY, Sales $7.92M Down From $8.55M YoY", "summary": "", "symbols": ["SSY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41924061/sunlink-health-systems-q1-eps-0-06-same-yoy-sales-7-92m-down-from-8-55m-yoy", "tags": ["earnings"]}
{"id": 41924077, "time": "2024-11-12 17:30:33", "headline": "TeraWulf Stock Tumbles After Worse-Than-Expected Q3 Results", "summary": "TeraWulf Inc. (NASDAQ:WULF) reported its third-quarter results after Tuesday&#39;s closing bell. Here&#39;s a look at the details from the report.\u00a0\u00a0", "symbols": ["BTCUSD", "WULF"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/24/11/41924077/terawulf-stock-tumbles-after-worse-than-expected-q3-results", "tags": ["earnings"]}
{"id": 41924078, "time": "2024-11-12 17:30:35", "headline": "Adams Resources & Energy Q3 2024 GAAP EPS $(1.76) Misses $(0.28) Estimate, Sales $695.163M Beat $654.996M Estimate", "summary": "", "symbols": ["AE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41924078/adams-resources-energy-q3-2024-gaap-eps-1-76-misses-0-28-estimate-sales-695-163m-beat-654-996m-esti", "tags": ["earnings"]}
{"id": 41924088, "time": "2024-11-12 17:30:42", "headline": "Guardian Pharmacy Service Q3 2024 GAAP EPS $(2.00) Misses $0.21 Estimate, Sales $314.39M Beat $303.16M Estimate", "summary": "", "symbols": ["GRDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41924088/guardian-pharmacy-service-q3-2024-gaap-eps-2-00-misses-0-21-estimate-sales-314-39m-beat-303-16m-est", "tags": ["earnings"]}
{"id": 41924230, "time": "2024-11-12 17:31:47", "headline": "Guardian Pharmacy Services Sees FY24 Revenue $1.205B-$1.215B Vs $1.191B Estimate;  Sees Adj. EBITDA $86.5M-$87M", "summary": "", "symbols": ["GRDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41924230/guardian-pharmacy-services-sees-fy24-revenue-1-205b-1-215b-vs-1-191b-estimate-sees-adj-ebitda-86-5m", "tags": ["earnings"]}
{"id": 41924234, "time": "2024-11-12 17:32:07", "headline": "Terns Pharma Q3 EPS $(0.28) Beats $(0.34) Estimate", "summary": "", "symbols": ["TERN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41924234/terns-pharma-q3-eps-0-28-beats-0-34-estimate", "tags": ["earnings"]}
{"id": 41924235, "time": "2024-11-12 17:32:12", "headline": "Bolt Biotherapeutics Q3 2024 GAAP EPS $(0.40) Misses $(0.35) Estimate, Sales $1.141M Miss $1.263M Estimate", "summary": "", "symbols": ["BOLT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41924235/bolt-biotherapeutics-q3-2024-gaap-eps-0-40-misses-0-35-estimate-sales-1-141m-miss-1-263m-estimate", "tags": ["earnings"]}
{"id": 41924239, "time": "2024-11-12 17:32:38", "headline": "Aris Mining Q3 2024 Adj. EPS $0.08 Misses $0.14 Estimate, Sales $131.577M Miss $138.440M Estimate", "summary": "", "symbols": ["ARMN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41924239/aris-mining-q3-2024-adj-eps-0-08-misses-0-14-estimate-sales-131-577m-miss-138-440m-estimate", "tags": ["earnings"]}
{"id": 41924254, "time": "2024-11-12 17:33:03", "headline": "Oriental Culture Holding H1 EPS $(0.28) Up From $(0.50) YoY, Sales $0.447M Down From $0.799M YoY", "summary": "", "symbols": ["OCG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41924254/oriental-culture-holding-h1-eps-0-28-up-from-0-50-yoy-sales-0-447m-down-from-0-799m-yoy", "tags": ["earnings"]}
{"id": 41924270, "time": "2024-11-12 17:35:10", "headline": "Occidental Petroleum Shares Steady After Mixed Q3 Results", "summary": "Occidental Petroleum reported its third-quarter results after Tuesday&#39;s closing bell. Here&#39;s a look at the key figures from the quarter.", "symbols": ["OXY"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/24/11/41924270/occidental-petroleum-shares-steady-after-mixed-q3-results", "tags": ["earnings"]}
{"id": 41924324, "time": "2024-11-12 17:36:12", "headline": "Calidi Biotherapeutics Q3 2024 GAAP EPS $(0.65) Beats $(0.85) Estimate", "summary": "", "symbols": ["CLDI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41924324/calidi-biotherapeutics-q3-2024-gaap-eps-0-65-beats-0-85-estimate", "tags": ["earnings"]}
{"id": 41924367, "time": "2024-11-12 17:37:20", "headline": "Nerdy Reveals Receipt Of Non-Compliance Notice From NYSE On November 12", "summary": "", "symbols": ["NRDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41924367/nerdy-reveals-receipt-of-non-compliance-notice-from-nyse-on-november-12", "tags": []}
{"id": 41924406, "time": "2024-11-12 17:38:54", "headline": "Orla Mining Q3 2024 Adj EPS $0.06 Misses $0.08 Estimate, Sales $99.31M Beat $80.39M Estimate", "summary": "", "symbols": ["ORLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41924406/orla-mining-q3-2024-adj-eps-0-06-misses-0-08-estimate-sales-99-31m-beat-80-39m-estimate", "tags": ["earnings"]}
{"id": 41924428, "time": "2024-11-12 17:40:29", "headline": "Faraday Future Subsidiary Faraday X Signs Definitive Agreements Relating To Two Planned Products With Top Original Equipment Manufacturers", "summary": "", "symbols": ["FFIE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41924428/faraday-future-subsidiary-faraday-x-signs-definitive-agreements-relating-to-two-planned-products-wit", "tags": []}
{"id": 41924463, "time": "2024-11-12 17:41:49", "headline": "Tradepulse Power Inflow Alert: Eli Lilly & Company Moves Up Over 13 Points After Signal", "summary": " ", "symbols": ["LLY"], "source": "benzinga", "author": "Finit", "url": "https://www.benzinga.com/signals/24/11/41924463/tradepulse-power-inflow-alert-eli-lilly-company-moves-up-over-13-points-after-signal", "tags": []}
{"id": 41924466, "time": "2024-11-12 17:42:01", "headline": "Nuvei Q3 Adj $0.34 Misses $0.50 Estimate, Sales $357.62M Beat $336.98M Estimate", "summary": "", "symbols": ["NVEI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41924466/nuvei-q3-adj-0-34-misses-0-50-estimate-sales-357-62m-beat-336-98m-estimate", "tags": []}
{"id": 41924510, "time": "2024-11-12 17:43:52", "headline": "Jack In The Box Reveals Return Of Lance Tucker As CFO, Effective January 13, 2025; Tucker Served As Its CFO From March 2018 To July 2020", "summary": "", "symbols": ["JACK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41924510/jack-in-the-box-reveals-return-of-lance-tucker-as-cfo-effective-january-13-2025-tucker-served-as-its", "tags": ["management"]}
{"id": 41924766, "time": "2024-11-12 17:46:17", "headline": "KORE's Previously Issued Unaudited Condensed Consolidated Financial Statements Contained Within The Quarterly Report On Form 10-Q For The Quarter Ended June 30, 2024 Should No Longer Be Relied Upon Due To Errors In Computing A Non-cash Goodwill Impairment Charge; Company To Restate Q2 2024 Financial Statements; No Impact To Revenues, Cash Flows Or Adjusted EBITDA Expected For The Period Affected", "summary": "", "symbols": ["KORE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41924766/kores-previously-issued-unaudited-condensed-consolidated-financial-statements-contained-within-the-", "tags": []}
{"id": 41924407, "time": "2024-11-12 17:38:59", "headline": "MultiSensor AI  Q3 EPS $(0.34) Misses $(0.02) Estimate, Sales $1.60M Up From $1.50M YoY", "summary": "", "symbols": ["MSAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41924407/infrared-cameras-holdings-q3-eps-0-34-misses-0-02-estimate-sales-1-60m-up-from-1-50m-yoy", "tags": ["earnings"]}
{"id": 41924795, "time": "2024-11-12 17:48:03", "headline": "KORE Group Rescheduling The Release Of The Company's Financial Results For Q3 2024 And Live Webcast To Discuss Those Results From Previously Scheduled November 13, 2024 At 5pm ET To November 19, 2024 At The Same Time", "summary": "", "symbols": ["KORE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41924795/kore-group-rescheduling-the-release-of-the-companys-financial-results-for-q3-2024-and-live-webcast-t", "tags": []}
{"id": 41924869, "time": "2024-11-12 17:50:11", "headline": "SKYX Platforms Q3 EPS $(0.08) Beats $(0.09) Estimate, Sales $22.17M Miss $23.41M Estimate", "summary": "", "symbols": ["SKYX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41924869/skyx-platforms-q3-eps-0-08-beats-0-09-estimate-sales-22-17m-miss-23-41m-estimate", "tags": ["earnings"]}
{"id": 41924871, "time": "2024-11-12 17:50:27", "headline": "Nauticus Robotics Q3 EPS $(4.24) Up From $(15.46) YoY, Sales $370.19K Down From $1.59M YoY", "summary": "", "symbols": ["KITT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41924871/nauticus-robotics-q3-eps-4-24-up-from-15-46-yoy-sales-370-19k-down-from-1-59m-yoy", "tags": ["earnings"]}
{"id": 41924879, "time": "2024-11-12 17:51:32", "headline": "Phoenix New Media Expected Q4 2024 revenue: RMB 197.9 - 212.9 million.", "summary": "", "symbols": ["FENG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41924879/phoenix-new-media-expected-q4-2024-revenue-rmb-197-9-212-9-million", "tags": ["earnings"]}
{"id": 41924889, "time": "2024-11-12 17:52:06", "headline": "Chegg Stock Slips After Q3 Results, 21% Workforce Reduction, Weak Q4 Guidance", "summary": "Chegg shares are down after the company reported its third-quarter results after Tuesday&#39;s closing bell. Here&#39;s a look at the details from the report.", "symbols": ["CHGG"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/general/education/24/11/41924889/chegg-stock-slips-after-q3-results-21-workforce-reduction-weak-q4-guidance", "tags": ["earnings", "guidance"]}
{"id": 41925022, "time": "2024-11-12 17:53:04", "headline": "New Jersey Enforces Hemp THC Ban, Delays Cannabis Lounge Approvals", "summary": "NJ enforces hemp THC ban, targeting synthetic cannabinoids, while cannabis lounge approvals face delays, frustrating retailers and investors.", "symbols": [], "source": "benzinga", "author": "Patricio Liddle", "url": "https://www.benzinga.com/government/regulations/24/11/41925022/new-jersey-enforces-hemp-thc-ban-delays-cannabis-lounge-approvals", "tags": []}
{"id": 41925096, "time": "2024-11-12 17:56:15", "headline": "Cannabis Delivery Giant Eaze Rises From Ashes: How $10M Funding Could Power Its Comeback", "summary": "California&#39;s largest cannabis delivery service Eaze is making a comeback.Eaze Technologies Inc., which recently announced it will be ceasing operation by the year will be reorganized as Eaze Inc..The company announced on Tuesday $10 million in series B funding following the acquisition of select assets from Eaze Technologies.", "symbols": [], "source": "benzinga", "author": "Jelena Martinovic", "url": "https://www.benzinga.com/markets/cannabis/24/11/41925096/cannabis-delivery-giant-eaze-rises-from-ashes-how-10m-funding-could-power-its-comeback", "tags": []}
{"id": 41925143, "time": "2024-11-12 17:57:48", "headline": "Rumble Q3 Earnings: Revenue Miss, EPS Miss, Monthly Active Users Jump To 67M, Election Night 'Broke Records'", "summary": "Rumble shares are trading lower in Tuesday&#39;s after-hours session on the heels of the company&#39;s third-quarter financial results. Here&#39;s a rundown of the report.", "symbols": ["RUM"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/general/social-media/24/11/41925143/rumble-q3-earnings-revenue-miss-eps-miss-monthly-active-users-jump-to-67m-election-night-broke-records", "tags": ["earnings", "why_moving"]}
{"id": 41925195, "time": "2024-11-12 18:00:01", "headline": "Eupraxia Reports Additional Clinical Data From Its RESOLVE Phase 1b/2a Trial; Says Higher Dosing Levels Are Yielding Improved Patient Responses", "summary": "", "symbols": ["EPRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41925195/eupraxia-reports-additional-clinical-data-from-its-resolve-phase-1b2a-trial-says-higher-dosing-level", "tags": ["fda"]}
{"id": 41925261, "time": "2024-11-12 18:01:55", "headline": "Rocket Shares Fall After Q3 Revenue Miss: Details", "summary": "Rocket Companies reported its third-quarter results after Tuesday&#39;s closing bell. Here&#39;s a look at the key figures from the quarter.", "symbols": ["RKT"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/24/11/41925261/rocket-shares-fall-after-q3-revenue-miss-details", "tags": ["earnings"]}
{"id": 41925267, "time": "2024-11-12 18:02:12", "headline": "Nano Dimension Shareholder Murchinson Urges Shareholders To Support Its Proposals And Elect Its Nominees At  2024 Annual Meeting", "summary": "", "symbols": ["NNDM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41925267/nano-dimension-shareholder-murchinson-urges-shareholders-to-support-its-proposals-and-elect-its-nomi", "tags": []}
{"id": 41924462, "time": "2024-11-12 17:41:42", "headline": "Rivian Stock Races Higher After The Bell: What's Going On?", "summary": "Rivian Automotive shares are moving higher in Tuesday&#39;s after-hours session after the company announced the launch of its joint venture with Volkswagen Group.", "symbols": ["RIVN"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/contracts/24/11/41924462/rivian-stock-races-higher-after-the-bell-whats-going-on", "tags": ["why_moving"]}
{"id": 41925328, "time": "2024-11-12 18:04:55", "headline": "XChange TEC.INC Receives Nasdaq Notice On Non-Compliance With Requirement To Maintain Minimum Bid Price", "summary": "", "symbols": ["XHG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41925328/xchange-tec-inc-receives-nasdaq-notice-on-non-compliance-with-requirement-to-maintain-minimum-bid-pr", "tags": []}
{"id": 41925571, "time": "2024-11-12 18:21:14", "headline": "Walker & Dunlop Secures $113M Acquisition Financing For Class-A Property In Bay Area", "summary": "", "symbols": ["WD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41925571/walker-dunlop-secures-113m-acquisition-financing-for-class-a-property-in-bay-area", "tags": []}
{"id": 41925574, "time": "2024-11-12 18:21:59", "headline": "Techprecision Q1 EPS $(0.16) Down From $(0.06) YoY, Sales $7.99M Up From $7.37M YoY", "summary": "", "symbols": ["TPCS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41925574/techprecision-q1-eps-0-16-down-from-0-06-yoy-sales-7-99m-up-from-7-37m-yoy", "tags": ["earnings"]}
{"id": 41925800, "time": "2024-11-12 18:39:49", "headline": "Urgency, Debate Mark COP29 As Leaders Push For Carbon Market Rules, Worry About Trump", "summary": "Global leaders gather at COP29 to address climate change, carbon market mechanisms, and climate finance. Urgency and controversy at a fossil fuel reliant host country, but focus on establishing rules for a global carbon market.", "symbols": ["F", "FAN", "ICLN", "SHEL", "TAK", "TAN", "VWAGY"], "source": "benzinga", "author": "Stjepan Kalinic", "url": "https://www.benzinga.com/news/global/24/11/41925800/urgency-debate-mark-cop29-as-leaders-push-for-carbon-market-rules-worry-about-trump", "tags": []}
{"id": 41925928, "time": "2024-11-12 18:46:31", "headline": "Weedmaps Net Income Surges 312% YOY, Cash Reserves Up 31%", "summary": "Weedmaps Q3 2024 results: WM Technology reports 312% net income growth, stable revenue at $46.6M, and a 31% rise in cash reserves.", "symbols": ["MAPS"], "source": "benzinga", "author": "Patricio Liddle", "url": "https://www.benzinga.com/news/earnings/24/11/41925928/weedmaps-net-income-surges-312-yoy-cash-reserves-up-31", "tags": ["earnings"]}
{"id": 41926301, "time": "2024-11-12 19:15:19", "headline": "Sustainable Investment Under Trump: 'Performance Matters Far More Than Politics,' JPMorgan Analyst Says", "summary": "JPMorgan analyst Virgina Martin Heriz weighs in on the potential impacts of a second Trump presidency on sustainable investing.\u00a0", "symbols": ["BLNK", "CHPT", "EVGO", "FCEL", "FSLR", "NOVA", "PLUG", "RUN"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/government/regulations/24/11/41926301/sustainable-investment-under-trump-performance-matters-far-more-than-politics-jpmorgan-analyst-says", "tags": []}
{"id": 41926584, "time": "2024-11-12 19:32:46", "headline": "Chamath Palihapitiya Says Cut The Federal Budget By Trillions And Then Do This With A 'Fraction' Of The Money To 'Make America Great Again'", "summary": "Chamath Palihapitiya proposed on X to cut trillions from the federal budget for nationwide internet access, aligning with Trump&#39;s and Musk&#39;s cost-cutting goals after Trump&#39;s 2024 win.", "symbols": [], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/24/11/41926584/chamath-palihapitiya-says-cut-the-federal-budget-by-trillions-and-then-do-this-with-a-fraction-of-the-money-to-make-america-great-again", "tags": []}
{"id": 41926735, "time": "2024-11-12 19:50:03", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["ACAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41926735/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 41926736, "time": "2024-11-12 19:50:03", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["ACABU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41926736/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 41926737, "time": "2024-11-12 19:50:04", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["ACABW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41926737/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 41927099, "time": "2024-11-12 20:16:57", "headline": "Safe Harbor Financial's $3.3M Comeback: Turning Losses Into Profit Despite Revenue Drop", "summary": "&#34;Our strategic priorities focused on innovation, operational excellence, and client service,&#34; said CEO Sundie Seefried.", "symbols": ["SHFS"], "source": "benzinga", "author": "Nicol\u00e1s Jose Rodriguez", "url": "https://www.benzinga.com/news/earnings/24/11/41927099/safe-harbor-financials-3-3m-comeback-turning-losses-into-profit-despite-revenue-drop", "tags": ["earnings", "management"]}
{"id": 41927135, "time": "2024-11-12 20:20:27", "headline": "Greg Brockman Returns To Work At ChatGPT's Parent Company: 'Back To Building OpenAI'", "summary": "OpenAI co-founder Greg Brockman has resumed his role after a three-month leave, returning during a time of notable executive departures and a soaring valuation of $157 billion.", "symbols": ["MSFT"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/tech/24/11/41927135/greg-brockman-returns-to-work-at-chatgpts-parent-company-back-to-building-openai", "tags": []}
{"id": 41927289, "time": "2024-11-12 20:35:56", "headline": "Trump Appoints Elon Musk And Vivek Ramaswamy To Lead 'DOGE,' Aiming to Slash Bureaucracy And $6.5 Trillion Federal Spending: 'We Will Not Go Gently'", "summary": "President-elect Donald Trump announced Tuesday his plan to appoint Tesla Inc (NASDAQ:TSLA) CEO Elon Musk and former presidential candidate Vivek Ramaswamy to lead a new Department of Government Efficiency (DOGE), aimed at restructuring fede", "symbols": ["DOGEUSD", "TSLA"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/news/global/24/11/41927289/trump-appoints-elon-musk-and-vivek-ramaswamy-to-lead-doge-targeting-bureaucracy-and-65-trillion-federal-spending-we-will-not-go-gently", "tags": ["management"]}
{"id": 41927291, "time": "2024-11-12 20:36:18", "headline": "MARA Holdings, SoundHound AI, Spotify, Rivian, Tesla: Why These 5 Stocks Are On Investors' Radars Today", "summary": "On Tuesday, the U.S. stock market ended the day on a lower note, with the Dow Jones index dropping by more than 380 points. The Dow traded down 0.9% to 43,910.98, while the NASDAQ fell slightly by 0.1% to 19,281.40. The S&amp;P 500 also experienced a dip, falling 0.3% to 5,983.99.", "symbols": ["BTCUSD", "MARA", "RIVN", "SOUN", "SPOT", "TSLA"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/24/11/41927291/mara-holdings-soundhound-ai-spotify-rivian-tesla-why-these-5-stocks-are-on-investors-radars-today", "tags": []}
{"id": 41927379, "time": "2024-11-12 20:45:14", "headline": "Elon Musk Says The 'Prophecy Has Been Fulfilled' \u2014 Peanut The Squirrel-Themed Meme Coin Spikes 11%", "summary": "Tech mogul Elon Musk invoked a six-year-old meme to highlight how pet squirrel \u2018Peanut&#39;s&#39; death changed the course of the 2024 U.S. elections, causing the price of the associated meme coin to jump 11%.\n\n\n\nWhat happened: In an X post on Tuesday night, Musk wrote, &#34;The prophecy has been fulfilled,&#34; responding to an old Reddit post about squirrels.", "symbols": ["SOLUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41927379/elon-musk-says-the-prophecy-has-been-fulfilled-peanut-the-squirrel-themed-meme-coin-spikes-11", "tags": []}
{"id": 41927913, "time": "2024-11-12 21:31:56", "headline": "Amazon Confirms Vendor Data Breach Affecting 2.8M+ Employee Contacts, Adds To Growing List Of MOVEit Hack Victims (UPDATED)", "summary": "Amazon confirmed a data breach via a third-party vendor tied to the MOVEit hack, compromising employee contact information and highlighting risks associated with third-party vulnerabilities.", "symbols": ["AMZN"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/media/24/11/41927913/amazon-confirms-vendor-data-breach-affecting-2-8m-employee-contacts-adds-to-growing-list-of-moveit-hack-victims", "tags": []}
{"id": 41927985, "time": "2024-11-12 21:45:47", "headline": "Bitcoin, Ethereum Consolidate, Dogecoin Surges As Election Rally Takes A Breather: Analyst Says Pullback 'Typical' For Healthy Market", "summary": "Leading cryptocurrencies cooled down from their blistering election run Tuesday, although Bitcoin briefly hit the $90,000 milestone.", "symbols": ["BTC", "BTCUSD", "DOGEUSD", "ETHUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41927985/bitcoin-ethereum-consolidate-dogecoin-surges-as-election-rally-takes-a-breather-analyst-says-pullback-typical-for-healthy-market", "tags": []}
{"id": 41928036, "time": "2024-11-12 21:52:56", "headline": "Indigenous Cannabis Summit: Experts To Discuss Hemp, PTSD And Sustainability", "summary": " ", "symbols": [], "source": "benzinga", "author": "Nina Zdinjak", "url": "https://www.benzinga.com/news/events/24/11/41928036/indigenous-cannabis-summit-experts-to-discuss-hemp-ptsd-and-sustainability", "tags": []}
{"id": 41928049, "time": "2024-11-12 21:55:04", "headline": "Apple's New AI Wall Tablet With Siri And Video Calling Set To Challenge Amazon And Google In Smart Home Race", "summary": "Apple plans to launch a new AI-powered wall tablet, codenamed J490, by March 2025, positioning it to compete with Amazon and Google in the smart home market with features like video calling, appliance control, and Siri integration.", "symbols": ["AAPL", "AMZN", "GOOG", "GOOGL"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/media/24/11/41928049/apples-new-ai-wall-tablet-with-siri-and-video-calling-set-to-challenge-amazon-and-google-in-smart-home-race", "tags": []}
{"id": 41925770, "time": "2024-11-12 18:35:19", "headline": "Three Paths To Cannabis Profits: Village Farms, Green Thumb, And Jushi Show Divergent Strategies\u2014Which Will Deliver?", "summary": "Cannabis giants Village Farms, Green Thumb, and Jushi Holdings show distinct strategies for navigating a challenging landscape.\u00a0", "symbols": ["GTBIF", "JUSH", "VFF"], "source": "benzinga", "author": "Nicol\u00e1s Jose Rodriguez", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41925770/three-paths-to-cannabis-profits-village-farms-green-thumb-and-jushi-show-divergent-", "tags": []}
{"id": 41928127, "time": "2024-11-12 22:12:33", "headline": "Jim Cramer Says Eli Lilly's 'Pathetic' Stock Performance Could Get A Breather If Amgen Has Hidden Bone Risk Data After 7% Stock Drop", "summary": "Amgen Inc.&#39;s stock dropped over 7% on Tuesday following revelations about bone density loss in early trials of its experimental obesity drug MariTide, while CNBC&#39;s Jim Cramer suggested the news could benefit rival Eli Lilly And Co.", "symbols": ["AMGN", "LLY", "NVO"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/general/health-care/24/11/41928127/jim-cramer-says-eli-lillys-pathetic-stock-performance-could-get-a-breather-if-amgen-has-hidden-bone-risk-data-after-7-stock-drop", "tags": []}
{"id": 41928272, "time": "2024-11-12 22:40:17", "headline": "Cathie Wood-Led Ark Sees Boost For Bitcoin, Crypto Under Trump Administration, Says IPO Window For Circle, Kraken Could Reopen", "summary": "Asset management giant\u00a0Ark Invest was optimistic about the positive impact of the incoming Donald Trump administration on the cryptocurrency industry in the U.S.", "symbols": ["ARKB", "BTCUSD", "USDC", "USDCUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/24/11/41928272/cathie-woods-ark-invest-foresees-crypto-industry-boost-under-incoming-trump-administration", "tags": []}
{"id": 41928562, "time": "2024-11-12 23:18:46", "headline": "Tesla Falls 6% As Hedge Funds Carry Out 'Trump Trade' Rebalancing, Gary Black Says President-Elect Could Help Secure Robotaxi Approvals", "summary": "Black noted that Tesla&#39;s forward earnings estimates have remained largely unchanged, with fiscal year 2025 and 2029 projections increasing by less than 1%.", "symbols": ["TSLA"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/news/global/24/11/41928562/tesla-falls-6-as-hedge-funds-carry-out-trump-trade-rebalancing-gary-black-says-president-elect-could-help-secure-robotaxi-approvals", "tags": ["earnings"]}
{"id": 41928817, "time": "2024-11-12 23:40:08", "headline": "Bonk, Floki Drive Meme Coin Gains As Dogecoin, Shiba Inu Take Back Seat", "summary": "Dog-themed meme coins topped the price charts Tuesday, with the lesser-known ones outperforming the heavyweights.\u00a0", "symbols": ["BONKUSD", "DOGEUSD", "ETHUSD", "FLOKIUSD", "SHIBUSD", "SOL", "SOLUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41928817/bonk-floki-drive-meme-coin-gains-as-dogecoin-shiba-inu-take-back-seat", "tags": []}
{"id": 41928832, "time": "2024-11-12 23:44:07", "headline": "Anthropic CEO Says AI Similar To Human Intelligence Could Be Around The Corner: 'We'll Get There By 2026 Or 2027'", "summary": "Anthropic CEO Dario Amodei forecasts that AGI could emerge by 2026-2027, but warns that factors like data limitations and geopolitical issues might hinder progress.", "symbols": [], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/tech/24/11/41928832/anthropic-ceo-says-ai-similar-to-human-intelligence-could-be-around-the-corner-well-get-there-by-2026-or-2027", "tags": ["management"]}
{"id": 41910180, "time": "2024-11-12 15:16:57", "headline": "EXCLUSIVE: Chris Christie Says Trump Will Remove Federal Restrictions On Marijuana, Find 'Sweet Spot' For Crypto Regulation (UPDATED)", "summary": "Chris Christie sees Trump descheduling cannabis and easing crypto regulation. Here&#39;s what it could mean for investors and business owners alike.", "symbols": [], "source": "benzinga", "author": "Javier Hasse", "url": "https://www.benzinga.com/markets/cannabis/24/11/41910180/exclusive-chris-christie-says-trump-will-remove-federal-restrictions-on-marijuana-find-sweet-spot-for-crypto-regulation", "tags": []}
{"id": 41915099, "time": "2024-11-12 13:48:28", "headline": "Cannabis Stocks Pop Following Chris Christie's Prediction That Trump Will Deschedule Cannabis", "summary": "Cannabis stocks rally on prediction of Trump descheduling marijuana; MSOS leads gains with a 15% surge, followed by Cronos at nearly 13%.", "symbols": ["CRON", "ISPR", "MJ", "MSOS", "OGI", "TLRY", "VFF", "YOLO"], "source": "benzinga", "author": "Rolando Garc\u00eda", "url": "https://www.benzinga.com/government/regulations/24/11/41915099/cannabis-stocks-pop-following-chris-christies-prediction-that-trump-will-deschedule-cannabis", "tags": []}
{"id": 41919071, "time": "2024-11-12 16:09:34", "headline": "12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session", "summary": "Editor&#39;s note:\u00a0A previous iteration of this article stated that GEN Restaurant Gr (NASDAQ:GENK) market cap was $49.1 million. The article has been corrected to reflect their correct market cap at the time of publication, which was $341.1 million.\n\n\u00a0", "symbols": ["AMBO", "BQ", "EVGO", "FWRG", "GENK", "NIU", "PC", "PIK", "RMBL", "SYPR", "TKLF", "WKHS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/11/41919071/12-consumer-discretionary-stocks-moving-in-tuesdays-pre-market-session", "tags": ["why_moving"]}
{"id": 41911007, "time": "2024-11-12 11:45:38", "headline": "Coal Market Analysis: Investment Opportunities in a Misunderstood Sector - Benzinga Edge Interview", "summary": " ", "symbols": [], "source": "benzinga", "author": "Tim Melvin", "url": "https://www.benzinga.com/24/11/41911007/coal-market-analysis-investment-opportunities-in-a-misunderstood-sector", "tags": []}
{"id": 41910283, "time": "2024-11-12 11:26:45", "headline": "Understanding Market Dynamics with Louis Navellier - Benzinga Edge Interview", "summary": " ", "symbols": [], "source": "benzinga", "author": "Tim Melvin", "url": "https://www.benzinga.com/opinion/24/11/41910283/understanding-market-dynamics-with-louis-navellier", "tags": []}
{"id": 41905720, "time": "2024-11-12 10:00:13", "headline": "XRP Rises More Than 14% In 24 hours", "summary": "XRP&#39;s (CRYPTO: XRP) price has increased 14.34% over the past 24 hours to $0.67. Over the past week, XRP has experienced an uptick of over 27.0%, moving from $0.51 to its current price.  As it stands right now, the coin&#39;s all-time high is $3.40. ", "symbols": ["XRPUSD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/cryptocurrency/24/11/41905720/test0-5628740131992409-xrp-rises-more-than-14-in-24-hours", "tags": []}
